AASDHPPT
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
AASDHPPT; aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase; L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase; AASD PPT; CGI 80; LYS5; 4 phosphopantetheinyl transferase; 4-phosphopantetheinyl transferase; AASD-PPT; ADPPT_HUMAN; Alpha aminoadipic semialdehyde dehydrogenase phosphopantetheinyl transferase; Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase; HAH P; LYS2; LYS5 ortholog; CGI-80;
ABL1
c-abl oncogene 1, non-receptor tyrosine kinase
ABL1; c-abl oncogene 1, non-receptor tyrosine kinase; ABL; JTK7; p150; c-ABL; v-abl; c-ABL1; bcr/abl; tyrosine-protein kinase ABL1; proto-oncogene c-Abl; bcr/c-abl oncogene protein; Abelson tyrosine-protein kinase 1; c-abl oncogene 1, receptor tyrosine kinase; proto-oncogene tyrosine-protein kinase ABL1; v-abl Abelson murine leukemia viral oncogene homolog 1;
ACY1
aminoacylase 1
ACY1; aminoacylase 1; aminoacylase-1; acylase; N-acyl-L-amino-acid amidohydrolase; ACY-1; ACY1D;
ADAT1
adenosine deaminase, tRNA-specific 1
ADAT1; adenosine deaminase, tRNA-specific 1; tRNA-specific adenosine deaminase 1; adenosine deaminase acting on tRNA; tRNA-specific adenosine-37 deaminase; HADAT1;
ADAT2
adenosine deaminase, tRNA-specific 2
ADAT2; adenosine deaminase, tRNA-specific 2; adenosine deaminase, tRNA specific 2, TAD2 homolog (S. cerevisiae) , DEADC1, deaminase domain containing 1; tRNA-specific adenosine deaminase 2; dJ20N2.1; TAD2; tRNA specific adenosine deaminase 2 homolog (S.;
ADK
adenosine kinase
ADK; adenosine kinase; adenosine 5 phosphotransferase; AK; 5033405D03Rik; AI255373; AI987814; MGC6593; 2310026J05Rik; ADK_HUMAN; OTTHUMP00000019864; OTTHUMP00000019865; adenosine 5-phosphotransferase;
AES
amino-terminal enhancer of split
AES; amino-terminal enhancer of split; GRG; ESP1; GRG5; TLE5; AES-1; AES-2; gp130-associated protein GAM;
AGR2
anterior gradient 2 homolog (Xenopus laevis)
AGR2; anterior gradient 2 homolog (Xenopus laevis); anterior gradient protein 2 homolog; AG2; HAG 2; PDIA17; protein disulfide isomerase family A; member 17; XAG 2; AG-2; HPC8; anterior gradient homolog 2; secreted cement gland homolog; secreted cement gl;
AGT
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
AGT; angiotensinogen (serpin peptidase inhibitor, clade A, member 8); ANHU; SERPINA8;
AGXT
alanine-glyoxylate aminotransferase
AGXT; alanine-glyoxylate aminotransferase; SPAT; serine--pyruvate aminotransferase; AGT; AGT1; AGXT1; glycolicaciduria; L alanine: glyoxylate aminotransferase 1; oxalosis I; PH1; primary hyperoxaluria type 1; serine:pyruvate aminotransferase; SPT; serine-;
AHCY
adenosylhomocysteinase
AHCY; adenosylhomocysteinase; S adenosylhomocysteine hydrolase; SAHH; adoHcyase; S-adenosylhomocysteine hydrolase; S-adenosyl-L-homocysteine hydrolase;
AIMP1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
AIMP1; aminoacyl tRNA synthetase complex-interacting multifunctional protein 1; p43; EMAP2; SCYE1; EMAPII; aminoacyl tRNA synthase complex-interacting multifunctional protein 1; OTTHUMP00000161877; OTTHUMP00000161878; OTTHUMP00000219673; ARS-interacting multifunctional protein 1; endothelial monocyte-activating polypeptide 2; multisynthase complex auxiliary component p43; endothelial-monocyte activating polypeptide II; multisynthetase complex auxiliary component p43; small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating); AIMP1/p43; 9830137A06Rik;
ALAS2
aminolevulinate, delta-, synthase 2
ALAS2; aminolevulinate, delta-, synthase 2; aminolevulinate, delta , synthase 2 (sideroblastic/hypochromic anemia) , ASB; 5-aminolevulinate synthase, erythroid-specific, mitochondrial; sideroblastic/hypochromic anemia; 5-aminolevulinic acid synthase; ALAS E; ALASE; ANH1; Delta aminolevulinate synthase; FLJ93603; OTTMUSP00000020679; XLSA; 5 @aminolevulinate synthase erythroid specific; 5 aminolevulinic acid synthase 2; 5-aminolevulinate synthase 2; 5-aminolevulinate synthase; Alas 2; ALAS; ALAS, erythroid; Aminolevulinic acid synthase 2, erythroid; ASB; Delta ALA synthase 2; Delta ALA synthetase; Delta aminolevulinate synthase 2; Erythroid specific ALAS; OTTHUMP00000023388; OTTHUMP00000023389; RP23-338A17.1; XLDPP; OTTHUMP00000204081; delta-ALA synthase 2; delta-ALA synthetase; 5-aminolevulinic acid synthase 2; delta-aminolevulinate synthase 2; XLEPP; ALAS-E;
AMD1
adenosylmethionine decarboxylase 1
AMD1; adenosylmethionine decarboxylase 1; S adenosylmethionine decarboxylase 1; S-adenosylmethionine decarboxylase proenzyme; SAMDC; S-adenosylmethionine decarboxylase 1; AMD; ADOMETDC; FLJ26964; DKFZp313L1234;
Anpep
alanyl (membrane) aminopeptidase
APN; CD13; LAP1; P150; PEPN; GP150; ANPEP; minopeptidase N; AP-M; AP-N; hAPN; aminopeptidase M; OTTHUMP00000194690; alanyl aminopeptidase; microsomal aminopeptidase; myeloid plasma membrane glycoprotein CD13;
ASS1
argininosuccinate synthase 1
ASS1; argininosuccinate synthase 1; argininosuccinate synthase; Argininosuccinate synthetase 1; ASS; Ass-1; ASSA; ASSY_HUMAN; Citrulline aspartate ligase; Citrulline--aspartate ligase; CTLN1; citrullinemia;
AUH
AU RNA binding protein/enoyl-CoA hydratase
AUH; AU RNA binding protein/enoyl-CoA hydratase; AU RNA binding protein/enoyl Coenzyme A hydratase , AU RNA binding protein/enoyl Coenzyme A hydratase; methylglutaconyl-CoA hydratase, mitochondrial; 3 methylglutaconyl CoA hydratase; AU binding protein/enoyl CoA hydratase; AU RNA binding protein/enoyl CoA hydratase; AU RNA binding protein/enoyl Coenzyme A hydratase; AU specific RNA binding enoyl CoA hydratase; Methylglutaconyl CoA hydratase; Methylglutaconyl CoA hydratase mitochondrial; MGA Type I; OTTHUMP00000021631; OTTHUMP00000021632; 3-methylglutaconyl-CoA hydratase; AU-binding protein/Enoyl-CoA hydratase; AU-specific RNA-binding enoyl-CoA hydratase; AU RNA binding protein/enoyl-Coenzyme A hydratase; AU RN;
BAG1
BCL2-associated athanogene
BAG1; BCL2-associated athanogene; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-binding protein; receptor-associated protein, 46-KD; Bcl-2 associating athanogene-1 protein; glucocortoid receptor-associated protein RAP46; HAP; RAP46;
BAG2
BCL2-associated athanogene 2
BAG2; BCL2-associated athanogene 2; BAG family molecular chaperone regulator 2; bcl-2-associated athanogene 2; BAG-family molecular chaperone regulator-2; dJ417I1.2 (BAG-family molecular chaperone regulator 2); BAG-2; dJ417I1.2; KIAA0576; MGC149462;
BAG3
BCL2-associated athanogene 3
BAG3; BCL2-associated athanogene 3; BIS; MFM6; BAG-3; CAIR-1; BAG family molecular chaperone regulator 3; docking protein CAIR-1; BCL2-binding athanogene 3; bcl-2-binding protein Bis;
BAMBI
BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)
BAMBI; BMP and activin membrane-bound inhibitor homolog (Xenopus laevis); BMP and activin membrane-bound inhibitor homolog; NMA; BAMBI_HUMAN; BMP and activin membrane bound inhibitor homolog; Non metastatic gene A protein; Non-metastatic gene A protein; Putative transmembrane protein NMA; OTTHUMP00000019384;
BCAS2
breast carcinoma amplified sequence 2
BCAS2; breast carcinoma amplified sequence 2; pre-mRNA-splicing factor SPF27; DAM1; Snt309; SPF27; DNA amplified in mammary carcinoma 1 protein; Spliceosome associated protein SPF 27; Breast carcinoma-amplified sequence 2; MGC7712; Pre mRNA splicing factor SPF27; SPF27_HUMAN; Spliceosome associated protein amplified in breast cancer; Spliceosome-associated protein SPF 27; OTTHUMP00000013668; spliceosome associated protein, amplified in breast cancer;
BMX
BMX non-receptor tyrosine kinase
BMX; BMX non-receptor tyrosine kinase; cytoplasmic tyrosine-protein kinase BMX; ETK; PSCTK3; NTK38 tyrosine kinase; Etk/Bmx cytosolic tyrosine kinase; epithelial and endothelial tyrosine kinase; bone marrow tyrosine kinase gene in chromosome X protein; PS;
CEACAM1
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
CEACAM1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); BGP; carcinoembryonic antigen-related cell adhesion molecule 1; BGP1; CD66a; antigen CD66; CD66a antigen; BGPI; Arcitumomab; CEA-Scan; 154361-48-5;
CEACAM3
carcinoembryonic antigen-related cell adhesion molecule 3
CEACAM3; carcinoembryonic antigen-related cell adhesion molecule 3; CGM1; CD66d; CD66d antigen; carcinoembryonic antigen CGM1; nonspecific cross-reacting antigen; carcinoembryonic antigen gene family member 1; CEA; W264; W282; CD66D; MGC119875;
CEACAM5
carcinoembryonic antigen-related cell adhesion molecule 5
CEACAM5; carcinoembryonic antigen-related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100; DKFZp781M2392;
CEACAM6
CEACAM6 carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
CEACAM6; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); NCA; CEAL; CD66c; carcinoembryonic antigen-related cell; CD66c antigen; Non-specific crossreacting antigen; carcinoembryonic antigen-related cell; adhesion molecule 6; Sulesomab; LeukoScan; 167747-19-5;
CEACAM8
carcinoembryonic antigen-related cell adhesion molecule 8
CEACAM8; carcinoembryonic antigen-related cell adhesion molecule 8; CGM6; CD66b; CD67 antigen; carcinoembryonic antigen CGM6; non-specific cross-reacting antigen NCA-95; carcinoembryonic antigen gene family member 6; CD67; NCA-95;
CFL1
cofilin 1 (non-muscle)
CFL1; cofilin 1 (non-muscle); CFL; HEL-S-15; cofilin-1; p18; 18 kDa phosphoprotein; cofilin, non-muscle isoform; epididymis secretory protein Li 15;
ClpB
ClpB caseinolytic peptidase B homolog (E. coli)
CLPB;ClpB caseinolytic peptidase B homolog (E. coli);caseinolytic peptidase B protein homolog;FLJ13152;HSP78;SKD3;suppressor of potassium transport defect 3;
CMPK1
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
CMPK1; cytidine monophosphate (UMP-CMP) kinase 1, cytosolic; CMPK, cytidylate kinase; UMP-CMP kinase; Cytidine monophosphate kinase; UMP CMP kinase; UMP CMPK; UMP/CMP kinase; cytidylate kinase; deoxycytidylate kinase; uridine monophosphate kinase; uridin;
CRABP1
cellular retinoic acid binding protein 1
CRABP1; cellular retinoic acid binding protein 1; cellular retinoic acid binding protein 1 , RBP5; cellular retinoic acid-binding protein 1; CRABP; CRABP I; CRABPI; cellular retinoic acid-binding protein I; RBP5; CRABP-I;
CRABP2
cellular retinoic acid binding protein 2
CRABP2; cellular retinoic acid binding protein 2; cellular retinoic acid-binding protein 2; CRABP II; Cellular retinoic acid binding protein II; Cellular retinoic acid-binding protein II; CRABP-II; CRABPII; RABP2_HUMAN; RBP6; OTTHUMP00000038730; OTTHUMP00000038732;
CROT
carnitine O-octanoyltransferase
CROT; carnitine O-octanoyltransferase; peroxisomal carnitine O-octanoyltransferase; COT; Carnitine O octanoyltransferase; OCTC_HUMAN; Peroxisomal carnitine acyltransferase; Peroxisomal carnitine O octanoyltransferase; OTTHUMP00000161500; OTTHUMP00000205461; OTTHUMP00000205463;
CRYZL1
crystallin, zeta (quinone reductase)-like 1
CRYZL1; crystallin, zeta (quinone reductase)-like 1; quinone oxidoreductase-like protein 1; 4P11; QOH 1; quinone reductase like 1; Protein 4P11; QOH-1; QOH1; QORL1_HUMAN; Quinone oxidoreductase homolog 1; Quinone oxidoreductase like 1; Zeta crystallin homolog; Zeta-crystallin homolog; quinone reductase-like 1;
CXADR
coxsackie virus and adenovirus receptor
CXADR; coxsackie virus and adenovirus receptor; coxsackievirus and adenovirus receptor; CAR; HCVADR; CVB3-binding protein; coxsackievirus B-adenovirus receptor; 46 kD coxsackievirus and adenovirus receptor (CAR) protein; HCAR; CAR4/6;
DAO
D-amino-acid oxidase
DAO; D-amino-acid oxidase; DAMOX; DAAO; DAO1; EC 1.4.3.3; MGC35381; OXDA; OXDA_HUMAN; D-amino acid oxidase;
Dcc
deleted in colorectal carcinoma
DCC; deleted in colorectal carcinoma; netrin receptor DCC; IGDCC1; immunoglobulin superfamily; DCC subclass; member 1; colorectal tumor suppressor; colorectal cancer suppressor; tumor suppressor protein DCC; deleted in colorectal cancer protein; immunoglobulin superfamily DCC subclass member 1; immunoglobulin superfamily, DCC subclass, member 1; CRC18; CRCR1;
DDAH1
Dimethylarginine Dimethylaminohydrolase 1
DDAH1; N(G),N(G)-dimethylarginine dimethylaminohydrolase 1; DDAHI; DDAH-1; dimethylargininase-1; NG, NG-dimethylarginine dimethylaminohydrolase; EC 3.5.3.18; OTTHUMP00000012304; FLJ2553; FLJ21264; dimethylarginine dimethylaminohydrolase 1;
DDC
dopa decarboxylase (aromatic L-amino acid decarboxylase)
DDC; dopa decarboxylase (aromatic L-amino acid decarboxylase); aromatic-L-amino-acid decarboxylase; AADC;
DECR1
2,4-dienoyl CoA reductase 1, mitochondrial
DECR1; 2,4-dienoyl CoA reductase 1, mitochondrial; DECR; 2,4-dienoyl-CoA reductase, mitochondrial; SDR18C1; short chain dehydrogenase/reductase family 18C; member 1; 4-enoyl-CoA reductase; short chain dehydrogenase/reductase family 18C, member 1; NADPH;
DNER
delta/notch-like EGF repeat containing
DNER; delta/notch-like EGF repeat containing; delta and Notch-like epidermal growth factor-related receptor; bet; UNQ26; Brain EGF repeat-containing transmembrane protein; Bret; Delta/notch-like EGF-related receptor; DNER_HUMAN; Transmembrane protein Bet; H_NH0150O02.1; OTTHUMP00000204223; WUGSC:H_NH0150O02.1; delta-notch-like EGF repeat-containing transmembrane;
ECH1
enoyl CoA hydratase 1, peroxisomal
ECH1; enoyl CoA hydratase 1, peroxisomal; enoyl Coenzyme A hydratase 1, peroxisomal; delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial; HPXEL; dienoyl-CoA isomerase; peroxisomal enoyl-CoA hydratase 1; delta3,5-delta2,4-dienoyl-CoA isomerase;
ECHS1
enoyl CoA hydratase, short chain, 1, mitochondrial
ECHS1; enoyl CoA hydratase, short chain, 1, mitochondrial; enoyl Coenzyme A hydratase, short chain, 1, mitochondrial; enoyl-CoA hydratase, mitochondrial; SCEH; C80529; EC 4.2.1.17; ECHS 1; Enoyl CoA hydratase 1; Enoyl CoA hydratase mitochondrial; Enoyl CoA hydratase short chain 1 mitochondrial; Enoyl Coenzyme A hydratase short chain 1; Enoyl Coenzyme A hydratase short chain 1 mitochondrial; Mitochondrial short chain enoyl coenzyme A hydratase 1; OTTHUMP00000020811; Short chain enoyl CoA hydratase; enoyl-CoA hydratase 1; short-chain enoyl-CoA hydratase;
ENO1
enolase 1, (alpha)
ENO1; enolase 1, (alpha); ENO1L1, MPB1; alpha-enolase; c-myc promoter-binding protein-1; MBP 1; PPH; enolase-alpha; tau-crystallin; non-neural enolase; alpha enolase like 1; phosphopyruvate hydratase; plasminogen-binding protein; MYC promot;
ENO2
enolase 2 (gamma, neuronal)
ENO2; enolase 2 (gamma, neuronal); NSE; HEL-S-279; gamma-enolase; neural enolase; neuron-specific enolase; neurone-specific enolase; neuron specific gamma enolase; 2-phospho-D-glycerate hydrolyase; 2-phospho-D-glycerate hydro-lyase; epididymis secretory protein Li 279;
ENOPH1
enolase-phosphatase 1
ENOPH1; enolase-phosphatase 1; enolase-phosphatase E1; acireductone synthase; E1; Enolase phosphatase E1; MASA; 2 3 diketo 5 methylthio 1 phosphopentane phosphatase; 2; 3-diketo-5-methylthio-1-phosphopentane phosphatase; DKFZp586M0524; E 1 enzyme; Enolase phosphatase 1; ENOPH_HUMAN; FLJ12594; MASA homolog; MST145; MSTP145 protein; OTTHUMP00000160806; OTTHUMP00000219541; 2,3-diketo-5-methylthio-1-phosphopentane phosphatase;
ENOSF1
enolase superfamily member 1
ENOSF1; enolase superfamily member 1; mitochondrial enolase superfamily member 1; HSRTSBETA; rTS; TYMSAS; ENOSF 1; RTS alpha; RTS beta; RTS beta protein; antisense RNA to thymidylate synthase;
ENPEP
glutamyl aminopeptidase (aminopeptidase A)
ENPEP; glutamyl aminopeptidase (aminopeptidase A); glutamyl aminopeptidase; CD249; gp160; EAP; AP-A; aminopeptidase A; differentiation antigen gp160; APA;
EPHX1
epoxide hydrolase 1, microsomal (xenobiotic)
EPHX1; epoxide hydrolase 1, microsomal (xenobiotic); EPHX; epoxide hydrolase 1; epoxide hydratase; MEH; EPOX; HYL1;
ERAP2
endoplasmic reticulum aminopeptidase 2
ERAP2; endoplasmic reticulum aminopeptidase 2; L RAP; leukocyte derived arginine aminopeptidase; LRAP; leukocyte-derived arginine aminopeptidase; L-RAP;
FCN1
ficolin (collagen/fibrinogen domain containing) 1
FCN1; ficolin (collagen/fibrinogen domain containing) 1; ficolin-1; FCNM; Collagen/fibrinogen domain containing protein 1; Collagen/fibrinogen domain-containing protein 1; FCN1_HUMAN; Ficolin 1; Ficolin A; Ficolin alpha; Ficolin-A; Ficolin-alpha; M ficolin; M-ficolin; OTTHUMP00000022519; ficolin (collagen/fibrinogen domain-containing) 1;
FMO1
flavin containing monooxygenase 1
FMO1; flavin containing monooxygenase 1; dimethylaniline monooxygenase [N-oxide-forming] 1; FMO 1; dimethylaniline oxidase 1; Flavin-containing monooxygenase 1 (fetal liver); fetal hepatic flavin-containing monooxygenase 1;
FMO3
flavin containing monooxygenase 3
FMO3; flavin containing monooxygenase 3; dimethylaniline monooxygenase [N-oxide-forming] 3; Dimethylaniline monooxygenase [N oxide forming] 3; Dimethylaniline monooxygenase 3; Dimethylaniline oxidase 3; dJ127D3.1; FMO 3; FMO form 2; FMO II; FMO3_HUMAN; FMOII; Hepatic flavin containing monooxygenase 3; Hepatic flavin-containing monooxygenase 3; MGC34400; hepatic flavin-containing monooxygenase-3; TMAU;
FMO5
flavin containing monooxygenase 5
FMO5; flavin containing monooxygenase 5; dimethylaniline monooxygenase [N-oxide-forming] 5; Dimethylaniline monooxygenase [N oxide forming] 5; Dimethylaniline oxidase 5; FMO 5; Hepatic flavin containing monooxygenase 5; OTTHUMP00000016306; OTTHUMP00000016307; OTTHUMP00000231953; OTTHUMP00000231954; hepatic flavin-containing monooxygenase 5;
FTCD
formiminotransferase cyclodeaminase
FTCD; formiminotransferase cyclodeaminase; formimidoyltransferase-cyclodeaminase; formiminotransferase-cyclodeaminase; formimidoyltransferase cyclodeaminase; LCHC1;
FURIN
furin (paired basic amino acid cleaving enzyme)
FURIN; furin (paired basic amino acid cleaving enzyme); FUR, PACE, paired basic amino acid cleaving enzyme (furin, membrane associated receptor protein) , PCSK3; SPC1; FES upstream region; dibasic processing enzyme; dibasic-processing enzyme; furi;
GAMT
Gamt guanidinoacetate methyltransferase
GAMT; guanidinoacetate methyltransferase; guanidinoacetate N-methyltransferase; Spintz1; AA571402;
GMPR2
guanosine monophosphate reductase 2
GMPR2; guanosine monophosphate reductase 2; GMP reductase 2; 5730544D12Rik; 1810008P16Rik; AA959850; Guanosine 5 monophosphate oxidoreductase 2; MGC108877; MGC15084; guanosine monophosphate reductase isolog; guanosine 5-monophosphate oxidoreductase 2;
GOT1
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)
GOT1; glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1); aspartate aminotransferase, cytoplasmic; transaminase A; growth-inhibiting protein 18; glutamate oxaloacetate transaminase 1; GIG18; ASTQTL1;
Gpt
glutamic-pyruvate transaminase (alanine aminotransferase)
GPT; glutamic-pyruvate transaminase (alanine aminotransferase); alanine aminotransferase 1; ALT1; GPT1; AAT1; Alanine aminotransferase; ALAT1_HUMAN; Glutamate pyruvate transaminase 1; Glutamic alanine transaminase 1; Glutamic pyruvic transaminase 1; Glutamic--alanine transaminase 1; Glutamic--pyruvic transaminase 1; GPT 1; OTTHUMP00000228783; glutamic-alanine transaminase 1;
Gpt2
glutamic pyruvate transaminase (alanine aminotransferase) 2
GPT2; glutamic pyruvate transaminase (alanine aminotransferase) 2; alanine aminotransferase 2; ALT2; AAT2; Glutamate pyruvate transaminase 2; Glutamic alanine transaminase 2; Glutamic pyruvic transaminase 2; GPT 2; glutamic--alanine transaminase 2; glutamic--pyruvic transaminase 2; glutamic-pyruvate transaminase 2;
IgM
Immunoglobulin M
Constant region of heavy chain of IgM; Hepatitis B virus receptor binding protein; Ig mu chain C region; IGHM; Immunoglobulin mu chain; Imunoglobulin heavy chain; VH; IgM; Immunoglobulin M; IgMμ; Immunoglobulin Mμ; IgM heavy chain, Immunoglobulin M heavy chain; IgMμheavy chain; Immunoglobulin Mμheavy chain;
IMPA1
inositol(myo)-1(or 4)-monophosphatase 1
IMPA1; inositol(myo)-1(or 4)-monophosphatase 1; IMP; IMPA; inositol monophosphatase 1; IMP 1; IMPase 1; inositol-1(or 4)-monophosphatase 1; lithium-sensitive myo-inositol monophosphatase A1;
IMPA2
inositol(myo)-1(or 4)-monophosphatase 2
IMPA2; inositol(myo)-1(or 4)-monophosphatase 2; inositol monophosphatase 2; IMP 2; IMPase 2; inosine monophosphatase 2; myo-inositol monophosphatase A2; inositol monophosphatase 2 variant 1; inositol monophosphatase 2 variant 2;
IMPDH1
IMP (inosine 5-monophosphate) dehydrogenase 1
IMPDH1; IMP (inosine 5-monophosphate) dehydrogenase 1; IMPD; RP10; IMPD1; LCA11; sWSS2608; inosine-5-monophosphate dehydrogenase 1; IMPD 1; IMPDH 1; IMPDH-I; IMP dehydrogenase 1; IMP (inosine monophosphate) dehydrogenase 1;
IMPDH2
IMP (inosine 5-monophosphate) dehydrogenase 2
IMPDH2; IMP (inosine 5-monophosphate) dehydrogenase 2; inosine-5-monophosphate dehydrogenase 2; EC 1.1.1.205; IMDH2_HUMAN; IMP (inosine monophosphate) dehydrogenase 2; IMP dehydrogenase 2; IMP oxireductase 2; IMPD 2; IMPD2; IMPDH 2; IMPDH II; IMPDH-II; IMPDHII; Inosine 5 monophosphate dehydrogenase 2; inosine 5 phosphate dehydrogenase 2; inosine monophosphate dehydrogenase type II;
ITPA
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
ITPA;inosine triphosphatase (nucleoside triphosphate pyrophosphatase);C20orf37;inosine triphosphate pyrophosphatase;dJ794I6.3;HLC14 06 P;NTPase;My049 protein;inosine triphosphatase-A;putative oncogene protein HLC14-06-P;nucleoside triphosphate diphosphatase;nucleoside-triphosphate diphosphatase;non-standard purine NTP pyrophosphatase;nucleoside-triphosphate pyrophosphatase;non-canonical purine NTP pyrophosphatase;inosine triphosphate pyrophosphohydrolase;ITPase;HLC14-06-P;
KIR2DL1
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DL1; 47.11; CD158A; cl 42; nkat1; p58.1; NKAT-1; killer Ig receptor; p58 NK receptor CL-42/47.11; MHC class I NK cell receptor; killer inhibitory receptor 2-2-1; CD158 antigen-like family member A; natural killer-associated transcript 1; p58 NK cell inhibitory receptor NKR-K6; p58.1 MHC class-I-specific NK receptor; p58 killer cell inhibitory receptor KIR-K64; p58 natural killer cell receptor clones CL-42/47.11; NKAT; KIR221; KIR-K64;
KIR2DL3
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3; killer cell immunoglobulin-like receptor 2DL3; CD158B2; cl 6; nkat2; nkat2a; nkat2b; p58; CD158b; GL183; Killer Cell Immunoglobulin Like Receptor 2DL3; Killer inhibitory receptor CL2 3; KIR023GB; MHC Class I NK Cell Receptor; Natural Killer Associated Transcript 2; p58 Natural Killer Cell Receptor Clone CL6; p58 NK Receptor; p58.2 MHC Class I Specific NK Receptor; NKAT-2; NK-receptor; OTTHUMP00000068619; p58 NK receptor CL-6; killer inhibitory receptor cl 2-3; CD158 antigen-like family member B2; natural kill; NKAT; KIR-K7b; KIR-K7c; KIRCL23; KIR-023GB;
KIR2DL4
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
KIR2DL4; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DL4; 15.212; 103AS; CD158D; KIR-103AS; NK cell receptor; killer Ig receptor; CD158 antigen-like family member D; MHC class;
KIR2DS4
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
KIR2DS4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DS4; CD158i; cl 39; KKA3; nkat8; CD158 antigen like family member I; CD158i antigen; CL 17; CL17; CL39; Killer cell immunoglobulin like receptortwo domains short cytoplasmic tail 4; Killer inhibitory receptor 4 1 2; KIR antigen 2DS4; KIR1D; KIR412; MGC120019; MGC125315; MGC125317; MHC class I NK cell receptor; Natural killer associated transcript 8; Natural killer cell inhibitory receptor; NKAT 8; P58 natural killer cell receptor clone CL 39; p58 NK receptor; NKAT-8; OTTHUMP00000199030; p58 NK receptor CL-39/CL-17; killer inhibitory receptor 4-1-2; CD158 antigen-like family member I; natural killer-associated transcript 8; na;
KIR3DL1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; KIR; killer cell immunoglobulin-like receptor 3DL1; AMB11; CD158e1; CD158e1/2; CD158e2; cl 2; cl 11; nkat3; NKB1; NKB1B; CD158 antigen-like family member E; CD158E; CD158e antigen; CL11; CL2; HLA-BW4-specific inhibitory NK cell receptor; killer cell immunoglobulin like receptor; Killer cell immunoglobulin like receptor three domains , short cytoplasmic tail, 1; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 1; KIR antigen 3DL1; KIR G1; KIR3DS1; Kirl1; Kirl2; Krl1; MGC119726; MGC119728; MGC126589; MGC126591; MHC class I NK cell receptor; Natural killer associated transcript 3; Natural killer cell inhibitory receptor; NK receptor; NK-associated transcript 10; NK-associated transcript 3; NK-associated transcript 3delIg1; NKAT10; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL 2/CL 11; NKAT-3; NK-receptor; OTTHUMP00000068687; OTTHUMP00000068688; OTTHUMP00000081758; killer Ig receptor; p70 NK receptor CL-2/CL-11; p70 ki; KIR3DL1/S1;
LAIR1
leukocyte-associated immunoglobulin-like receptor 1
LAIR1; leukocyte-associated immunoglobulin-like receptor 1; leukocyte associated Ig like receptor 1; CD305; 5133400O11Rik; D7Bwg0421e; hLAIR1; LAIR 1; LAIR-1; LAIR1 protein; LAIR1_HUMAN; Leukocyte associated immunoglobulin like receptor 1; OTTHUMP00000068183; OTTHUMP00000068184; OTTHUMP00000068185; OTTHUMP00000068186; OTTHUMP00000068187; leukocyte-associated Ig-like receptor 1;
LAIR2
leukocyte-associated immunoglobulin-like receptor 2
LAIR2; leukocyte-associated immunoglobulin-like receptor 2; leukocyte associated Ig like receptor 2; CD306; CD306 antigen; LAIR 2; LAIR-2; LAIR2_HUMAN; Leukocyte associated immunoglobulin like receptor 2; MGC71634; OTTHUMP00000068389; OTTHUMP00000068390; leukocyte-associated Ig-like receptor 2; leukocyte-associated Ig-like receptor-2;
LILRB3
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
LILRB3; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3; leukocyte immunoglobulin-like receptor subfamily B member 3; CD85a; HL9; ILT5; LIR 3; LIR3; CD85 antigen like family member A; CD85a antigen; IL T5; Immunoglobulin like transcript 5; Leukocyte immunoglobulin like receptor 3; Leukocyte immunoglobulin like receptor subfamily B (with TM and ITIM domains) member 3; Leukocyte immunoglobulin like receptor subfamily B member 3; MGC138403; Monocyte inhibitory receptor HL9; PIRB; ILT-5; OTTHUMP00000069587; OTTHUMP00000197712; OTTHUMP00000237014; immunoglobulin-like transcript 5; CD85 antigen-like family member A; leukocyte immunoglobulin-like re; LIR-3;
MAGEA1
melanoma antigen family A, 1 (directs expression of antigen MZ2-E)
MAGEA1; melanoma antigen family A, 1 (directs expression of antigen MZ2-E); MAGE1; melanoma-associated antigen 1; cancer/testis antigen family 1; member 1; CT1.1; melanoma antigen family A 1; melanoma antigen MAGE 1; melanoma associated antigen 1; melanoma associated antigen MZ2 E; MGC9326; antigen MZ2-E; MAGE-1 antigen; melanoma antigen MAGE-1; cancer/testis antigen 1.1; melanoma-associated antigen MZ2-E; cancer/testis antigen family 1, member 1;
MAGEA3
melanoma antigen family A, 3
MAGEA3; melanoma antigen family A, 3; MAGE3; melanoma-associated antigen 3; antigen MZ2 D; cancer/testis antigen family 1; member 3; CT1.3; HIP8; HYPD; MAGE 3 antigen; melanoma associated antigen 3; MGC14613; MGC1461; MAGEA6; Melanoma antigen family A 3; antigen MZ2-D; MAGE-3 antigen; cancer/testis antigen 1.3; cancer/testis antigen family 1, member 3;
MAGEA4
melanoma antigen family A, 4
MAGEA4; melanoma antigen family A, 4; MAGE4; melanoma-associated antigen 4; cancer/testis antigen family 1; member 4; CT1.4; MAGE 41; MAGE X2; MAGE4A; MAGE4B; melanoma associated antigen 4; MGC21336; MAGE-4 antigen; MAGE-41 antigen; MAGE-X2 antigen; cance;
MAOB
monoamine oxidase B
MAOB; monoamine oxidase B; amine oxidase [flavin-containing] B; MAO-B; MAO, brain; MAO, platelet; tyramine oxidase; adrenalin oxidase; monoamine oxidase type B; MGC26382;
Marco
macrophage receptor with collagenous structure
MARCO; SCARA2; Macrophage receptor MARCO; Macrophage receptor with collagenous structure; MARCO_HUMAN; Scavenger receptor class A member 2;
MAT1A
methionine adenosyltransferase I, alpha
MAT1A;methionine adenosyltransferase I, alpha;S-adenosylmethionine synthase isoform type-1;MAT;MATA1;S adenosylmethionine synthetase;SAMS;SAMS1;MAT 1;MAT-I/III;adoMet synthase 1;adoMet synthetase 1;methionine adenosyltransferase 1;methionine adenosyltransferase I/III;S-adenosylmethionine synthetase isoform type-1;
MAT2A
methionine adenosyltransferase II, alpha
MAT2A; methionine adenosyltransferase II, alpha; S-adenosylmethionine synthase isoform type-2; MATA2; MATII; SAMS2; MAT 2; MAT-II; adoMet synthase 2; adoMet synthetase 2; methionine adenosyltransferase 2;
MAT2B
methionine adenosyltransferase II, beta
MAT2B; methionine adenosyltransferase II, beta; methionine adenosyltransferase 2 subunit beta; MATIIbeta; SDR23E1; short chain dehydrogenase/reductase family 23E; member 1; 1110064C04Rik; 2410018D16Rik; AI182287; AU022853; MAT II; MGC12237; Nbla02999; Beta regulatory subunit of methionine adenosyltransferase; dTDP 4 keto 6 deoxy D glucose 4 reductase; DTDP-4-keto-6-deoxy-D-glucose 4-reductase; MAT II beta; MAT2B_HUMAN; Methionine adenosyltransferase 2 beta subunit; Methionine adenosyltransferase II beta; OTTMUSP00000005600; Putative protein product of Nbla02999; RP23-382C18.2; Short chain dehydrogenase/reductase family 23E member 1; TGR; putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase; short chain dehydrogenase/reductase family 23E, member 1; MAT-II;
Mbl1
mannose-binding lectin (protein A) 1
MBL1; mannose-binding lectin (protein A) 1; mannose-binding protein A; mannose binding lectin (A); MBP A; S MBP; raRF p28B; mannan-binding protein; mannose binding lectin, serum (A); ra-reactive factor polysaccharide-binding component p28B; MBL-A; MBP-A; S-MBP;
MBL2
mannose-binding lectin (protein C) 2, soluble
COLEC 1; COLEC1; Collectin-1; HSMBPC; Mannan binding lectin; Mannan binding protein; Mannan-binding protein; Mannose binding lectin (protein C)3soluble; Mannose binding lectin (protein C) 2, soluble (opsonic defect); Mannose binding lectin (protein C) 2, soluble; Mannose binding lectin3soluble; Mannose binding lectin 2, soluble (opsonic defect); Mannose binding lectin; Mannose binding lectin protein C2 soluble opsonic defect; Mannose binding protein; Mannose binding protein C; Mannose binding protein C precursor; Mannose-binding lectin; Mannose-binding protein C; MBL 2; MBL; MBL2; MBL2_HUMAN; MBL2D; MBP 1; MBP; MBP C; MBP-C; MBP1; MBPC; MGC116832; MGC116833; Opsonic defect; protein C; Soluble mannose binding lectin;
MCAM
melanoma cell adhesion molecule
MCAM; melanoma cell adhesion molecule; cell surface glycoprotein MUC18; CD146; Gicerin; MUC18; melanoma adhesion molecule; cell surface glycoprotein P1H12; melanoma-associated antigen A32; melanoma-associated antigen MUC18; S-endo 1 endothelial-associated antigen;
Mdga2
MAM domain containing glycosylphosphatidylinositol anchor 2
MDGA2; MAM domain containing glycosylphosphatidylinositol anchor 2; MAM domain containing 1 , MAMDC1; MAM domain-containing glycosylphosphatidylinositol anchor protein 2; MAM domain containing 1; MAMDC1; c14_5286;
MECR
mitochondrial trans-2-enoyl-CoA reductase
MECR; mitochondrial trans-2-enoyl-CoA reductase; trans-2-enoyl-CoA reductase, mitochondrial; CGI 63; FASN2B; mitochondrial 2 enoyl thioester reductase; NRBF1; nuclear receptor binding factor 1; HsNrbf1; mitochondrial; AI195831; Homolog of yeast 2 enoyl thioester reductase; HsNrbf-1; MECR_HUMAN; NRBF 1; NRBF-1; Nuclear receptor-binding factor 1; OTTMUSP00000009996; RP23-13A13.1; Trans 2 enoyl CoA reductase, mitochondrial; Trans-2-enoyl-CoA reductase; mitochondrial 2-enoyl thioester reductase; homolog of yeast 2-enoyl thioester reductase; CGI-63;
METAP1
methionyl aminopeptidase 1
METAP1; methionyl aminopeptidase 1; methionine aminopeptidase 1; KIAA0094; MAP1A; MetAP1A; Peptidase M; DKFZp781C0419; MAP 1; MetAP 1; Peptidase M 1;
METAP2
methionyl aminopeptidase 2
METAP2; methionyl aminopeptidase 2; methionine aminopeptidase 2; MAP2; MNPEP; p67; Peptidase M; MAP 2; metAP 2; peptidase M 2; eIF-2-associated p67 homolog; initiation factor 2-associated 67 kDa glycoprotein; p67eIF2;
MGLL
Mgll monoglyceride lipase
MGLL; monoglyceride lipase; monoacylglycerol lipase; Mgl; Magl; AA589436;
MIA
melanoma inhibitory activity
MIA; melanoma inhibitory activity; melanoma-derived growth regulatory protein; CD RAP; CD-RAP;
MIA2
melanoma inhibitory activity 2
MIA2; melanoma inhibitory activity 2; melanoma inhibitory activity protein 2; FLJ22404; MIA2_HUMAN;
MSH2
mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
MSH2; mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli); COCA1, mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1); DNA mismatch repair protein Msh2; HNPCC; HNPCC1; hMSH2; FCC1; COCA1; LCFS2;
MSMB
Microseminoprotein, Beta-
MSMB; microseminoprotein, beta-; MSP; PSP; IGBF; MSPB; PN44; PRPS; HPC13; PSP57; PSP94; PSP-94; beta-microseminoprotein; OTTHUMP00000019596; OTTHUMP00000019597; seminal plasma beta-inhibin; immunoglobulin binding factor; prostate secreted seminal plasma protein; prostate secretory protein of 94 amino acids;
MTAP
methylthioadenosine phosphorylase
MTAP; methylthioadenosine phosphorylase; S-methyl-5-thioadenosine phosphorylase; c86fus; MSAP; MTAPase; MTA phosphorylase; MeSAdo phosphorylase; 5-methylthioadenosine phosphorylase;
MYL6
myosin, light chain 6, alkali, smooth muscle and non-muscle
MYL6; myosin, light chain 6, alkali, smooth muscle and non-muscle; myosin, light polypeptide 6, alkali, smooth muscle and non muscle; myosin light polypeptide 6; ESMLC; MLC1SM; MLC3NM; myosin light chain A3; 17 kDa myosin light chain; myosin light chain a;
NANOG
Nanog homeobox
NANOG; Nanog homeobox; homeobox protein NANOG; ES cell-associated protein 4; homeobox transcription factor Nanog; early embryo specific expression NK family; early embryo specific expression NK-type homeobox protein; ENK; ecat4; 2410002E02Rik;
NDUFA10
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa
NDUFA10; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10 (42kD); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial; CI 42k; complex I 42kDa subunit; CI 42KD; CI-42k; Complex I-42kD; MGC5103; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 42kDa; NADH ubiquinone oxidoreductase 42 kDa subunit mitochondrial precursor; NADH-ubiquinone oxidoreductase 42 kDa subunit; ndufa10l; CI-42KD;
NDUFS3
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)
NDUFS3; NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 3 (30kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial; CI 30; comp;
NDUFS4
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)
NDUFS4; NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 4 (18kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial; AQDQ; CI 18;
NHP2L1
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)
NHP2L1; NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae); non histone chromosome protein 2 (S. cerevisiae) like 1 , sperm specific antigen 1 , SSFA1; NHP2-like protein 1; 15.5K; FA 1; small nuclear ribonucleoprotein 15.5kDa (U4/U6.U5); SNRNP15 5; SNU13; SPAG12; [U4/U6.U5] tri snRNP; High mobility group like nuclear protein 2 homolog 1; hSNU13; NHP2 non histone chromosome protein 2 like 1 (S. cerevisiae); NHP2L 1; NHPX; OTK27; sperm specific antigen 1; U4/U6.U5 tri-snRNP 15.5 kDa protein; non-histone chromosome protein 2-like 1; [U4/U6.U5] tri-snRNP 15.5 kD RNA binding protein; high mobility group-like nuclear protein 2 homolog 1; FA1; FA-1; SSFA1; SNRNP15-5;
NME2
non-metastatic cells 2, protein (NM23B) expressed in
NME2; non-metastatic cells 2, protein (NM23B) expressed in; nucleoside diphosphate kinase B; NM23 H2; NDP kinase B; c-myc transcription factor; histidine protein kinase NDKB; nucleotide diphosphate kinase B; c-myc purine-binding transcription factor PUF;
NME3
non-metastatic cells 3, protein expressed in
NME3; non-metastatic cells 3, protein expressed in; nucleoside diphosphate kinase 3; DR nm23; NM23 H3; NDK 3; NDP kinase 3; NDP kinase C; nucleoside diphosphate kinase C; NDPKC; NDPK-C; NM23H3; DR-nm23; NM23-H3; c371H6.2; KIAA0516;
NME4
non-metastatic cells 4, protein expressed in
NME4; non-metastatic cells 4, protein expressed in; nucleoside diphosphate kinase, mitochondrial; nm23 H4; NM23H4; NDK; NDPKD; NDP kinase D; NDP kinase, mitochondrial; nucleoside diphosphate kinase D; NDPK-D; nm23-H4;
NOS1
Nos1 nitric oxide synthase 1, neuronal
NOS1; nitric oxide synthase 1, neuronal; nitric oxide synthase, brain; N-NOS; NC-NOS; NOS type I; neuronal NOS; constitutive NOS; neuronal nitric oxide synthase; peptidyl-cysteine S-nitrosylase NOS1; NO; bNOS; nNOS; NOS-I; Nos-1; 2310005C01Rik;
Notch1
notch 1
NOTCH1; notch 1; hN1; TAN1; neurogenic locus notch homolog protein 1; Notch homolog 1, translocation-associated; translocation-associated notch protein TAN-1;
Notch2
notch 2
NOTCH2; notch 2; hN2; AGS2; HJCYS; neurogenic locus notch homolog protein 2; Notch homolog 2;
NOTCH3
notch 3
NOTCH3; notch 3; IMF2; CASIL; CADASIL; neurogenic locus notch homolog protein 3; Notch homolog 3;
Nqo1
NAD(P)H dehydrogenase, quinone 1
NQO1; NAD(P)H dehydrogenase, quinone 1; DTD; QR1; DHQU; DIA4; NMOR1; NMORI; NAD(P)H dehydrogenase [quinone] 1; azoreductase; diaphorase-4; DT-diaphorase; dioxin-inducible 1; menadione reductase; quinone reductase 1; phylloquinone reductase; NAD(P)H:quinone oxireductase; NAD(P)H:quinone oxidoreductase 1; NAD(P)H:menadione oxidoreductase 1; NAD(P)H:Quinone acceptor oxidoreductase type 1; diaphorase (NADH/NADPH) (cytochrome b-5 reductase);
NQO2
NAD(P)H dehydrogenase, quinone 2
NQO2; NAD(P)H dehydrogenase, quinone 2; NAD(P)H menadione oxidoreductase 2, dioxin inducible , NMOR2; ribosyldihydronicotinamide dehydrogenase [quinone]; DHQV; DIA6; QR2; Ox2; EC 1.10.99.2; MGC94180; NAD(P)H dehydrogenase quinone 2; NAD(P)H menadione oxidoreductase 1 dioxin inducible 2; NAD(P)H menadione oxidoreductase 2 dioxin inducible; NMOR2; NQO 2; NRH dehydrogenase; NRH:quinone oxidoreductase 2; OTTHUMP00000015948; OTTHUMP00000015949; OTTHUMP00000015953; Ox 2; Quinone; Quinone reductase 2; Ribosyldihydronicotinamide dehydrogenase; OTTHUMP00000015950; OTTHUMP00000015951; OTTHUMP00000015952; NRH dehydrogenase [quinone] 2; NAD(P)H menadione oxidoreductase 2, dioxin-inducible; NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2;
OAT
ornithine aminotransferase
OAT; ornithine aminotransferase; ornithine aminotransferase, mitochondrial; gyrate atrophy; HOGA; ornithine aminotransferase precursor; GACR; OATASE; OKT; Ornithine aminotransferase (gyrate atrophy); Ornithine aminotransferase mitochondrial; Ornithine aminotransferase, mitochondrial precursor; Ornithine delta aminotransferase; Ornithine oxo acid aminotransferase; OTTHUMP00000020690; ornithine delta-aminotransferase; ornithine-delta-aminotransferase; ornithine-oxo-acid aminotransferase; ornithine--oxo-acid aminotransferase;
PCBD1
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha
PCBD1; pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha; 6 pyruvoyl tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) , DCOH, PCBD, pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1); pterin-4-alpha-carbinolamine dehydratase; dimerizing cofactor for HNF1; PCD; pterin 4 alpha carbinolamine dehydratase; Pterin 4a carbinolamine dehydratase (dimerization cofactor of hepatic nuclear factor 1 alpha); 4 alpha hydroxy tetrahydropterin dehydratase; 4-alpha-hydroxy-tetrahydropterin dehydratase; 6 pyruvoyl tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1); 6 pyruvoyl tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha; DCoH; Dimerization cofactor of hepatic nuclear factor 1 alpha; Dimerization cofactor of hepatocyte nuclear factor 1 alpha; Dimerization cofactor of hepatocyte nuclear factor 1-alpha; Dimerization cofactor of HNF1; PCBD 1; PCBD; Phenylalanine hydroxylase stimulating protein; Phenylalanine hydroxylase-stimulating protein; PHS; PHS_HUMAN; Pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1); Pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha; Pterin carbinolamine dehydratase; OTTHUMP00000019765; 6-pyruvoyl-tetrahydropterin synthase/dimeriza;
PEBP1
phosphatidylethanolamine binding protein 1
PEBP1; phosphatidylethanolamine binding protein 1; PBP, prostatic binding protein; phosphatidylethanolamine-binding protein 1; HCNP; hippocampal cholinergic neurostimulating peptide; PEBP; Raf kinase inhibitory protein; RKIP; neuropolypeptide h3; prostat;
PECI
peroxisomal D3,D2-enoyl-CoA isomerase
PECI; peroxisomal D3,D2-enoyl-CoA isomerase; DRS1; ACBD2; HCA88; KIAA0536; dJ1013A10.3; peroxisomal 3,2-trans-enoyl-CoA isomerase; DRS-1; OTTHUMP00000015976; DBI-related protein 1; dodecenoyl-CoA isomerase; D3,D2-enoyl-CoA isomerase; renal carcinoma antigen NY-REN-1; delta(3),delta(2)-enoyl-CoA isomerase; acyl-Coenzyme A binding domain containing 2; diazepam-binding inhibitor-related protein 1; hepatocellular carcinoma-associated antigen 88; EC 5.3.3.8; Peroxisomal 3,2-trans-enoyl-CoA isomerase;
PGC
progastricsin (pepsinogen C)
progastricsin (pepsinogen C); PEPC; PGII; FLJ99563; Gastricsin; PEPC_HUMAN; Pepsinogen C; PGC; Progastricsin; Pepsinogen II;
Pigf
phosphatidylinositol glycan anchor biosynthesis, class F
PIGF; phosphatidylinositol glycan anchor biosynthesis, class F; phosphatidylinositol glycan, class F; phosphatidylinositol-glycan biosynthesis class F protein; PIG-F; GPI11 homolog; MGC32646; MGC33136;
PIGR
polymeric immunoglobulin receptor
PIGR; polymeric immunoglobulin receptor; poly-Ig receptor; hepatocellular carcinoma associated protein TB6; hepatocellular carcinoma-associated protein TB6; FLJ22667; MGC125361; MGC125362;
PIK3CA
phosphoinositide-3-kinase, catalytic, alpha polypeptide
PIK3CA; phosphoinositide-3-kinase, catalytic, alpha polypeptide; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3K; PI3K-alpha; PI3-kinase p110 subunit alpha; ptdIns-3-kinase subunit p110-alpha; serine/threonine protein;
PIK3CB
phosphoinositide-3-kinase, catalytic, beta polypeptide
PIK3CB; phosphoinositide-3-kinase, catalytic, beta polypeptide; PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform; PI3K-beta; PtdIns-3-kinase p110; PI3-kinase subunit beta; PI3-kinase p110 subunit beta; ptdIns-3-kinase;
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta; APDS; PI3K; IMD14; p110D; P110DELTA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform; PI3Kdelta; phosphoinositide-3-kinase C; PI3-kinase p110 subunit delta; ptdIns-3-kinase subunit p110-delta; phosphoinositide-3-kinase, catalytic, delta polypeptide variant p37delta; phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta isoform;
PIK3CG
phosphoinositide-3-kinase, catalytic, gamma polypeptide
PIK3CG; phosphoinositide-3-kinase, catalytic, gamma polypeptide; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform; p110gamma; p120-PI3K; PI3K-gamma; p110-gamma; PI3-kinase subunit gamma; ptdIns-3-kinase subunit gamma; 1-phosp;
PIK3R1
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); phosphatidylinositol 3-kinase regulatory subunit alpha; GRB1; p85; p85 ALPHA; PI3-kinase subunit p85-alpha; PI3K regulatory subunit alpha; ptdIns-3-kinase regulatory subunit alpha; phosphati;
PIK3R2
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta); phosphatidylinositol 3-kinase regulatory subunit beta; p85; P85B; PI3-kinase subunit p85-beta; PI3K regulatory subunit beta; PI3-kinase regulatory subunit beta; ptdIns-3-kinase regulatory sub;
Pilra
paired immunoglobin-like type 2 receptor alpha
PILRA; paired immunoglobin-like type 2 receptor alpha; paired immunoglobulin-like type 2 receptor alpha; FDF03; Cell surface receptor FDF03; Inhibitory receptor PILR-alpha; paired immunoglobulin-like receptor alpha; PILRA_HUMAN; paired immunoglobulin-like type 2 receptor alpha; PILRA; cell surface receptor FDF03; inhibitory receptor PILR-alpha; paired immunoglobulin-like receptor alpha; paired immunoglobin-like receptor alpha; OTTHUMP00000207544; OTTHUMP00000207543; OTTHUMP00000207542; OTTHUMP00000207541; inhibitory receptor PILRalpha;
PIP4K2B
phosphatidylinositol-5-phosphate 4-kinase, type II, beta
PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase, type II, beta; phosphatidylinositol 4 phosphate 5 kinase, type II, beta , PIP5K2B; phosphatidylinositol-5-phosphate 4-kinase type-2 beta; PIP5KIIB; PIP5KIIbeta; PIP4KII-beta; PTDINS(4)P-5-kinase; PI(5)P;
PITPNA
phosphatidylinositol transfer protein, alpha
PITPNA; phosphatidylinositol transfer protein, alpha; phosphotidylinositol transfer protein , PITPN; phosphatidylinositol transfer protein alpha isoform; VIB1A; MGC99649; Phosphatidylinositol transfer protein alpha; Phosphotidylinositol transfer protein; PITP alpha; PITPNB; PtdIns transfer protein alpha; PtdInsTP; PI-TP-alpha; ptdInsTP alpha; PITPN; PI-TPalpha;
PITPNB
phosphatidylinositol transfer protein, beta
PITPNB;phosphatidylinositol transfer protein, beta;phosphatidylinositol transfer protein beta isoform;VIB1B;ptdInsTP beta;PtdIns transfer protein beta;phosphotidylinositol transfer protein, beta;PtdInsTP;PI-TP-beta;
PLA2G2A
phospholipase A2, group IIA (platelets, synovial fluid)
PLA2G2A; phospholipase A2, group IIA (platelets, synovial fluid); phospholipase A2, membrane associated; GIIC sPLA2; enhancing factor; modifier of Min1; group IIA phospholipase A2; secretory group II phospholipase A2; phosphatidylcholine 2-acylhydrolase 2A; non-pancreatic secreted type II phospholipase A2; EF; Mom1; Pla2; sPLA2; sPla2-IIA;
PLAT
plasminogen activator, tissue
PLAT; plasminogen activator, tissue; TPA; T-PA; DKFZp686I03148; tissue-type plasminogen activator; alteplase; reteplase; OTTHUMP00000225783; OTTHUMP00000225784; OTTHUMP00000225785; OTTHUMP00000225786; OTTHUMP00000225787; OTTHUMP00000225788; t-plasminogen activator; plasminogen activator, tissue type; tissue plasminogen activator (t-PA);
PLAU
plasminogen activator, urokinase
PLAU; PLAU plasminogen activator, urokinase; ATF; UPA; URK; u-PA urokinase-type plasminogen activator; OTTHUMP00000019849; OTTHUMP00000019850; OTTHUMP00000019851; U-plasminogen activator; plasminogen activator, urinary.;
Plaur
Plasminogen Activator, Urokinase Receptor
ATF; ATF uPA; Plasminogen activator; Plasminogen activator urinary; Plasminogen activator urokinase; PLAU; u PA; U plasminogen activator; U-plasminogen activator; UPA; URK; UROK_HUMAN; Urokinase plasminogen activator; Urokinase type plasminogen activator; Urokinase type plasminogen activator precursor; Urokinase-type plasminogen activator chain B;
PMM1
phosphomannomutase 1
PMM1; phosphomannomutase 1; brain glucose 1; 6 bisphosphatase; Sec53; PMM 1; PMMH-22; brain glucose-1,6-bisphosphatase;
PMM2
phosphomannomutase 2
PMM2; phosphomannomutase 2; CDG1; CDG1a; CDGS; AI585868; BOS_22465; C86848; CDG 1; MGC127449; PMM 2; OTTHUMP00000160109;
Pnck
pregnancy up-regulated non-ubiquitously expressed CaM kinase
PNCK; pregnancy up-regulated non-ubiquitously expressed CaM kinase; pregnancy upregulated non ubiquitously expressed CaM kinase; calcium/calmodulin-dependent protein kinase type 1B; CaMK1b; MGC45419; caMKI-beta; caM-KI beta; caM kinase IB; caM kinase I be;
PNMT
phenylethanolamine N-methyltransferase
PNMT; phenylethanolamine N-methyltransferase; PENT; PNMTase; phenylethanolamine N-methylase; noradrenaline N-methyltransferase;
PPA1
pyrophosphatase (inorganic) 1
PPA1; pyrophosphatase (inorganic) 1; PP, pyrophosphatase (inorganic); inorganic pyrophosphatase; cytosolic inorganic pyrophosphatase; inorganic pyrophosphatase 1; IOPPP; PP1; Ppase; pyrophosphate phospho hydrolase; SID6 8061; pyrophosphatase 1; in;
PPCDC
phosphopantothenoylcysteine decarboxylase
PPCDC; phosphopantothenoylcysteine decarboxylase; FLJ14585; MDS018; CoaC; MGC102190; 1810057I13Rik; 8430432M10Rik; COAC_HUMAN; PPC-DC; RGD1306267;
PPCS
phosphopantothenoylcysteine synthetase
PPCS; phosphopantothenoylcysteine synthetase; phosphopantothenate--cysteine ligase; FLJ11838; PPC synthetase; RP11-163G10.1; MGC117357; MGC138220;
PSAT1
phosphoserine aminotransferase 1
PSAT1; phosphoserine aminotransferase 1; phosphoserine aminotransferase; PSA; EC 2.6.1.52; MGC1460; Phosphohydroxythreonine aminotransferase; PSAT; SERC_HUMAN; endometrial progesterone-induced protein; EPIP;
PSMD10
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
PSMD10; proteasome (prosome, macropain) 26S subunit, non-ATPase, 10; 26S proteasome non-ATPase regulatory subunit 10; gankyrin; p28; ankyrin repeat protein; 26S proteasome regulatory subunit p28; hepatocellular carcinoma-associated protein p28-II; p28(GAN;
PSMD11
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11
PSMD11; proteasome (prosome, macropain) 26S subunit, non-ATPase, 11; 26S proteasome non-ATPase regulatory subunit 11; MGC3844; p44.5; Rpn6; S9; 26S proteasome regulatory subunit 9; 26S proteasome regulatory subunit S9; 26S proteasome regulatory subunit RPN6; 26S proteasome regulatory subunit p44.5;
PTPN1
protein tyrosine phosphatase, non-receptor type 1
PTPN1; protein tyrosine phosphatase, non-receptor type 1; PTP1B; tyrosine-protein phosphatase non-receptor type 1; protein tyrosine phosphatase 1B; protein-tyrosine phosphatase 1B; protein tyrosine phosphatase, placental;
PTPN11
protein tyrosine phosphatase, non-receptor type 11
PTPN11; protein tyrosine phosphatase, non-receptor type 11; Noonan syndrome 1 , NS1; tyrosine-protein phosphatase non-receptor type 11; BPTP3; PTP2C; SH PTP2; SHP 2; SHP2; PTP-2C; protein tyrosine phosphatase-2; protein-tyrosine phosphatase 1D; protein-tyrosine phosphatase 2C; CFC; NS1; PTP-1D; SH-PTP2; SH-PTP3; MGC14433;
PTPN12
protein tyrosine phosphatase, non-receptor type 12
PTPN12; protein tyrosine phosphatase, non-receptor type 12; tyrosine-protein phosphatase non-receptor type 12; PTP PEST; PTPG1; protein-tyrosine phosphatase G1; PTP-PEST;
PTPN13
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
PTPN13; protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase); tyrosine-protein phosphatase non-receptor type 13; PTP BAS; PTP BL; PTP1E; PTPL1; hPTPE1; protein-tyrosine phosphatase 1E; protein-tyrosine phosphatase PTPL1; fas-associated protein-tyrosine phosphatase 1; PNP1; FAP-1; PTPLE; PTP-BL; hPTP1E; PTP-BAS; DKFZp686J1497;
PTPN14
protein tyrosine phosphatase, non-receptor type 14
PTPN14; protein tyrosine phosphatase, non-receptor type 14; tyrosine-protein phosphatase non-receptor type 14; PEZ; protein-tyrosine phosphatase pez; cytoskeletal-associated protein tyrosine phosphatase; PTP36; MGC126803;
PTPN2
protein tyrosine phosphatase, non-receptor type 2
PTPN2; protein tyrosine phosphatase, non-receptor type 2; PTN2; PTPT; TCPTP; TC-PTP; TCELLPTP; tyrosine-protein phosphatase non-receptor type 2; T-cell protein tyrosine phosphatase;
PTPN4
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)
PTPN4; protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte); MEG; PTPMEG; PTPMEG1; tyrosine-protein phosphatase non-receptor type 4; PTPase-MEG1; megakaryocyte phosphatase; protein tyrosine phosphatase MEG1; protein-tyrosine phosphatase MEG1; megakaryocyte protein-tyrosine phosphatase;
PTPN6
protein tyrosine phosphatase, non-receptor type 6
PTPN6; protein tyrosine phosphatase, non-receptor type 6; HCP; HCPH; SHP1; SHP-1; HPTP1C; PTP-1C; SHP-1L; SH-PTP1; tyrosine-protein phosphatase non-receptor type 6; hematopoietic cell phosphatase; protein-tyrosine phosphatase 1C; protein-tyrosine phosphatase SHP-1; hematopoietic cell protein-tyrosine phosphatase;
PTPN7
protein tyrosine phosphatase, non-receptor type 7
PTPN7; protein tyrosine phosphatase, non-receptor type 7; tyrosine-protein phosphatase non-receptor type 7; HEPTP; LC PTP; BPTP 4; BPTP4; Dual specificity phosphatase 1; Hematopoietic protein tyrosine phosphatase; Hematopoietic protein-tyrosine phosphatase; LCPTP; LPTP; Protein tyrosine phoshatase non receptor type stress induced; Protein tyrosine phoshatase nonreceptor type stress induced; Protein tyrosine phosphatase LC PTP; Protein tyrosine phosphatase non receptor type 7; Protein-tyrosine phosphatase LC-PTP; PTN7_HUMAN; PTPN 7; PTPNI; Tyrosine protein phosphatase non receptor type 7; protein-tyrosine phosphatase, nonreceptor-type, stress induced; BPTP-4; LC-PTP;
PTPN9
protein tyrosine phosphatase, non-receptor type 9
PTPN9; protein tyrosine phosphatase, non-receptor type 9; tyrosine-protein phosphatase non-receptor type 9; MEG2; PTPase MEG2; PTPase-MEG2; protein-tyrosine phosphatase MEG2; PTPMEG2;
QPRT
quinolinate phosphoribosyltransferase
QPRT; quinolinate phosphoribosyltransferase; nicotinate-nucleotide pyrophosphorylase [carboxylating]; nicotinate nucleotide pyrophosphorylase (carboxylating); QPRTase; QAPRTase; nicotinate-nucleotide pyrophosphorylase (carboxylating);
RARA
retinoic acid receptor, alpha
RARA; retinoic acid receptor, alpha; retinoic acid receptor alpha; NR1B1; RAR; RAR-alpha; retinoic acid receptor, alpha polypeptide; nuclear receptor subfamily 1 group B member 1; retinoic acid nuclear receptor alpha variant 1; retinoic acid nuclear recep;
RARB
RARB retinoic acid receptor, beta
RARB; retinoic acid receptor, beta; retinoic acid receptor beta; HAP; NR1B2; RRB2; RAR-beta; RAR-epsilon; HBV-activated protein; retinoic acid receptor beta 2; retinoic acid receptor beta 4; retinoic acid receptor beta 5; hepatitis B virus activated protein; retinoic acid receptor beta variant 1; retinoic acid receptor beta variant 2; retinoic acid receptor, beta polypeptide; nuclear receptor subfamily 1 group B member 2; MGC97363;
RARG
retinoic acid receptor, gamma
RARG; retinoic acid receptor, gamma; retinoic acid receptor gamma; NR1B3; RARC; Nuclear receptor subfamily 1 group B member 3; RAR gamma; Retinoic acid receptor gamma 1; Retinoic acid receptor gamma 2; Retinoic acid receptor gamma polypeptide; RAR-gamma; OTTHUMP00000045736; OTTHUMP00000241950; OTTHUMP00000241951; OTTHUMP00000241952; retinoic acid nuclear receptor gamma variant 1; retinoic acid nuclear receptor gamma variant 2;
Rarres2
retinoic acid receptor responder (tazarotene induced) 2
HP10433; TIG2; RAR-responsive protein TIG2; chemerin; retinoic acid receptor responder protein 2; tazarotene-induced gene 2 protein;
RB1
retinoblastoma 1
RB1; retinoblastoma 1; RB; pRb; OSRC; pp110; p105-Rb; retinoblastoma-associated protein; retinoblastoma suspectibility protein; prepro-retinoblastoma-associated protein;
RBBP4
retinoblastoma binding protein 4
RBBP4; retinoblastoma binding protein 4; NURF55; RBAP48; histone-binding protein RBBP4; RBBP-4; CAF-I p48; CAF-1 subunit C; CAF-I 48 kDa subunit; MSI1 protein homolog; retinoblastoma-binding protein 4; retinoblastoma-binding protein p48; chromatin assembly factor 1 subunit C; chromatin assembly factor I p48 subunit; chromatin assembly factor/CAF-1 p48 subunit; nucleosome-remodeling factor subunit RBAP48;
RBP4
retinol binding protein 4, plasma
RBP4; retinol binding protein 4, plasma; RDCCAS; retinol-binding protein 4; RBP; PRBP; plasma retinol-binding protein; retinol-binding protein 4, interstitial; Retinol-binding protein 4; Plasma retinol-binding protein;
RBP5
retinol binding protein 5, cellular
RBP5;retinol binding protein 5, cellular;retinol-binding protein 5;CRBPIII;HRBPiso;retinol-binding protein 5, cellular;cellular retinol-binding protein III;putative cellular retinol-binding protein CRBP III;CRBP3;CRBP-III;
RBP7
retinol binding protein 7, cellular
RBP7; retinol binding protein 7, cellular; retinoid-binding protein 7; CRBPIV; Cellular retinoic acid binding protein 4; Cellular retinoic acid-binding protein IV; CRABP IV; CRBP4; Retinoid binding protein 7; CRABP4; CRABP-IV; cellular retinoic acid-binding protein 4; putative cellular retinol-binding protein CRBP IV;
RXRA
RXRA retinoid X receptor, alpha
RXRA; retinoid X receptor, alpha; retinoic acid receptor RXR-alpha; NR2B1; nuclear receptor subfamily 2 group B member 1; retinoid X nuclear receptor alpha; FLJ00280; FLJ00318; FLJ16020; FLJ16733; MGC102720;
RXRB
RXRB retinoid X receptor, beta
RXRB; retinoid X receptor, beta; retinoic acid receptor RXR-beta; H 2RIIBP; NR2B2; nuclear receptor subfamily 2 group B member 2; RCoR 1; retinoid X nuclear receptor beta; MHC class I promoter binding protein; DAUDI6; RCoR-1; H-2RIIBP; MGC1831;
SEMA3A
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
SEMA3A; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A; HH16; SemD; COLL1; SEMA1; SEMAD; SEMAL; coll-1; Hsema-I; SEMAIII; Hsema-III; semaphorin-3A; collapsin 1; semaphorin D; semaphorin L; semaphorin III;
SEPSECS
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
SEPSECS;Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase;
SEPX1
Selenoprotein X, 1
SEPX1; selenoprotein X, 1; SELR; SELX; MSRB1; HSPC270; methionine-R-sulfoxide reductase B1; selenoprotein R; methionine sulfoxide reductase; EC 1.8.4.-;
SERPINE1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
SERPINE1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; PAI; PAI1; PAI-1; PLANH1; plasminogen activator inhibitor 1; serpin E1; endothelial plasminogen activator inhibitor; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1;
Serpine2
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
SERPINE2; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2; PI7, serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2; glia-derived nexin; GDN; glial derived nexin 1; nexin; PN1; PNI; Glia derived nexin; Protease inhibitor 7; GDN_HUMAN; P17; Peptidase inhibitor 7; Pi-7; Plasminogen activator inhibitor type 1, member 2; PN-1; Protease nexin 1; Protease nexin I; Serpin E2; SERPINE 2; OTTHUMP00000164215; OTTHUMP00000203766; OTTHUMP00000203767; OTTHUMP00000203768; glial-derived neurite promoting factor; PI7;
Sigirr
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
SIGIRR; single immunoglobulin and toll-interleukin 1 receptor (TIR) domain; single Ig IL-1-related receptor; single immunoglobulin domain IL1R1 related; TIR8; Single immunoglobulin domain containing IL1R related protein; Toll/interleukin 1 receptor 8; Ig IL1 related receptor; MGC110992; SIGIR_HUMAN; Single Ig IL 1 related receptor; Single Ig IL-1R-related molecule; Single Ig IL1R Related Molecule; Single immunoglobulin and toll interleukin 1 receptor (TIR) domain; Single immunoglobulin and toll interleukin 1 receptor domain; Single immunoglobulin domain-containing IL1R-related protein; TIR 8; Toll/interleukin-1 receptor 8; OTTHUMP00000229641; OTTHUMP00000229642; OTTHUMP00000229643; OTTHUMP00000229644; OTTHUMP00000229645; single immunoglobulin;
SILV
PMEL premelanosome protein
P1; SI; SIL; ME20; P100; SILV; ME20M; gp100; ME20-M; PMEL17; D12S53E; melanocyte protein PMEL; melanocyte protein mel 17; silver, mouse, homolog of; melanocyte protein Pmel 17; melanosomal matrix protein17; silver locus protein homolog; melanoma-associated ME20 antigen; melanocytes lineage-specific antigen GP100;
SNCA
synuclein, alpha (non A4 component of amyloid precursor)
SNCA; synuclein, alpha (non A4 component of amyloid precursor); PD1; NACP; PARK1; PARK4; alpha-synuclein; synuclein alpha-140; non A-beta component of AD amyloid;
SPSB1
splA/ryanodine receptor domain and SOCS box containing 1
SPSB1;splA/ryanodine receptor domain and SOCS box containing 1;SPRY domain-containing SOCS box protein 1;SSB 1;novel SPRY domain containing protein;SPRY domain-containing SOCS box protein SSB-1;SSB1;SSB-1;
SPTAN1
spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)
SPTAN1; spectrin, alpha, non-erythrocytic 1 (alpha-fodrin); spectrin alpha chain, brain; alpha-II spectrin; fodrin alpha chain; spectrin, non-erythroid alpha chain; NEAS; EIEE5; SPTA2; FLJ17738; FLJ44613;
SSX4
synovial sarcoma, X breakpoint 4
SSX4; synovial sarcoma, X breakpoint 4; protein SSX4; CT5.4; MGC12411; Synovial sarcoma X breakpoint 4; OTTHUMP00000024292; OTTHUMP00000216158; cancer/testis antigen 5.4; SSX4B;
ST13
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
ST13; suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein); hsc70-interacting protein; FAM10A1; HIP; HSPABP1; P48; progesterone receptor associated p48 protein; SNC6; Hsp70-interacting protein; aging-associated protein 2; putativ;
TDGF1
teratocarcinoma-derived growth factor 1
TDGF1; teratocarcinoma-derived growth factor 1; CR; CRGF; CRIPTO; cripto-1 growth factor; epidermal growth factor-like cripto protein CR1;
TIE1
TIE1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1
TIE1; tyrosine kinase with immunoglobulin-like and EGF-like domains 1; TIE, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; tyrosine-protein kinase receptor Tie-1; JTK14; tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; TIE;
TIGIT
T cell immunoreceptor with Ig and ITIM domains
TIGIT; T cell immunoreceptor with Ig and ITIM domains; V set and immunoglobulin domain containing 9 , V set and transmembrane domain containing 3 , VSIG9, VSTM3; T-cell immunoreceptor with Ig and ITIM domains; DKFZp667A205; FLJ39873; V-set and transmembrane domain containing 3; V-set and immunoglobulin domain containing 9; Washington University cell adhesion molecule; V-set and transmembrane domain-containing protein 3; V-set and immunoglobulin domain-containing protein 9; VSIG9; VSTM3; WUCAM;
Timd4
T-cell immunoglobulin and mucin domain containing 4
TIMD4; T-cell immunoglobulin and mucin domain containing 4; T-cell immunoglobulin and mucin domain-containing protein 4; TIM-4; TIMD-4; T-cell membrane protein 4; TIM4; SMUCKLER; FLJ27515;
TNK1
tyrosine kinase, non-receptor, 1
TNK1; tyrosine kinase, non-receptor, 1; non-receptor tyrosine-protein kinase TNK1; CD38 negative kinase 1; MGC46193;
UQCRC2
ubiquinol-cytochrome c reductase core protein II
UQCRC2; ubiquinol-cytochrome c reductase core protein II; cytochrome b-c1 complex subunit 2, mitochondrial; QCR2; UQCR2; mitochondrial; Complex III subunit 2; Core protein II; Cytochrome b-c1 complex subunit 2; EC 1.10.2.2; QCR2_HUMAN; Ubiquinol cytochrome c reductase complex core protein 2 mitochondrial; Ubiquinol cytochrome c reductase core protein II; Ubiquinol-cytochrome-c reductase complex core protein 2;
UROD
uroporphyrinogen decarboxylase
UROD; uroporphyrinogen decarboxylase; uroporphyrinogen III decarboxylase; PCT; UPD;
UROS
uroporphyrinogen III synthase
UROS; uroporphyrinogen III synthase; uroporphyrinogen-III synthase; congenital erythropoietic porphyria; HEM4_HUMAN; Hydroxymethylbilane hydrolyase [cyclizing]; Hydroxymethylbilane hydrolyase; UROIIIS; Uroporphyrinogen III cosynthetase; Uroporphyrinogen III synthase (congenital erythropoietic porphyria); Uroporphyrinogen-III cosynthase; OTTHUMP00000020709; OTTHUMP00000020710; OTTHUMP00000020712;
Vsig4
V-set and immunoglobulin domain containing 4
VSIG4; V-set and immunoglobulin domain containing 4; V-set and immunoglobulin domain-containing protein 4; Z39IG; protein Z39Ig; Ig superfamily protein; complement receptor of the immunoglobulin superfamily; CRIg;
XPNPEP1
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble
XPNPEP1; X-prolyl aminopeptidase (aminopeptidase P) 1, soluble; X prolyl aminopeptidase (aminopeptidase P) like , XPNPEP, XPNPEPL, XPNPEPL1; xaa-Pro aminopeptidase 1; Aminoacylproline aminopeptidase; Cytosolic aminopeptidase P; Soluble aminopeptidase P; soluble; X Pro aminopeptidase 1; X prolyl aminopeptidase 1 soluble; aminopeptidase P, cytosolic; APP1; RP11 451M19.1; SAMP; X prolyl aminopeptidase (aminopeptidase P) 1; X prolyl aminopeptidase (Aminopeptidase P) 1 soluble; X prolyl aminopeptidase 1; X-Pro aminopeptidase 1; X-prolyl aminopeptidase 1; Xaa Pro aminopeptidase 1; XPNPEP 1; XPNPEP; XPNPEPL; XPNPEPL1; XPP1_HUMAN; X-prolyl aminopeptidase 1, soluble;
YWHAB
YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide
YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide; tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, alpha polypeptide , YWHAA; 14-3-3 protein beta/alpha; 14 3 3 alpha; 14 3 3 beta; 14-3-3 alpha; protein 1054; brain protein 14-3-3, beta isoform; protein kinase C inhibitor protein 1; protein kinase C inhibitor protein-1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, alpha polypeptide; HS1; GW128; YWHAA; KCIP-1;
YWHAE
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; 14-3-3 protein epsilon; 14 3 3 epsilon; FLJ45465; 14-3-3 epsilon; protein kinase C inhibitor protein-1; mitochondrial import stimulation factor L subunit;
YWHAG
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide; 14-3-3 protein gamma; 14 3 3 gamma; KCIP-1; 14-3-3 gamma; protein kinase C inhibitor protein 1; 14-3-3GAMMA;
YWHAH
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein, Eta Polypeptide
YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; YWHA1; 14-3-3 eta; Protein AS1; 14-3-3 protein eta; OTTHUMP00000028905;
YWHAQ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide
YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; 14-3-3 protein theta; 14 3 3; HS1; protein tau; 14-3-3 protein tau; 14-3-3 protein T-cell; 1C5; 14-3-3;
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, delta polypeptide , YWHAD; 14-3-3 protein zeta/delta; 14 3 3 delta; 14 3 3 zeta; KCIP;
IGHE
Immunoglobulin heavy constant epsilon
immunoglobulin heavy constant epsilon; IgE; IGHE; immunoglobulin gene; IgE; Omalizumab; Xolair; 242138-07-4; Quilizumab; 1228538-47-3;
FGA
fibrinogen alpha chain
Fibrinogen; FGA; FGA protein; FGB; FGG; Fib2; Fibrinogen A alpha polypeptide; Fibrinogen A alpha polypeptide chain; Fibrinogen alpha chain; Fibrinogen B alpha polypeptide; Fibrinogen beta chain; Fibrinogen G alpha polypeptide; Fibrinogen gamma chain; MGC104327; MGC119422; MGC119423; MGC119425; MGC120405;
IP6K2
Inositol Hexakisphosphate Kinase 2
PIUS; IHPK2; IP6K2; inositol hexakisphosphate kinase 2; insp6 kinase 2; OTTHUMP00000164824; OTTHUMP00000210210; OTTHUMP00000210211; OTTHUMP00000210215; OTTHUMP00000210229; OTTHUMP00000210234; pi uptake stimulator; inositol hexaphosphate kinase 2; ATP:1D-myo-inositol-hexakisphosphate phosphotransferase;
SLC3A2
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
4F2; CD98; MDU1; 4F2HC; 4T2HC; NACAE; CD98HC; SLC3A2; 4F2 cell-surface antigen heavy chain; heavy chain; CD98 heavy chain; OTTHUMP00000082735; OTTHUMP00000236708; OTTHUMP00000236709; OTTHUMP00000236712; OTTHUMP00000238367; 4F2 heavy chain antigen Monoclonal 44D7; lymphocyte activation antigen 4F2 large subunit; antigen defined by Monoclonal 4F2, heavy chain; antigen identified by Monoclonal antibodies 4F2, TRA1.10, TROP4, and T43;
B3GAT1
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)
B3GAT1; beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P); CD57, CD57 antigen , LEU7; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1; GlcAT P; HNK 1; NK 1; glcUAT-P; LEU7 antigen; glucuronosyltransferase P; UDP-GlcUA:glyco;
CR1
CR1 complement component (3b/4b) receptor 1 (Knops blood group)
CR1; complement component (3b/4b) receptor 1 (Knops blood group); complement component (3b/4b) receptor 1, including Knops blood group system; complement receptor type 1; CD35; KN; CD35 antigen; C3b/C4b receptor; C3-binding protein; Knops blood group antigen; complement component receptor 1; C3BR; C4BR;
GABRB1
gamma-aminobutyric acid (GABA) A receptor, beta 1
GABRB1; gamma-aminobutyric acid (GABA) A receptor, beta 1; gamma-aminobutyric acid receptor subunit beta-1; GABA(A) receptor; beta 1; GABA(A) receptor, beta 1; GABA(A) receptor subunit beta-1;
GRIA1
glutamate receptor, ionotropic, AMPA 1
GRIA1; glutamate receptor, ionotropic, AMPA 1; GLUH1; GLUR1; GLURA; GluA1; HBGR1; glutamate receptor 1; AMPA 1; gluR-1; gluR-A; gluR-K1; AMPA-selective glutamate receptor 1;
GRIA2
glutamate receptor, ionotropic, AMPA 2
GRIA2; glutamate receptor, ionotropic, AMPA 2; GLUR2; GLURB; GluA2; HBGR2; GluR-K2; glutamate receptor 2; gluR-2; gluR-B; AMPA-selective glutamate receptor 2;
GRIN1
glutamate receptor, ionotropic, N-methyl D-aspartate 1
GRIN1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; NR1; MRD8; GluN1; NMDA1; NMDAR1; glutamate receptor ionotropic, NMDA 1; NMD-R1; glutamate [NMDA] receptor subunit zeta 1; glutamate [NMDA] receptor subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; N-methyl-D-aspartate receptor channel, subunit zeta-1;
GRIN2B
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
GRIN2B; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; MRD6; NR2B; hNR3; GluN2B; NMDAR2B; glutamate receptor ionotropic, NMDA 2B; NR3; glutamate receptor subunit epsilon-2; N-methyl-D-aspartate receptor subunit 3; N-methyl D-aspartate receptor subtype 2B; glutamate [NMDA] receptor subunit epsilon-2;
MYL12A
myosin, light chain 12A, regulatory, non-sarcomeric
MYL12A; myosin, light chain 12A, regulatory, non-sarcomeric; myosin, light polypeptide, regulatory, non sarcomeric (20kD); myosin regulatory light chain 12A; MLCB; MRCL3; MRLC3; MYL2B; myosin regulatory light chain 3; nonsarcomeric; RLC; ML12A_HUMAN; MLC 2B; MLC-2B; Myosin regulatory light chain 2; Myosin regulatory light chain 2, nonsarcomeric; Myosin regulatory light chain MRCL3; Myosin regulatory light chain MRLC3; Myosin RLC; OTTHUMP00000162243; myosin, light polypeptide, regula;
PLCG2
phospholipase C, gamma 2 (phosphatidylinositol-specific)
PLC-gamma2; PLC; Phospholipase C; PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific);
NDUFV2
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa
NDUFV2; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa; NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial; mitochondrial; 24kDa subunit of Complex I; CI-24k; NADH dehydrogenase [ubiquinone] flavoprotein 2; NADH ubiquinone oxidoreductase 24 kDa subunit; NADH-ubiquinone oxidoreductase 24 kDa subunit; NDUV2_HUMAN; Ubiquinoneflavoprotein 2, mitochondrial precursor; NADH dehydrogenase subunit II; NADH dehydrogenase flavoprotein 2; NADH-ubiquinone reductase 24 kDa mitochondrial;
PSMD4
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
PSMD4; proteasome (prosome, macropain) 26S subunit, non-ATPase, 4; 26S proteasome non-ATPase regulatory subunit 4; AF; AF 1; Rpn10; S5A; angiocidin; RPN10 homolog; antisecretory factor 1; S5a/antisecretory factor protein; multiubiquitin chain-binding prot;
QDPR
quinoid dihydropteridine reductase
QDPR; quinoid dihydropteridine reductase; dihydropteridine reductase; 6; 7 dihydropteridine reductase; DHPR; PKU2; SDR33C1; short chain dehydrogenase/reductase family 33C; member 1; DHPR_HUMAN; HDHPR; HPR; OTTHUMP00000158671; OTTHUMP00000217799; OTTHUMP00000217800; OTTHUMP00000217802; OTTHUMP00000217914; OTTHUMP00000217915; 6,7-dihydropteridine reductase; short chain dehydrogenase/reductase family 33C, member 1;
ACY3
aspartoacylase (aminocyclase) 3
ACY3; aspartoacylase (aminocyclase) 3; aspartoacylase-2; ACY 3; HCBP1; MGC9740; 0610006H10Rik; AA3; ACY-3; ACY3_HUMAN; Acylase III; Aminoacylase 3; Aminoacylase III; Aminoacylase-3; ASPA2; Aspartoacylase (aminoacylase) 3; Aspartoacylase 2; AW107362; EC 3.5.1.-; EC 3.5.1.15; Hepatitis C virus core binding protein 1; Hepatitis C virus core-binding protein 1; MGC108859; RGD1305394; OTTHUMP00000235614; OTTHUMP00000235615;
NDUFAF2
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2
NDUFAF2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2; NDUFA12 like , NDUFA12L; mimitin, mitochondrial; B17.2L; mimitin; MMTN; Myc induced mitochondrial protein; NDUFA12-like protein; Myc-induced mitochondrial protein; NDUFA12L; F;
SULT1A2
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
SULT1A2;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2;STP2;sulfotransferase 1A2;HAST4;P-PST 2;aryl sulfotransferase 2;phenol sulfotransferase 2;arylamine sulfotransferase;thermostable phenol sulfotransferase;phenolic-metabolizing (P) form of PST;phenol-preferring phenol sulfotransferase2;phenol-sulfating phenol sulfotransferase 2;P-PST;ST1A2;TSPST2;MGC142287;MGC142289;
LRIT3
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3
LRIT3; leucine-rich repeat, immunoglobulin-like and transmembrane domains 3; leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3; fibronectin type III; immunoglobulin and leucine rich repeat domains 4; FIGLER4; FLJ44691; immunoglobulin-like domain and transmembrane domain-containing protein 3; Leucine-rich repeat; leucine-rich repeat, immunoglobulin like and transmembrane domains 3; LRIT3 protein; LRIT3_HUMAN; MGC120618; OTTHUMP00000205710; fibronectin type III, immunoglobulin and leucine rich repeat domains 4;
AAAS
achalasia, adrenocortical insufficiency, alacrimia
AAAS; achalasia, adrenocortical insufficiency, alacrimia; achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple A); aladin; Allgrove; triple A; Allgrove, triple-A; AAA; AAASb; GL003; ADRACALA; ADRACALIN; DKFZp586G1624;
ACCS
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)
ACCS; 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional); 1-aminocyclopropane-1-carboxylate synthase-like protein 1; ACS; PHACS; ACC synthase-like protein 1;
ACD
adrenocortical dysplasia homolog (mouse)
ACD; adrenocortical dysplasia homolog (mouse); adrenocortical dysplasia protein homolog; Pip1; POT1 and TIN2 organizing protein; Ptop; TIN2 interacting protein 1; Tint1; Tpp1; POT1 and TIN2-interacting protein;
AHCYL1
adenosylhomocysteinase-like 1
AHCYL1; adenosylhomocysteinase-like 1; S adenosylhomocysteine hydrolase like 1; putative adenosylhomocysteinase 2; inositol 1; 4; 5 trisphosphate receptor binding protein; IRBIT; XPVKONA; adoHcyase 2; DC-expressed AHCY-like molecule; S-adenosyl-L-homocyst;
ALAS1
aminolevulinate, delta-, synthase 1
ALAS1; aminolevulinate, delta-, synthase 1; ALAS, ALAS3; 5-aminolevulinate synthase, nonspecific, mitochondrial; mitochondrial; nonspecific; 5 aminolevulinate synthase; 5 aminolevulinate synthase nonspecific mitochondrial; 5 aminolevulinic acid synthase; 5-aminolevulinate synthase; 5-aminolevulinic acid synthase 1; Alas 1; ALAS 3; ALAS; ALAS H; ALAS HOUSEKEEPING TYPE; ALAS N; ALAS-H; ALAS3; ALASH; Aminolevulinate delta synthase 1; Aminolevulinic acid synthase 1; Delta ALA synthetase; Delta aminolevulinate synthase; Delta-ALA synthase 1; Delta-aminolevulinate synthase 1; HEM1_HUMAN; MIG 4; MIG4; Migration inducing protein 4; OTTHUMP00000212619; OTTHUMP00000212620; OTTHUMP00000212621; OTTHUMP00000212622; migration-inducing protein 4;
AMPD2
adenosine monophosphate deaminase 2
AMPD2; adenosine monophosphate deaminase 2; adenosine monophosphate deaminase 2 (isoform L); AMP deaminase 2; AMPD isoform L; adenosine monophosphate deaminase 2 isoform L; AMP deaminase isoform L; AMPD 2; AMPD2_HUMAN; AMPD;
B3GAT3
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)
B3GAT3; beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I); galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3; GlcAT I; Beta 1,3 glucuronyltransferase 3; EC 2.4.1.135; Galactosylgalactosylxylosylprotein 3 beta glucuronosyltransferase 3; GLCATI; GlcUATI; Glucuronosyltransferase I; Sqv 8 like protein; UDP GlcUA:Gal beta 1,3 GalR glucuronyltransferase; glcUAT-I; OTTHUMP00000236456; OTTHUMP00000236457; OTTHUMP00000236459; Sqv-8-like protein; UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase;
BAAT
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)
BAAT; bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase); bile acid Coenzyme A: amino acid N acyltransferase (glycine N choloyltransferase); bile acid-CoA:amino acid N-acyltransferase; BAT; FLJ20300; BACAT; Bile acid CoA:amino acid N acyltransferase; Bile acid Coenzyme A amino acid N acyltransferase glycine N choloyltransferase; Bile acid Coenzyme A: amino acid N acyltransferase; Glycine N choloyltransferase; Long chain fatty acyl CoA hydrolase; MGC104432; OTTHUMP00000021802; long-chain fatty-acyl-CoA hydrolase; bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase);
BAG5
BCL2-associated athanogene 5
BAG5; BCL2-associated athanogene 5; BAG family molecular chaperone regulator 5; bcl-2-associated athanogene 5; BAG-family molecular chaperone regulator-5; BAG-5;
BCAS1
breast carcinoma amplified sequence 1
BCAS1; breast carcinoma amplified sequence 1; breast carcinoma-amplified sequence 1; AIBC1; NABC1; novel amplified in breast cancer 1; amplified and overexpressed in breast cancer;
CD79A
CD79a molecule, immunoglobulin-associated alpha
CD79A; CD79a molecule, immunoglobulin-associated alpha; CD79A antigen (immunoglobulin associated alpha) , IGA; B-cell antigen receptor complex-associated protein alpha chain; MB 1; ig-alpha; MB-1 membrane glycoprotein; surface IgM-associated protein; CD79;
CD79B
CD79b molecule, immunoglobulin-associated beta
CD79B; CD79b molecule, immunoglobulin-associated beta; CD79B antigen (immunoglobulin associated beta) , IGB; B-cell antigen receptor complex-associated protein beta chain; B29; Ig-beta; B-cell-specific glycoprotein B29; immunoglobulin-associated B29 protein; CD79b antigen (immunoglobulin-associated beta); IGB; AGM6;
CER1
cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis)
CER1; cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis); cerberus 1 (Xenopus laevis) homolog (cysteine knot superfamily); cerberus; DAND4; CER 1; CER1_HUMAN; Cerberus 1; Cerberus 1 cysteine knot superfamily homolog (Xenopus laevis); Cerberus related 1; Cerberus related protein; Cerberus-related protein; Cerberus1; DAN domain family member 4; DAND 4; MGC119894; MGC119895; MGC96951; OTTHUMP00000022757; cerberus-related 1;
CLN3
ceroid-lipofuscinosis, neuronal 3
CLN3; ceroid-lipofuscinosis, neuronal 3; BTS; JNCL; battenin; batten disease protein;
CLPP
ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog
CLPP; ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli); ClpP (caseinolytic protease, ATP dependent, proteolytic subunit, E. coli) homolog , ClpP caseinolytic protease, ATP dependent, proteolytic subunit homolog (E. coli);
CMAS
cytidine monophosphate N-acetylneuraminic acid synthetase
CMAS; cytidine monophosphate N-acetylneuraminic acid synthetase; N-acylneuraminate cytidylyltransferase; CMP Neu5Ac synthetase; CMP-NeuNAc synthase; CMP-Neu5Ac synthetase; CMP-NeuNAc synthetase; CMP-N-acetylneuraminic acid synthase; CMP-N-acetylneuraminic;
CNO
cappuccino homolog (mouse)
CNO; cappuccino homolog (mouse); protein cappuccino homolog; BCAS4L; FLJ11230;
CNOT2
CCR4-NOT transcription complex, subunit 2
CNOT2; CCR4-NOT transcription complex, subunit 2; NOT2; CCR4-NOT transcription complex subunit 2; CDC36; NOT2H; CCR4 associated factor 2; CCR4 NOT transcription complex subunit 2; CCR4-associated factor 2; HSPC131; MSTP046; NOT2 (negative regulator of transcription 2 yeast) homolog; OTTHUMP00000241224; OTTHUMP00000241234; OTTHUMP00000241236; negative regulator of transcription 2;
CNOT3
CCR4-NOT transcription complex, subunit 3
CNOT3; CCR4-NOT transcription complex, subunit 3; NOT3; CCR4-NOT transcription complex subunit 3; KIAA0691; LENG2; NOT3 (negative regulator of transcription 3; yeast) homolog; NOT3H; CCR4 associated factor 3; CCR4-associated factor 3; CNOT3_HUMAN; Leukocyte receptor cluster member 2; NOT3 (negative regulator of transcription 3, yeast) homolog; OTTHUMP00000069287; OTTHUMP00000197713;
CNOT7
CCR4-NOT transcription complex, subunit 7
CNOT7; CCR4-NOT transcription complex, subunit 7; CAF1; CCR4-NOT transcription complex subunit 7; BTG1 binding factor 1; BTG1-binding factor 1; CAF 1; CAF-1; Carbon catabolite repressor protein (CCR4) associative factor 1; CCR4 associated factor 1; CCR4 NOT transcription complex subunit 7; CCR4-associated factor 1; CNOT 7; CNOT7_HUMAN; hCAF 1; hCAF1; OTTHUMP00000122444; OTTHUMP00000225203; OTTHUMP00000225205; carbon catabolite repressor protein (CCR4)-associative factor 1; hCAF-1;
CNR1
Cnr1 cannabinoid receptor 1 (brain)
CNR1; cannabinoid receptor 1 (brain); cannabinoid receptor 1; brain-type cannabinoid receptor; striatal cannabinoid receptor type 1 protein; CB1; CB-R; CB1R;
CNR2
cannabinoid receptor 2 (macrophage)
CNR2; cannabinoid receptor 2 (macrophage); CB2; CX5; CB-2; cannabinoid receptor 2; testis-dominant CNR2 isoform CB2;
CTNS
cystinosin, lysosomal cystine transporter
CTNS; cystinosin, lysosomal cystine transporter; cystinosis, nephropathic; cystinosin; CTNS LSB; PQLC4; CTNS-LSB;
DECR2
2,4-dienoyl CoA reductase 2, peroxisomal
DECR2; 2,4-dienoyl CoA reductase 2, peroxisomal; peroxisomal 2,4-dienoyl-CoA reductase; PDCR; SDR17C1; short chain dehydrogenase/reductase family 17C; member 1; 2 4 dienoyl CoA reductase 2; 2 4 dienoyl CoA reductase 2 peroxisomal; 2; 4-dienoyl-CoA reductase 2; 4-dienoyl-CoA reductase; DECR 2; DECR2_HUMAN; EC 1.3.1.34; Peroxisomal 2 4 dienoyl CoA reductase; Peroxisomal 2; Short chain dehydrogenase/reductase family 17C member 1; 2,4-dienoyl-CoA reductase 2; short chain dehydrogenase/reductase family 17C, member 1;
DHODH
dihydroorotate dehydrogenase (quinone)
DHODH; dihydroorotate dehydrogenase (quinone); dihydroorotate dehydrogenase; dihydroorotate dehydrogenase (quinone), mitochondrial; dihydroorotate oxidase; human complement of yeast URA1; URA1; POADS; DHOdehase;
DIAPH1
diaphanous homolog 1 (Drosophila)
DIAPH1; diaphanous homolog 1 (Drosophila); DFNA1, diaphanous (Drosophila, homolog) 1; protein diaphanous homolog 1; hDIA1; LFHL1; FLJ25265; Deafness autosomal dominant 1; deafness, autosomal dominant 1; DFNA1; DIAP1; DIAP1_HUMAN; diaphanous homolog 1; Diaphanous protein homolog 1; Diaphanous related formin 1; Diaphanous-related formin-1; DRF1; low frequency hearing loss 1; p140DIA; OTTHUMP00000195047; OTTHUMP00000195048; OTTHUMP00000195049; OTTHUMP00000224777; diaphanous-related formin 1; DIA1;
DNPEP
aspartyl aminopeptidase
DNPEP; aspartyl aminopeptidase; ASPEP; DAP; OTTHUMP00000064850; OTTHUMP00000064853; OTTHUMP00000227669;
EDEM2
ER degradation enhancer, mannosidase alpha-like 2
EDEM2; ER degradation enhancer, mannosidase alpha-like 2; C20orf31, C20orf49, chromosome 20 open reading frame 31; ER degradation-enhancing alpha-mannosidase-like 2; bA4204.1; FLJ10783; C20orf49; EDEM 2; EDEM2_HUMAN; ER degradation enhancer mannosidase alpha like 2; ER degradation enhancing alpha mannosidase like 2; ER degradation enhancing mannosidase like protein 2; OTTHUMP00000030728; ER degradation-enhancing-mannosidase-like protein 2; C20orf31;
ELAVL4
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D)
ELAVL4; ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D); HUD; ELAV-like protein 4; PNEM; hu-antigen D; paraneoplastic encephalomyelitis antigen HuD; Embryonic lethal, abnormal vision, Drosophila, homolog of, like-4;
EML1
echinoderm microtubule associated protein like 1
EML1; echinoderm microtubule associated protein like 1; EMAPL; echinoderm microtubule-associated protein-like 1; ELP79; EMAP; HuEMAP; EMAL1_HUMAN; EMAP-1; FLJ45033; HuEMAP-1;
EML2
echinoderm microtubule associated protein like 2
EML2; echinoderm microtubule associated protein like 2; echinoderm microtubule-associated protein-like 2; echinoderm MT associated protein (EMAP) like protein 70; ELP70; EMAP 2; EMAP2; microtubule associated protein like echinoderm EMAP; microtubule-assoc;
EML4
echinoderm microtubule associated protein like 4
EML4; echinoderm microtubule associated protein like 4; C2orf2; echinoderm microtubule-associated protein-like 4; ELP120; ROPP120; ropp 120; restrictedly overexpressed proliferation-associated protein; EMAP-4; EMAPL4; FLJ10942; FLJ32318; DKFZp686P18118;
ENO3
enolase 3 (beta, muscle)
ENO3; enolase 3 (beta, muscle); enolase 3, (beta, muscle); beta-enolase; muscle-specific enolase; skeletal muscle enolase; 2-phospho-D-glycerate hydrolyase; MSE; GSD13;
ERAP1
endoplasmic reticulum aminopeptidase 1
ERAP1; endoplasmic reticulum aminopeptidase 1; A LAP; adipocyte derived leucine aminopeptidase; aminopeptidase regulator of TNFR1 shedding; ARTS 1; ERAAP1; KIAA0525; PILS AP; puromycin insensitive leucyl specific aminopeptidase; aminopeptidase PILS; adipo;
FGB
fibrinogen beta chain
FGB; fibrinogen beta chain; fibrinogen, B beta polypeptide; MGC104327; MGC120405;
FGL1
fibrinogen-like 1
FGL1; fibrinogen-like 1; fibrinogen-like protein 1; HFREP 1; FGL 1; FGL1_HUMAN; Fibrinogen like 1; Fibrinogen like protein 1; Fibrinogen related protein 1; Hepassocin; Hepatocellular carcinoma related sequence; Hepatocyte derived fibrinogen related protein 1; Hepatocyte-derived fibrinogen-related protein 1; HFREP-1; HFREP1; HP 041; HP-041; HP041; LFIRE 1; LFIRE-1; LFIRE1; Liver fibrinogen related protein 1; Liver fibrinogen-related protein 1; MFIRE 1; MGC108569; MGC12455; MGC37822; OTTHUMP00000122468; OTTHUMP00000224774; OTTHUMP00000224775; OTTHUMP00000224776; OTTHUMP00000224916; hepatocellular carcinoma-related sequence; hepatocyte-derived fibrinogen-related;
GABBR2
gamma-aminobutyric acid (GABA) B receptor, 2
GABBR2; gamma-aminobutyric acid (GABA) B receptor, 2; G protein coupled receptor 51 , GPR51; gamma-aminobutyric acid type B receptor subunit 2; GABABR2; GPRC3B; HG20; gb2; GABA-BR2; GABA-B-R2; GABA-B receptor 2; GABA-B receptor, R2 subunit; G protein-coup;
GART
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
GART; phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase; PGFT, PRGS; trifunctional purine biosynthetic protein adenosine-3; AIRS; GARS; PAIS; PGFT; PRGS; GARTF; MGC47764;
GCSH
glycine cleavage system protein H (aminomethyl carrier)
GCSH; glycine cleavage system protein H (aminomethyl carrier); glycine cleavage system H protein, mitochondrial; lipoic acid containing protein; mitochondrial; GCE; GCSH_HUMAN; Glycine cleavage system H protein; Glycine cleavage system H protein mitochondrial; Glycine cleavage system protein H; Mitochondrial glycine cleavage system H protein; NKH; OTTHUMP00000174971; lipoic acid-containing protein; mitochondrial glycine cleavage system H-protein;
GML
glycosylphosphatidylinositol anchored molecule like protein
GML; glycosylphosphatidylinositol anchored molecule like protein; GPI anchored molecule like protein; glycosyl-phosphatidylinositol-anchored molecule-like protein; LY6DL; Glycosylphosphatidylinositol-anchored molecule-like protein;
GMPPA
GDP-mannose pyrophosphorylase A
GMPPA; GDP-mannose pyrophosphorylase A; mannose-1-phosphate guanyltransferase alpha; GDP mannose pyrophosphorylase A; GTP mannose 1 phosphate guanylyltransferase alpha; Mannose 1 phosphate guanylyltransferase (GDP); OTTHUMP00000064859; OTTHUMP00000064860; OTTHUMP00000064861; OTTHUMP00000064862; OTTHUMP00000071324; OTTHUMP00000199572; mannose-1-phosphate guanylyltransferase (GDP); GTP-mannose-1-phosphate guanylyltransferase alpha;
GMPPB
GDP-mannose pyrophosphorylase B
GMPPB; GDP-mannose pyrophosphorylase B; mannose-1-phosphate guanyltransferase beta; KIAA1851; mannose-1-phosphate guanylyltransferase; GTP-mannose-1-phosphate guanylyltransferase beta;
GOT2
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)
GOT2; glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2); aspartate aminotransferase, mitochondrial; KAT4; KATIV; kynurenine aminotransferase IV; mitAAT; ASPATA; FABP pm; Got 2; MGC102129; MGC115763; mitochondrial; AATM_HUMAN; AL022787; Aspartate aminotransferase; Aspartate aminotransferase 2; EC 2.6.1.1; FABP 1; FABP-1; FABPpm; Fatty acid binding protein; Fatty acid-binding protein; FLJ40994; Glutamate oxaloacetate transaminase 2; Glutamate oxaloacetate transaminase 2, mitochondrial; Glutamate oxaloacetate transaminase, mitochondrial; Glutamic oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2); mAspAT; Mitochondrial aspartate aminotransferase; OTTMUSP00000017748; Plasma membrane fatty acid binding protein; Plasma membrane-associated fatty acid-binding protein; Transaminase A;
GRIA3
Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3)
GRIA3; glutamate receptor, ionotropic, AMPA3 (alpha 3); glutamate receptor 3; glutamate receptor subunit 3; AMPA-selective glutamate receptor 3; glutamate receptor ionotropic, AMPA 3; glutamate receptor channel alpha3 subunit; GluA3; Glur3; GluR-C; Glur-3; GluR-K3; mKIAA4184; Gluralpha3; 2900064I19Rik; KIAA4184;
GRID1
glutamate receptor, ionotropic, delta 1
GRID1; glutamate receptor, ionotropic, delta 1; glutamate receptor delta-1 subunit; KIAA1220; GluR delta 1; GluR delta 1 subunit; GluR delta-1 subunit; Glutamate receptor delta 1 subunit; Glutamate receptor ionotropic delta 1; GRID 1; GRID1_HUMAN; OTTHUMP00000020002; OTTHUMP00000020003;
GRID2
glutamate receptor, ionotropic, delta 2
GRID2; glutamate receptor, ionotropic, delta 2; glutamate receptor delta-2 subunit; GluR delta 2; GLUR D2; GLURD 2; GLURD2; Glutamate receptor delta 2 subunit; Glutamate receptor ionotropic delta 2; GRID 2; MGC117022; MGC117023; MGC117024; GluR-delta-2; OTTHUMP00000161600; OTTHUMP00000219270; gluR delta-2 subunit;
HYAL1
hyaluronoglucosaminidase 1
HYAL1; hyaluronoglucosaminidase 1; hyaluronidase-1; FUS2; HYAL 1; LUCA1; NAT6; Hyal-1; HYAL1_HUMAN; Hyaluronidase 1; Hyaluronoglucosaminidase-1; Hyaluronoglucosaminidase1; LUCA 1; LUCA-1; Lung carcinoma protein 1; MGC45987; Plasma hyaluronidase; Tumor suppressor LUCA 1; tumor suppressor LUCA-1;
ICT1
immature colon carcinoma transcript 1
ICT1; immature colon carcinoma transcript 1; peptidyl-tRNA hydrolase ICT1, mitochondrial; DS 1; Digestion substraction 1; DS1; Immature colon carcinoma transcript 1 protein; DS-1;
IGDCC4
immunoglobulin superfamily, DCC subclass, member 4
IGDCC4; immunoglobulin superfamily, DCC subclass, member 4; immunoglobulin superfamily DCC subclass member 4; likely ortholog of mouse neighbor of Punc E11; LOC57722; NOPE; DDM 36; DDM36; FLJ42051; hDDM 36; hDDM36; KIAA1628; Neighbor of Punc E11; Protein DDM36; OTTHUMP00000164176;
IGFN1
immunoglobulin-like and fibronectin type III domain containing 1
IGFN1; immunoglobulin-like and fibronectin type III domain containing 1; immunoglobulin-like and fibronectin type III domain-containing protein 1; DKFZp434B1231; EEF1A2BP1; EEF1A2-binding protein 1; immunoglobulin like and fibronectin type III domain containing 1; KY interacting protein 1; eEF1A2 binding protein; KY-interacting protein 1;
IGHV4-30-1
Immunoglobulin Heavy Variable 4-30-1
IGHV4-30-1; IGHV4-3; immunoglobulin heavy variable 4-30-1;
IGSF6
immunoglobulin superfamily, member 6
immunoglobulin superfamily member 6; down-regulated by activation (immunoglobulin superfamily); IGSF6; Protein DORA; DORA; OTTHUMP00000115880; immunoglobulin superfamily, member 6;
IGSF8
immunoglobulin superfamily, member 8
IGSF8; immunoglobulin superfamily, member 8; EWI2; PGRL; CD316; EWI-2; KCT-4; CD81P3; LIR-D1; immunoglobulin superfamily member 8; CD81 partner 3; prostaglandin regulatory-like protein; glu-Trp-Ile EWI motif-containing protein 2; keratinocytes-associated transmembrane protein 4;
INPP4A
inositol polyphosphate-4-phosphatase, type I, 107kDa
INPP4A; inositol polyphosphate-4-phosphatase, type I, 107kDa; inositol polyphosphate 4 phosphatase, type I, 107kD , INPP4; type I inositol 3,4-bisphosphate 4-phosphatase; type I inositol-3,4-bisphosphate 4-phosphatase; INPP4; TVAS1;
INPP5D
inositol polyphosphate-5-phosphatase, 145kDa
INPP5D; inositol polyphosphate-5-phosphatase, 145kDa; inositol polyphosphate 5 phosphatase, 145kD; phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1; hp51CN; SHIP; SHIP-1; p150Ship; SH2 domain-containing inositol phosphatase 1; SH2 containing inositol phosphatase, isoform b; SH2 domain-containing inositol 5-phosphatase 1; SH2 domain-containing inositol-5-phosphatase 1; inositol polyphosphate-5-phosphatase of 145 kDa; signaling inositol polyphosphate 5 phosphatase SIP-145; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1; SHIP1; SIP-145; MGC104855; MGC142140; MGC142142;
ITPK1
inositol-tetrakisphosphate 1-kinase
ITPK1; inositol-tetrakisphosphate 1-kinase; inositol 1,3,4 triphosphate 5/6 kinase; ins(1,3,4)P(3) 5/6-kinase; inositol-triphosphate 5/6-kinase; inositol 1,3,4-triphosphate 5/6 kinase; inositol 1,3,4-trisphosphate 5/6 kinase; inositol 1,3,4-trisphosphate;
ITPKB
inositol-trisphosphate 3-kinase B
ITPKB; inositol-trisphosphate 3-kinase B; inositol 1,4,5 trisphosphate 3 kinase B; IP3 3KB; IP3KB; 1D myo inositol trisphosphate 3 kinase B; Inositol 1 4 5 trisphosphate 3 kinase B; Inositol trisphosphate 3 kinase B; IP3 3 kinase; IP3 3 kinase B; IP3K; IP3K B; PIG 37; PIG37; Proliferation inducing protein 37; IP3 3-kinase B; insP 3-kinase B; OTTHUMP00000035705; proliferation-inducing protein 37; inositol 1,4,5-trisphosphate 3-kinase B; IP3K-B; IP3-3KB;
ITPR1
Itpr1 inositol 1,4,5-trisphosphate receptor 1
ITPR1; inositol 1,4,5-trisphosphate receptor 1; inositol 1,4,5-trisphosphate receptor type 1; IP3R 1; insP3R1; IP3 receptor; opisthotonus; InsP3R type I; protein PCD-6; InsP> 3< R type I; type 1 InsP3 receptor; Purkinje cell protein 1; inositol 1,4,5-triphosphate receptor 1; type 1 inositol 1,4,5-trisphosphate receptor; inositol 1,4,5-trisphosphate-binding protein P400; opt; Ip3r; P400; Pcp1; IP3R1; Pcp-1; D6Pas2; InsP3R; Itpr-1; Gm10429; ENSMUSG00000072853;
LILRA3
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
LILRA3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3; leukocyte immunoglobulin-like receptor subfamily A member 3; CD85e; HM31; HM43; ILT6; LIR 4; LIR4; CD 85E; CD85 antigen-like family member E; CD85e antigen; e3; HM 31; HM 43; ILT 6; ILT-6; Immunoglobulin like transcript 6; Immunoglobulin-like transcript 6; Leucocyte immunoglobulin like receptor; Leukocyte immunoglobulin like receptor 4; Leukocyte immunoglobulin like receptor A3; Leukocyte immunoglobulin like receptor subfamily A (without TM domain) member 3; Leukocyte immunoglobulin like receptor subfamily A member 3; Leukocyte immunoglobulin-like receptor 4; LILRA 3; LIR-4; LIRA3_HUMAN; Monocyte inhibitory receptor HM43/HM31; OTTHUMP00000067955; OTTHUMP00000067956; OTTHUMP00000067957; leucocyte immunoglobulin-like receptor; monocyte inhibitory recept;
LILRB1
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
LILRB1; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1; leukocyte immunoglobulin-like receptor subfamily B member 1; CD85; CD85j; ILT2; LIR 1; LIR1; MIR 7; ILT-2; CD85 antigen; Ig-like transcript 2; leukocyte Ig-like receptor-1; immunoglobulin-like transcript 2; CD85 antigen-like family member J; leukocyte immunoglobulin-like receptor 1; monocyte/macrophage immunoglobulin-like receptor 7; leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform; MIR7; LIR-1; MIR-7; FLJ37515;
LILRB2
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
LILRB2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; leukocyte immunoglobulin-like receptor subfamily B member 2; CD85d; ILT4; LIR 2; LIR2; MIR 10; MIR10; ILT-4; Ig-like transcript 4; immunoglobulin-like transcript 4; CD85 antigen-like family member D; leukocyte immunoglobulin-like receptor 2; monocyte/macrophage immunoglobulin-like receptor 10; leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform; eukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6; LIR-2; LILRA6; MIR-10;
LRAT
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
LRAT; lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase); lecithin retinol acyltransferase; LCA14; MGC33103;
MAN1B1
mannosidase, alpha, class 1B, member 1
MAN1B1; mannosidase, alpha, class 1B, member 1; endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase; alpha 1; 2 mannosidase; endoplasmic reticulum alpha mannosidase 1; endoplasmic reticulum mannosyl oligosaccharide 1; 2 alpha mannosidase;
MCCC1
methylcrotonoyl-CoA carboxylase 1 (alpha)
MCCC1; methylcrotonoyl-CoA carboxylase 1 (alpha); methylcrotonoyl Coenzyme A carboxylase 1 (alpha); methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial; MCCA; 3-methylcrotonyl-CoA carboxylase 1; MCCase subunit alpha; OTTHUMP00000212827; OTTHUMP00000212828; OTTHUMP00000212829; OTTHUMP00000212832; methylcrotonoyl-Coenzyme A carboxylase 1 (alpha); 3-methylcroto; MCC-B;
MGAT4A
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A
MGAT4A; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A; mannosyl (alpha 1,3 ) glycoprotein beta 1,4 N acetylglucosaminyltransferase, isoenzyme A; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferas;
MOGAT3
monoacylglycerol O-acyltransferase 3
MOGAT3; monoacylglycerol O-acyltransferase 3; 2-acylglycerol O-acyltransferase 3; DC7; DGAT2L7; 2 acylglycerol O acyltransferase 3; Acyl CoA:monoacylglycerol acyltransferase 3; Acyl coenzyme A:monoacylglycerol acyltransferase 3; Acyl-CoA:monoacylglycerol acyltransferase 3; DC 7; Diacylglycerol acyltransferase 2 like protein 7; Diacylglycerol acyltransferase 2-like protein 7; Diacylglycerol O acyltransferase candidate 7; Diacylglycerol O-acyltransferase candidate 7; hDC 7; hDC7; MGAT 3; MGAT3; MGC119203; MGC119204; MOGAT 3; MOGT3_HUMAN; Monoacylglycerol O acyltransferase 3; OTTHUMP00000024946; OTTHUMP00000211465; OTTHUMP00000211466; acyl coenzyme A:monoa;
MRC1
mannose receptor, C type 1
MRC1; mannose receptor, C type 1; MMR; CD206; MRC1L1; CLEC13D; CLEC13DL; bA541I19.1; macrophage mannose receptor 1; mannose receptor, C type 1-like 1; C-type lectin domain family 13 member D; macrophage mannose receptor 1-like protein 1;
MRC2
mannose receptor, C type 2
MRC2; mannose receptor, C type 2; C-type mannose receptor 2; CD280; CLEC13E; ENDO180; KIAA0709; C-type lectin domain family 13 member E; CD 280; CD280 antigen; CLEC 13E; ENDO 180; Endocytic receptor (macrophage mannose receptor family); Endocytic receptor 180; FLJ35911; Macrophage mannose receptor 2; Mannose receptor C type 2; MRC 2; MRC2_HUMAN; UPAR-associated protein; UPARAP; Urokinase plasminogen activator receptor associated protein; Urokinase receptor associated protein; Urokinase receptor-associated protein; Urokinase-type plasminogen activator receptor-associated protein; urokinase plasmino;
MREG
melanoregulin
MREG; melanoregulin; DSU; FLJ10116; WDT2; Dilute suppressor; Dilute suppressor protein homolog; MGC90296; OTTHUMP00000206794; OTTHUMP00000206795; OTTHUMP00000206796; WDT 2; Whn dependent transcript 2; OTTHUMP00000206792; whn-dependent transcript 2;
MRTO4
mRNA turnover 4 homolog (S. cerevisiae)
MRTO4; mRNA turnover 4 homolog (S. cerevisiae); C1orf33, chromosome 1 open reading frame 33 , MRT4, mRNA turnover 4, homolog (S. cerevisiae); mRNA turnover protein 4 homolog; dJ657E11.4; MRT4; 60S acidic ribosomal protein PO; mRNA turnover 4 homolog; MRT 4; MRT4 mRNA turnover 4 homolog; MRTO 4; Ribosomal protein large P0 like; Ribosomal protein P0 like protein; OTTHUMP00000002580; MRT4, mRNA turnover 4, homolog; C1orf33;
MYL6B
myosin, light chain 6B, alkali, smooth muscle and non-muscle
MYL6B; myosin, light chain 6B, alkali, smooth muscle and non-muscle; myosin, light polypeptide 6B, alkali, smooth muscle and non muscle; myosin light chain 6B; MLC1SA; myosin light chain 1 slow a; MYL 6B; MYL6B_HUMAN; Myosin alkali light chain 1 slow a; Myosin light chain 1 slow twitch muscle A isoform; Myosin light chain 1 slow-twitch muscle A isoform; Myosin light chain 6B alkali smooth muscle and non muscle; Myosin light polypeptide 6B alkali smooth muscle and non muscle; Myosin light polypeptide 6B; Smooth muscle and non muscle myosin alkali light chain 6B; Smooth muscle and nonmuscle myosin light chain alkali 6B; OTTHUMP00000243208; OTTHUMP00000243210; OTTHUMP00000243299; myosin light chain 1, slow-twitch muscle A isoform; smooth muscl;
NAAA
N-acylethanolamine acid amidase
NAAA; N-acylethanolamine acid amidase; ASAHL, N acylsphingosine amidohydrolase (acid ceramidase) like; N-acylethanolamine-hydrolyzing acid amidase; Acid ceramidase like protein; ASAH like protein; N acylethanolamine acid amidase; N acylethanolamine hydrolyzing acid amidase; N acylsphingosine amidohydrolase (acid ceramidase) like; N acylsphingosine amidohydrolase like; N acylsphingosine amidohydrolase like protein; PLT; ASAH-like protein; OTTHUMP00000219231; OTTHUMP00000219430; OTTHUMP00000221103; acid ceramidase-like protein; ASAHL;
NCAPD2
non-SMC condensin I complex, subunit D2
NCAPD2; non-SMC condensin I complex, subunit D2; CNAP1; CAP-D2; hCAP-D2; condensin complex subunit 1; XCAP-D2 homolog; chromosome-associated protein D2; chromosome condensation related SMC associated protein 1; chromosome condensation-related SMC-associated protein 1;
NCAPD3
non-SMC condensin II complex, subunit D3
NCAPD3; non-SMC condensin II complex, subunit D3; condensin-2 complex subunit D3; CAP D3; FLJ42888; hCAP D3; hcp 6; hHCP 6; KIAA0056; CAPD 3; CAPD3; Condensin II complex subunit D3; Hcp6; hHCP6; MGC104671; NCAPD 3; Non SMC condensin II complex subunit D3; OTTHUMP00000235403; OTTHUMP00000235404; hcp-6; CAP-D3; hHCP-6; hCAP-D3;
NCAPG
non-SMC condensin I complex, subunit G
NCAPG; non-SMC condensin I complex, subunit G; condensin complex subunit 3; CAP G; chromosome condensation protein G; FLJ12450; hCAP G; XCAP-G homolog; condensin subunit CAP-G; melanoma antigen NY-MEL-3; chromosome-associated protein G; CAPG; CHCG; HCAP-G;
NCAPH
non-SMC condensin I complex, subunit H
NCAPH; non-SMC condensin I complex, subunit H; barren (Drosophila) homolog , barren homolog (Drosophila) , barren homolog 1 (Drosophila) , BRRN1; condensin complex subunit 2; CAP H; hCAP H; XCAP-H homolog; barren homolog 1; barren homolog protein 1; chr;
NDUFA9
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa
NDUFA9; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (39kD) , NDUFS2L; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial; CI 39k; complex I 39kDa subunit; SDR;
NDUFAB1
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa
NDUFAB1; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 (8kD, SDAP); acyl carrier protein, mitochondrial; ACP; acyl carrier protein; mitochondrial; complex I SDAP subunit; FASN2A; SDAP; Acyl carrier protein mitochondrial; CI SDAP; FASN 2A; MGC65095; Mitochondrial acyl carrier protein; NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 8kDa; NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1; NADH ubiquinone oxidoreductase 9.6 kDa subunit; NADH ubiquinone oxidoreductase SDAP subunit; NDUFAB 1; CI-SDAP; OTTHUMP00000122463; NADH:ubiquinone oxidoreductase SDAP subunit; NADH-ubiquinone oxidoreductase 9.6 kDa subunit;
NDUFAF1
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1
NDUFAF1; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1; complex I intermediate-associated protein 30, mitochondrial; CGI 65; CIA30; mitochondrial; CGI65; CIA30_HUMAN; Complex I intermediate associated protein 30; Complex I intermediate associated protein 30 mitochondrial; Complex I intermediate-associated protein 30; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 1; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1; NDUFAF 1; CGI-65;
NDUFB11
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa
NDUFB11; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial; complex I NP17.3 subunit; ESSS; Np15; NP17.3; CI ESSS; Complex I ESSS; FLJ20494; MGC111182; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 11 17.3kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 11; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11 mitochondrial; NADH ubiquinone oxidoreductase ESSS subunit; NDUFB 11; Neuronal protein 17.3; P17.3; CI-ESSS; complex I-ESSS; OTTHUMP00000023193; OTTHUMP00000023194; NADH-ubiquinone oxidoreductase ESSS subunit;
NDUFB3
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa
NDUFB3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3 (12kD, B12); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3; B12; complex I B12 subunit; CI B12; Complex I B12; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 12kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3; NADH ubiquinone oxidoreductase B12 subunit; NDUFB 3; CI-B12; complex I-B12; OTTHUMP00000163716; OTTHUMP00000206488; OTTHUMP00000206489; NADH-ubiquinone oxidoreductase B12 subunit;
NDUFB5
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa
NDUFB5; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 (16kD, SGDH); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial; CI SGDH; complex I SGDH subunit; MGC12314; SGDH; Complex I SGDH; DKFZp686N02262; FLJ30597; MGC111204; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 5; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 5 16kDa; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5 mitochondrial; NADH ubiquinone oxidoreductase SGDH subunit; complex I-SGDH; OTTHUMP00000212214; OTTHUMP00000212215; OTTHUMP00000212257; OTTHUMP00000212259; NADH-ubiquinone oxidoreductase SGDH subunit; CISGDH;
NDUFB7
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa
NDUFB7; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18kD, B18); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7; B18; CI B18; complex I B18 subunit; MGC2480; NADH ubiquinone oxidoreductase B18 subunit; 1110002H15Rik; Cell adhesion protein SQM1; Complex I B18; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 7 18kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 7; complex I-B18; NADH-ubiquinone oxidoreductase B18 subunit; CI-B18;
NDUFV1
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa
NDUFV1; NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa; NADH dehydrogenase (ubiquinone) flavoprotein 1 (51kD); NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial; CI 51K; complex I 51kDa subunit; NADH dehydrogenase [ubiquinone] flavoprotein 1; mitochondrial; CI 51kD; CI-51kD; Complex I 51kD; Complex I-51kD; FLJ59059; NADH dehydrogenase (ubiquinone) flavoprotein 1; NADH dehydrogenase flavoprotein 1; NADH ubiquinone oxidoreductase 51 kDa subunit; NADH ubiquinone oxidoreductase; NADH-ubiquinone oxidoreductase 51 kDa subunit; NDUFV 1; NDUV1_HUMAN; UQOR1; OTTHUMP00000232178; OTTHUMP00000232181; OTTHUMP00000232183; OTTHUMP00000232187; complex I 51 kda subunit; complex I, mitochondrial respiratory chain; NADH-ubiquinone oxidoredu; CI-51K; CI51KD;
NODAL
nodal growth differentiation factor
NODAL; nodal growth differentiation factor; HTX5; nodal homolog;
NOP16
NOP16 nucleolar protein homolog (yeast)
NOP16; NOP16 nucleolar protein homolog (yeast); nucleolar protein 16 homolog (yeast); nucleolar protein 16; HBV pre S2 trans regulated protein 3; HSPC111; HSPC185; hypothetical protein HSPC111; LOC51491; CGI 117; NOP16 Gene; NOP16 nucleolar protein homolog; Nucleolar protein 16 homolog; OTTHUMP00000223274; OTTHUMP00000223277; OTTHUMP00000223273; HBV pre-S2 trans-regulated protein 3;
NOTCH2NL
notch 2 N-terminal like
NOTCH2NL; notch 2 N-terminal like; Notch homolog 2 (Drosophila) N terminal like; notch homolog 2 N-terminal-like protein; N2N; Notch homolog 2 (Drosophila) N-terminal like; OTTHUMP00000015594; Notch homolog 2 N-terminal like protein;
NPEPL1
aminopeptidase-like 1
NPEPL1; aminopeptidase-like 1; probable aminopeptidase NPEPL1; bA261P9.2; FLJ11583; Aminopeptidase like 1; KIAA1974; NPEPL 1; OTTHUMP00000206100; OTTHUMP00000235827; OTTHUMP00000235828;
PAPSS2
3-phosphoadenosine 5-phosphosulfate synthase 2
PAPSS2; 3-phosphoadenosine 5-phosphosulfate synthase 2; bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 2; ATPSK2; SK 2; PAPSS 2; PAPS synthase 2; PAPS synthetase 2; ATP sulfurylase/APS kinase 2; ATP sulfurylase/adenosine 5-phosphosulfate kinase;
PCK1
phosphoenolpyruvate carboxykinase 1 (soluble)
PCK1; phosphoenolpyruvate carboxykinase 1 (soluble); PEPCK1; PEPCKC; PEPCK-C; phosphoenolpyruvate carboxykinase, cytosolic [GTP]; PEP carboxykinase; phosphopyruvate carboxylase; phosphoenolpyruvate carboxylase; phosphoenolpyruvate carboxykinase, cytosolic;
PGA3
pepsinogen 3, group I (pepsinogen A)
PGA3; pepsinogen 3, group I (pepsinogen A); pepsin A; DKFZp666J2410; pepsinogen 3 group I (pepsinogen A); Pepsinogen 3 group I; pepsinogen A3; OTTHUMP00000237816; OTTHUMP00000238421; PGA4; PGA5;
PGA5
pepsinogen 5, group I (pepsinogen A)
PGA5; pepsinogen 5, group I (pepsinogen A); pepsin A; Pepsinogen 5 group I; Pepsinogen A5; OTTHUMP00000237822; PGA3; PGA4;
PIBF1
progesterone immunomodulatory binding factor 1
PIBF1; progesterone immunomodulatory binding factor 1; C13orf24, chromosome 13 open reading frame 24; progesterone-induced-blocking factor 1; progesterone induced blocking factor 1; KIAA1008; PIBF 1; PIBF; RP11 505F3.1; OTTHUMP00000018501; progesterone-induced blocking factor 1; C13orf24; RP11-505F3.1;
PIGO
phosphatidylinositol glycan anchor biosynthesis, class O
PIGO; phosphatidylinositol glycan anchor biosynthesis, class O; phosphatidylinositol glycan, class O; GPI ethanolamine phosphate transferase 3; DKFZp434M222; FLJ00135; MGC20536; MGC3079; FLJ00350; mFLJ00350; OTTHUMP00000021324; OTTHUMP00000021325; OTTMUSP00000007085; Phosphatidylinositol glycan anchor biosynthesis class O; Phosphatidylinositol glycan biosynthesis class O protein; Phosphatidylinositol glycan class O; PIG O; RP11-182N22.4; RP23-124L1.7; PIG-O; phosphatidylinositol-glycan biosynthesis class O protein;
PIK3C2B
phosphoinositide-3-kinase, class 2, beta polypeptide
PIK3C2B; phosphoinositide-3-kinase, class 2, beta polypeptide; phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit beta; C2 PI3K; PI3K C2beta; PI3K-C2beta; PI3K-C2-beta; PTDINS-3-kinase C2 beta; ptdIns-3-kinase C2 subunit beta; phosphoi;
PIK3R4
phosphoinositide-3-kinase, regulatory subunit 4
PIK3R4; phosphoinositide-3-kinase, regulatory subunit 4; phosphoinositide 3-kinase regulatory subunit 4; p150; VPS15; PI3-kinase p150 subunit; PI3-kinase regulatory subunit 4; phosphoinositide 3-kinase adaptor protein; phosphatidylinositol 3-kinase-associ;
PIKFYVE
phosphoinositide kinase, FYVE finger containing
PIKFYVE; phosphoinositide kinase, FYVE finger containing; phosphatidylinositol 3 phosphate/phosphatidylinositol 5 kinase, type III , PIP5K3; 1-phosphatidylinositol 3-phosphate 5-kinase; KIAA0981; MGC40423; p235; PIP5K; PIPkin-III; type III PIP ki;
PKNOX1
PBX/knotted 1 homeobox 1
PKNOX1; PBX/knotted 1 homeobox 1; homeobox protein PKNOX1; PREP1; human homeobox containing protein; Pbx regulating protein 1; PBX/knotted homeobox 1; homeobox protein PREP-1; Pbx regulating protein-1; human homeobox-containing protein; pkonx1c;
PKNOX2
PBX/knotted 1 homeobox 2
PKNOX2; PBX/knotted 1 homeobox 2; homeobox protein PKNOX2; FLJ13074; Homeobox protein PREP 2; PBX/knotted homeobox 2; PREP2; OTTHUMP00000231418; OTTHUMP00000231419; OTTHUMP00000231420; homeobox protein PREP-2;
PLAG1
pleiomorphic adenoma gene 1
PLAG1; pleiomorphic adenoma gene 1; zinc finger protein PLAG1; ZNF912; FGFR1/PLAG1 fusion variant 3; PLAG1_HUMAN; Pleiomorphic adenoma gene 1 protein; PSA; SGPA; OTTHUMP00000226422; OTTHUMP00000226423; OTTHUMP00000226424; COL1A2/PLAG1 fusion;
PLGLB2
plasminogen-like B2
PLGLB2; plasminogen-like B2; plasminogen pseudogene 1 , PLGP1; plasminogen-related protein B; Plasminogen like B2; Plasminogen pseudogene 1; Plasminogen related protein B; PLGLB 2; PLGP 1; PLGP1; Type B plasminogen related; OTTHUMP00000160773; OTTHUMP00000203594; PLGLB1;
POMC
proopiomelanocortin
POMC; proopiomelanocortin; LPH; MSH; NPP; POC; ACTH; CLIP; adrenocorticotropic hormone; adrenocorticotropin; alpha-melanocyte stimulating hormone; beta-endorphin; beta-lipotropin; beta-melanocyte stimulating hormone; Pro-opiomelanocortin; Corticotropin-lipotropin; Melanotropin gamma; Gamma-MSH; Potential peptide; Corticotropin; Adrenocorticotropic hormone; Melanotropin alpha; Alpha-MSH; Corticotropin-like intermediary peptide; Lipotropin beta; Beta-LPH; Lipotropin gamma; Gamma-LPH; Melanotropin beta; Beta-MSH; Beta-endorphin; Met-enkephalin; pro-opiomelanocortin; beta-LPH; beta-MSH; alpha-MSH; gamma-LPH; gamma-MSH; beta-endorphin; met-enkephalin; lipotropin beta; lipotropin gamma; melanotropin beta; OTTHUMP00000119991; OTTHUMP00000200964; OTTHUMP00000200965; OTTHUMP00000200966; melanotropin alpha; melanotropin gamma; pro-ACTH-endorphin; adrenocorticotropin; corticotropin-lipotropin; proopiomelanocortin preproprotein; corticotropin-like intermediary peptide;
POMGNT1
protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase
POMGNT1; protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase; protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1; FLJ20277; MGAT1.2; protein O mannose beta 1; 2 N acetylglucosaminyltransferase; UDP-GlcNAc:alpha-D-mannoside be;
PPOX
protoporphyrinogen oxidase
PPOX; protoporphyrinogen oxidase; variegate porphyria , VP; PPO; VP; V290M; MGC8485;
PRKAB1
protein kinase, AMP-activated, beta 1 non-catalytic subunit
PRKAB1; protein kinase, AMP-activated, beta 1 non-catalytic subunit; AMPK; HAMPKb; 5-AMP-activated protein kinase subunit beta-1; AMPKb; AMPK beta 1; AMPK beta -1 chain; AMPK subunit beta-1; AMP-activated protein kinase beta subunit; 5-AMP-activated protein kinase beta-1 subunit; protein kinase, AMP-activated, noncatalytic, beta-1;
PRKAB2
protein kinase, AMP-activated, beta 2 non-catalytic subunit
PRKAB2; protein kinase, AMP-activated, beta 2 non-catalytic subunit; 5-AMP-activated protein kinase subunit beta-2; AMPK beta 2; AMPK beta-2 chain; AMPK subunit beta-2; 5-AMP-activated protein kinase, beta-2 subunit; MGC61468;
PRKAG1
protein kinase, AMP-activated, gamma 1 non-catalytic subunit
PRKAG1; protein kinase, AMP-activated, gamma 1 non-catalytic subunit; 5-AMP-activated protein kinase subunit gamma-1; AMPK gamma1; AMPK gamma-1 chain; 5-AMP-activated protein kinase, gamma-1 subunit; AMPKG; MGC8666;
PSMD14
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14
PSMD14; proteasome (prosome, macropain) 26S subunit, non-ATPase, 14; 26S proteasome non-ATPase regulatory subunit 14; pad1; POH1; Rpn11; 26S proteasome regulatory subunit rpn11; 26S proteasome-associated PAD1 homolog 1;
PSMD5
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5
PSMD5; proteasome (prosome, macropain) 26S subunit, non-ATPase, 5; 26S proteasome non-ATPase regulatory subunit 5; KIAA0072; S5B; 26S proteasome subunit S5B; 26S protease subunit S5 basic; MGC23145;
PSMD6
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6
PSMD6; proteasome (prosome, macropain) 26S subunit, non-ATPase, 6; 26S proteasome non-ATPase regulatory subunit 6; KIAA0107; p44S10; Rpn7; S10; 26S proteasome regulatory subunit RPN7; 26S proteasome regulatory subunit S10; Breast cancer-associated protein SGA-113M; p42A; PFAAP4; Phosphonoformate immuno-associated protein 4; Proteasome regulatory particle subunit p44S10; SGA-113M; OTTHUMP00000213406; OTTHUMP00000213407; OTTHUMP00000213408; phosphonoformate immuno-ass;
PSMD7
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
PSMD7; proteasome (prosome, macropain) 26S subunit, non-ATPase, 7; proteasome (prosome, macropain) 26S subunit, non ATPase, 7 (Mov34 homolog); 26S proteasome non-ATPase regulatory subunit 7; MOV34; Mov34 homolog; P40; Rpn8; S12; proteasome subunit p40; 26S proteasome regulatory subunit S12; 26S proteasome regulatory subunit rpn8; Moloney leukemia virus-34 proviral integration; proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 (Mov34 homolog);
PSMD9
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
PSMD9; proteasome (prosome, macropain) 26S subunit, non-ATPase, 9; 26S proteasome non-ATPase regulatory subunit 9; p27; Rpn4; homolog of rat Bridge 1; 26S proteasome regulatory subunit p27; proteasome 26S non-ATPase regulatory subunit 9; MGC8644;
RAB15
RAB15, member RAS onocogene family
RAB15; RAB15, member RAS onocogene family; ras-related protein Rab-15; Rab 15; RAB15 member RAS onocogene family; Ras related protein Rab 15; Ras related protein Rab15; RAB15, member RAS oncogene family;
RBBP6
retinoblastoma binding protein 6
RBBP6; retinoblastoma binding protein 6; E3 ubiquitin-protein ligase RBBP6; P2P R; PACT; proliferation potential related protein; SNAMA; protein P2P-R; RB-binding Q-protein 1; retinoblastoma-binding Q protein 1; proliferation potential-related protein; p5;
RBBP9
retinoblastoma binding protein 9
RBBP9; retinoblastoma binding protein 9; putative hydrolase RBBP9; Bog; B5T overexpressed gene protein; B5T-overexpressed gene protein; Bog protein; MGC9236; OTTHUMP00000030360; Protein BOG; RBBP 10; RBBP 9; RBBP-10; RBBP-9; RBBP10; RBBP9_HUMAN; Retinoblastoma binding protein 10; Retinoblastoma-binding protein 10; Retinoblastoma-binding protein 9; Retinoma binding protein 9; retinoma-binding protein 9;
RBL2
retinoblastoma-like 2 (p130)
RBL2; retinoblastoma-like 2 (p130); retinoblastoma-like protein 2; p130; Rb2; PRB2; RBR-2; retinoblastoma-related protein 2; 130 kDa retinoblastoma-associated protein; FLJ26459;
RBP3
retinol binding protein 3, interstitial
RBP3; retinol binding protein 3, interstitial; retinol-binding protein 3; D10S64; D10S65; D10S66; Interphotoreceptor retinoid binding protein; Interphotoreceptor retinoid-binding protein; Interstitial retinol binding protein; Interstitial retinol-binding protein; IRBP; RBP 3; RBPI; RET3_HUMAN; Retinol binding protein 3; Retinol binding protein 3 interstitial; OTTHUMP00000019536;
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
RBPJ; recombination signal binding protein for immunoglobulin kappa J region; SUH; csl; AOS3; CBF1; KBF2; RBP-J; RBPJK; IGKJRB; RBPSUH; IGKJRB1; recombining binding protein suppressor of hairless; CBF-1; RBP-JK; RBP-J kappa; H-2K binding factor-2; suppressor of hairless homolog; renal carcinoma antigen NY-REN-30; immunoglobulin kappa J region recombination signal binding protein 1;
RDH11
retinol dehydrogenase 11 (all-trans/9-cis/11-cis)
RDH11; retinol dehydrogenase 11 (all-trans/9-cis/11-cis); retinol dehydrogenase 11 (all trans and 9 cis); retinol dehydrogenase 11; androgen regulated short chain dehydrogenase/reductase 1; ARSDR1; MDT1; SDR7C1; short chain dehydrogenase/reductase family 7C; member 1; C85936; CGI 82; RALR1; Androgen-regulated short-chain dehydrogenase/reductase 1; AU045252; FLJ32633; HCBP12; HCV core binding protein; HCV core binding protein HCBP12; HCV core-binding protein HCBP12; Prostate short chain dehydrogenase/reductase 1; Prostate short-chain dehydrogenase/reductase 1; PSDR1; RDH11_HUMAN; Retinal reductase 1; retinol dehydrogenase 11 (all trans/9 cis/11 cis); SCALD; Short chain dehydrogenase/reductase family 7C, member 1; OTTHUMP00000245403; OTTHUMP00000245404; OTTHUMP00000245405; OTTHUMP00000245538; prostate short-chain dehydrogenase reductase 1; short ch; CGI82;
RNPEP
arginyl aminopeptidase (aminopeptidase B)
RNPEP; arginyl aminopeptidase (aminopeptidase B); aminopeptidase B; AMPB_HUMAN; Ap B; AP-B; APB; Arginine aminopeptidase; Arginyl aminopeptidase; OTTHUMP00000034046; OTTHUMP00000034047; OTTHUMP00000034048;
RXRG
RXRG retinoid X receptor, gamma
RXRG; retinoid X receptor, gamma; retinoic acid receptor RXR-gamma; NR2B3; nuclear receptor subfamily 2 group B member 3; RXRC;
SEMA4B
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B
SEMA4B; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; SEMAC; semaphorin-4B; KIAA1745; MGC131831; SemC; Sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain (semaphorin) 4B; Sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain 4B; Semaphorin 4B; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4B;
SEMA4D
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
SEMA4D; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; CD100; SEMAJ; coll-4; C9orf164; M-sema-G; semaphorin-4D; A8; GR3; BB18; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D;
SEMA7A
sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A
SEMA7A; sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A; Semal; CDw108; H-Sema-L; M-Sema-L; 2900057C09Rik; semaphorin-7A; sema L; sema K1; H-Sema K1; semaphorin-L; Semaphorin K1; semaphorin-K1;
SLC18A1
solute carrier family 18 (vesicular monoamine), member 1
SLC18A1; solute carrier family 18 (vesicular monoamine), member 1; VAT1, VMAT1; chromaffin granule amine transporter; CGAT; 4832416I10Rik; Adrenal chromaffin granule amine transporter; MGC28683; MGC37299; Solute carrier family 18 member 1; VAT 1; VAT1; Vesicular amine transporter 1; VMAT 1; VMAT1_HUMAN; OTTHUMP00000122508; OTTHUMP00000224712; OTTHUMP00000224713; OTTHUMP00000224714; OTTHUMP00000237226; VMAT1;
SLC36A2
solute carrier family 36 (proton/amino acid symporter), member 2
SLC36A2; solute carrier family 36 (proton/amino acid symporter), member 2; proton-coupled amino acid transporter 2; PAT2; TRAMD1; tramdorin; MGC119660; A530067G19Rik; FLJ16051; MGC119658; Proton coupled amino acid transporter 2; Proton/amino acid transporter 2; Solute carrier family 36 (proton/amino acid symporter) member 2; Solute carrier family 36 member 2; Tramdorin 1; tramdorin-1; OTTHUMP00000160624; OTTHUMP00000224111;
SPSB2
splA/ryanodine receptor domain and SOCS box containing 2
SPSB2; splA/ryanodine receptor domain and SOCS box containing 2; SPRY domain-containing SOCS box protein 2; GRCC9; SSB 2; gene-rich cluster protein C9; SPRY domain-containing SOCS box protein SSB-2; SSB2; MGC2519; FLJ17395;
ST14
suppression of tumorigenicity 14 (colon carcinoma)
ST14; suppression of tumorigenicity 14 (colon carcinoma); HAI; MTSP1; SNC19; ARCI11; MT-SP1; PRSS14; TADG15; TMPRSS14; suppressor of tumorigenicity 14 protein; prostamin; serine protease 14; serine protease TADG-15; membrane-type serine protease 1; tumor associated differentially expressed gene 15 protein; tumor-associated differentially-expressed gene 15 protein; suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin);
SULT1A3
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
SULT1A3; sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3; STM; sulfotransferase 1A3/1A4; TL PST; sulfokinase; phenol sulfotransferase 1A5; aryl sulfotransferase 1A3/1A4; dopamine-specific sulfotransferase; placental estrogen sulfotrans;
TGS1
trimethylguanosine synthase 1
TGS1; trimethylguanosine synthase 1; NCOA6IP, nuclear receptor coactivator 6 interacting protein , trimethylguanosine synthase homolog (S. cerevisiae); trimethylguanosine synthase; PIMT; Cap specific guanine N2 methyltransferase; CLL associated antigen KW 2; DKFZp762A163; FLJ22995; HCA137; Hepatocellular carcinoma associated antigen 137; NCOA6IP; Nuclear receptor coactivator 6 interacting protein; PIPMT; PRIP interacting protein PIPMT; PRIP interacting protein with methyltransferase domain; PRIP interacting protein with methyltransferase motif; SEREX defined; TGS 1; Trimethylguanosine synthase homolog (S. cerevisiae); Trimethylguanosine synthase homolog; SEREX-defined; CLL-associated antigen KW-2; PRIP-interacting protein PIPMT; cap-specific guanine-N2 methyltransferase; hepatocellular carcinoma-associated antigen 137; nuclear receptor coactivator 6-interacting protein; PRIP-interacting protein with methyltransferase motif; PRIP-interacting protein with methyltransferase domain;
UGT2B10
UDP glucuronosyltransferase 2 family, polypeptide B10
UGT2B10; UDP glucuronosyltransferase 2 family, polypeptide B10; UDP glycosyltransferase 2 family, polypeptide B10; UDP-glucuronosyltransferase 2B10; MGC142209; UDP glucuronosyltransferase 2 family polypeptide B10; UDP glucuronosyltransferase 2B10; UDP glycosyltransferase 2 family polypeptide B10; UDPGT; UDPGT 2B10; OTTHUMP00000220324; OTTHUMP00000220325; UDPGT2B10;
UMPS
uridine monophosphate synthetase
UMPS; uridine monophosphate synthetase; uridine 5-monophosphate synthase; orotate phosphoribosyl transferase and orotidine 5 decarboxylase; OMPdecase; OPRT; OPRtase; Orotate phosphoribosyltransferase phosphoribosyltransferase; Orotidine 5 phosphate decarboxylase; UMP synthase; Uridine 5 monophosphate synthase; OTTHUMP00000215261; orotate phosphoribosyltransferase; orotidine 5-phosphate decarboxylase;
WIPI1
WD repeat domain, phosphoinositide interacting 1
WIPI1; WD repeat domain, phosphoinositide interacting 1; WD repeat domain phosphoinositide-interacting protein 1; Atg18; ATG18A; FLJ10055; WIPI49; ATG 18; Atg18 protein homolog; WD repeat domain phosphoinositide interacting 1; WD repeat domain phosphoinositide interacting protein 1; WD40 repeat protein interacting with phosphoinositides of 49 kDa; WD40 repeat protein interacting with phosphoInositides of 49kDa; WIPI 1 alpha; WIPI 1; WIPI 49; WIPI 49 kDa; WIPI-1; WIPI1_HUMAN; WIPI-1 alpha;
PIGL
phosphatidylinositol glycan anchor biosynthesis, class L
PIGL; phosphatidylinositol glycan anchor biosynthesis, class L; phosphatidylinositol glycan, class L; N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase; N acetylglucosaminylphosphatidylinositol deacetylase; Phosphatidylinositol glycan anchor biosynthesis class L; Phosphatidylinositol glycan class L; Phosphatidylinositol-glycan biosynthesis class L protein; PIG-L; PIGL_HUMAN; N-acetylglucosaminylphosphatidylinositol deacetylase;
PIGS
phosphatidylinositol glycan anchor biosynthesis, class S
PIGS; phosphatidylinositol glycan anchor biosynthesis, class S; GPI transamidase component PIG-S; DKFZp686K20216; FLJ45226; GPI transamidase subunit; Phosphatidylinositol glycan anchor biosynthesis class S; Phosphatidylinositol glycan class S; Phosphatidylinositol-glycan biosynthesis class S protein; PIGS_HUMAN; phosphatidylinositol glycan, class S homolog; Gm393; Gm689; BC058979;
SELM
selenoprotein M
SELM; selenoprotein M; SelM protein; SEPM; OTTHUMP00000199395; OTTHUMP00000199396; selenoprotein SelM;
IGHA1
immunoglobulin alpha 1 heavy chain constant region
IGHA1; immunoglobulin alpha 1 heavy chain constant region; IgA1; FLJ14473; FLJ41548; FLJ41552; FLJ43248; FLJ43594; FLJ44293; FLJ46028; FLJ46621; FLJ46724; FLJ46811; FLJ46824; MGC102857;
GPLD1
glycosylphosphatidylinositol specific phospholipase D1
GPLD1; glycosylphosphatidylinositol specific phospholipase D1; PLD; GPIPLD; PIGPLD; GPIPLDM; PIGPLD1; phosphatidylinositol-glycan-specific phospholipase D; GPI-PLD; PI-G PLD; GPI-specific phospholipase D; glycoprotein phospholipase D; glycosylphosphatidylinositol specific phospholipase D1, isoform 2;
PTPN5
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)
PTPN5; protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched); PTPSTEP; STEP;
NDUFB9
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa
NDUFB9; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9; B22; complex I B22 subunit; LYRM3; UQOR22; CI-B22; complex;
NHEJ1
nonhomologous end-joining factor 1
NHEJ1; nonhomologous end-joining factor 1; XLF; non-homologous end-joining factor 1; XRCC4-like factor; protein cernunnos;
NSMCE2
non-SMC element 2, MMS21 homolog (S. cerevisiae)
NSMCE2; non-SMC element 2, MMS21 homolog (S. cerevisiae); C8orf36, chromosome 8 open reading frame 36 , non SMC element 2 homolog (MMS21, S. cerevisiae); E3 SUMO-protein ligase NSE2; FLJ32440; MMS21; NSE2; C8orf36; hMMS21; hNSE2; methyl methanesulfonate sensitivity gene 21; MMS21 homolog; non-SMC element 2; Non-SMC element 2 homolog; Non-structural maintenance of chromosomes element 2 homolog; NSE2_HUMAN;
SLC7A8
solute carrier family 7 (amino acid transporter light chain, L system), member 8
SLC7A8; solute carrier family 7 (amino acid transporter light chain, L system), member 8; LAT2; LPI-PC1; large neutral amino acids transporter small subunit 2; integral membrane protein E16H; L-type amino acid transporter 2; solute carrier family 7 (amino acid transporter, L-type), member 8; solute carrier family 7 (cationic amino acid transporter, y+ system), member 8;
MAGEB18
melanoma antigen family B, 18
MAGEB18; melanoma antigen family B, 18; melanoma-associated antigen B18; MGC33889; B430216B18Rik; MAGBI_HUMAN; MAGE-B18 antigen; MAGEB18 antigen; MGC114496; RGD1560369; RP23-289C5.3;
MICAL1
microtubule associated monoxygenase, calponin and LIM domain containing 1
MICAL1; microtubule associated monoxygenase, calponin and LIM domain containing 1; NEDD9 interacting protein with calponin homology and LIM domains , NICAL; NEDD9-interacting protein with calponin homology and LIM domains; DKFZp434B1517; FLJ11937; FLJ21739; MICAL; CasL interacting molecule; MICA1_HUMAN; MICAL 1; Molecule interacting with CasL protein 1; NEDD9 interacting protein with calponin homology and LIM domains; NICAL; OTTHUMP00000016969; MICAL-1;
PECR
peroxisomal trans-2-enoyl-CoA reductase
PECR; peroxisomal trans-2-enoyl-CoA reductase; HSA250303; SDR29C1; short chain dehydrogenase/reductase family 29C; member 1; TERP; 2 4 dienoyl CoA reductase related protein; 2; 4-dienoyl-CoA reductase-related protein; DCR RP; DCR-RP; DCRRP; HPDHase; OTTHUMP00000206786; PECR_HUMAN; Peroxisomal trans 2 enoyl CoA reductase; PRO1004; Putative short chain alcohol dehydrogenase; pVI ARL; pVI-ARL; PVIARL; Short chain dehydrogenase/reductase family 29C member 1; 2,4-dienoyl-CoA reductase-related protein; short chain dehydrogenase/reductase family 29C, member 1;
PIP4K2A
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase, type II, alpha; phosphatidylinositol 4 phosphate 5 kinase, type II, alpha , PIP5K2A; phosphatidylinositol-5-phosphate 4-kinase type-2 alpha; PIP5KIIA; PIP5KIIalpha; PIP5KIII; PIP4KII-alpha; PI(5)P 4-kina;
PLEKHA3
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3
PLEKHA3; pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3; pleckstrin homology domain-containing family A member 3; FAPP1; four phosphate adaptor protein 1; FAPP 1; FAPP-1; FLJ20067; PH domain-containing family A member 3; Phosphatidylinositol-four-phosphate adapter protein 1; Phosphoinositol 4 phosphate adaptor protein 1; Phosphoinositol 4-phosphate adapter protein 1; PKHA3_HUMAN; Pleckstrin homology domain containing family A (phosphoinositide binding specific) member 3; Pleckstrin homology domain containing family A member 3; PLEKHA 3; OTTHUMP00000205697; four-phosphate-adaptor protein 1; p;
RDH14
retinol dehydrogenase 14 (all-trans/9-cis/11-cis)
RDH14; retinol dehydrogenase 14 (all-trans/9-cis/11-cis); retinol dehydrogenase 14 (all trans and 9 cis); retinol dehydrogenase 14; PAN2; SDR7C4; short chain dehydrogenase/reductase family 7C; member 4; RGD1565196; 3110030G19Rik; Alcohol dehydrogenase PAN2; AW215439; Pancreas protein 2; RDH14_HUMAN; Retinol dehydrogenase 14 (all trans/9 cis/11 cis); Short chain dehydrogenase/reductase family 7C member 4; UNQ529/PRO1072; retinol dehydrogenase 14 (all-trans and 9-cis); short chain dehydrogenase/reductase family 7C, member 4;
SULT1A1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
SULT1A1; sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1; STP, STP1; sulfotransferase 1A1; P PST; Aryl sulfotransferase 1; HAST1/HAST2; Human aryl sulfotransferase mRNA complete cds; MGC131921; MGC5163; OTTHUMP00000162568; OTTHUMP00000162569; PPST 1; P-PST 1; Phenol sulfating phenol sulfotransferase 1; Phenol sulfotransferase 1; Phenol-sulfating phenol sulfotransferase 1; PST; ST1A1; ST1A1_HUMAN; ST1A3; STP; STP1; Sulfotransferase family 1A phenol preferring member 1; Sulfotransferase family cytosolic 1A phenol preferring member 1; Sulfotransferase phenol preferring 1; Thermostable phenol sulfotransferase; Ts-PST; TSPST1; thermostable phenol sulfotransferase1; P-PST;
PSMD2
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2
PSMD2; proteasome (prosome, macropain) 26S subunit, non-ATPase, 2; 26S proteasome non-ATPase regulatory subunit 2; MGC14274; P97; Rpn1; S2; TRAP2; 26S proteasome non ATPase regulatory subunit 2; 26S proteasome regulatory subunit RPN1; 26S proteasome regulatory subunit S2; 26S proteasome subunit p97; 55.11 protein; Proteasome (prosome macropain) 26S subunit non ATPase 2; Proteasome 26S subunit non ATPase 2; Protein 55.11; PSMD 2; PSMD2_HUMAN; TNFR associated protein 2; TRAP 2; Tumor necrosis factor receptor associated protein 2; Tumor necrosis factor type 1 receptor associated protein 2; Tumor necrosis factor type 1 receptor-associated protein 2; OTTHUMP00000210627; OTTHUMP00000210628; OTTHUMP00000210629; TNFR-associated protein 2; tumor necrosis factor receptor-associated protein 2;
SSX1
synovial sarcoma, X breakpoint 1
SSX1; synovial sarcoma, X breakpoint 1; protein SSX1; cancer/testis antigen family 5; member 1; CT5.1; X breakpoint 1; Cancer/testis antigen 5.1; Cancer/testis antigen family 5 member 1; MGC150425; MGC5162; sarcoma, synovial, X chromosome related 1; SSRC; SSX1_HUMAN; Synovial sarcoma; cancer/testis antigen family 5, member 1; sarcoma, synovial, X-chromosome-related 1;
SSX2
synovial sarcoma, X breakpoint 2
SSX2; synovial sarcoma, X breakpoint 2; SSX; protein SSX2; cancer/testis antigen family 5; member 2a; CT5.2a; HD21; HOM MEL 40; MGC3884; MGC15364; MGC119055; sarcoma; synovial; X chromosome related 2; synovial sarcoma; X breakpoint 2; isoform b; X breakpo;
IGBP1
IGBP1 immunoglobulin (CD79A) binding protein 1
IGBP1; immunoglobulin (CD79A) binding protein 1; IBP1; immunoglobulin-binding protein 1; alpha 4; protein alpha-4; CD79a-binding protein 1; renal carcinoma antigen NY-REN-16; B cell signal transduction molecule alpha 4; B-cell signal transduction molecule alpha 4; protein phosphatase 2A, regulatory subunit alpha-4; bA351K23.1 (immunoglobulin binding protein 1 (CD79A) ); ALPHA-4;
LMAN1
lectin, mannose-binding, 1
LMAN1; lectin, mannose-binding, 1; coagulation factor V factor VIII combined deficiency , F5F8D; protein ERGIC-53; endoplasmic reticulum golgi intermediate compartment protein 53; ERGIC 53; ERGIC53; FMFD1; gp58; MCFD1; MR60; intracellular mannose specific;
SLC18A2
solute carrier family 18 (vesicular monoamine), member 2
SLC18A2; solute carrier family 18 (vesicular monoamine), member 2; VMAT2; synaptic vesicular amine transporter; SVAT; SVMT; monoamine transporter; vesicular amine transporter 2; vesicle monoamine/H+ antiporter; solute carrier family 18 member 2; vesicle m;
PAICS
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase
PAICS; phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase; PAIS; multifunctional protein ADE2; ADE2H1; AIRC; ADE2; AIR carboxylase; DKFZp781N1372; MGC1343; MGC5024; Phosphoribosylaminoimidazole carboxylase; PUR6_HUMAN; SAICAR synthetase; multifunctional protein ADE2H1;
RBP1
retinol binding protein 1, cellular
RBP1; retinol binding protein 1, cellular; retinol-binding protein 1; CRABP I; CRBP; CRBP1; CRBPI; RBPC; CRBP-I; cellular retinol-binding protein I; retinol-binding protein 1, cellular; CRABP-I;
MIOX
myo-inositol oxygenase
MIOX; myo-inositol oxygenase; aldehyde reductase (aldose reductase) like 6 , ALDRL6; inositol oxygenase; kidney specific protein 32; RSOR; 0610009I10Rik; AI314022; Aldehyde reductase-like 6; ALDRL6; C85427; Kidney-specific protein 32; MGC90217; MI oxygenase; MIOX_HUMAN; Renal-specific oxidoreductase; OTTHUMP00000196606; OTTHUMP00000196607; OTTHUMP00000196608; OTTHUMP00000196609; aldehyde reductase (aldose reductase) like 6;
VSIG2
V-set and immunoglobulin domain containing 2
VSIG2; V-set and immunoglobulin domain containing 2; V-set and immunoglobulin domain-containing protein 2; CTH; CTXL; CT-like protein; cortical thymocyte-like protein; cortical thymocyte receptor (X. laevis CTX) like; 2210413P10Rik;
ASL
argininosuccinate lyase
ASL; argininosuccinate lyase; Argininosuccinase; Arginosuccinase; ARLY_HUMAN; ASAL; EC 4.3.2.1;
UGT1A1
UDP glucuronosyltransferase 1 family, polypeptide A1
UGT1A1; UDP glucuronosyltransferase 1 family, polypeptide A1; GNT1, UDP glycosyltransferase 1 family, polypeptide A1 , UGT1; UDP-glucuronosyltransferase 1-1; UGT1A; UGT-1A; UGT1*1; UGT1.1; UGT1-01; UDP-glucuronosyltransferase 1-A; UDP-glucuronosyltransferase 1A1; bilirubin-specific UDPGT isozyme 1; bilirubin UDP-glucuronosyltransferase 1-1; bilirubin UDP-glucuronosyltransferase isozyme 1; UDP glycosyltransferase 1 family, polypeptide A1; GNT1; UGT1; UDPGT; HUG-BR1; BILIQTL1; UDPGT 1-1;
MGAT5
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
MGAT5; mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A; GNT V; glcNAc-T V; N-acetylglucosaminyl-transferase V; mannoside acetylglucosaminyltransferase 5;
DPP10
dipeptidyl-peptidase 10 (non-functional)
DPP10; dipeptidyl-peptidase 10 (non-functional); dipeptidyl peptidase 10 , dipeptidylpeptidase 10; inactive dipeptidyl peptidase 10; DPRP3; DPP X; DPRP-3; dipeptidyl peptidase X; dipeptidyl peptidase 10; dipeptidyl peptidase like protein 2; dipeptidyl pe;
BNIPL
BCL2/adenovirus E1B 19kD interacting protein like
BNIPL; BCL2/adenovirus E1B 19kD interacting protein like; bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein; BNIPl 1; BNIPL 2; PP753; Bcl 2/adenovirus E1B 19 kDa interacting protein 2 like protein; BNIP 2 similar; BNIP S; BNIP2 similar; BNIPL1; BNIPL2; BNIPS; BNIP-2 similar; BNIP-S; BNIPL-1; BNIPL-2;
COQ7
coenzyme Q7 homolog, ubiquinone (yeast)
COQ7; coenzyme Q7 homolog, ubiquinone (yeast); coenzyme Q, 7 (rat, yeast) homolog; ubiquinone biosynthesis protein COQ7 homolog; CAT5; CLK 1; CLK1; Coenzyme Q biosynthesis protein 7 homolog; Coenzyme Q7 homolog ubiquinone; COQ7 coenzyme Q 7 homolog ubiquinone; COQ7 protein; COQ7_HUMAN; Timing protein clk-1 homolog; placental protein KG-20; COQ7 coenzyme Q, 7 homolog ubiquinone; CLK-1;
SEMA4A
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
SEMA4A; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; semaphorin-4A; sema B; semaphorin-B; semaphorin 4A; SemB; Semab; AI132332;
WFIKKN2
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
WFIKKN2;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2;WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2;WFIKKNRP;WFIKKN-related protein;multivalent protease inhibitor protein;WAP, FS, Ig, two KU and NTR module related protein;growth and differentiation factor-associated serum protein 1;WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-related protein;GASP-1;hGASP-1;
XPNPEP2
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
XPNPEP2; X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound; xaa-Pro aminopeptidase 2; mAmP; membrane-bound APP; membrane-bound AmP; X-Pro aminopeptidase 2; aminoacylproline aminopeptidase; membrane-bound aminopeptidase P; APP2;
MPI
mannose phosphate isomerase
MPI; mannose phosphate isomerase; mannose-6-phosphate isomerase; mannose 6 phosphate isomerase; PMI1; Phosphohexomutase; Phosphomannose isomerase; FLJ39201; MGC94106; MPI_HUMAN; PMI; phosphomannose isomerase 1; mannose-6- phosphate isomerase; CDG1B;
ACMSD
aminocarboxymuconate semialdehyde decarboxylase
ACMSD; aminocarboxymuconate semialdehyde decarboxylase; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; 2 amino 3 carboxymuconate 6 semialdehyde decarboxylase; Picolinate carboxylase; OTTHUMP00000162500; OTTHUMP00000162501;
ADORA2A
Adora2a adenosine A2a receptor
ADORA2A; adenosine A2a receptor; adenosine receptor A2a; A2a, Rs; A2aR; A2AAR; AA2AR; MGC118414;
ADORA3
adenosine A3 receptor
ADORA3; adenosine A3 receptor; adenosine receptor A3; AD026; A3AR; A3R; AA3R; AA3R_HUMAN; AD 026; ADORA 3; ARA3; bA552M11.5; Gpcr2; RP11 552M11.7; TGPCR1; RP11-552M11.7;
ANO1
anoctamin 1, calcium activated chloride channel
ANO1; anoctamin 1, calcium activated chloride channel; DOG1; TAOS2; ORAOV2; TMEM16A; anoctamin-1; Ca2+-activated Cl- channel; oral cancer overexpressed 2; tumor-amplified and overexpressed sequence 2; discovered on gastrointestinal stromal tumors protein 1; transmembrane protein 16A (eight membrane-spanning domains);
ANO10
anoctamin 10
ANO10; anoctamin 10; TMEM16K, transmembrane protein 16K; anoctamin-10; FLJ10375; MGC47890; SCAR10; Hypothetical protein LOC55129; TMEM 16K; Transmembrane protein 16K; OTTHUMP00000164038; OTTHUMP00000164039; OTTHUMP00000209958; OTTHUMP00000209959; OTTHUMP00000209960; TMEM16K;
APC
adenomatous polyposis coli
APC; adenomatous polyposis coli; adenomatosis polyposis coli; adenomatous polyposis coli protein; DP2; DP2.5; DP3; PPP1R46; protein phosphatase 1; regulatory subunit 46; deleted in polyposis 2.5; adenomatosis polyposis coli tumor suppressor; protein phosphatase 1, regulatory subunit 46; GS; BTPS2;
ATP8B1
ATPase, aminophospholipid transporter, class I, type 8B, member 1
ATP8B1;ATPase, aminophospholipid transporter, class I, type 8B, member 1;ATPase, class I, type 8B, member 1, ATPase, Class I, type 8B, member 1, BRIC, FIC1, PFIC1;probable phospholipid-transporting ATPase IC;ATPIC;PFIC;E1-E2 ATPase;ATPase, class I, type 8B, member 1;phospholipid-transporting ATPase IC;familial intrahepatic cholestasis type 1;BRIC;FIC1;PFIC1;
BAG4
BCL2-associated athanogene 4
BAG4; BCL2-associated athanogene 4; BAG family molecular chaperone regulator 4; silencer of death domains; SODD; bcl-2-associated athanogene 4; BAG-family molecular chaperone regulator-4; BAG-4; DKFZp586O2022;
BAT3
BAG6 BCL2-associated athanogene 6
G3; BAT3; BAG-6; D6S52E; large proline-rich protein BAG6; scythe; protein G3; protein Scythe; OTTHUMP00000029237; OTTHUMP00000029238; OTTHUMP00000029239; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; large proline-rich protein BAT3; BAG family molecular chaperone regulator 6;
BCAT1
branched chain amino-acid transaminase 1, cytosolic
BCAT1; branched chain amino-acid transaminase 1, cytosolic; BCT1, branched chain aminotransferase 1, cytosolic; branched-chain-amino-acid aminotransferase, cytosolic; cytosolic; BCAT; BCAT(c); BCAT1_HUMAN; BCT1; Branched chain amino acid aminotransferase, cytosolic; Branched-chain-amino-acid aminotransferase; DKFZp686E12175; EC 2.6.1.42; ECA39; MECA39; PNAS 121; Protein ECA39; placental protein 18; branched chain aminotransferase 1, cytosolic; PP18; BCATC; PNAS121;
BNIP1
BCL2/adenovirus E1B 19kDa interacting protein 1
BNIP1; BCL2/adenovirus E1B 19kDa interacting protein 1; BCL2/adenovirus E1B 19kD interacting protein 1; vesicle transport protein SEC20; Nip1; SEC20; BCL2 adenovirus E1B 19kD interacting protein 1; BCL2/adenovirus E1B 19 kDa protein-interacting protein 1; MGC41600; OTTHUMP00000161077; OTTHUMP00000161078; OTTHUMP00000161079; OTTHUMP00000223580; SEC20_HUMAN; SEC20L; Transformation-related gene 8 protein; TRG-8; TRG8;
BNIP3L
BCL2/adenovirus E1B 19kDa interacting protein 3-like
BNIP3L; BCL2/adenovirus E1B 19kDa interacting protein 3-like; BCL2/adenovirus E1B 19kD interacting protein 3 like; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like; BNIP3a; Nix; NIP3L; NIP3-like protein X; adenovirus E1B19k-binding protein B5; BCL2/adenovirus E1B 19-kd protein-interacting protein 3a; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A;
CDIPT
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
CDIPT; CDP-diacylglycerol--inositol 3-phosphatidyltransferase; CDP diacylglycerol inositol 3 phosphatidyltransferase (phosphatidylinositol synthase); phosphatidylinositol synthase; PIS; PIS1; MGC1328; CDP diacylglycerol inositol 3 phosphatidyltransferase (phosphatidylinositol synthase); CDP diacylglycerol inositol 3 phosphatidyltransferase; PtdIns synthase; PI synthase;
CNOT4
CCR4-NOT transcription complex, subunit 4
CNOT4; CCR4-NOT transcription complex, subunit 4; NOT4; CCR4-NOT transcription complex subunit 4; CLONE243; NOT4H; CCR4-associated factor 4; E3 ubiquitin-protein ligase CNOT4; potential transcriptional repressor NOT4Hp; NOT4 (negative regulator of transcr;
CNOT6
CCR4-NOT transcription complex, subunit 6
CNOT6; CCR4-NOT transcription complex, subunit 6; CCR4-NOT transcription complex subunit 6; CCR4; KIAA1194; fa03c11; wu:fc17f01; zgc:65822; A230103N10Rik; AA407540; AW456442; carbon catabolite repression 4 protein; Carbon catabolite repressor protein 4 homolog; CCR4 carbon catabolite repression 4 like; CCR4 carbon catabolite repression 4-like; Cytoplasmic deadenylase; EC 3.1.-.-; fc17f01; MGC98472; OTTHUMP00000161544; wu:fa03c11;
CNOT8
CCR4-NOT transcription complex, subunit 8
CNOT8; CCR4-NOT transcription complex, subunit 8; POP2; CCR4-NOT transcription complex subunit 8; CAF1; CALIF; hCAF1; PGK promoter directed over production; CAF 1; CAF 2; CAF1 like protein; CAF2; CALIFp; CCR4 associated factor 8; CCR4 NOT transcription complex subunit 8; CNOT 8; POP 2; CAF1-like protein; CCR4-associated factor 8;
CTRB1
chymotrypsinogen B1
CTRB1; chymotrypsinogen B1; CTRB; chymotrypsinogen B; ChymotrypsinogenB; ChymotrypsinogenB1; CTRB 1; FLJ42412; MGC88037; OTTHUMP00000214638;
DAPP1
dual adaptor of phosphotyrosine and 3-phosphoinositides
DAPP1; dual adaptor of phosphotyrosine and 3-phosphoinositides; dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide; BAM32; DKFZp667E0716; B cell adapter molecule of 32 kDa; B lymphocyte adapter protein Bam32; B-cell adapter molecule of 32 kDa; DAPP1_HUMAN; Dual adaptor of phosphotyrosine and 3 phosphoinositides; hDAPP1; OTTHUMP00000219463; OTTHUMP00000219464;
DDAH2
Dimethylarginine Dimethylaminohydrolase 2
N(G),N(G)-dimethylarginine dimethylaminohydrolase 2; dime-thylarginine dimethylaminohydrolase 2; DDAH-2; DDAH; DDAH2; protein G6a; S-phase protein; dimethylargininase-2; NG30; G6a; dimethylarginine dimethylaminohydrolase II; NG-dimethylarginine dimethylamino hydrolase homolog; dimethylarginine dimethylaminohydrolase 2; OT-THUMP00000029307; OTTHUMP00000029308; OT-THUMP00000029310; OTTHUMP00000174406; OT-THUMP00000174488; OTTHUMP00000174489; EC 3.5.3.18; alternative name: NG30, G6a;
DGUOK
deoxyguanosine kinase
DGUOK; deoxyguanosine kinase; deoxyguanosine kinase, mitochondrial; dGK; Deoxyguanosine kinase mitochondrial; OTTHUMP00000160251; OTTHUMP00000160252; mitochondrial deoxyguanosine kinase; MTDPS3;
EDEM1
ER degradation enhancer, mannosidase alpha-like 1
EDEM1; ER degradation enhancer, mannosidase alpha-like 1; ER degradation-enhancing alpha-mannosidase-like 1; EDEM; KIAA0212; OTTHUMP00000206910; OTTHUMP00000206911;
ERVWE1
endogenous retrovirus group W, member 1
endogenous retroviral family W, env(C7), member 1; envelope glycoprotein; HERVW; envelope protein; HERV-7q; enverin; HERV-W-ENV; HERV-tryptophan envelope protein; Envelope polyprotein gPr73; HERV-W Env glycoprotein; HERV-7q Envelope protein; HERV-W_7q21.2 provirus ancestral Env polyprotein; HERV-W envelope protein; HERV-W{7q21.1} provirus ancestral Env polyprotein; HERV-W; human endogenous retrovirus W envC7-1 envelope protein; ENV; syncytin A; ENVW; syncytin-1; HERV7Q; Env-W; HERVWENV; OTTHUMP00000161914; Syncytin; ERVWE1; endogenous retrovirus group W member 1;
ETNK1
ethanolamine kinase 1
ETNK1; ethanolamine kinase 1; EKI; EKI1; EKI 1; putative protein product of Nbla10396; Nbla10396;
FCN3
ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen)
FCN3; ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen); ficolin-3; FCNH; HAKA1; Collagen/fibrinogen domain containing lectin 3 p35; Collagen/fibrinogen domain containing protein 3; FCN 3; Ficolin (collagen/fibrinogen domain containing) 3; Ficolin 3; H ficolin; Hakata antigen; MGC22543; H-ficolin; OTTHUMP00000006338; OTTHUMP00000006339; collagen/fibrinogen domain-containing protein 3; collagen/fibrinogen domain-containing lectin 3 p35;
GABBR1
gamma-aminobutyric acid (GABA) B receptor, 1
GABBR1; gamma-aminobutyric acid (GABA) B receptor, 1; gamma-aminobutyric acid type B receptor subunit 1; GABA B receptor; GPRC3A; hGB1a; FLJ92613; GABA-B receptor 1; GABA-B-R1; GABA-BR1; GABAB R1; GABAB subunit 1c; GABABR1; GABR1_HUMAN; Gamma aminobutyric acid (GABA) B receptor 1; Gb1; GABAB, subunit 1c; seven transmembrane helix receptor; GABBR1-3; dJ271M21.1.1; dJ271M21.1.2;
GABRA3
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3
GABRA3; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3; gamma-aminobutyric acid receptor subunit alpha-3; GABA(A) receptor subunit alpha 3; GABR A3; GABRA 3; Gamma aminobutyric acid (GABA) A receptor alpha 3; Gamma aminobutyric acid A receptor alpha 3; Gamma aminobutyric acid receptor subunit alpha 3; MGC33793; OTTMUSP00000019432; OTTMUSP00000019433; GABA(A) receptor subunit alpha-3; Gabra-3;
GATM
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
GATM; glycine amidinotransferase (L-arginine:glycine amidinotransferase); glycine amidinotransferase, mitochondrial; AGAT; mitochondrial; AT; GATM_HUMAN; Glycine amidinotransferase; L-arginine:glycine amidinotransferase; Transamidinase;
GMPR
guanosine monophosphate reductase
GMPR; guanosine monophosphate reductase; GMP reductase 1; GMPR1_HUMAN; Guanosine 5 monophosphate oxidoreductase 1; Guanosine 5-monophosphate oxidoreductase 1; Guanosine monophosphate reductase 1; guanine monophosphate reductase; GMPR1;
GRIK3
glutamate receptor, ionotropic, kainate 3
GRIK3; glutamate receptor, ionotropic, kainate 3; glutamate receptor, ionotropic kainate 3; GLUR7; EAA5; Excitatory amino acid receptor 5; GLR 7; GLR7; GLU R7; GLUR 7; GluR 7a; GluR7a; Glutamate receptor 7; Glutamate receptor ionotropic kainate 3; GRIK 3; gluR-7; dJ1090M5.1 (glutamate receptor, ionotropic, kainate 3 (GLUR7));
GRINL1A
glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A
glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A; Glutamate receptor-like protein 1A; DKFZp586F1918; GRINL1A downstream protein Gdown4; protein GRINL1A; protein GRINL1A, isoforms 4/5; OTTHUMP00000163345; OTTHUMP00000163421;
HYAL3
hyaluronoglucosaminidase 3
HYAL3; hyaluronoglucosaminidase 3; hyaluronidase-3; LUCA 3; LUCA14; Minna14; Hyal-3; HYAL3_HUMAN; Hyaluronidase 3; Hyaluronoglucosaminidase-3; LUCA-3; LUCA3; Lung carcinoma protein 3; OTTHUMP00000211052; OTTHUMP00000211054; OTTHUMP00000219781;
IGHA2
Immunoglobulin heavy constant alpha 2(A2m marker)
IGHA2;Immunoglobulin heavy constant alpha 2(A2m marker);immunoglobulin heavy constant alpha 2 (A2m marker);
IGHG3
Immunoglobulin heavy constant gamma 3(G3m marker)
IGHG3; Immunoglobulin heavy constant gamma 3(G3m marker);
IGKC
immunoglobulin kappa constant
immunoglobulin light chain; Human Kappa Protein; Kappa Protein; IGKC; immunoglobulin kappa constant;
IGSF1
immunoglobulin superfamily, member 1
IGSF1; immunoglobulin superfamily, member 1; immunoglobulin superfamily member 1; IGCD1; IGDC1; INHBP; KIAA0364; MGC75490; PGSF2; Immunoglobulin like domain containing protein 1; Inhibin binding protein; p120; Pituitary gland specific factor 2; inhibin-binding protein; pituitary gland-specific factor 2; immunoglobulin-like domain-containing protein 1;
INPP1
inositol polyphosphate-1-phosphatase
INPP1; inositol polyphosphate-1-phosphatase; inositol polyphosphate 1-phosphatase; EC 3.1.3.57; Inositol polyphosphate 1 phosphatase; IPP; IPPase;
INPP4B
inositol polyphosphate-4-phosphatase, type II, 105kDa
INPP4B; inositol polyphosphate-4-phosphatase, type II, 105kDa; inositol polyphosphate 4 phosphatase, type II, 105kD; type II inositol 3,4-bisphosphate 4-phosphatase; inositol polyphosphate 4-phosphatase type II; type II inositol-3,4-bisphosphate 4-phospha;
INPP5A
inositol polyphosphate-5-phosphatase, 40kDa
INPP5A; inositol polyphosphate-5-phosphatase, 40kDa; inositol polyphosphate 5 phosphatase, 40kD; type I inositol-1,4,5-trisphosphate 5-phosphatase; 5PTASE; 43 kDa inositol polyphosphate 5 phophatase; CTCL tumor antigen HD CL 02; inositol polyphosphate 5 phophatase; 40kDa; InsP3 5 phosphatase; type I inositol 1; 4; 5 trisphosphate 5 phosphatase; 43 kDa inositol polyphosphate 5-phophatase; 5-trisphosphate 5-phosphatase; CTCL tumor antigen HD-CL-02; DKFZp434A1721; I5P1; I5P1_HUMAN; Inositol polyphosphate 5 phosphatase; inositol polyphosphate-5-phosphatase A; inositol trisphosphate-5-phosphatase; INPP5A inositol polyphosphate-5-phosphatase; InsP3 5-phosphatase; MGC116947; MGC116949; Type I inositol-1; type I inositol-1,4,5-trisphosphate 5-phophatase; OTTHUMP00000020775; OTTHUMP00000020776; OTTHUMP00000020777; inositol trisphosphate-5-phosphatase, 40kD; type I inosito;
INPP5K
inositol polyphosphate-5-phosphatase K
INPP5K; inositol polyphosphate-5-phosphatase K; inositol polyphosphate 5-phosphatase K; skeletal muscle and kidney enriched inositol phosphatase; SKIP; 43 kDa form skeletal muscle and kidney enriched inositol phosphatase; INP5K_HUMAN; muscle and kidney-enriched inositol phosphatase; PPS; Skeletal muscle and kidney-enriched inositol phosphatase;
INPPL1
inositol polyphosphate phosphatase-like 1
INPPL1; inositol polyphosphate phosphatase-like 1; phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2; 51C protein; SHIP2; SHIP-2; INPPL-1; protein 51C; SH2 domain-containing inositol 5-phosphatase 2; SH2 domain-containing inositol-5-phosphatase 2;
KIR2DL2
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 2DL2; CD158B1; CD158k; cl 43; nkat6; CD158 antigen-like family member B1; CD158b; KI2L2_HUMAN; MHC class I NK cell receptor; Natural killer-associated transcript 6; NKAT 6; NKAT-6; p58 natural killer cell receptor clone CL-43; p58 NK receptor CL-43; p58.2;
LILRA2
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
LILRA2; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2; leukocyte immunoglobulin-like receptor subfamily A member 2; CD85h; ILT1; LIR 7; LIR7; CD85 antigen-like family member H; ILT-1; Immunoglobulin like transcript 1; Immunoglobulin-like transcript 1; Leukocyte immunoglobulin like receptor 7; Leukocyte immunoglobulin like receptor subfamily A member 2; Leukocyte immunoglobulin-like receptor 7; LIR-7; LIRA2_HUMAN; OTTHUMP00000068394; OTTHUMP00000068395; OTTHUMP00000068396; OTTHUMP00000068397; leuko;
LSS
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
LSS; lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase); lanosterol synthase; OSC; hOSC; oxidosqualene--lanosterol cyclase; 2,3-epoxysqualene-lanosterol cyclase; 2,3-epoxysqualene--lanosterol cyclase; FLJ25486; FLJ35015; FLJ39450; FLJ46393;
MAGEA11
melanoma antigen family A, 11
MAGEA11; melanoma antigen family A, 11; MAGE11; melanoma-associated antigen 11; cancer/testis antigen family 1; member 11; CT1.11; MAGE 11; MAGE 11 antigen; MAGEA 11; melanoma associated antigen 11; MGC10511; MAGE-11 antigen; cancer/testis antigen 1.11; c;
MAGEA2
melanoma antigen family A, 2
MAGEA2; melanoma antigen family A, 2; MAGE2; melanoma-associated antigen 2; cancer/testis antigen family 1; member 2; CT1.2; MAGEA2A; MAGE-2 antigen; melanoma antigen 2; cancer/testis antigen 1.2; cancer/testis antigen family 1, member 2; MAGEA2B; MGC1319;
MAGEA8
melanoma antigen family A, 8
MAGEA8; melanoma antigen family A, 8; MAGE8; melanoma-associated antigen 8; cancer/testis antigen family 1; member 8; CT1.8; MAGE 8 antigen; MGC2182; MAGE8 antigen; Melanoma antigen family A 8; Melanoma associated antigen 8; MAGE-8 antigen; OTTHUMP00000024218; cancer/testis antigen 1.8; cancer/testis antigen family 1, member 8;
MAGEA9
melanoma antigen family A, 9
MAGEA9; melanoma antigen family A, 9; MAGE9; melanoma-associated antigen 9; cancer/testis antigen family 1; member 9; CT1.9; MAGE 9 antigen; melanoma associated antigen 9; MGC8421; MAGE-9 antigen; cancer/testis antigen 1.9; cancer/testis antigen family 1,;
MAGEB1
melanoma antigen family B, 1
MAGEB1; melanoma antigen family B, 1; melanoma-associated antigen B1; cancer/testis antigen family 3; member 1; CT3.1; DAM10; DSS/AHC critical interval MAGE superfamily 10; MAGE Xp; MAGEL1; MGC9322; Cancer/testis antigen 3.1; DSS AHC critical interval MAGE superfamily 10; MAGE B1 antigen; MAGEXP antigen; Melanoma associated antigen B1; MAGE-B1 antigen; MAGE-XP antigen; cancer/testis antigen family 3, member 1; DSS-AHC critical interval MAGE superfamily 10; MAGE-Xp;
MAGEB6
melanoma antigen family B, 6
MAGEB6; melanoma antigen family B, 6; melanoma-associated antigen B6; cancer/testis antigen family 3; member 4; CT3.4; FLJ40242; MAGE B6; MAGEB6A; Cancer/testis antigen 3.4; MAGEB6 antigen; Melanoma associated antigen B6; MAGE-B6 antigen; cancer/testis antigen family 3, member 4; MAGE-B6;
MAGED1
Maged1 melanoma antigen, family D, 1
MAGED1; melanoma antigen, family D, 1; melanoma-associated antigen D1; MAGE-D1 antigen; neurotrophin receptor-interacting MAGE homolog; NRAGE; Dlixin; Dlxin1; Dlxin-1; mFLJ00163; DXBwg1492e; 2810433C11Rik; 5430405L04Rik; FLJ00163;
MAGED2
melanoma antigen family D, 2
MAGED2; melanoma antigen family D, 2; melanoma-associated antigen D2; 11B6; BCG1; breast cancer associated gene 1; HCA10; hepatocellular carcinoma associated protein; hepatocellular carcinoma associated protein HCA10; JCL 1; MAGE D2; MAGED; melanoma assoc;
MAGEH1
melanoma antigen family H, 1
MAGEH1; melanoma antigen family H, 1; melanoma-associated antigen H1; APR1; restin; MAGE-H1 antigen; apoptosis-related protein 1; melanoma antigen, family H, 1 protein; APR-1; MAGEH;
MAN2A1
mannosidase, alpha, class 2A, member 1
MAN2A1; mannosidase, alpha, class 2A, member 1; alpha-mannosidase 2; 3-1; 6-alpha-mannosidase; Alpha mannosidase 2; alpha Mannosidase II; AMAN II; Golgi alpha mannosidase II; Golgi alpha-mannosidase II; MA2A1_HUMAN; MAN II; MANA 2; MANA2; MANII; Mann II; Mannosidase alpha class 2A member 1; Mannosidase Two; Mannosyl oligosaccharide 13 16 alpha mannosidase; Mannosyl-oligosaccharide 1; mannosidase alpha 2; alpha-mannosidase II; mannosidase 2, alpha 1; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase; Manno;
MCCC2
methylcrotonoyl-CoA carboxylase 2 (beta)
MCCC2; methylcrotonoyl-CoA carboxylase 2 (beta); methylcrotonoyl Coenzyme A carboxylase 2 (beta); methylcrotonoyl-CoA carboxylase beta chain, mitochondrial; MCCB; biotin carboxylase; MCCase subunit beta; 3-methylcrotonyl-CoA carboxylase 2; methylcrotonoyl;
MFI2
antigen p97 (melanoma associated) identified
MFI2; antigen p97 (melanoma associated) identified; melanotransferrin; CD228; FLJ38863; MAP97; membrane bound transferrin like protein; MGC4856; MTF1; Antigen p97; CD228 antigen; Melanoma associated antigen p97; Melanoma-associated antigen p97; TRFM_HUMAN; membrane-bound transferrin-like protein; melanoma-associated antigen p97, isoform 2;
MGAT1
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
MGAT1; mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase; GLYT1, MGAT; alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; GLCNAC TI; GNT 1; glcNAc-T I; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosam;
MGAT3
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
MGAT3; mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase; GNT III; GlcNAc-T III; N-acetylglucosaminyltransferase III; N-glycosyl-oligosaccharide-glycoprotein N;
MGAT4B
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B
MGAT4B; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B; mannosyl (alpha 1,3 ) glycoprotein beta 1,4 N acetylglucosaminyltransferase, isoenzyme B; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B; GnT Ivb; Alpha 1 3 mannosyl glycoprotein beta 1 4 N acetylglucosaminyltransferase; Aminyltransferase; GlcNAc T IVb; GNT IV; GNTIV; GNTIVB; Mannosyl (alpha 1 3) glycoprotein beta 1 4 N acetylglucosaminyltransferase isozyme B; MGAT 4B; N acetylglucosaminyltransferase IVb; N glycosyl oligosaccharide glycoprotein; N glycosyl oligosaccharide glycoprotein N acetylglucosaminyltransferase IVb; UDP N acetylglucosamine alpha 1 3 D mannoside beta 1 4 N acetylglucosaminyltransferase IV; UDP N acetylglucosamine alpha 1 3 D mannoside beta 1 4 N acetylglucosaminyltransferase IVb; glcNAc-T IVb; N-acetylglucosaminyltransferase IVb; alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isoenzyme B; UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV; UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb; GNT-IV; GNT-IVB;
MOXD1
monooxygenase, DBH-like 1
MOXD1; monooxygenase, DBH-like 1; DBH-like monooxygenase protein 1; dJ248E1.1; DKFZP564G202; MOX; DBH like monooxygenase protein 1; Monooxygenase X; monooxygenase, DBH like 1; MOXD1_HUMAN; PRO5780; dopamine-oxygenase;
MRAP
melanocortin 2 receptor accessory protein
MRAP; melanocortin 2 receptor accessory protein; C21orf61, chromosome 21 open reading frame 61; melanocortin-2 receptor accessory protein; B27; FALP; fat tissue-specific low MW protein; fat cell-specific low molecular weight protein; FGD2; GCCD2; C21orf6;
MYH9
myosin, heavy chain 9, non-muscle
MYH9; myosin, heavy chain 9, non-muscle; DFNA17, myosin, heavy polypeptide 9, non muscle; myosin-9; EPSTS; FTNS; MHA; NMHC II A; NMMHCA; nonmuscle myosin heavy chain II A; myosin heavy chain 9; non-muscle myosin heavy chain A; non-muscle myosin heavy cha;
MYST3
MYST histone acetyltransferase (monocytic leukemia) 3
RUNXBP2; MOZ; Monocytic leukemia zinc finger protein; ZNF220; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3; KAT6A; EC 2.3.1.48; runt-related transcription factor binding protein 2; MGC167033; Runt-related transcription factor-binding protein 2; Zinc finger protein 220; EC 3.1.26.4; MYST3; histone acetyltransferase MYST3; MYST-3; OTTHUMP00000197392; OTTHUMP00000197394; OTTHUMP00000225722; MYST histone acetyltransferase (monocytic leukemia) 3;
MYST4
MYST histone acetyltransferase monocytic leukemia 4
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4; MOZ2; EC 2.3.1.48; MORF; KAT6B; DKFZp313G1618; qkf; FLJ90335; querkopf; OTTHUMP00000019866; Histone acetyltransferase MORF; OTTHUMP00000019867; Histone acetyltransferase MOZ2; OTTHUMP00000019869; Monocytic leukemia zinc finger protein-related factor; OTTHUMP00000019870; KIAA0383; MOZ-related factor; MYST4; histone acetyltransferase MYST4; MYST-4; OTTHUMP00000019868; MYST histone acetyltransferase (monocytic leukemia) 4;
NDUFA1
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa
NDUFA1; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 (7.5kD, MWFE); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1; CI MWFE; complex I MWFE subunit; MWFE; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex; 1 (7.5kD; MWFE); NADH:ubiquinone oxidoreductase (complex 1); type I dehydrogenase; Complex I MWFE; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 1 7.5kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 1; NADH ubiquinone oxidoreductase (complex 1); NADH ubiquinone oxidoreductase MWFE subunit; NDUFA 1; ZNF 183; ZNF183; complex I-MWFE; OTTHUMP00000023930; NADH oxidoreductase subunit MWFE; NADH-ubiquinone oxidoreductase MWFE subu; CI-MWFE;
NDUFA2
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa
NDUFA2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (8kD, B8); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2; B8; complex I B8 subunit; CD 14; CD14; CI B8; Complex I B8; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 2 8kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 2; NADH ubiquinone oxidoreductase B8 subunit; NDUFA 2; OTTHUMP00000159890; OTTHUMP00000223709; NADH-ubiquinone oxidoreductase subunit CI-B8; CIB8;
NDUFA5
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa
NDUFA5;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (13kD, B13);NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5;B13;CI 13kB;CI 13KD B;complex I 13kDa subunit B;NADH ubiquinone oxidoreductase 13 kDa B subunit;NUFM;type I dehydrogenase;ubiquinone reductase;UQOR13;Complex I-13KD-B;complex I subunit B13;NADH-ubiquinone oxidoreductase 13 kDa-B subunit;CI-13kB;CI-13KD-B;FLJ12147;DKFZp781K1356;
NDUFA8
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa
NDUFA8; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 (19kD, PGIV); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8; complex I PGIV subunit; MGC793; PGIV; complex I-19kD; c;
NDUFS7
NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)
NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 7 (20kD) (NADH coenzyme Q reductase); CI 20; complex I 20kDa subunit; FLJ45860; FLJ46880; NADH dehydrogenase [ubiquinon;
NME6
non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase)
NME6; non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 6; IPIA ALPHA; NM23 H6; NDP kinase 6; inhibitor of p53-induced apoptosis-alpha; NDK 6; NM23-H6; IPIA-ALPHA;
NPHP4
nephronophthisis 4
NPHP4; nephronophthisis 4; nephrocystin-4; KIAA0673; nephrocystin 4; nephroretinin; POC10; POC10 centriolar protein homolog (Chlamydomonas); SLSN4; NPHP4_HUMAN; POC10 centriolar protein homolog;
OSCAR
osteoclast associated, immunoglobulin-like receptor
OSCAR; osteoclast associated, immunoglobulin-like receptor; osteoclast-associated immunoglobulin-like receptor; hOSCAR; hOSCARM2; hOSCARM3; mOSCAR; Oscar protein; OSCAR_HUMAN; OSCARS1; OSCARS2; Osteoclast associated immunoglobulin like receptor; Osteoclast associated receptor; Osteoclast-associated receptor; PIgR-3; PIGR3; Poly Ig receptor 3; Poly-Ig receptor 3; Polymeric immunoglobulin receptor 3; OTTHUMP00000067447; OTTHUMP00000067448; OTTHUMP00000067450; OTTHUMP00000067451; OTTHUMP00000067452; OTTHUMP00000067460; OTTHUMP00000081759; polymer;
PAPSS1
3-phosphoadenosine 5-phosphosulfate synthase 1
PAPSS1; 3-phosphoadenosine 5-phosphosulfate synthase 1; bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 1; ATPSK1; PAPSS; SK 1; PAPSS 1; PAPS synthase 1; sulfurylase kinase 1; 3-prime-phosphoadenosine 5-prime-phosphosulfate synthase 1; SK1;
PCK2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
PCK2; phosphoenolpyruvate carboxykinase 2 (mitochondrial); PEPCK; PEPCK2; PEPCK-M; phosphoenolpyruvate carboxykinase [GTP], mitochondrial; PEP carboxykinase; phosphopyruvate carboxylase; phosphoenolpyruvate carboxylase;
PDPK1
3-phosphoinositide dependent protein kinase-1
PDPK1; 3-phosphoinositide dependent protein kinase-1; 3-phosphoinositide-dependent protein kinase 1; PDK1; PkB kinase; PkB-like 1; PkB kinase like gene 1; PRO0461; MGC20087; MGC35290;
PDYN
prodynorphin
PDYN; prodynorphin; ADCA; PENKB; SCA23; proenkephalin-B; rimorphin; leumorphin; leu-enkephalin; preprodynorphin; preproenkephalin B; beta-neoendorphin-dynorphin; neoendorphin-dynorphin-enkephalin prepropeptide;
PHYH
phytanoyl-CoA 2-hydroxylase
PHYH; phytanoyl-CoA 2-hydroxylase; phytanoyl CoA hydroxylase , phytanoyl CoA hydroxylase (Refsum disease); phytanoyl-CoA dioxygenase, peroxisomal; PAHX; PHYH1; phytanoyl CoA dioxygenase; RD; Refsum disease; phytanic acid oxidase; phytanoil-CoA alpha hydr;
PI4K2A
phosphatidylinositol 4-kinase type 2 alpha
PI4K2A; phosphatidylinositol 4-kinase type 2 alpha; phosphatidylinositol 4-kinase type 2-alpha; DKFZP761G1923; PI4KII; PIK42A; phosphatidylinositol 4-kinase type II-alpha; phosphatidylinositol 4-kinase type II (PI4KII); RP11-548K23.6;
PI4KB
phosphatidylinositol 4-kinase, catalytic, beta
PI4KB; phosphatidylinositol 4-kinase, catalytic, beta; PIK4CB; phosphatidylinositol 4-kinase beta; PI4K BETA; pi4K92; PtdIns 4-kinase beta; type III phosphatidylinositol 4-kinase beta; phosphatidylinositol 4-kinase, wortmannin-sensitive; NPIK; PI4;
PIGB
phosphatidylinositol glycan anchor biosynthesis, class B
PIGB;phosphatidylinositol glycan anchor biosynthesis, class B;phosphatidylinositol glycan, class B;GPI mannosyltransferase 3;PIG-B;GPI-MT-III;GPI mannosyltransferase III;phosphatidylinositol-glycan biosynthesis class B protein;MGC21236;
PIGC
phosphatidylinositol glycan anchor biosynthesis, class C
PIGC; phosphatidylinositol glycan anchor biosynthesis, class C; phosphatidylinositol glycan, class C; phosphatidylinositol N-acetylglucosaminyltransferase subunit C; GPI2; Phosphatidylinositol glycan biosynthesis class C protein; Phosphatidylinositol N acetylglucosaminyltransferase subunit C; PIG-C; OTTHUMP00000032652; phosphatidylinositol-glycan biosynthesis class C protein; phosphatidylinositol-glycan biosynthesis, class C protein;
PIGH
phosphatidylinositol glycan anchor biosynthesis, class H
PIGH; phosphatidylinositol glycan anchor biosynthesis, class H; phosphatidylinositol glycan, class H; phosphatidylinositol N-acetylglucosaminyltransferase subunit H; GPI H; GPIH; Phosphatidylinositol glycan anchor biosynthesis class H; Phosphatidylinositol glycan biosynthesis class H protein; Phosphatidylinositol glycan class H; Phosphatidylinositol N acetylglucosaminyltransferase subunit H; Phosphatidylinositol-glycan biosynthesis class H protein; PIG H; PIG-H; PIGH_HUMAN; OTTHUMP00000246879; phosphatidylinositol-glycan biosynthesis, class H protein; GPI-H;
PIGP
phosphatidylinositol glycan anchor biosynthesis, class P
PIGP; phosphatidylinositol glycan anchor biosynthesis, class P; Down syndrome critical region gene 5 , DSCR5, phosphatidylinositol glycan, class P; phosphatidylinositol N-acetylglucosaminyltransferase subunit P; DCRC; DSRC; phosphatidylinositol n acetylglucosaminyltranferase subunit; DCRC S; Down syndrome critical region gene 5; Down syndrome critical region protein 5; Down syndrome critical region protein C; DSCR 5; DSCR5; DSCRC; Phosphatidylinositol glycan anchor biosynthesis class P; Phosphatidylinositol glycan biosynthesis class P; Phosphatidylinositol glycan biosynthesis class P protein; Phosphatidylinositol glycan class P; Phosphatidylinositol N acetylglucosaminyltransferase subunit P; PIG-P; OTTHUMP00000109075; OTTHUMP00000109076; OTTHUMP00000109077; OTTHUMP00000109078; OTTHUMP00000109079; phosphatidylinositol glycan, class P; Down syndrome cri; DCRC-S;
PIGQ
phosphatidylinositol glycan anchor biosynthesis, class Q
PIGQ; phosphatidylinositol glycan anchor biosynthesis, class Q; phosphatidylinositol glycan, class Q; phosphatidylinositol N-acetylglucosaminyltransferase subunit Q; GPI1; hGPI1; PIG-Q; N-acetylglucosamyl transferase component GPI1; N-acetylglucosaminyl t;
PIGT
phosphatidyl inositol glycan class T
PIGT;phosphatidyl inositol glycan class T;phosphatidylinositol glycan, class T;GPI transamidase subunit;Q969N2;phosphatidylinositol glycan anchor biosynthesis, class T;OTTHUMP00000031110;OTTHUMP00000031112;Phosphatidylinositol-glycan biosynthesis class T protein;GPI transamidase component PIG-T;FLJ41596;MGC8909;neurotrophin-regulated neuronal development-associated protein;NDAP;
PIK3C2A
phosphoinositide-3-kinase, class 2, alpha polypeptide
PIK3C2A; phosphoinositide-3-kinase, class 2, alpha polypeptide; phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha; PI3K C2alpha; PI3K-C2alpha; PI3K-C2-alpha; ptdIns-3-kinase C2 subunit alpha; phosphoinositide 3-kinase-C2-alpha;
PIK3C2G
phosphoinositide-3-kinase, class 2, gamma polypeptide
PIK3C2G; phosphoinositide-3-kinase, class 2, gamma polypeptide; phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma; PI3K-C2-gamma; PTDINS-3-kinase C2 gamma; ptdIns-3-kinase C2 subunit gamma; phosphoinositide 3-kinase-C2-gamma; ph;
PIK3R3
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); phosphatidylinositol 3-kinase regulatory subunit gamma; p55; p55PIK; PI3-kinase subunit p55-gamma; PI3K regulatory subunit gamma; 100% homology to SWISS-PROT Q92569; PI3-kinase regulatory su;
PIP5K1C
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase, type I, gamma; phosphatidylinositol-4-phosphate 5-kinase type-1 gamma; KIAA0589; LCCS3; PIP5Kgamma; PIP5K1-gamma; type I PIP kinase; diphosphoinositide kinase; ptdIns(4)P-5-kinase 1 gamma; Human homolog;
PIP5K3
likely ortholog of mouse phosphatidylinositol-4-phosphate 5-kinase, type III
PIP5K3; likely ortholog of mouse phosphatidylinositol-4-phosphate 5-kinase, type III; p235; PIP5K; KIAA0981;
PLAGL1
pleiomorphic adenoma gene-like 1
PLAGL1; pleiomorphic adenoma gene-like 1; ZAC; LOT1; ZAC1; zinc finger protein PLAGL1; LOT-1; PLAG-like 1; tumor supressor ZAC; tumor suppressor ZAC; lost on transformation 1; pleiomorphic adenoma-like protein 1;
POMT2
protein-O-mannosyltransferase 2
POMT2; protein-O-mannosyltransferase 2; protein O-mannosyl-transferase 2; A830009D15Rik; AW046274; DKFZp686G10254; Dolichyl phosphate mannose protein mannosyltransferase 2; FLJ22309; POMT 2; Protein O mannosyltransferase 2; Protein O mannosyltransferase; Putative protein O mannosyltransferase; rCG_20643; dolichyl-phosphate-mannose--protein mannosyltransferase 2; MDDGA2; MDDGB2; MDDGC2;
PRKAG2
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
PRKAG2; protein kinase, AMP-activated, gamma 2 non-catalytic subunit; 5-AMP-activated protein kinase subunit gamma-2; AAKG; AAKG2; AMPK gamma2; CMH6; H91620p; WPWS; AMPK subunit gamma-2;
RAET1E
retinoic acid early transcript 1E
RAET1E; retinoic acid early transcript 1E; NKG2D ligand 4; bA350J20.7; LETAL; ULBP4; Lymphocyte effector toxicity activation ligand; MGC125308; MGC125309; N2DL-4; N2DL4; NKG2D ligand 4 precursor; NKG2DL4; RAE-1-like transcript 4; RAET1E2; RL-4; OTTHUMP00000017403; OTTHUMP00000017404; OTTHUMP00000229731;
RARRES1
retinoic acid receptor responder (tazarotene induced) 1
RARRES1; retinoic acid receptor responder (tazarotene induced) 1; LXNL; TIG1; retinoic acid receptor responder protein 1; latexin-like; RAR-responsive protein TIG1; tazarotene-induced gene 1 protein;
RARRES3
retinoic acid receptor responder (tazarotene induced) 3
RARRES3; retinoic acid receptor responder (tazarotene induced) 3; retinoic acid receptor responder protein 3; HRASLS4; TIG3; MGC8906; RAR responsive protein TIG3; Retinic acid inducible gene 1; Retinoid inducible gene 1 protein; RIG 1; rig1; Tazarotene induced gene 3 protein; TIG 3; OTTHUMP00000237066; OTTHUMP00000237067; RAR-responsive protein TIG3; retinoic acid-inducible gene 1; retinoid-inducible gene 1 protein; tazarotene-induced gene 3 protein; PLA1/2-3;
RBL1
retinoblastoma-like 1 (p107)
RBL1; retinoblastoma-like 1 (p107); retinoblastoma-like protein 1; cp107; p107; PRB1; cellular protein 107; 107 kDa retinoblastoma-associated protein; MGC40006;
RBP2
retinol binding protein 2, cellular
RBP2; retinol binding protein 2, cellular; retinol-binding protein 2; CRABP II; CRBP2; CRBPII; RBPC2; MGC159254; MGC159256; Retinol binding protein 2 cellular; Cellular retinol binding protein II; Cellular retinol-binding protein II; Crbp 2; CRBP II; CRBP-II; Rbp 2; RET2_HUMAN; Retinol binding protein 2; retinol-binding protein 2, cellular; CRABP-II;
RDH12
retinol dehydrogenase 12 (all-trans/9-cis/11-cis)
RDH12; retinol dehydrogenase 12 (all-trans/9-cis/11-cis); retinol dehydrogenase 12 (all trans and 9 cis); retinol dehydrogenase 12; FLJ30273; LCA13; SDR7C2; short chain dehydrogenase/reductase family 7C; member 2; All trans and 9 cis retinol dehydrogenase; All-trans and 9-cis retinol dehydrogenase; LCA 3; LCA3; RDH 12; RDH12_HUMAN; Retinol dehydrogenase 12 (all trans/9 cis/11 cis); retinol dehydrogenase 12, all-trans and 9-cis; short chain dehydrogenase/reductase family 7C, member 2;
SCNN1D
sodium channel, nonvoltage-gated 1, delta
SCNN1D; sodium channel, nonvoltage-gated 1, delta; amiloride-sensitive sodium channel subunit delta; dNaCh; ENaCdelta; Amiloride sensitive sodium channel subunit delta; Delta ENaC; Delta NaCH; Epithelial Na(+) channel subunit delta; Nonvoltage gated sodium channel 1 subunit delta; SCNED; Sodium channel, nonvoltage gated 1, delta; delta-ENaC; delta-NaCH; nonvoltage-gated sodium channel 1 subunit delta; sodium channel, voltage-gated, type I, delta polypeptide; ENaCd;
SCNN1G
sodium channel, non-voltage-gated 1, gamma subunit
SCNN1G; sodium channel, non-voltage-gated 1, gamma subunit; PHA1; BESC3; ENaCg; SCNEG; ENaCgamma; amiloride-sensitive sodium channel subunit gamma; gamma-ENaC; gamma-NaCH; ENaC gamma subunit; epithelial Na(+) channel subunit gamma; sodium channel, nonvoltage-gated 1, gamma; nonvoltage-gated sodium channel 1 subunit gamma; amiloride-sensitive sodium channel gamma-subunit; amiloride-sensitive epithelial sodium channel gamma subunit;
SEMA4G
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
SEMA4G; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; semaphorin-4G; FLJ20590; KIAA1619; sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain (semaphorin) 4G; semaphorin 4G; Semaphorin 4G precursor;
SEPHS1
selenophosphate synthetase 1
SEPHS1; selenophosphate synthetase 1; selenide, water dikinase 1; SPS; SPS1; selenium donor protein 1; selenophosphate synthase 1; selenophosphate synthetase 1 +E9; selenophosphate synthetase 1 +E9a; selenophosphate synthetase 1 major; selenophosphate syn;
SEPHS2
selenophosphate synthetase 2
SEPHS2; selenophosphate synthetase 2; selenide, water dikinase 2; SPS2; selenium donor protein 2; selenophosphate synthase 2;
SLC5A3
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
SLC5A3; solute carrier family 5 (sodium/myo-inositol cotransporter), member 3; solute carrier family 5 (inositol transporter), member 3; sodium/myo-inositol cotransporter; SMIT; BCW2 protein; Na(+)/myo-inositol cotransporter; solute carrier family 5 membe;
SLC6A19
solute carrier family 6 (neutral amino acid transporter), member 19
SLC6A19; solute carrier family 6 (neutral amino acid transporter), member 19; sodium-dependent neutral amino acid transporter B(0)AT1; Hartnup disease; solute carrier family 6 member 19; system B0 neutral amino acid transporter; system B(0) neutral amino;
SLC6A20
solute carrier family 6 (proline IMINO transporter), member 20
SLC6A20; solute carrier family 6 (proline IMINO transporter), member 20; sodium- and chloride-dependent transporter XTRP3; XT3; Xtrp3; MGC161475; Neurotransmitter transporter RB21A; Neurotransmitter transporter rB21A homolog; Orphan transporter XT3; SIT 1; SIT1; Sodium and chloride dependent transporter XTRP3; Sodium/imino acid transporter 1; Solute carrier family 6 (neurotransmitter transporter) member 20; Solute carrier family 6 (proline IMINO transporter) member 20; Solute carrier family 6 member 20; X transporter protein 3; XT 3; Xtrp 3; OTTHUMP00000164648; OTTHUMP00000164649; transporter rB21A homolog; sodium/imino-acid transporter 1; solute carrier family 6 (neu;
SLC7A1
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
SLC7A1; solute carrier family 7 (cationic amino acid transporter, y+ system), member 1; ERR; ATRC1; CAT-1; HCAT1; REC1L; high affinity cationic amino acid transporter 1; CAT1; ecotropic retroviral receptor; solute carrier family 7 member 1; amino acid transporter, cationic 1; ecotropic retrovirus receptor homolog; system Y+ basic amino acid transporter; ecotropic retroviral leukemia receptor homolog;
SLC7A5
solute carrier family 7 (amino acid transporter light chain, L system), member 5
SLC7A5; solute carrier family 7 (amino acid transporter light chain, L system), member 5; large neutral amino acids transporter small subunit 1; CD98; D16S469E; E16; LAT1; MPE16; 4F2 LC; 4F2 light chain; CD98 light chain; integral membrane protein E16; L-;
SLC7A7
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
SLC7A7; solute carrier family 7 (amino acid transporter light chain, y+L system), member 7; LPI; Y+L amino acid transporter 1; y+LAT 1; monocyte amino acid permease 2; y(+)L-type amino acid transporter 1; solute carrier family 7 (cationic amino acid trans;
SMG1
SMG1 phosphatidylinositol 3-kinase-related kinase
SMG1; SMG1 phosphatidylinositol 3-kinase-related kinase; ATX; LIP; 61E3.4; serine/threonine-protein kinase SMG1; lambda-interacting protein; PI-3-kinase-related kinase SMG-1; lambda/iota protein kinase C-interacting protein; smg-1 homolog, phosphatidylinositol 3-kinase-related kinase;
SMUG1
single-strand-selective monofunctional uracil-DNA glycosylase 1
SMUG1; single-strand-selective monofunctional uracil-DNA glycosylase 1; single-strand selective monofunctional uracil DNA glycosylase; FDG; HMUDG; UNG3; MGC104370; Single strand selective monofunctional uracil DNA glycosylase 1; Single strand selective monofunctional uracil DNA glycosylase; SMUG 1; SMUG1 protein; SMUG1_HUMAN; UNG 3;
SPTBN2
spectrin, beta, non-erythrocytic 2
SPTBN2; spectrin, beta, non-erythrocytic 2; SCA5, spinocerebellar ataxia 5; spectrin beta chain, brain 2; beta-III spectrin; spectrin, non-erythroid beta chain 2; glutamate transporter EAAT4-associated protein 41; SCA5; GTRAP41;
SS18
synovial sarcoma translocation, chromosome 18
SS18; synovial sarcoma translocation, chromosome 18; SSXT; protein SSXT; SYT; MGC116875; Protein SYT; SSXT/SSX4v fusion; SSXT_HUMAN; Synovial sarcoma translocated to X chromosome; Synovial sarcoma translocated to X chromosome protein; Synovial sarcoma translocation chromosome 18; SYT SSX1; SYT SSX2; SYT/SSX4v fusion protein; SYTSSX1; SYTSSX2; synovial sarcoma, translocated to X chromosome;
SSX3
synovial sarcoma, X breakpoint 3
SSX3; synovial sarcoma, X breakpoint 3; protein SSX3; CT5.3; MGC119054; Cancer/testis antigen 5.3; MGC14495; SSX3_HUMAN; synovial sarcoma, X breakpoint 3, isoform a;
SYVN1
synovial apoptosis inhibitor 1, synoviolin
SYVN1; synovial apoptosis inhibitor 1, synoviolin; E3 ubiquitin-protein ligase synoviolin; HRD1; KIAA1810; MGC40372;
UCRC
UQCR10 ubiquinol-cytochrome c reductase, complex III subunit X
QCR9; UCRC; HSPC051; HSPC119; HSPC151; UCCR7.2; cytochrome b-c1 complex subunit 9; OTTHUMP00000199673; OTTHUMP00000199674; complex III subunit 9; complex III subunit X; cytochrome C1, nonheme 7kDa protein; cytochrome c1 non-heme 7 kDa protein; ubiquinol-cytochrome c reductase complex (7.2 kD); ubiquinol-cytochrome c reductase complex 7.2 kDa protein; ubiquinol-cytochrome c reductase, complex III subunit X, 7.2kDa;
UGT1A10
UDP glucuronosyltransferase 1 family, polypeptide A10
UGT1A10; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glycosyltransferase 1 family, polypeptide A10; UDP-glucuronosyltransferase 1-10; UGT1J; GNT1; UDP glucuronosyltransferase 1A10; UDP glycosyltransferase; UDPGT; UGT 1J; UGT1; UDPGT 1-10; OTTHUMP00000065196; OTTHUMP00000065197; UDP-glucuronosyltransferase 1-J; UDP-glucuronosyltransferase 1A10; UGT-1J; UGT1-10; UGT1.10;
UGT1A3
UDP glucuronosyltransferase 1 family, polypeptide A3
UGT1A3; UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glycosyltransferase 1 family, polypeptide A3; UDP-glucuronosyltransferase 1-3; UGT1C; EC 2.4.1.17; GNT 1; GNT1; UDP glucuronosyltransferase 1 3; UDP glucuronosyltransferase 1 family polypeptide A3; UDP glucuronosyltransferase 1A3; UDP glucuronosyltransferase; UDP glycosyltransferase 1 family polypeptide A3; UDPGT; UGT 1; UGT 1C; UGT1; UGT1 03; UGT1*3; UGT1.3; OTTHUMP00000065193; UDP-glucuronosyltransferase 1-C; UDP-glucuronosyltransferase 1A3; UGT-1C; UGT1-03; UDPGT 1-3;
UGT1A6
UDP glucuronosyltransferase 1 family, polypeptide A6
UGT1A6; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glycosyltransferase 1 family, polypeptide A6; UDP-glucuronosyltransferase 1-6; GNT1; HLUGP; UGT1F; HLUGP1; Phenol metabolizing UDP glucuronosyltransferase; Phenol-metabolizing UDP-glucuronosyltransferase; UD16_HUMAN; UDP glucuronosyltransferase 1 family polypeptide A6; UDP glucuronosyltransferase 1A6; UDP glycosyltransferase 1 family polypeptide A6; UDP-glucuronosyltransferase 1-F; UDP-glucuronosyltransferase 1A6; UDPGT; UDPGT 1-6; UGT 1F; UGT-1F; UGT1; UGT1 06; UGT1*6; UGT1-06; UGT1.6; UDP-glucuronosyltransferase 1 family polypeptide A6s; UGT1A6S;
UGT1A9
UDP glucuronosyltransferase 1 family, polypeptide A9
UGT1A9; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glycosyltransferase 1 family, polypeptide A9; UDP-glucuronosyltransferase 1-9; HLUGP4; LUGP4; UGT1AI; UDP-glucuronosyltransferase 1-I; UDP-glucuronosyltransferase 1A9; UDPGT; UGT1I; UGT-1I;
UGT2B4
UDP glucuronosyltransferase 2 family, polypeptide B4
UGT2B4; UDP glucuronosyltransferase 2 family, polypeptide B4; UDP glycosyltransferase 2 family, polypeptide B4; UDP-glucuronosyltransferase 2B4; UGT2B11; EC 2.4.1.17; HLUG25; Hyodeoxycholic acid; UDP glucuronosyltransferase 2 family polypeptide B4; UDP glucuronosyltransferase 2B4 precursor; UDP glucuronyltransferase family 2 beta 4; UDP glycosyltransferase 2 family polypeptide B4; UDP glycosyltransferase; UDPGT; UDPGTh 1; UDPGTh1; UDPGTh-1; UDPGT 2B4; OTTHUMP00000220485; OTTHUMP00000220486; UDP glucuronosyltransferase 2B4; hyodeoxycholic acid-specific UDPGT; UDP-glucuronyltransferase, family 2, beta-4; UDPGT2B4;
UPF1
UPF1 regulator of nonsense transcripts homolog (yeast)
UPF1; UPF1 regulator of nonsense transcripts homolog (yeast); regulator of nonsense transcripts 1 , RENT1; regulator of nonsense transcripts 1; HUPF1; KIAA0221; NORF1; pNORF1; smg 2; smg 2 homolog; nonsense mediated mRNA decay factor (C. elegans); UP Frameshift 1; delta helicase; yeast Upf1p homolog; ATP-dependent helicase RENT1; nonsense mRNA reducing factor 1; up-frameshift mutation 1 homolog; up-frameshift suppressor 1 homolog; smg-2 homolog, nonsense mediated mRNA decay factor; RENT1; smg-2; FLJ43809; FLJ46894;
UPF3A
UPF3 regulator of nonsense transcripts homolog A
UPF3A; UPF3 regulator of nonsense transcripts homolog A (yeast); regulator of nonsense transcripts 3A; HUPF3A; RENT3A; UPF3; hUpf3; nonsense mRNA reducing factor 3A; up-frameshift suppressor 3 homolog A; FLJ35267; FLJ57970;
UQCRH
ubiquinol-cytochrome c reductase hinge protein
UQCRH; ubiquinol-cytochrome c reductase hinge protein; cytochrome b-c1 complex subunit 6, mitochondrial; QCR6; ubiquinol cytochrome c reductase; complex III subunit VIII; UQCR8; Complex III subunit 6; Cytochrome b c1 complex subunit 6; Cytochrome b c1 complex subunit 6 mitochondrial; Cytochrome c1 non heme 11 kDa protein; MGC111572; Mitochondrial hinge protein; QCR 6; Ubiquinol cytochrome c reductase complex 11 kDa protein; Ubiquinol cytochrome c reductase complex 11 kDa protein mitochondrial; Ubiquinol cytochrome c reductase hinge protein; cytochrome c1 non-heme 11 kDa protein; ubiquinol-cytochrome c reductase complex 11 kDa protein; ubiquinol-cytochrome c reductase, complex III subunit VIII;
IGSF11
immunoglobulin superfamily, member 11
IGSF11; immunoglobulin superfamily, member 11; immunoglobulin superfamily member 11; BT IgSF; cancer/testis antigen 119; CT119; Igsf13; MGC35227; VSIG3; CXADR like 1; V-set and immunoglobulin domain containing 3; V-set and immunoglobulin domain-containing;
LHPP
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
LHPP; phospholysine phosphohistidine inorganic pyrophosphate phosphatase; HDHD2B; hLHPP; FLJ44846; FLJ46044; MGC117251; MGC142189; MGC142191;
PCYT2
phosphate cytidylyltransferase 2, ethanolamine
PCYT2; phosphate cytidylyltransferase 2, ethanolamine; ET; ethanolamine-phosphate cytidylyltransferase; phosphorylethanolamine transferase; CTP:phosphoethanolamine cytidylyltransferase;
PI4K2B
phosphatidylinositol 4-kinase type 2 beta
PI4K2B; phosphatidylinositol 4-kinase type 2 beta; phosphatidylinositol 4-kinase type 2-beta; FLJ11105; PI4KIIB; PIK42B; PI4KII-BETA; phosphatidylinositol 4-kinase type II-beta; phosphatidylinositol 4-kinase type-II beta;
PIP5K1A
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase, type I, alpha; phosphatidylinositol-4-phosphate 5-kinase type-1 alpha; PIP5KIalpha; PIP5K1-alpha; ptdIns(4)P-5-kinase 1 alpha; 68 kDa type I phosphatidylinositol-4-phosphate 5-kinase alpha;
HIV
Human immunodeficiency virus
HIV 1; HTLV3; Human Immunodeficiency Virus 1; Group VI (ssRNA-RT); Retroviridae; Lentivirus; human immunodeficiency virus;
DIAPH3
diaphanous homolog 3 (Drosophila)
DIAPH3; diaphanous homolog 3 (Drosophila); auditory neuropathy, autosomal dominant 1 , AUNA1, diaphanous (Drosophila, homolog) 3; protein diaphanous homolog 3; AN; DRF3; FLJ34705; NSDAN; Dia2; diap3; DKFZp434C0931; DKFZp686A13178; RP11-26P21.1; DIAP3_HUMAN; Diaphanous homolog 3; Diaphanous related formin 3; Diaphanous-related formin-3; OTTHUMP00000018480; OTTHUMP00000180577; OTTHUMP00000180578; OTTHUMP00000180579; OTTHUMP00000180580; diaphanous-related formin 3; auditory neuropathy, autosomal dominant 1; AUNA1; mDia2;
DLEU1
deleted in lymphocytic leukemia 1 (non-protein coding)
deleted in lymphocytic leukemia 1 (non-protein coding); DLEU2; LEU1; LEU2; XTP6; MGC22430; NCRNA00021; Deleted in lymphocytic leukemia 1; deleted in lymphocytic leukemia, 1; HBV X-transactivated gene 6 protein; BCMS; HBV XAg-transactivated protein 6; DLB1;
IGLC@
immunoglobulin lambda constant cluster
immunoglobulin lambda constant group; IGLC; immunoglobulin lambda constant cluster; IGLC@;
INPP5J
inositol polyphosphate-5-phosphatase J
INPP5J; inositol polyphosphate-5-phosphatase J; phosphatidylinositol (4,5) bisphosphate 5 phosphatase, A , PIB5PA; phosphatidylinositol 4,5-bisphosphate 5-phosphatase A; INPP5; inositol polyphosphate 5-phosphatase J; phosphatidylinositol (4,5) bisphosphat;
KIR3DX1
killer cell immunoglobulin-like receptor, three domains, X1
killer cell immunoglobulin-like receptor, three domains, X1; FLJ00060; KIR3DL0; LENG12; leukocyte receptor cluster (LRC) member 12; Leukocyte receptor cluster member 12; KIR3DX1;
LAP3
leucine aminopeptidase 3
LAP3; leucine aminopeptidase 3; PEPS, peptidase S; cytosol aminopeptidase; LAP; LAPEP; LAP-3; peptidase S; leucyl aminopeptidase; prolyl aminopeptidase; proline aminopeptidase; PEPS;
LRIG3
leucine-rich repeats and immunoglobulin-like domains 3
LRIG3; leucine-rich repeats and immunoglobulin-like domains 3; leucine-rich repeats and immunoglobulin-like domains protein 3; FLJ90440; KIAA3016; LIG3; LRIG1-3; LIG-3; OTTHUMP00000242498; OTTHUMP00000242499; OTTHUMP00000242500;
MAN2C1
mannosidase, alpha, class 2C, member 1
MAN2C1;mannosidase, alpha, class 2C, member 1;MANA, MANA1;alpha-mannosidase 2C1;alpha mannosidase 6A8B;mannosidase, alpha 6A8;alpha-D-mannoside mannohydrolase;mannosidase, alpha A, cytoplasmic;MANA;MANA1;MAN6A8;MGC87979;DKFZp686E23167;
NME5
non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)
NME5; non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase homolog 5; nm23 H5; radial spoke 23 homolog (Chlamydomonas); RSPH23; NDK-H 5; IPIA-beta; NDP kinase homolog 5; radial spoke 23 homolog; testi;
NME7
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase)
NME7; non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 7; FLJ37194; NM23 H7; NDK 7; NDP kinase 7; nucleoside-diphosphate kinase 7; MN23H7; nm23-H7;
PIP4K2C
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma
PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase, type II, gamma; phosphatidylinositol 4 phosphate 5 kinase, type II, gamma , PIP5K2C; phosphatidylinositol-5-phosphate 4-kinase type-2 gamma; FLJ22055; PIP4KII-gamma; PI(5)P 4-kinase type II gamma; phosph;
RSAD2
radical S-adenosyl methionine domain containing 2
RSAD2;radical S-adenosyl methionine domain containing 2;radical S-adenosyl methionine domain-containing protein 2;cig5;vig1;viperin;cytomegalovirus-induced gene 5 protein;virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible;cig33;2510004L01Rik;
SHISA5
shisa homolog 5 (Xenopus laevis)
SHISA5; shisa homolog 5 (Xenopus laevis); protein shisa-5; hShisa5; SCOTIN; Putative NFkB activating protein 120; putative NF-kappa-B-activating protein 120;
TMIGD1
transmembrane and immunoglobulin domain containing 1
TMIGD1;transmembrane and immunoglobulin domain containing 1;TMIGD;transmembrane and immunoglobulin domain-containing protein 1;UNQ9372;AWKS9372;
TRBV5-3
T cell receptor beta variable 5-3 (non-functional)
T cell receptor beta variable 5-3 (non-functional); TCRBV5S3; TCRBV5S5P; TRBV53; T cell receptor beta variable 5-3; TRBV5-3;
XPR1
xenotropic and polytropic retrovirus receptor 1
XPR1; xenotropic and polytropic retrovirus receptor 1; xenotropic and polytropic retrovirus receptor; SYG1; X3; FLJ90308; OTTHUMP00000033084; OTTHUMP00000033085; Polytropic murine leukamia virus receptor SYG 1; Polytropic murine leukamia virus receptor SYG1; Protein SYG1 homolog; SYG 1; SYG1 protein; X-receptor; Xenotropic and polytropic murine leukemia virus receptor X3; XPR 1; XPR1 protein; XPR1_HUMAN;
ADARB1
adenosine deaminase, RNA-specific, B1
ADARB1; adenosine deaminase, RNA-specific, B1; adenosine deaminase, RNA specific, B1 (homolog of rat RED1); double-stranded RNA-specific editase 1; ADAR2; ADAR2a; ADAR2a L1; ADAR2a L2; ADAR2a L3; ADAR2b; ADAR2c; ADAR2d; ADAR2g; DRABA2; DRADA2; hRED1; RED1; RED1 homolog (rat); ADARB 1; 1700057H01Rik; Adenosine deaminase, RNA specific, 2; Adenosine deaminase, RNA specific, B1 (RED1 homolog rat); Adenosine deaminase, RNA specific, B1; AW124433; AW558573; BB220382; D10Bwg0447e; Double stranded RNA specific editase 1; dsRNA adenosine deaminase; EC 3.5.-.-; Human dsRNA adenosine deaminase DRADA2; Human dsRNA adenosine deaminase DRADA2b, EC 3.5; OTTHUMP00000115341; OTTHUMP00000115342; RED 1; RNA editase; RNA editase 1; RNA editing deaminase 1; RNA editing enzyme 1; RNA editing enzyme 1, rat, homolog of; RNA specific adenosine deaminase B1; RED1 homolog; OTTHUMP00000115339; OTTHUMP00000115340; OTTHUMP00000174981; OTTHUMP00000214128; RNA-editing enzyme 1; RNA-editing deaminase 1; dsRNA ad;
BNIP3
BCL2/adenovirus E1B interacting protein 3
BNIP3; BCL2/adenovirus E1B interacting protein 3; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3; BCL2/adenovirus E1B interacting protein 1, NIP3; BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP3; BCL2/adenovirus E1B 19 kDa-interacting prot;
CEACAM19
carcinoembryonic antigen-related cell adhesion molecule 19
CEACAM19; carcinoembryonic antigen-related cell adhesion molecule 19; CEAL1; Carcinoembryonic antigen like 1; Carcinoembryonic antigen related cell adhesion molecule 19; CEA related cell adhesion molecule 19; MGC105097; OTTHUMP00000200169; OTTHUMP00000200170; carcinoembryonic antigen-like 1;
CEACAM20
carcinoembryonic antigen-related cell adhesion molecule 20
CEACAM20; carcinoembryonic antigen-related cell adhesion molecule 20; UNQ9366; carcinoembryonic antigen related cell adhesion molecule 20; GPAD9366;
CEACAM7
carcinoembryonic antigen-related cell adhesion molecule 7
CEACAM7; carcinoembryonic antigen-related cell adhesion molecule 7; CGM2; carcinoembryonic antigen gene family member 2; CEA; Carcinoembryonic antigen CGM 2; Carcinoembryonic antigen CGM2; Carcinoembryonic antigen related cell adhesion molecule 7; CEACAM 7; CGM 2; OTTHUMP00000199040; OTTHUMP00000199041;
CRYZ
crystallin, zeta (quinone reductase)
CRYZ; crystallin, zeta (quinone reductase); quinone oxidoreductase; NADPH:quinone reductase; Zeta crystallin; Crystallin zeta (quinone reductase); Crystallin zeta; DKFZp779E0834; FLJ41475; MS766; QOR_HUMAN; Zeta-crystallin; OTTHUMP00000011194; OTTHUMP00000011210; OTTHUMP00000011211; OTTHUMP00000011213;
DBH
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
DBH; dopamine beta-hydroxylase (dopamine beta-monooxygenase); dopamine beta-hydroxylase; DBM;
EHHADH
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase
EHHADH; enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase; ECHD, enoyl Coenzyme A, hydratase/3 hydroxyacyl Coenzyme A dehydrogenase; peroxisomal bifunctional enzyme; 3 hydroxyacyl CoA dehydrogenase; 3,2 trans enoyl CoA isomerase; 3-hydroxyacyl-CoA dehydrogenase; ECHD; ECHP_HUMAN; Enoyl Coenzyme A, hydratase/3 hydroxyacyl Coenzyme A dehydrogenase; L 3 hydroxyacyl CoA dehydrogenase; L bifunctional protein, peroxisomal; L PBE; LBFP; LBP; MGC120586; MS730; PBE; PBFE; Peroxisomal enoyl CoA hydratase; 3,2-trans-enoyl-CoA isomerase; peroxisomal enoyl-CoA hydratase; L-3-hydroxyacyl-CoA dehydrogenase; L-bifunctional protein, peroxisomal; enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase; L-PBE;
EPX
eosinophil peroxidase
EPX; eosinophil peroxidase; EPO; EPP; EPX PEN; Eosinophil peroxidase [Precursor]; EPER; PERE; EPX-PEN;
FCN2
ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin)
FCN2; ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin); ficolin-2; collagen/fibrinogen domain containing protein 2; EBP 37; FCNL; ficolin B; ficolin 2; hucolin; L ficolin; P35; serum lectin p35; 37 kDa elastin-binding protein; Ficolin beta; OTTHUMP00000022518; RP11-263F14.2; L-ficolin; ficolin-B; ficolin-beta; collagen/fibrinogen domain-containing protein 2; EBP-37;
GABRD
gamma-aminobutyric acid (GABA) A receptor, subunit delta
GABRD; gamma-aminobutyric acid (GABA) A receptor, subunit delta; gamma-aminobutyric acid receptor subunit delta; GABA(A) receptor subunit delta; gamma-aminobutyric acid (GABA-A) receptor, subunit delta; AI853201; MGC151209; MGC151213;
GRIN2A
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
Grin2a; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; NMDAR2A; NR2A; hNR2A; N-methyl D-aspartate receptor subtype 2A; OTTHUMP0000016013; OTTHUMP00000174531; glutamate [NMDA] receptor subunit epsilon-1; N-methyl-D-aspartate receptor channel, subunit epsilon-1; N-methyl-D-aspartate receptor subunit 2A; NMDA receptor subtype 2A; glutamate receptor, ionotropic, NMDA2A (epsilon1); GluN2A; GluRepsilon1; OTTMUSP00000017426;
GRIN2C
Grin2c glutamate receptor, ionotropic, NMDA2C (epsilon 3)
GRIN2C; glutamate receptor, ionotropic, NMDA2C (epsilon 3); glutamate [NMDA] receptor subunit epsilon-3; GluRepsilon3; N-methyl D-aspartate receptor subtype 2C; NR2C; NMDAR2C;
HADHA
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
HADHA; hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit; GBP; ECHA; HADH; LCEH; MTPA; LCHAD; TP-ALPHA; trifunctional enzyme subunit alpha, mitochondrial; 3-oxoacyl-CoA thiolase; gastrin-binding protein; 78 kDa gastrin-binding protein; long-chain 2-enoyl-CoA hydratase; long-chain-3-hydroxyacyl-CoA dehydrogenase; mitochondrial trifunctional enzyme, alpha subunit; mitochondrial trifunctional protein, alpha subunit; 3-ketoacyl-Coenzyme A (CoA) thiolase, alpha subunit; mitochondrial long-chain 2-enoyl-Coenzyme A (CoA) hydratase, alpha subunit; mitochondrial long-chain L-3-hydroxyacyl-Coenzyme A (CoA) dehydrogenase, alpha subunit; hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit;
HADHB
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
HADHB; hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit; hydroxyacyl Coenzyme A dehydrogenase/3 ketoacyl Coenzyme A thiolase/enoyl Coenzyme A hydratase (trifunctional protein), beta subunit; trifunctional enzyme subunit beta, mitochondrial; mitochondrial trifunctional protein; beta subunit; MTPB; 2 enoyl Coenzyme A (CoA) hydratase beta subunit; 3 ketoacyl Coenzyme A (CoA) thiolase of mitochondrial trifunctional protein beta subunit; 3 ketoacyl Coenzyme A thiolase; 3 ketoacyl Coenzyme A thiolase of mitochondrial trifunctional protein beta subunit; 3-ketoacyl-CoA thiolase; Acetyl CoA acyltransferase; Acetyl-CoA acyltransferase; Beta ketothiolase; Beta-ketothiolase; ECHB; ECHB_HUMAN; HADH; Hydroxyacyl Coenzyme A (CoA) dehydrogenase beta subunit; Hydroxyacyl Coenzyme A dehydrogenase; Hydroxyacyl Coenzyme A dehydrogenase beta subunit; Hydroxyacyl Coenzyme A dehydrogenase/3 ketoacyl Coenzyme A thiolase/enoyl Coenzyme A hydratase (trifunctional protein) beta subunit; MGC87480; Mitochondrial trifunctional enzyme beta subunit; Mitochondrial trifunctional protein beta subunit; MS733; MSTP 029; MSTP029; TP beta; TP-beta; TPbeta; Trifunctional enzyme subunit beta; Trifunctional enzyme subunit beta mitochondrial; Trifunctional protein; OTTHUMP00000122456; OTTHUMP00000200808; 2-enoyl-Coenzyme A (CoA) hydratase, beta subunit; mitochondrial trifunctional enzyme, beta subunit; mitochondrial trifunction;
HIVEP2
human immunodeficiency virus type I enhancer binding protein 2
HIVEP2; human immunodeficiency virus type I enhancer binding protein 2; transcription factor HIVEP2; c myc intron binding protein 1; HIV EP2; MBP 2; MIBP1; Schnurri 2; ZAS2; ZNF40B; HIV-EP2; Human immunodeficiency virus type I enhancer-binding protein 2; MBP-2; MHC binding protein 2; MHC-binding protein 2; SHN2; ZEP2_HUMAN; Schnurri-2; OTTHUMP00000017321; OTTHUMP00000017322; MHC binding protein-2; c-myc intron binding protein 1; c-myc intron-binding protein 1;
IGJ
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
IGJ; immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides; immunoglobulin J chain; IGCJ; JCH; IGJ_HUMAN; Immunoglobulin J polypeptide linker protein for immunoglobulin alpha and mu polypeptides; OTTHUMP00000160357; OTTHUMP00000219133; OTTHUMP00000219134; OTTHUMP00000219135;
LILRA4
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
LILRA4; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4; leukocyte immunoglobulin-like receptor subfamily A member 4; CD85g; ILT7; ILT-7; OTTHUMP00000067952; immunoglobulin-like transcript 7; CD85 antigen-like family member G; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4;
LMAN2
lectin, mannose-binding 2
LMAN2; lectin, mannose-binding 2; C5orf8, chromosome 5 open reading frame 8; vesicular integral-membrane protein VIP36; GP36B; VIP36; glycoprotein GP36b; vesicular integral protein of 36 kDa; vesicular integral-membrane protein 36; C5orf8;
LOC442228
similar to dJ22I17.2 (novel protein with EGF-like and laminin G domains)
LOC442228; similar to dJ22I17.2 (novel protein with EGF-like and laminin G domains); similar to dJ22I17.2 (novel protein with EGF-like and laminin G; dJ22I17.2;
MAGEA12
melanoma antigen family A, 12
MAGEA12; melanoma antigen family A, 12; MAGE12; melanoma-associated antigen 12; cancer/testis antigen family 1; member 12; CT1.12; MAGE-12 antigen; MAGE12F antigen; cancer/testis antigen 1.12; cancer/testis antigen family 1, member 12;
MAGEC1
melanoma antigen family C, 1
MAGEC1; melanoma antigen family C, 1; melanoma-associated antigen C1; cancer/testis antigen family 7; member 1; CT7; CT7.1; MAGE C1; MGC39366; MAGE-C1 antigen; cancer/testis antigen 7.1; cancer/testis antigen family 7, member 1;
MUM1
melanoma associated antigen (mutated) 1
MUM1; melanoma associated antigen (mutated) 1; PWWP domain-containing protein MUM1; MUM 1; protein expandere; melanoma ubiquitous mutated protein; mutated melanoma-associated antigen 1; MUM-1; EXPAND1; HSPC211; FLJ14868; FLJ22283; MGC131891; MGC163315;
NDUFA13
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
NDUFA13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13; B16.6; CDA016; CGI 39; complex I B16.6 subunit; GRIM 19; GRIM19; CI-B16.6; complex I-B16.6; cell death-regulatory protein GRIM19; cell death regulatory protein GRIM-19; NADH-ubiquinone oxidoreductase B16.6 subunit; gene associated with retinoic and IFN-induced mortality 19 protein; gene associated with retinoic and interferon-induced mortality 19 protein; CGI-39; GRIM-19; FLJ58045; FLJ59191;
NDUFS2
NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)
NDUFS2; NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 2 (49kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial; CI 49; complex I 49kDa subunit; NADH dehydrogenase [ubiquinone] iron sulfur protein 2; mitochondrial; CI 49kD; CI-49kD; Complex I 49kD; Complex I-49kD; NADH dehydrogenase [ubiquinone] iron sulfur protein 2, mitochondrial; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2; NADH ubiquinone oxidoreductase 49 kDa subunit; NADH-ubiquinone oxidoreductase 49 kDa subunit; NDUS2_HUMAN; OTTHUMP00000032241; NADH-ubiquinone oxidoreductase NDUFS2 subunit; complex 1, mitochondrial res; CI-49;
NONO
non-POU domain containing, octamer-binding
NONO; non-POU domain containing, octamer-binding; P54; NMT55; NRB54; P54NRB; non-POU domain-containing octamer-binding protein; p54(nrb); 55 kDa nuclear protein; 54 kDa nuclear RNA- and DNA-binding protein; DNA-binding p52/p100 complex, 52 kDa subunit; non-POU domain-containing octamer (ATGCAAAT) binding protein;
NOTCH4
notch 4
NOTCH4; notch 4; INT3; NOTCH3; neurogenic locus notch homolog protein 4; Notch homolog 4;
NPEPPS
aminopeptidase puromycin sensitive
NPEPPS; aminopeptidase puromycin sensitive; puromycin-sensitive aminopeptidase; metalloproteinase MP100; MP100; PSA; puromycin sensitive aminopeptidase; METALLOPROTEASE 100; METALLOPROTEASE MP100; MP 100; OTTHUMP00000229852; OTTHUMP00000229855; cytosol alanyl aminopeptidase; AAP-S;
PAM
peptidylglycine alpha-amidating monooxygenase
PAM; peptidylglycine alpha-amidating monooxygenase; peptidyl-glycine alpha-amidating monooxygenase; PAL; peptidyl alpha hydroxyglycine alpha amidating lyase; peptidylglycine alpha hydroxylating monooxygenase; PHM; AMD_HUMAN; Pancreatic peptidylglycine alpha amidating monooxygenase; Peptidyl alpha amidating enzyme; Peptidyl-alpha-hydroxyglycine alpha-amidating lyase; Peptidylamidoglycolate lyase; Peptidylglycine 2 hydroxylase; Peptidylglycine alpha amidating monooxygenase; OTTHUMP00000158920; OTTHUMP00000158921; OTTHUMP00000158922; OTTHUMP00000158923; OTTHUMP00000222752; OTTHUMP00000227957; peptidylglycine 2-hydroxylase; peptidyl alpha-amidating enzyme; pep;
PF14_0039
conserved Plasmodium protein PF14_0039, unknown function
PF14_0039; conserved Plasmodium protein, unknown function; Hypothetical Protein 9; Putative uncharacterized protein;
PMEL
premelanosome protein
PMEL; premelanosome protein; P1; SI; SIL; ME20; P100; SILV; ME20M; gp100; ME20-M; PMEL17; D12S53E; melanocyte protein PMEL; melanocyte protein mel 17; silver, mouse, homolog of; melanocyte protein Pmel 17; melanosomal matrix protein17; silver locus protein homolog; melanoma-associated ME20 antigen; melanocytes lineage-specific antigen GP100;
PRG2
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
PRG2; proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein); MBP; BMPG; MBP1; bone marrow proteoglycan; bone-marrow proteoglycan; proteoglycan 2 preproprotein; natural killer cell activator; eosinophil major basic protein; eosinophil granule major basic protein; prg-2; Piwi (fruitfly) Related Gene; Piwi (fruitfly) Related Gene family member (prg-2); 4H292; tag-292;
PSMD1
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1
PSMD1; proteasome (prosome, macropain) 26S subunit, non-ATPase, 1; 26S proteasome non-ATPase regulatory subunit 1; P112; Rpn2; S1; MGC133041; 26S proteasome non ATPase regulatory subunit 1; 26S proteasome non ATPase subunit 1; 26S proteasome regulatory subunit RPN2; 26S proteasome regulatory subunit S1; 26S proteasome subunit p112; MGC133040; Proteasome (prosome macropain) 26S subunit, non ATPase 1; PSMD1_HUMAN; OTTHUMP00000164295; OTTHUMP00000204737;
PSMD8
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8
PSMD8; proteasome (prosome, macropain) 26S subunit, non-ATPase, 8; 26S proteasome non-ATPase regulatory subunit 8; HIP6; HYPF; Nin1p; p31; Rpn12; S14; 26S proteasome non ATPase regulatory subunit 8; 26S proteasome regulatory subunit p31; 26S proteasome regulatory subunit RPN12; 26S proteasome regulatory subunit S14; AAV38494; MGC1660; Proteasome (prosome macropain) 26S subunit non ATPase 8; PSMD8_HUMAN; OTTHUMP00000198258;
RAET1C
retinoic acid early transcript gamma
RAET1C; retinoic acid early transcript gamma; retinoic acid early-inducible protein 1-gamma; RAE-1-gamma; Rae-1 alpha; RAE-1gamma;
SLC17A6
Slc17a6 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6
SLC17A6; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6; vesicular glutamate transporter 2; differentiation-associated BNPI; solute carrier family 17 member 6; solute carrier family 17 (vesicular glutamate transporter), member 6; differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; DNPI; VGLUT2; 2900073D12Rik;
SLC17A8
Slc17a8 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8
SLC17A8; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8; vesicular glutamate transporter 3; solute carrier family 17 member 8; vesicular glutamate transporter-3; Vglut3; BC042593;
SMG6
SMG6 nonsense mediated mRNA decay factor
SMG6; SMG6 nonsense mediated mRNA decay factor; EST1A; SMG-6; C17orf31; hSMG5/7a; telomerase-binding protein EST1A; telomerase subunit EST1A; ever shorter telomeres 1A; EST1 telomerase component homolog A; smg-6 homolog, nonsense mediated mRNA decay factor;
TIMD2
T-cell immunoglobulin and mucin domain containing 2
TIMD2; T-cell immunoglobulin and mucin domain containing 2; T-cell immunoglobulin and mucin domain-containing protein 2; T cell immunoglobulin and mucin domain containing 2 protein; Tim2; TIMD-2; OTTMUSP00000005656; OTTMUSP00000005657; T-cell membrane protein 2; G9D3; TIM-2; C78111; AA816106; AU019358; AU019662;
VSIG1
V-set and immunoglobulin domain containing 1
1700062D20Rik; Cell surface A33 antigen; ChT1 thymocyte antigen; dJ889N15.1; Glycoprotein A34; GPA34; MGC44287; OTTHUMP00000023820; V set and immunoglobulin domain containing; V-set and immunoglobulin domain containing 1; V-set and immunoglobulin domain-containing protein 1; VSIG1; VSIG1_HUMAN;
WFIKKN1
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
WFIKKN1; WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1; C16orf12, chromosome 16 open reading frame 12; WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1; RJD2; WFIKKN; C16orf12; Chromosome 16 open reading frame 12; GASP 2; GASP2; Growth and differentiation factor-associated serum protein; hGASP 2; WAP, follistatin/kazal, immunoglobulin, kunitz and netrin; WAP, FS, Ig, KU, and NTR containing protein; GASP-2; hGASP-2; OTTHUMP00000115417; WAP, FS, Ig, KU, and NTR-containing protein; growth and differentiation factor-associated serum protein 2; WAP, follistatin, immunoglobulin, kunitz and;
WIPI2
WD repeat domain, phosphoinositide interacting 2
WIPI2; WD repeat domain, phosphoinositide interacting 2; WD repeat domain phosphoinositide-interacting protein 2; ATG18B; Atg21; CGI 50; DKFZP434J154; DKFZp686P02188; FLJ12979; FLJ14217; FLJ42984; WIPI49-like protein 2; WD40 repeat protein interacting wit;
GRIA4
Gria4 glutamate receptor, ionotropic, AMPA4 (alpha 4)
GRIA4; glutamate receptor, ionotropic, AMPA4 (alpha 4); glutamate receptor 4; spike wave 1; glutamate receptor channel alpha 4; AMPA-selective glutamate receptor 4; glutamate receptor ionotropic, AMPA 4; GluA4; Glur4; spkw1; GluR-D; Glur-4; Gluralpha4;
GRIK2
glutamate receptor, ionotropic, kainate 2
GRIK2; glutamate receptor, ionotropic, kainate 2; GLUR6; glutamate receptor, ionotropic kainate 2; MRT6; gluR-6; bA487F5.1; OTTHUMP00000017949; OTTHUMP00000017950; OTTHUMP00000017951; glutamate receptor 6; glutamate receptor form A; glutamate receptor form B; glutamate receptor form C; glutamate receptor form D; glutamate recep; EAA4; GLR6; GLUK6;
NDUFB6
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa
NDUFB6; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (17kD, B17); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6; B17; CI; complex I; mitochondrial respiratory chain; B17 subunit; NADH ubiquinone oxidoreductase B17 subunit; NADH ubiquinone oxidoreductase beta subunit; 6; CI B17; CI-B17; Complex I mitochondrial respiratory chain B17 subunit; Complex I-B17; Complex IB17; MGC13675; MS108; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 6; NADH ubiquinone oxidoreductase beta subunit 6; NADH-ubiquinone oxidoreductase B17 subunit; NDUB6_HUMAN; OTTHUMP00000021179; OTTHUMP00000021180; NADH-ubiquinone oxidoreductase beta subunit, 6; complex I, mitochondrial respiratory chain, B1;
RBBP7
retinoblastoma binding protein 7
RBBP7; retinoblastoma binding protein 7; RbAp46; histone-binding protein RBBP7; RBBP-7; retinoblastoma-binding protein 7; retinoblastoma-binding protein p46; retinoblastoma-binding protein RbAp46; histone acetyltransferase type B subunit 2; nucleosome-remodeling factor subunit RBAP46; G1/S transition control protein-binding protein RbAp46;
MYH10
myosin, heavy chain 10, non-muscle
Cellular myosin heavy chain; Cellular myosin heavy chain type B; Cellular myosin heavy chain type B type B; MGC134913; MGC134914; MYH 10; Myh10; MYH10_HUMAN; Myosin 10; Myosin heavy chain 10; Myosin heavy chain 10 non muscle; Myosin heavy chain; Myosin heavy chain non muscle 11b; <br/>Myosin heavy chain nonmuscle IIb; Myosin heavy chain nonmuscle type B; Myosin heavy polypeptide 10 non muscle; Myosin-10; Myosin10; NMMHC B; <br/>NMMHC II b; NMMHC II-b; NMMHC IIB; NMMHC-B; NMMHC-IIB; NMMHCB; Non muscle myosin heavy chain B; Non muscle myosin heavy chain IIB; Non muscle myosin II heavy chain B; non-muscle IIb; Non-muscle myosin heavy chain B; Non-muscle myosin heavy chain IIb; Nonmuscle myosin heavy chain B; Nonmuscle myosin heavy chain IIB; Nonmuscle myosin II heavy chain B; type B; cytoplasmic nonmuscle myosin II;
NDUFB8
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa
NDUFB8; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8 (19kD, ASHI); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial; ASHI; CI ASHI; complex I ASHI subunit; mitochondrial; CI-ASHI; Complex I-ASHI; MS105; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 19kDa; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8 mitochondrial; NADH-ubiquinone oxidoreductase ASHI subunit; NDUB8_HUMAN; NADH:ubiquinone oxidoreductase ASHI subunit;
NDUFS8
NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase)
NDUFS8; NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 8 (23kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial; CI 23k; complex I 23kDa subunit; NADH dehydrogenase [ubiquinone] iron sulfur protein 8; mitochondrial; TYKY; BC021616; CI23KD; MGC101957; MGC37950; MS109; NADH dehydrogenase (ubiquinone) Fe S protein 8, 23kDa (NADH coenzyme Q reductase); NADH ubiquinone oxidoreductase 23 kDa subunit; TYKY subunit; complex I-23kD; NADH-ubiquinone oxidoreductase 23 kDa subunit; CI-23k;
ADRB2
adrenoceptor beta 2, surface
ADRB2; adrenoceptor beta 2, surface; BAR; B2AR; ADRBR; ADRB2R; BETA2AR; beta-2 adrenergic receptor; beta-2 adrenoceptor; beta-2 adrenoreceptor; catecholamine receptor; adrenoceptor beta 2 surface; adrenergic, beta-2-, receptor, surface;
ALAD
aminolevulinate dehydratase
ALAD; aminolevulinate dehydratase; aminolevulinate, delta , dehydratase; delta-aminolevulinic acid dehydratase; ALADH; PBGS; porphobilinogen synthase; MGC5057; OTTMUSP00000009377; RP11-10I9.1; ALADR; Delta aminolevulinic acid dehydratase; Lv; OTTMUSP00000009376; RP24-189G18.9; aminolevulinate, delta-, dehydratase;
APEH
N-acylaminoacyl-peptide hydrolase
APEH; N-acylaminoacyl-peptide hydrolase; D3F15S2, D3S48E, DNF15S2; acylamino-acid-releasing enzyme; acyl-peptide hydrolase; acylaminoacyl-peptidase; oxidized protein hydrolase; APH; OPH; AARE; ACPH; D3S48E; D3F15S2; DNF15S2; MGC2178;
ATIC
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ATIC; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase; bifunctional purine biosynthesis protein PURH; AICARFT; IMPCHASE; phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase; PURH; AICARFT/IMPCHAS;
ECI2
enoyl-CoA delta isomerase 2
ECI2; enoyl-CoA delta isomerase 2; PECI, peroxisomal D3,D2 enoyl CoA isomerase; enoyl-CoA delta isomerase 2, mitochondrial; Hepatocellular carcinoma associated antigen 88; ACBD2; acyl Coenzyme A binding domain containing 2; DRS1; HCA88; DBI-related prote;
ENOX1
ecto-NOX disulfide-thiol exchanger 1
ENOX1; ecto-NOX disulfide-thiol exchanger 1; cCNOX; CNOX; FLJ10094; PIG38; bA64J21.1; Candidate growth related and time keeping constitutive hydroquinone [NADH] oxidase; Cell proliferation inducing gene 38 protein; Constitutive Ecto NOX; Ecto NOX disulfide thiol exchanger 1; OTTHUMP00000018332; Proliferation inducing protein 38; constitutive Ecto-NOX; cell proliferation-inducing gene 38 protein; candidate growth-related and time keeping constitutive hydroquinone (NADH) oxidase; candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase;
GABRB3
gamma-aminobutyric acid (GABA) A receptor, beta 3
Gamma-aminobutyric acid type A receptors; GABAA receptors; GABRB3; gamma-aminobutyric acid (GABA) A receptor, beta 3; gamma-aminobutyric acid receptor subunit beta-3;
GRIK1
glutamate receptor, ionotropic, kainate 1
GRIK1; glutamate receptor, ionotropic, kainate 1; GLUR5; glutamate receptor, ionotropic kainate 1; GluK1; gluR-5; glutamate receptor 5; excitatory amino acid receptor 3; EAA3; EEA3; GLR5;
GRIK4
glutamate receptor, ionotropic, kainate 4
GRIK4; glutamate receptor, ionotropic, kainate 4; GRIK; glutamate receptor, ionotropic kainate 4; GluK4; KA1; glutamate receptor KA1; glutamate receptor KA-1; excitatory amino acid receptor 1; EAA1;
INPP5B
inositol polyphosphate-5-phosphatase, 75kDa
INPP5B; inositol polyphosphate-5-phosphatase, 75kDa; inositol polyphosphate 5 phosphatase, 75kD; type II inositol-1,4,5-trisphosphate 5-phosphatase; 4; 5-trisphosphate 5-phosphatase; 5PTase; 75 kDa inositol polyphosphate 5 phosphatase; 75 kDa inositol polyphosphate-5-phosphatase; 75kDa; EC 3.1.3.36; I5P2_HUMAN; Inositol polyphosphate 5-phosphatase II; Inositol polyphosphate-5-phosphatase B; Inpp5b protein; INPP5P; MGC65156; MGC71303; OTTHUMP00000004726; OTTHUMP00000004727; OTTHUMP00000004728; Phosphoinositide 5 phosphatase; Phosphoinositide 5-phosphatase; Type II inositol 1,4,5 trisphosphate 5 phosphatase; Type II inositol-1;
M6PR
mannose-6-phosphate receptor (cation dependent)
M6PR; mannose-6-phosphate receptor (cation dependent); cation-dependent mannose-6-phosphate receptor; 46 kDa mannose 6 phosphate receptor; Cation dependent mannose 6 phosphate receptor; Cation dependent mannose 6 phosphate receptor precursor; Cation independent mannose 6 phosphate receptor; CD Man 6 P receptor; CD MPR; CD222; CIMPR; FLJ32994; IGFR2; Insulin like growth factor 2 receptor; M6PR protein; Man6PR; Mannose 6 phosphate receptor; MPR 46; MPR46; MPRD; MPRI; SMPR; Mr 46,000 Man6PR; CD Man-6-P receptor; small mannose 6-phosphate receptor; 46-kDa mannose 6-phosphate receptor; CD-MPR; MPR-46;
MAGEA6
melanoma antigen family A, 6
MAGEA6; melanoma antigen family A, 6; MAGE6; melanoma-associated antigen 6; cancer/testis antigen family 1; member 6; CT1.6; MAGE 6 antigen; melanoma antigen family A 6; melanoma associated antigen 6; Cancer/testis antigen 1.6; MAGA6_HUMAN; MAGE 3b; MAGE-6 antigen; MAGE3B; MAGE3B antigen; OTTHUMP00000024223; OTTHUMP00000024224; OTTHUMP00000205538; cancer/testis antigen family 1, member 6; MAGE-3b;
MAN1A1
mannosidase, alpha, class 1A, member 1
MAN1A1; mannosidase, alpha, class 1A, member 1; mannosyl-oligosaccharide 1,2-alpha-mannosidase IA; 2-alpha-mannosidase IA; 2-mannosidase IA; Alpha 1,2 mannosidase IA; Alpha-1; EC 3.2.1.113; HUMM3; HUMM9; MA1A1_HUMAN; Man(9) alpha mannosidase; Man(9)-alpha-mannosidase; MAN9; Man9 mannosidase; Man9-mannosidase; Mannosidase alpha class 1A member 1; Mannosyl-oligosaccharide 1; Mannosyl-oligosaccharide 1,2 alpha mannosidase IA; OTTHUMP00000017107; Processing alpha 1,2 mannosidase IA; Processing alpha-1; alpha-1,2-mannosidase IA; processing alpha-1,2-mannosidase IA;
MC1R
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
MC1R; melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor); melanocyte-stimulating hormone receptor; MSH R; MC1-R; Melanocortin 1 receptor; Melanocortin receptor 1; MSH-R; MSHR; MSHR_HUMAN; melanotropin receptor; CMM5; SHEP2;
MC4R
melanocortin 4 receptor
MC4R; melanocortin 4 receptor; melanocortin receptor 4; MC4-R; MGC126851; MGC138197;
NCAPH2
non-SMC condensin II complex, subunit H2
NCAPH2; non-SMC condensin II complex, subunit H2; condensin-2 complex subunit H2; 384D8 2; CAP H2; CAP H2 subunit of the condensin II complex; hCAP H2; kleisin beta; Chromosome associated protein H2; Chromosome-associated protein H2; CNDH2_HUMAN; hCAP-H2; Kleisin-beta; Non SMC condensin II complex subunit H2; Non-SMC condensin II complex subunit H2; CAP-H2 subunit of the condensin II complex; CAPH2;
NDUFB10
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa
NDUFB10; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 (22kD, PDSW); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10; complex I PDSW subunit; PDSW; 0610011B04Rik; 22kDa; CI PDSW; Complex I PDSW; NADH ubiquinone oxidoreductase PDSW subunit; NDUFB 10; CI-PDSW; complex I-PDSW; NADH-ubiquinone oxidoreductase PDSW subunit; NADH ubiquinone oxidoreductase PDSW subunit (RH 16p13.3);
NOP56
NOP56 ribonucleoprotein homolog (yeast)
NOP56; NOP56 ribonucleoprotein homolog (yeast); NOL5A, nucleolar protein 5A (56kD with KKE/D repeat) , nucleolar protein 5A (56kDa with KKE/D repeat); nucleolar protein 56; SCA36; spinocerebellar ataxia 36; Nucleolar protein 5A (56kD with KKE/D repeat); Nucleolar protein 5A; Nucleolar protein Nop56; nucleolar protein 5A (56kDa with KKE/D repeat); NOL5A;
NSMCE1
non-SMC element 1 homolog
NSMCE1; non-SMC element 1 homolog (S. cerevisiae); non-structural maintenance of chromosomes element 1 homolog; NSE1;
PI4KA
phosphatidylinositol 4-kinase, catalytic, alpha
PI4KA; phosphatidylinositol 4-kinase, catalytic, alpha; PIK4CA; phosphatidylinositol 4-kinase alpha; PI4K ALPHA; pi4K230; PI4-kinase alpha; ptdIns-4-kinase alpha; phosphatidylinositol 4-kinase 230; phosphatidylinositol 4-kinase, type III, alpha; PI4K-ALPH;
PIK3R5
phosphoinositide-3-kinase, regulatory subunit 5
PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5; phosphoinositide 3-kinase regulatory subunit 5; p101; P101 PI3K; F730038I15Rik; FOAP2; OTTHUMP00000135339; Phosphatidylinositol 4,5 bisphosphate 3 kinase regulatory subunit; Phosphoinositide 3 kinase, regulatory subunit 5; Phosphoinositide 3 kinase, regulatory subunit 5, p101; Phosphoinositide 3 kinase, regulatory subunit, polypeptide p101; PI3 kinase p101 subunit; PI3 kinase regulatory subunit 5; PIK3 R5; Protein FOAP 2; PtdIns 3 kinase p101; PtdIns 3 kinase regulatory subunit; protein FOAP-2; ptdIns-3-kinase p101; PI3-kinase p101 subunit; phosphatidylinositol-4,5-bisphosphate 3-kinase regulatory subunit; FOAP-2; P101-PI3K;
PSMD3
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3
PSMD3; proteasome (prosome, macropain) 26S subunit, non-ATPase, 3; tissue specific transplantation antigen 2 , TSTA2; 26S proteasome non-ATPase regulatory subunit 3; P58; Rpn3; S3; 26S proteasome non ATPase regulatory subunit 3; 26S proteasome regulatory subunit RPN3; 26S proteasome regulatory subunit S3; OTTHUMP00000164347; Proteasome (prosome, macropain) 26S subunit non ATPase 3; Proteasome subunit p58; PSMD3_HUMAN; Tissue specific transplantation antigen 2; TSTA2;
PTPN23
protein tyrosine phosphatase, non-receptor type 23
PTPN23; protein tyrosine phosphatase, non-receptor type 23; tyrosine-protein phosphatase non-receptor type 23; DKFZP564F0923; HD PTP; KIAA1471; EC 3.1.3.48; HDPTP; His domain containing protein tyrosine phosphatase; His domain protein tyrosine phosphatase; protein tyrosine phosphatase non-receptor type 23; Protein tyrosine phosphatase TD 14; protein tyrosine phosphatase TD14; PTP TD14; PTPN 23; Tyrosine protein phosphatase non receptor type 23; His-domain protein tyrosine phosphatase; his domain-containing protein tyrosine phosphatase; HD-PTP; PTP-TD14;
RBBP5
retinoblastoma binding protein 5
RBBP5; retinoblastoma binding protein 5; RBQ3; SWD1; retinoblastoma-binding protein 5; RBBP-5; retinoblastoma-binding protein RBQ-3; SWD1, Set1c WD40 repeat protein, homolog;
RDH13
retinol dehydrogenase 13 (all-trans/9-cis)
RDH13; retinol dehydrogenase 13 (all-trans/9-cis); retinol dehydrogenase 13 (all trans and 9 cis); retinol dehydrogenase 13; SDR7C3; short chain dehydrogenase/reductase family 7C; member 3; RDH13_HUMAN; Retinol dehydrogenase 13 (all trans/9 cis); retinol dehydrogenase 13 (all-trans and 9-cis); short chain dehydrogenase/reductase family 7C, member 3;
SLC7A11
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
SLC7A11; solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11; xCT; CCBR1; cystine/glutamate transporter; amino acid transport system xc-; solute carrier family 7 member 11; calcium channel blocker resistance protein CCBR1; solute carrier family 7, (cationic amino acid transporter, y+ system) member 11;
SPTBN1
spectrin, beta, non-erythrocytic 1
SPTBN1; spectrin, beta, non-erythrocytic 1; spectrin beta chain, brain 1; beta-fodrin; beta-G spectrin; beta-spectrin 2; beta-II spectrin; beta-spectrin II; fodrin beta chain; embryonic liver beta-fodrin; spectrin, non-erythroid beta chain 1; ELF; SPTB2;
TNK2
tyrosine kinase, non-receptor, 2
TNK2; tyrosine kinase, non-receptor, 2; activated CDC42 kinase 1; ACK; ACK1; activated Cdc42 associated kinase 1; p21cdc42Hs; activated p21cdc42Hs kinase; activated Cdc42-associated kinase 1; tyrosine kinase non-receptor protein 2; ACK-1; FLJ44758; FLJ455;
UGT1A7
UDP glucuronosyltransferase 1 family, polypeptide A7
UGT1A7; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glycosyltransferase 1 family, polypeptide A6; UDP-glucuronosyltransferase 1-7; UGT1G; GNT1; OTTHUMP00000065199; UD17_HUMAN; UDP glucuronosyltransferase 1A7; UDP glucuronosyltransferase; UDP glycosyltransferase 1 family polypeptide A7; UDP-glucuronosyltransferase 1 family polypeptide A7s; UDP-glucuronosyltransferase 1-G; UDP-glucuronosyltransferase 1A7; UDPGT; UDPGT 1-7; UGT-1G; UGT1; UGT1*7; UGT1-07; UGT1.7; UDP glycosyltransferase 1 family, polypeptide A7;
UPF3B
UPF3 regulator of nonsense transcripts homolog B (yeast)
UPF3B; UPF3 regulator of nonsense transcripts homolog B (yeast); MRX62; UPF3X; HUPF3B; MRXS14; RENT3B; regulator of nonsense transcripts 3B; hUpf3p-X; mental retardation, X-linked 62; nonsense mRNA reducing factor 3B; up-frameshift suppressor 3 homolog B; up-frameshift suppressor 3 homolog on chromosome X;
AMPD1
adenosine monophosphate deaminase 1
AMPD1; adenosine monophosphate deaminase 1; adenosine monophosphate deaminase 1 (isoform M); AMP deaminase 1; AMPD isoform M; MAD; MADA; skeletal muscle AMPD; AMPD; myoadenylate deaminase; adenosine monophosphate deaminase-1 (muscle);
ANK3
Ankyrin 3, Node Of Ranvier (ankyrin G)
ANK3; ANKYRIN-G; ankyrin-3; ankyrin G119; ankyrin 3, node of Ranvier (ankyrin G); ankyrin-3, node of Ranvier; FLJ45464; OTTHUMP00000019653; OTTHUMP00000019656; OT-THUMP00000217458; OTTHUMP00000217575;
DPM1
dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit
DPM1; dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit; dolichol-phosphate mannosyltransferase; CDGIE; MPDS; dolichol monophosphate mannose synthase; Dolichol phosphate mannose synthase; Dolichol-phosphate mannose synthase; Dolichyl phosphate beta D mannosyltransferase; dolichyl phosphate mannosyltransferase polypeptide 1; dolichyl phosphate mannosyltransferase polypeptide 1 catalytic subunit; Dolichyl-phosphate beta-D-mannosyltransferase; DPM synthase; DPM1_HUMAN; Mannose P dolichol synthase; Mannose-P-dolichol synthase; MPD synthase;
Gabra1
gamma-aminobutyric acid (GABA) A receptor, alpha 1
GABRA1; gamma-aminobutyric acid (GABA) A receptor, alpha 1; EJM; ECA4; EJM5; EIEE19; gamma-aminobutyric acid receptor subunit alpha-1; GABA(A) receptor, alpha 1; GABA(A) receptor subunit alpha-1;
Gabra2
gamma-aminobutyric acid (GABA) A receptor, alpha 2
GABRA2; gamma-aminobutyric acid (GABA) A receptor, alpha 2; gamma-aminobutyric acid receptor subunit alpha-2; GABA(A) receptor; alpha 2; GABA(A) receptor, alpha 2; GABA(A) receptor subunit alpha-2; FLJ97076;
Gabra4
gamma-aminobutyric acid (GABA) A receptor, alpha 4
GABRA4; gamma-aminobutyric acid (GABA) A receptor, alpha 4; gamma-aminobutyric acid receptor subunit alpha-4; GABA(A) receptor; alpha 4; GABA(A) receptor, alpha 4;
Gabra5
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5
GABRA5; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5; gamma-aminobutyric acid receptor subunit alpha-5; GABAA receptor alpha5 subunit; GABA(A) receptor subunit alpha-5; ligand-gated ion channel subunit; gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5; A230018I05Rik;
Gabra6
gamma-aminobutyric acid (GABA) A receptor, alpha 6
GABRA6; gamma-aminobutyric acid (GABA) A receptor, alpha 6; gamma-aminobutyric acid receptor subunit alpha-6; GABA A; GABA A Receptor alpha 6polypeptide; GABA A receptor alpha 6; GABA A receptor subunit alpha 6; GABA subunit A receptor alpha 6; GABA(A) receptor subunit alpha-6; GABRA 6; Gamma aminobutyric acid A receptor alpha 6; Gamma aminobutyric acid GABA A receptor alpha 6; Gamma aminobutyric acid receptor subunit alpha 6; GBRA6_HUMAN; MGC116903; MGC116904; GABA-A receptor alpha-6 subunit; gamma-aminobutyric acid A receptor, alpha 6; gamma-aminobutyric acidA receptor, alpha 6; gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6;
Gabrb2
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2
GABRB2; gamma-aminobutyric acid (GABA) A receptor, subunit beta 2; gamma-aminobutyric acid receptor subunit beta-2; GABA; GABA(A) receptor subunit beta-2; Gamma-aminobutyric-acid receptor subunit beta-2; OTTMUSP00000006670; gamma-aminobutyric acid receptor beta-2 subunit; gamma-aminobutyric acid A receptor, subunit beta 2; gamma-aminobutyric acid (GABA-A) receptor, subunit beta 2; Gabrab2; Gabrb-2; AI834970; C030002O17Rik; C030021G16Rik;
Gabrg2
gamma-aminobutyric acid (GABA) A receptor, gamma 2
GABRG2; gamma-aminobutyric acid (GABA) A receptor, gamma 2; gamma-aminobutyric acid receptor subunit gamma-2; GABA(A) receptor subunit gamma-2; gamma-aminobutyric acid A receptor, gamma 2; gamma-aminobutyric acidA receptor, gamma 2; gamma-aminobutyric aci;
Grasp
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein
GRASP; GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein; general receptor for phosphoinositides 1-associated scaffold protein; GRP1-associated scaffold protein; TAMALIN;
IGHD
Immunoglobulin heavy constant delta
IGHD;Immunoglobulin heavy constant delta;immunoglobulin heavy constant delta;FLJ00382;FLJ46727;MGC29633;
IGHG2
Immunoglobulin heavy constant gamma 2 (G2m marker)
DKFZp686I04196; G2m marker; Ig gamma 2 chain C region; IGHG 2; IGHG2; Immunoglobulin heavy constant gamma 2; Immunoglobulin G 2; IgG2;
Ighg2a
immunoglobulin heavy constant gamma 2A
Igh-1; Igh-1a; MGC18977; MGC102662; MGC118125; 1810060O09Rik; Ighg2a;
IGHG4
Immunoglobulin Heavy Constant Gamma 3 (G4m Marker)
IgG4; Immunoglobulin G; IGG; Immunoglobulin; IGHG4; immunoglobulin heavy constant gamma 4 (G4m marker); Alternative namesIg gamma 4 chain C region; MGC117419; Ig gamma-4 chain C region;
MYCL1
v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)
MYCL1; v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian); MYCL, v myc avian myelocytomatosis viral oncogene homolog 1, lung carcinoma derived; protein L-Myc-1; bHLHe38; l myc protein; LMYC; myc related gene from lung cancer; oncogene lmyc; l myc 1 proto oncogene; L myc 1 proto-oncogene protein; MYCL 1; MYCL; v myc avian myelocytomatosis viral oncogene homolog 1 lung carcinoma derived; l-myc-1 proto-oncogene; myc-related gene from lung cancer; class E basic helix-loop-helix protein 38;
PGA
pepsinogen A
PGA; pepsinogen A; pepsin A; ec 3.4.23.1; Pepsin a precursor; Pepsin; Pepsinogen 1 second locus; Pepsinogen 3 group 1; Pepsinogen a3; Pepsinogen; Pepsinogen group 1; pga3; pga4; pga5;
PIK3C3
phosphoinositide-3-kinase, class 3
PIK3C3; phosphoinositide-3-kinase, class 3; phosphatidylinositol 3-kinase catalytic subunit type 3; Vps34; hVps34; MGC61518; Phosphatidylinositol 3 kinase catalytic subunit type 3; Phosphatidylinositol 3 kinase class 3; Phosphatidylinositol 3 kinase p100 subunit; Phosphatidylinositol 3-kinase p100 subunit; Phosphoinositide 3 kinase class 3; Phosphoinositide-3-kinase class 3; PI3 kinase type 3; PI3-kinase type 3; PI3K type 3; PIK3KC 3; PK3C3_HUMAN; PtdIns 3 kinase type 3; PtdIns-3-kinase type 3; Vps 34;
SLC16A7
solute carrier family 16, member 7 (monocarboxylic acid transporter 2)
SLC16A7; solute carrier family 16, member 7 (monocarboxylic acid transporter 2); solute carrier family 16 (monocarboxylic acid transporters), member 7; monocarboxylate transporter 2; MCT2; MCT 2; solute carrier family 16 member 7;
Stra6
stimulated by retinoic acid gene 6 homolog (mouse)
STRA6; stimulated; stimulated by retinoic acid gene 6 protein homolog; FLJ12541; MCOPS9; PP14296;
AASDH
aminoadipate-semialdehyde dehydrogenase
AASDH; aminoadipate-semialdehyde dehydrogenase; acyl-CoA synthetase family member 4; ACSF4; acyl CoA synthetase family member 4; LYS2; NRPS998; A230062G08Rik; RGD1311135; 2 aminoadipic 6 semialdehyde dehydrogenase; A830035E16; Aminoadipate semialdehyde dehydrogenase; Non ribosomal peptide synthetase 1098; Non ribosomal peptide synthetase 998; NRPS1098; Protein NRPS998; U26; non-ribosomal peptide synthetase 998; non-ribosomal peptide synthetase 1098; 2-aminoadipic 6-semialdehyde dehydrogenase;
AASS
aminoadipate-semialdehyde synthase
AASS; aminoadipate-semialdehyde synthase; alpha-aminoadipic semialdehyde synthase, mitochondrial; LKRSDH; LORSDH; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase; alpha-aminoadipate semialdehyde synthase; lysine-ketoglutarate reductase;
ABAT
4-aminobutyrate aminotransferase
ABAT; 4-aminobutyrate aminotransferase; 4-aminobutyrate aminotransferase, mitochondrial; 4 aminobutyrate transaminase; GABAT; mitochondrial; (S) 3 amino 2 methylpropionate transaminase; (S)-3-amino-2-methylpropionate transaminase; 4 aminobutyrate aminotransferase; 4 aminobutyrate aminotransferase, mitochondrial; FLJ17813; FLJ30272; GABA aminotransferase; GABA AT; GABA T; GABA transaminase; GABA transferase; GABA-AT; GABA-T; GABT_HUMAN; Gamma amino N butyrate transaminase; Gamma-amino-N-butyrate transaminase; hCG1984265; L AIBAT; L-AIBAT; LAIBAT; NPD009; 4-aminobutyrate transaminase;
ADAL
adenosine deaminase-like
ADAL; adenosine deaminase-like; adenosine deaminase-like protein; Adenosine deaminase like; MGC63264; 4930578F03Rik; ADAL_HUMAN; DKFZp313B2137; FLJ44620; MGC62428; RP23-232N20.3;
ADAT3
adenosine deaminase, tRNA-specific 3
ADAT3; adenosine deaminase, tRNA-specific 3; adenosine deaminase, tRNA specific 3, TAD3 homolog (S. cerevisiae); tRNA-specific adenosine deaminase-like protein 3; TAD3; tRNA specific adenosine deaminase 3 homolog (S. cerevisiae); S863 5; FWP005; LOC113179; MST121; MSTP121; tRNA specific adenosine 34 deaminase subunit ADAT3; tRNA specific adenosine deaminase like protein 3; tRNA-specific adenosine deaminase 3 homolog; adenosine deaminase, tRNA-specific 3, TAD3 homolog; tRNA-specific adenosine-34 deaminase subunit ADAT3; S863-5;
ADO
2-aminoethanethiol (cysteamine) dioxygenase
ADO; 2-aminoethanethiol (cysteamine) dioxygenase; C10orf22, chromosome 10 open reading frame 22; 2-aminoethanethiol dioxygenase; cysteamine dioxygenase; FLJ14547; cysteamine (2-aminoethanethiol) dioxygenase (ADO); C10orf22; DKFZp564C046;
BCMO1
beta-carotene 15,15-monooxygenase 1
BCMO1; beta-carotene 15,15-monooxygenase 1; BCDO, BCDO1, beta carotene 15, 15 dioxygenase 1; beta,beta-carotene 15,15-monooxygenase; BCMO; FLJ10730; beta-carotene dioxygenase 1; beta-carotene 15, 15-dioxygenase 1; BCO; BCDO; BCO1; BCDO1;
ACOX3
acyl-CoA oxidase 3, pristanoyl
ACOX3; acyl-CoA oxidase 3, pristanoyl; acyl Coenzyme A oxidase 3, pristanoyl; peroxisomal acyl-coenzyme A oxidase 3; Acyl-CoA oxidase, pristanoyl, peroxisomal; Acyl-Coenzyme A oxidase 3, pristanoyl; Branched-chain acyl-CoA oxidase; BRCACox; BRCOX; EST-s59; PCOX; Pristanoyl-CoA oxidase;
AADAT
aminoadipate aminotransferase
AADAT; aminoadipate aminotransferase; kynurenine/alpha-aminoadipate aminotransferase, mitochondrial; KAT2; KATII; kynurenine aminotransferase II; L kynurenine/alpha aminoadipate aminotransferase; KAT/AadAT; 2-aminoadipate transaminase; 2-aminoadipate amin;
BCAS3
breast carcinoma amplified sequence 3
BCAS3; breast carcinoma amplified sequence 3; breast carcinoma-amplified sequence 3; FLJ20128; 1500019F07Rik; 2610028P08Rik; AU021018; BC028339; BCAS3_HUMAN; GAOB1; K20D4; MAAB; Maab1 protein; MGC4973; rudhira; protein Maab1; BCAS4/BCAS3 fusion; metastasis associated antigen of breast cancer; breast carcinoma amplified sequence 4/3 fusion protein;
AIM1L
absent in melanoma 1-like
AIM1L; absent in melanoma 1-like; beta gamma crystallin domain containing 2; CRYBG2; FLJ38020;
AGXT2
alanine--glyoxylate aminotransferase 2
AGXT2; alanine--glyoxylate aminotransferase 2; alanine glyoxylate aminotransferase 2; alanine--glyoxylate aminotransferase 2, mitochondrial; AGT2; beta ALAAT II; beta alanine pyruvate aminotransferase; beta-ALAAT II; beta-alanine-pyruvate aminotransferase;
AGXT2L1
alanine-glyoxylate aminotransferase 2-like 1
AGXT2L1; alanine-glyoxylate aminotransferase 2-like 1; alanine--glyoxylate aminotransferase 2-like 1;
APC2
adenomatosis polyposis coli 2
APC2; adenomatosis polyposis coli 2; APCL; adenomatous polyposis coli protein 2; adenomatous polyposis coli like;
AGL
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
AGL; amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase; amylo 1, 6 glucosidase, 4 alpha glucanotransferase; glycogen debranching enzyme; glycogen storage disease type III; 9430004C13Rik; 9630046L06Rik; AI850929; C77197; 1110061O17Rik; Amylo 1 6 glucosidase 4 alpha glucanotransferase; GDE; Glycogen debrancher; amylo-1, 6-glucosidase, 4-alpha-glucanotransferase;
ACCSL
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like
ACCSL; 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like; 1-aminocyclopropane-1-carboxylate synthase-like protein 2; 1 aminocyclopropane 1 carboxylate synthase homolog (Arabidopsis)(non functional) like; 1 aminocyclopropane 1 carboxylate synthase like protein 2; 1A1L2_HUMAN; ACC synthase like protein 2; ACC synthase-like protein 2;
ADAD2
adenosine deaminase domain containing 2
ADAD2; adenosine deaminase domain containing 2; adenosine deaminase domain-containing protein 2; FLJ00337; TENRL; ADAD2_HUMAN; Testis nuclear RNA-binding protein-like;
ALG1
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)
ALG1; asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae); asparagine linked glycosylation 1 homolog (yeast, beta 1,4 mannosyltransferase); chitobiosyldiphosphodolichol beta-mannosyltransferase; HMAT1; HMT 1; 4-mannosyltransferase; ALG1_HUMAN; asparagine-linked glycosylation 1 homolog (yeast, beta-1,4-mannosyltransferase); Asparagine-linked glycosylation protein 1 homolog; Beta 1 4 mannosyltransferase; Beta-1; CDG1K; GDP Man GlcNAc2 PP dolichol mannosyltransferase; GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase; GDP-mannose-dolichol diphosphochitobiose mannosyltransferase; Hmat-1; HMT1; Mannosyltransferase 1; Mannosyltransferase-1; MT 1; MT-1; MT1; OTTHUMP00000159923; beta-1,4 mannosyltransferase; beta-1,4-mannosyltransferase; HMT-1; Mat-1;
ADAR
adenosine deaminase, RNA-specific
ADAR; adenosine deaminase, RNA-specific; G1P1, IFI4, interferon induced protein 4; double-stranded RNA-specific adenosine deaminase; ADAR1; dsRNA adenosine deaminase; interferon-induced protein 4; interferon-inducible protein 4; adenosine deaminase actin;
AGPHD1
aminoglycoside phosphotransferase domain containing 1
AGPHD1; aminoglycoside phosphotransferase domain containing 1; aminoglycoside phosphotransferase domain-containing protein 1; LOC123688; AGPD1_HUMAN; Aminoglycoside phosphotransferase domain containing; C630028N24Rik; OTTMUSP00000025874; RGD1308677;
AIMP2
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
AIMP2; aminoacyl tRNA synthetase complex-interacting multifunctional protein 2; aminoacyl tRNA synthase complex-interacting multifunctional protein 2; JTV 1; JTV1; p38; PRO0992; protein JTV-1; ARS-interacting multi-functional protein 2; multisynthase comp;
ALG2
asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)
ALG2; asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae); asparagine linked glycosylation 2 homolog (yeast, alpha 1,3 mannosyltransferase); alpha-1,3/1,6-mannosyltransferase ALG2; CDGIi; FLJ14511; hALPG2; NET38; OTTHUMP00000123474; 3-mannosyltransferase ALG2; ALG2_HUMAN; Alpha 1,3 mannosyltransferase ALG2; Alpha-1; Asparagine linked glycosylation protein 2; Asparagine-linked glycosylation protein 2 homolog; GDP Man:Man(1)GlcNAc(2) PP dolichol mannosyltransferase; GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase; OTTHUMP00000021785; RP11-13B9.1; homolog of yeast ALG2; alpha-1,3-mannosyltransferase ALG2; GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase; GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase; asparagine-linked glycosylation 2 homolog (yeast, alpha-1,3-mannosyltransferase); asparagine-linked glycosylation 2 homolog (S. cerevisiae, alpha-1,3-mannosyltransferase);
ALG9
asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog
ALG9; asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae); asparagine linked glycosylation 9 homolog (yeast, alpha 1,2 mannosyltransferase) , asparagine linked glycosylation 9, alpha 1,2 mannosyltransferase homolog (;
MUG1
murinoglobulin 1
MUG1; murinoglobulin 1; murinoglobulin-1; alpha(1)-inhibitor 3; alpha-1-inhibitor III; Murinoglobulin 1 homolog; plasma proteinase inhibitor; alpha-X protein; alpha-1 inhibitor 3 variant I; plasma proteinase inhibitor alpha-1-inhibitor III;
APCDD1
adenomatosis polyposis coli down-regulated 1
APCDD1; adenomatosis polyposis coli down-regulated 1; protein APCDD1; B7323; Adenomatosis polyposis coli down regulated 1; Adenomatosis polyposis coli down regulated 1 protein; APCDD 1; DRAPC1; FP7019; adenomatosis polyposis coli down-regulated 1 protein; HHS; HTS;
ATP8A2
ATPase, aminophospholipid transporter, class I, type 8A, member 2
ATP8A2; ATPase, aminophospholipid transporter, class I, type 8A, member 2; ATPase, aminophospholipid transporter like, class I, type 8A, member 2 , ATPase, aminophospholipid transporter like, Class I, type 8A, member 2; probable phospholipid-transporting;
AMT
aminomethyltransferase
AMT; aminomethyltransferase; aminomethyltransferase (glycine cleavage system protein T); aminomethyltransferase, mitochondrial; GCST; glycine cleavage system protein T; NKH; GCE; GCVT; glycine cleavage system T protein;
MSMO1
methylsterol monooxygenase 1
MSMO1; methylsterol monooxygenase 1; SC4MOL, sterol C4 methyl oxidase like; DESP4; ERG25; MGC104344; 1500001G16Rik; C 4 methyl sterol; C-4 methylsterol oxidase; C78600; ERG25_HUMAN; Methylsterol monooxygenase; OTTHUMP00000219757; OTTHUMP00000219758; OTTHUMP00000219759; OTTHUMP00000219760; SC4MOL; sterol C4 methyl oxidase like; C-4 methyl sterol;
BCAS4
breast carcinoma amplified sequence 4
BCAS4; breast carcinoma amplified sequence 4; breast carcinoma-amplified sequence 4; CNOL; FLJ20495; BCAS4/BCAS3 fusion; breast carcinoma amplified sequence 4/3 fusion protein;
BAG6
BCL2-associated athanogene 6
BAG6; BCL2-associated athanogene 6; BAT3, HLA B associated transcript 3; large proline-rich protein BAG6; D6S52E; G3; scythe; protein G3; protein Scythe; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; large p;
ANO6
anoctamin 6
ANO6; anoctamin 6; TMEM16F, transmembrane protein 16F; anoctamin-6; DKFZp313M0720; transmembrane protein 16F; SCTS; BDPLT7; TMEM16F; MGC104751;
ANO7
anoctamin 7
ANO7; anoctamin 7; PCANAP5, TMEM16G, transmembrane protein 16G; anoctamin-7; IPCA 5; NGEP; PCANAP5L; transmembrane protein 16G; prostate cancer associated protein 5; Dresden-transmembrane protein of the prostate; DTMPP; IPCA5; D-TMPP; IPCA-5; PCANAP5; TM;
TAT
tyrosine aminotransferase
TAT; tyrosine aminotransferase; tyrosine aminotransferase, cytosolic; L-tyrosine:2-oxoglutarate aminotransferase;
B3GAT2
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)
B3GAT2; beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S); GlcAT S; GlcAT-S;
BIVM
basic, immunoglobulin-like variable motif containing
BIVM; basic, immunoglobulin-like variable motif containing; basic immunoglobulin-like variable motif-containing protein; FLJ20159; AI854267; FLJ44301; Basic immunoglobulin like variable motif containing; FLJ44556; MGC133326; OTTMUSP00000026562; OTTMUSP00000026563; RP11-484I6.1;
RMI1
RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae)
RMI1; RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae); C9orf76, chromosome 9 open reading frame 76; recQ-mediated genome instability protein 1; BLAP75; BLM Associated Polypeptide; 75 kDa; FLJ12888; BLM-associated protein of 75 kDa; C9orf76; FAAP75; RMI1 homolog; RMI1_HUMAN; BLM-associated protein 75 kDa; BLM-Associated Polypeptide, 75 kDa; homolog of yeast RecQ-mediated genome instability 1 (RMI1); RP11-346I8.1;
ATP12A
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
ATP12A; ATPase, H+/K+ transporting, nongastric, alpha polypeptide; ATP1AL1, ATPase, Na+/K+ transporting, alpha polypeptide like 1; potassium-transporting ATPase alpha chain 2; ATPase; Na+K+ transporting; alpha 1 polypeptide like; non gastric H(+)/K(+) ATPase alpha subunit; potassium transporting ATPase alpha chain 2; proton pump; sodium/potassium ATPase; alpha polypeptide like; ATP1AL1; ATPase H+/K+ transporting nongastric alpha polypeptide; ATPase Na+K+ transporting alpha-1 polypeptide-like; Hydrogen/potassium-exchanging ATPase 12A; Non-gastric H(+)/K(+) ATPase subunit alpha; Sodium/potassium ATPase alpha polypeptide-like; non-gastric H(+)/K(+) ATPase alpha subunit; ATPase, Na+/K+ transporting, alpha polypeptide-like 1;
BAGE2
B melanoma antigen family, member 2
BAGE2; B melanoma antigen family, member 2; B melanoma antigen 2; cancer/testis antigen family 2; member 2; CT2.2; cancer/testis antigen 2.2; cancer/testis antigen family 2, member 2;
BAGE3
B melanoma antigen family, member 3
BAGE3; B melanoma antigen family, member 3; B melanoma antigen 3; cancer/testis antigen family 2; member 3; CT2.3; cancer/testis antigen 2.3; cancer/testis antigen family 2, member 3;
BAGE4
B melanoma antigen family, member 4
BAGE4; B melanoma antigen family, member 4; MLL3 pseudogene , MLL3P; B melanoma antigen 4; cancer/testis antigen family 2; member 4; CT2.4; BAGE4_HUMAN; Cancer/testis antigen 2.4; MGC119851; MGC119852; MGC119853; MLL3P; MLL3 pseudogene; cancer/testis antigen family 2, member 4;
BCAT2
branched chain amino-acid transaminase 2, mitochondrial
BCAT2; branched chain amino-acid transaminase 2, mitochondrial; BCT2, branched chain aminotransferase 2, mitochondrial; branched-chain-amino-acid aminotransferase, mitochondrial; BCAM; mitochondrial; BCAT 2; BCAT(m); BCAT2_HUMAN; BCATM; BCT2; Branched chain aminotransferase 2, mitochondrial; Branched-chain-amino-acid aminotransferase; ECA40; Placental protein 18; PP18;
BNIP2
BCL2/adenovirus E1B 19kDa interacting protein 2
BNIP2; BCL2/adenovirus E1B 19kDa interacting protein 2; BCL2/adenovirus E1B 19kD interacting protein 2; BCL2/adenovirus E1B 19 kDa protein-interacting protein 2; BNIP 2; Nip2; BNIP-2;
SMG9
smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans)
SMG9; smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans); C19orf61, chromosome 19 open reading frame 61; protein SMG9; FLJ12886; DKFZp564H1322; F17127_1; Protein smg 9 homolog; Chromosome 19 open reading frame 61; SMG 9; Suppressor with morphogenetic effect on genitalia protein 9,; protein smg-9 homolog; C19orf61;
SMG8
smg-8 homolog, nonsense mediated mRNA decay factor (C. elegans)
SMG8; smg-8 homolog, nonsense mediated mRNA decay factor (C. elegans); C17orf71, chromosome 17 open reading frame 71; protein SMG8; FLJ10587; FLJ23205; ABC 2; ABC2; Amplified in breast cancer gene 2 protein; Chromosome 17 open reading; chromosome 17 open reading frame 71; Protein smg 8 homolog; SMG8 protein; protein smg-8 homolog; C17orf71;
CLN8
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
CLN8; ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation); C8orf61, chromosome 8 open reading frame 61 , EPMR; protein CLN8; FLJ39417; EPMR; C8orf61;
RUSC1-AS1
RUSC1 antisense RNA 1 (non-protein coding)
RUSC1-AS1; RUSC1 antisense RNA 1 (non-protein coding); C1orf104, chromosome 1 open reading frame 104; putative uncharacterized protein RUSC1-AS1; FLJ35976; Chromosome 1 open reading frame 104; Hypothetical protein LOC284618; RP11 21N7.3; Uncharacterized protein C1orf104; RUSC1 antisense gene protein 1; C1orf104; RP11-21N7.3;
CEACAM4
carcinoembryonic antigen-related cell adhesion molecule 4
CEACAM4; carcinoembryonic antigen-related cell adhesion molecule 4; CGM7; carcinoembryonic antigen CGM7; nonspecific cross-reacting antigen W236; Nonspecific cross-reacting antigen (NCA); non-specific cross-reacting antigen W236; carcinoembryonic antigen;
CPOX
coproporphyrinogen oxidase
CPOX; coproporphyrinogen oxidase; coproporphyrinogen oxidase (coproporphyria, harderoporphyria) , CPO; coproporphyrinogen-III oxidase, mitochondrial; coproporphyria; CPX; HCP; COX; coprogen oxidase; coproporphyrinogenase; CPO;
CCM2
cerebral cavernous malformation 2
CCM2; cerebral cavernous malformation 2; C7orf22, chromosome 7 open reading frame 22; malcavernin; MGC4607; C7orf22; CCM2_HUMAN; Cerebral cavernous malformations 2 protein; MGC4067; MGC74868; OTTHUMP00000159554; OTTHUMP00000214270; OTTHUMP00000214271; OTTHUMP00000214273; PP10187; OSM;
CEPT1
choline/ethanolamine phosphotransferase 1
CEPT1; choline/ethanolamine phosphotransferase 1; choline/ethanolaminephosphotransferase 1; CEPT1_HUMAN; DKFZp313G0615; hCEPT1; MGC45223; choline/ethanolaminephosphotransferase;
CEACAM21
carcinoembryonic antigen-related cell adhesion molecule 21
CEACAM21; carcinoembryonic antigen-related cell adhesion molecule 21; FLJ13540; R29124_1; Carcinoembryonic antigen related cell adhesion molecule 21; CEA21_HUMAN; CEACAM3; MGC119874; OTTHUMP00000199036;
CLN6
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
CLN6; ceroid-lipofuscinosis, neuronal 6, late infantile, variant; ceroid-lipofuscinosis neuronal protein 6; FLJ20561; HsT18960; nclf; CLN4A;
CNOT6L
CCR4-NOT transcription complex, subunit 6-like
CNOT6L; CCR4-NOT transcription complex, subunit 6-like; CCR4-NOT transcription complex subunit 6-like; DKFZp434K098; carbon catabolite repressor protein 4 homolog B; CCR4b;
CNOT10
CCR4-NOT transcription complex, subunit 10
CNOT10; CCR4-NOT transcription complex, subunit 10; CCR4-NOT transcription complex subunit 10; FLJ12890; FLJ13165; CCR4 NOT transcription complex subunit 10; CNOT 10; DKFZp434K115;
CNRIP1
cannabinoid receptor interacting protein 1
CNRIP1; cannabinoid receptor interacting protein 1; CB1 cannabinoid receptor-interacting protein 1; CRIP-1; C2orf32; AI854501; RP23-348N2.3; 1500041B16Rik; 3110054C06Rik; 5330437A18Rik;
ADOR
Adenosine receptor
ADOR; Adenosine receptor; CG9753 gene product from transcript CG9753-RA; CG9753-PA; AdoR-PA; anon-WO0170980.109; anon-WO0170980.110; CG9753; dAdoR; Dmel\CG9753;
RBBP8
retinoblastoma binding protein 8
RBBP8; retinoblastoma binding protein 8; RIM; COM1; CTIP; JWDS; SAE2; SCKL2; DNA endonuclease RBBP8; RBBP-8; CTBP-interacting protein; sporulation in the absence of SPO11 protein 2 homolog;
CMPK2
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial
CMPK2; cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial; UMP-CMP kinase 2, mitochondrial; cytidylate kinase 2; TYKi; UMP CMPK2; UMP CMP kinase 2, mitochondrial; 1200004E04Rik; Cytidine monophosphate (UMP CMP) kinase 2, mitochondrial; Mitochondrial UMP CMP kinase; OTTHUMP00000200305; Thymidine monophosphate kinase 2; TMPK2; mitochondrial UMP-CMP kinase; thymidylate kinase family LPS-inducible member; UMP-CMPK2;
CNPY2
canopy 2 homolog (zebrafish)
CNPY2; canopy 2 homolog (zebrafish); TMEM4, transmembrane protein 4; protein canopy homolog 2; HP10390; ZSIG9; transmembrane protein 4; putative secreted protein Zsig9; MIR-interacting saposin-like protein; MSAP; TMEM4;
PIEZO1
piezo-type mechanosensitive ion channel component 1
PIEZO1; piezo-type mechanosensitive ion channel component 1; DHS; Mib; FAM38A; protein PIEZO1; family with sequence similarity 38, member A; membrane protein induced by beta-amyloid treatment;
DIMT1
DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae)
DIMT1; DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae); DIM1 dimethyladenosine transferase 1 like (S. cerevisiae) , DIMT1L; probable dimethyladenosine transferase; HSA9761; 18S rRNA dimethylase; DIM1 dimethyladenosine transferase 1 like; Dimethyladenosine transferase; S adenosylmethionine 6 N,N adenosyl(rRNA) dimethyltransferase; OTTHUMP00000161884; OTTHUMP00000221860; probable 18S rRNA dimethylase; S-adenosylmethionine-6-N,N-adenosyl(rRNA) dimethyltransferase; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase; probable S-adenosylmethionine-6-N,N-adenosyl(rRNA) dimethyltransferase; probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase; DIM1; DIMT1L; HUSSY5;
DPM2
dolichol-phosphate (beta-D) mannosyltransferase 2
DPM2; dolichol-phosphate (beta-D) mannosyltransferase 2; dolichol phosphate-mannose biosynthesis regulatory protein; Dolichol phosphate (beta D) mannosyltransferase 2; Dolichol phosphate mannose biosynthesis regulatory protein; Dolichol phosphate mannose synthase 2; Dolichyl phosphate mannosyltransferase 2; Dolichyl phosphate mannosyltransferase polypeptide 2, regulatory subunit; R75484; RP23 255P20.5; OTTMUSP00000012854; OTTMUSP00000047627; AW557993;
DIAPH2
diaphanous homolog 2
DIAPH2; diaphanous homolog 2 (Drosophila); diaphanous (Drosophila, homolog) 2; protein diaphanous homolog 2; DIA; DIA2; POF; POF2; diaphorase-2; diaphanous-related formin-2; DRF2; FLJ11167;
DALLY
division abnormally delayed
DALLY; division abnormally delayed; CG4974 gene product from transcript CG4974-RA; CG4974; Dally protein; DALY_DROME; Division abnormally delayed protein; CG4974-PA; dally-PA; genitalia missing; anon-EST:Liang-1.63; clone 1.63; CT15952; Dmel\CG4974; gem; l(3)06464;
DACT2
dapper homolog 2, antagonist of beta-catenin (xenopus)
DACT2; dapper homolog 2, antagonist of beta-catenin (xenopus); Dpr2; Frd2; dapper2; A630024E20; 2900084M21Rik; dapper homolog 2; mDpr2; dapper antagonist of catenin 2; dapper, antagonist of beta-catenin, homolog 2;
ECI1
enoyl-CoA delta isomerase 1
ECI1; enoyl-CoA delta isomerase 1; DCI, dodecenoyl CoA isomerase , dodecenoyl Coenzyme A delta isomerase (3,2 trans enoyl Coenzyme A isomerase); enoyl-CoA delta isomerase 1, mitochondrial; 3; 2 trans enoyl CoA isomerase; 3,2 trans enoyl Coenzyme A isomerase; Acetylene allene isomerase; D3,D2 enoyl CoA isomerase; DCI protein; Delta(3),Delta(2) enoyl CoA isomerase; Delta3, delta2 enoyl CoA isomerase; Dodecenoyl CoA delta Isomerase; Dodecenoyl CoA isomerase; Dodecenoyl Coenzyme A delta isomerase; Dodecenoyl Coenzyme A delta isomerase (3,2 trans enoyl Coenzyme A isomerase); Dodecenoyl Coenzyme A delta isomerase 3,2 trans enoyl Coenzyme A isomerase, isoform CRA a; OTTHUMP00000159049; dodecenoyl-CoA isomerase; D3,D2-enoyl-CoA isomerase; acetylene-allene isomerase; 3,2 trans-enoyl-CoA isomerase; delta3, delta2-enoyl-CoA isomerase; 3,2 trans-enoyl-Coenzyme A isomerase; delta(3),Delta(2)-enoyl-CoA isomerase; 3,2-trans-enoyl-CoA isomerase, mitochondrial; dodecenoyl-CoA delta isomerase (3,2 trans-enoyl-CoA isomerase); dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase); DCI;
RNASE2
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
RNASE2; ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin); RNS2; non-secretory ribonuclease; EDN; Ear4; EC=3.1.27.5; Eosinophil cationic type ribonuclease 4; MR 4; Non secretory ribonuclease; R14; R15; R5; Ribonuclease 2; Ribonuclease RNase A family 2 (liver eosinophil derived neurotoxin); Ribonuclease US; RNase 2; RNase UpI 2; RNase UpI-2; eosinophil-derived neurotoxin;
DPM3
dolichyl-phosphate mannosyltransferase polypeptide 3
DPM3; dolichyl-phosphate mannosyltransferase polypeptide 3; dolichol-phosphate mannosyltransferase subunit 3; MGC34275; MGC125904; MGC125905; prostin 1; prostin-1; MPD synthase subunit 3; DPM synthase complex subunit 3; mannose-P-dolichol synthase subunit;
ECHDC1
enoyl CoA hydratase domain containing 1
ECHDC1; enoyl CoA hydratase domain containing 1; enoyl Coenzyme A hydratase domain containing 1; enoyl-CoA hydratase domain-containing protein 1; dJ351K20.2; Enoyl CoA hydratase domain containing protein 1; Uncharacterized hypothalamus protein HCDASE;
ECHDC2
enoyl CoA hydratase domain containing 2
ECHDC2; enoyl CoA hydratase domain containing 2; enoyl Coenzyme A hydratase domain containing 2; enoyl-CoA hydratase domain-containing protein 2, mitochondrial; FLJ10948; 2610009M20Rik; D4Ertd765e; 1300017C12Rik; RGD1308525; RP23-379K6.3;
EEFSEC
eukaryotic elongation factor, selenocysteine-tRNA-specific
EEFSEC; eukaryotic elongation factor, selenocysteine-tRNA-specific; selenocysteine-specific elongation factor; EFSEC; elongation factor for selenoprotein translation; SELB; elongation factor sec;
ergo-1
Endogenous-RNAi deficient arGOnaute
ergo-1; Endogenous-RNAi deficient arGOnaute; Endogenous-RNAi deficient arGOnaute family member (ergo-1); Endogenous RNAi deficient argonaute; Endogenous RNAi difficient argonaute family member; Ergo 1; Hypothetical protein R09A1.1;
ERV3-1
endogenous retrovirus group 3, member 1
ERV3-1; endogenous retrovirus group 3, member 1; endogenous retroviral sequence 3 , endogenous retroviral sequence 3 (includes zinc finger protein H plk/HPF9) , ERV3; HERV-R_7q21.2 provirus ancestral Env polyprotein; envR; ERV R; H PLK; HERV R; ERVR; Endogenous retroviral sequence 3; Endogenous retrovirus group 3 member 1; ENR1_HUMAN; Envelope polyprotein; ERV-3 envelope protein; ERV-R envelope protein; ERV3 1 envelope protein; ERV3; ERV3 envelope protein; FLJ23884; HERV-R envelope protein; HERVR; SU; TM; Transmembrane protein; ERV3-1 envelope protein; ERV-R; HERV-R;
SCNN1A
sodium channel, non-voltage-gated 1 alpha subunit
SCNN1A; sodium channel, non-voltage-gated 1 alpha subunit; SCNN1, sodium channel, non voltage gated 1 alpha , sodium channel, nonvoltage gated 1 alpha; amiloride-sensitive sodium channel subunit alpha; ENaCalpha; alpha-ENaC; alpha-NaCH; alpha ENaC-2; ep;
ETNK2
ethanolamine kinase 2
ETNK2; ethanolamine kinase 2; EKI2; FLJ10761; AI197444; HMFT1716; RP11 74C13.2; Tuc1; 4933417N20Rik; EC 2.7.1.82; EKI 2; EKI2_HUMAN; Ethanolamine kinase like protein; Ethanolamine kinase-like protein; ETNK 2; OTTHUMP00000034313; OTTHUMP00000034314; RP11-74C13.2;
PLEKHA8
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8
PLEKHA8; pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8; pleckstrin homology domain-containing family A member 8; FAPP2; MGC3358; FAPP-2; hFAPP2; PH domain-containing family A member 8; Phosphatidylinositol-four-phosphate adapter protein 2; Phosphoinositide binding specificmember 8; Phosphoinositol 4 phosphate adaptor protein 2; Phosphoinositol 4-phosphate adapter protein 2; PKHA8_HUMAN; Pleckstrin homology domain containing family A (Phosphoinositide binding specific) member 8; Pleckstrin homology domain containing family A; PLEKHA8 protein; Serologically defined breast cancer antigen NY-BR-86;
FMO4
flavin containing monooxygenase 4
FMO4; flavin containing monooxygenase 4; FMO2; dimethylaniline monooxygenase [N-oxide-forming] 4; Dimethylaniline monooxygenase [N oxide forming] 4; Dimethylaniline monooxygenase 4; Dimethylaniline oxidase 4; FMO 2; FMO 4; FMO4_HUMAN; Hepatic flavin containing monooxygenase 4; Hepatic flavin-containing monooxygenase 4; OTTHUMP00000060454;
MOGS
mannosyl-oligosaccharide glucosidase
MOGS; mannosyl-oligosaccharide glucosidase; GCS1; glucosidase I; processing A glucosidase I; processing A-glucosidase I; CDG2B;
GABRE
gamma-aminobutyric acid (GABA) A receptor, epsilon
GABRE; gamma-aminobutyric acid (GABA) A receptor, epsilon; gamma-aminobutyric acid receptor subunit epsilon; GABA(A) receptor; epsilon; GABA(A) receptor, epsilon; GABA(A) receptor subunit epsilon;
GNE
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
GNE; glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase; IBM2, UDP N acetylglucosamine 2 epimerase/N acetylmannosamine kinase; bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase; Uae1; IBM2; 2310066H07Rik; Bifunctional UDP N acetylglucosamine 2 epimerase/N acetylmannosamine kinase; DMRV; ManAc kinase; N acylmannosamine kinase; NM; RP23-209M8.6; UDP GlcNAc 2 epimerase; UDP GlcNAc 2 epimerase/ManAc kinase; Uridine diphosphate N acetylglucosamine 2 epimerase; N-acylmannosamine kinase; UDP-GlcNAc-2-epimerase/ManAc kinase; UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase; UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase; GLCNE;
IP6K3
inositol hexakisphosphate kinase 3
IP6K3; inositol hexakisphosphate kinase 3; IHPK3, inositol hexaphosphate kinase 3; INSP6K3; InsP6 kinase 3; inositol hexaphosphate kinase 3; ATP:1D-myo-inositol-hexakisphosphate phosphotransferase; IHPK3; MGC102928;
FMO2
flavin containing monooxygenase 2 (non-functional)
FMO2; flavin containing monooxygenase 2 (non-functional); flavin containing monooxygenase 2; dimethylaniline monooxygenase [N-oxide-forming] 2; MGC28212; OTTMUSP00000028687; 2310008D08Rik; 2310042I22Rik; AW107733; Dimethylaniline monooxygenase [N oxide forming] 2; Dimethylaniline oxidase 2; Flavin containing monooxygenase 2 (non functional); FLJ40826; FMO 1B1; FMO 2; FMO; FMO pulmonary; FMO1B1; OTTMUSP00000028686; Pulmonary flavin containing monooxygenase 2; FMO, pulmonary; pulmonary flavin-containing monooxygenase 2;
PF14_0491
conserved Plasmodium protein PF14_0491, unknown function
PF14_0491; conserved Plasmodium protein, unknown function;
GCN1L1
GCN1 general control of amino-acid synthesis 1-like 1
GCN1L1; GCN1 general control of amino-acid synthesis 1-like 1 (yeast); GCN1 (general control of amino acid synthesis 1, yeast) like 1; translational activator GCN1; GCN1; GCN1L; KIAA0219; hsGCN1; GCN1-like protein 1; GCN1 (general control of amino-acid sy;
GABRR1
gamma-aminobutyric acid (GABA) receptor, rho 1
GABRR1; gamma-aminobutyric acid (GABA) receptor, rho 1; gamma-aminobutyric acid receptor subunit rho-1; bA135P14.1 (gamma-aminobutyric acid (GABA) receptor rho 1); GABA(A) receptor subunit rho-1; gamma aminobutyric acid receptor rho 1; gamma-aminobutyric acid (GABA) A receptor rho-1; gamma-aminobutyric acid (GABA) receptor rho 1; MGC163216; GABA(C) receptor; OTTHUMP00000016849; OTTHUMP00000209035; gamma-aminobutyric acid (GABA) A receptor, rho-1; bA135P14.1 (gamma-aminobutyric acid (GABA) receptor, rho 1);
HYAL4
hyaluronoglucosaminidase 4
HYAL4; hyaluronoglucosaminidase 4; hyaluronidase-4; hyaluronidase 4; chondroitin sulfate hydrolase; CSHY; Hyal-4; HYAL4_HUMAN; Hyaluronoglucosaminidase-4;
GABRP
gamma-aminobutyric acid (GABA) A receptor, pi
GABRP; gamma-aminobutyric acid (GABA) A receptor, pi; gamma-aminobutyric acid receptor subunit pi; GABA(A) receptor subunit pi; Gamma aminobutyric acid (GABA) A receptor pi; Gamma aminobutyric acid A receptor pi; Gamma aminobutyric acid receptor pi subunit; Gamma aminobutyric acid receptor subunit pi; GBRP_HUMAN; MGC126386; MGC126387; gamma-aminobutyric acid (GABA-A) receptor, pi;
HMHA1
histocompatibility (minor) HA-1
HMHA1; histocompatibility (minor) HA-1; minor histocompatibility protein HA-1; ARHGAP45; HA 1; KIAA0223; HLA HA1; HLA-HA1; Minor histocompatibility antigen HA 1; Minor histocompatibility antigen HA-1; Minor histocompatibility protein HA 1; HA-1;
GRIK5
glutamate receptor, ionotropic, kainate 5
GRIK5; glutamate receptor, ionotropic, kainate 5; glutamate receptor, ionotropic kainate 5; KA2; glutamate receptor KA2; glutamate receptor KA-2; iGlu5;
GRINA
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)
GRINA; glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding); NMDARA1; protein lifeguard 1; HNRGW; LFG1; TMBIM3; transmembrane BAX inhibitor motif containing 3; putative MAPK-activating protein PM02; NMDA receptor g;
ISLR2
immunoglobulin superfamily containing leucine-rich repeat 2
ISLR2; immunoglobulin superfamily containing leucine-rich repeat 2; immunoglobulin superfamily containing leucine-rich repeat protein 2; leucine-rich repeat domain and immunoglobulin domain containing axon extension protein; leucine-rich repeat domain and;
GPAA1
glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast)
GPAA1; glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast); anchor attachment protein 1 (Gaa1p, yeast) homolog , GPAA1P anchor attachment protein 1 homolog (yeast); glycosylphosphatidylinositol anchor attachment 1 protein; GAA1; GPI transamidase subunit; hGAA1; GPI anchor attachment protein 1; GAA1 protein homolog; GPAA 1; GPAA1P anchor attachment protein 1 homolog; glycophosphatidylinositol anchor attachment 1; anchor attachment protein 1 (Gaa1p, yeast) homolog;
IGLL1
immunoglobulin lambda-like polypeptide 1
IGLL1; immunoglobulin lambda-like polypeptide 1; lambda 5; ig lambda-5; immunoglobulin lambda chain 5; CD179 antigen-like family member B; Igll; Igl-5; Lambda5; BB139905;
HYAL2
hyaluronoglucosaminidase 2
HYAL2; hyaluronoglucosaminidase 2; LUCA2; hyaluronidase-2; hyal-2; PH20 homolog; PH-20 homolog; hyaluronidase 2; lysosomal hyaluronidase; lung carcinoma protein 2; hyaluronoglucosaminidase-2;
TECR
trans-2,3-enoyl-CoA reductase
TECR; trans-2,3-enoyl-CoA reductase; glycoprotein, synaptic 2 , GPSN2, SC2; TER; glycoprotein, synaptic 2; synaptic glycoprotein SC2; SC2; GPSN2; MRT14;
DOHH
deoxyhypusine hydroxylase/monooxygenase
DOHH; deoxyhypusine hydroxylase/monooxygenase; HEAT like (PBS lyase) repeat containing 1 , HLRC1; deoxyhypusine hydroxylase; MGC4293; Deoxyhypusine dioxygenase; Deoxyhypusine monooxygenase; hDOHH; HEAT like PBS lyase repeat containing; HEAT like repeat containing protein 1; HEAT-like repeat-containing protein 1; HEAT-like (PBS lyase) repeat containing 1; HLRC1;
IMPAD1
inositol monophosphatase domain containing 1
IMPAD1; inositol monophosphatase domain containing 1; inositol monophosphatase 3; FLJ20421; IMPA3; IMP 3; IMPase 3; Inositol monophosphatase domain containing protein 1; Myo inositol monophosphatase A3; OTTHUMP00000226649; golgi-resident PAP phosphatase; myo-inositol monophosphatase A3; inositol-1(or 4)-monophosphatase 3; inositol monophosphatase domain-containing protein 1; Golgi 3-prime phosphoadenosine 5-prime phosphate 3-prime phosphatase; GPAPP;
INSM1
insulinoma-associated 1
INSM1; insulinoma-associated 1; insulinoma-associated protein 1; IA1; Insulinoma associated protein 1; Zinc finger protein IA1; zinc finger protein IA-1; insulinoma-associated protein (IA-1); IA-1;
ERVFRD-1
endogenous retrovirus group FRD, member 1
ERVFRD-1; endogenous retrovirus group FRD, member 1; HERV-FRD_6p24.1 provirus ancestral Env polyprotein; envFRD; ERVFRDE1; HERV FRD; HERV W/FRD; syncytin 2; envelope polyprotein; endogenous retrovirus group FRD member 1; HERV-FRD provirus ancestral Env po;
PPIP5K2
diphosphoinositol pentakisphosphate kinase 2
PPIP5K2; diphosphoinositol pentakisphosphate kinase 2; HISPPD1, histidine acid phosphatase domain containing 1; inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2; KIAA0433; VIP2; hsVIP2; VIP1 homolog 2; insP6 and PP-IP5 kinase 2;
PPIP5K1
diphosphoinositol pentakisphosphate kinase 1
PPIP5K1; diphosphoinositol pentakisphosphate kinase 1; HISPPD2A, histidine acid phosphatase domain containing 2A; inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1; IPS1; KIAA0377; VIP1; IP6K; Histidine acid phosphatase domain-containing protein 2A; hsVIP1; Inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinase 1; Inositol pyrophosphate synthase 1; InsP6 and PP IP5 kinase 1; IP6 kinase; PP IP5 kinase 1; VIP1 homolog; insP6 and PP-IP5 kinase 1; histidine acid phosphatase domain containing 2A; HISPPD2A;
KIR2DS1
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DS1; CD158H; EB6ActI; EB6ActII; p50.1; CD158 antigen-like family member H; CD158a; KI2S1_HUMAN; MHC class I NK cell receptor Eb6 ActI; XXbac-BCX195L8.7; KIR2DL1-KIR2DS1; killer-cell immunoglobulin-like receptor; killer cell immunoglobulin-like receptor KIRDS1;
ITPKC
inositol-trisphosphate 3-kinase C
ITPKC; inositol-trisphosphate 3-kinase C; inositol 1,4,5 trisphosphate 3 kinase C; IP3 3KC; IP3KC; Inositol trisphosphate 3 kinase C; InsP 3 kinase C; IP3K C; IP3 3-kinase C; insP 3-kinase C; inositol 1,4,5-trisphosphate 3-kinase C; IP3-3KC;
IP6K1
inositol hexakisphosphate kinase 1
IP6K1; inositol hexakisphosphate kinase 1; IHPK1, inositol hexaphosphate kinase 1; KIAA0263; IHPK1; Inositol hexaphosphate kinase 1; InsP6; InsP6 kinase 1; Itpk6; PiUS; Pi uptake stimulator; ATP:1D-myo-inositol-hexakisphosphate phosphotransferase;
LMLN
leishmanolysin-like (metallopeptidase M8 family)
LMLN; leishmanolysin-like (metallopeptidase M8 family); leishmanolysin-like peptidase; Gp63; Msp; GP63 like; Leishmanolysin Like Peptidase; invadolysin; leishmanolysin-2; INV; IX14;
UPF2
UPF2 regulator of nonsense transcripts homolog (yeast)
UPF2; UPF2 regulator of nonsense transcripts homolog (yeast); HUPF2; RENT2; smg-3; regulator of nonsense transcripts 2; yeast Upf2p homolog; nonsense mRNA reducing factor 2; up-frameshift suppressor 2 homolog; smg-3 homolog, nonsense mediated mRNA decay factor;
INSM2
insulinoma-associated 2
INSM2; insulinoma-associated 2; insulinoma-associated protein 2; IA 6; mlt 1; zinc finger protein IA-6; insulinoma-associated protein IA-6; IA6; IA-6; mlt1;
IPPK
inositol 1,3,4,5,6-pentakisphosphate 2-kinase
IPPK; inositol 1,3,4,5,6-pentakisphosphate 2-kinase; C9orf12, chromosome 9 open reading frame 12; inositol-pentakisphosphate 2-kinase; FLJ13163; INSP5K2; IP5K; IPK1; 3; 4; 5; 6)P5 2-kinase; 6-pentakisphosphate 2-kinase; bA476B13.1 (novel protein); C9orf12; inositol 1,3,4,5,6 pentakisphosphate 2 kinase; Inositol pentakisphosphate 2 kinase; Inositol-1; Ins; Ins(1; InsP5 2 kinase; InsP5 2-kinase; IPK1 homolog; IPPK_HUMAN; ins(1,3,4,5,6)P5 2-kinase; bA476B13.1;
MSMP
microseminoprotein, prostate associated
MSMP; microseminoprotein, prostate associated; prostate-associated microseminoprotein; PC 3; PSMP; MSMP_HUMAN; PC3 secreted microprotein homolog; PC3-secreted microprotein; Vmicroseminoprotein, prostate associated; PC3 prostate cancer cell-secreted microprotein;
ILDR1
immunoglobulin-like domain containing receptor 1
ILDR1; immunoglobulin-like domain containing receptor 1; deafness, autosomal recessive 42 , DFNB42; immunoglobulin-like domain-containing receptor 1; MGC50831; ILDR1alpha; ILDR1beta; Immunoglobulin like domain containing receptor 1 alpha; Immunoglobulin like domain containing receptor 1; Immunoglobulin like domain containing receptor 1 beta; OTTHUMP00000215507; OTTHUMP00000215508; OTTHUMP00000215509; OTTHUMP00000215510; immunoglobulin-like domain-containing receptor 1 beta; immunoglobulin-like domain-containing receptor 1 alpha; DFNB42;
INAD
inactivation no afterpotential D
INAD; inactivation no afterpotential D; CG3504 gene product from transcript CG3504-RA; Inactivation-no-after-potential D protein; INAD_DROME; CG3504-PA; inaD-PA; inactivation-no-afterpotential-D; inactivation, no after-depolarization; inactivation-no after potential D; CG3504; Dmel\CG3504; Ina-D;
IGSF21
immunoglobin superfamily, member 21
IGSF21; immunoglobin superfamily, member 21; immunoglobulin superfamily member 21; MGC15730; RP11 121A23.1; FLJ41177; IGSF 21; Immunoglobin superfamily member 21;
IGSF5
immunoglobulin superfamily, member 5
IGSF5; immunoglobulin superfamily, member 5; immunoglobulin superfamily member 5; JAM4; junctional adhesion molecule 4; GSF5; IGSF5_HUMAN; Immunoglobulin superfamily 5 like; JAM-4;
MLPH
melanophilin
MLPH; melanophilin; 2210418F23Rik; 5031433I09Rik; AW228792; D1Wsu84e; Exophilin 3; Exophilin-3; l(1)-3Rk; l1Rk3; Leaden; Leaden protein; ln; MELPH_HUMAN; MGC2771; MGC59733; Slac 2a; SlaC2-a; Slp homolog lacking C2 domains a; Synaptotagmin like protein 2a; Synaptotagmin like protein lacking C2 domains A; Synaptotagmin-like protein 2a; Slac-2a;
NSMCE4A
non-SMC element 4 homolog A
NSMCE4A; non-SMC element 4 homolog A (S. cerevisiae); C10orf86, chromosome 10 open reading frame 86; non-structural maintenance of chromosomes element 4 homolog A; bA500G22.3; FLJ20003; NSE4A; NS4EA; C10orf86;
INPP5E
inositol polyphosphate-5-phosphatase, 72 kDa
INPP5E; inositol polyphosphate-5-phosphatase, 72 kDa; JBTS1, Joubert syndrome 1; 72 kDa inositol polyphosphate 5-phosphatase; CORS1; PPI5PIV; Inositol polyphosphate 5 phosphatase; Phosphatidylinositol (4,5) bisphosphate 5 phosphatase; Phosphatidylinositol polyphosphate 5 phosphatase type IV; phosphatidylinositol-4,5-bisphosphate 5-phosphatase; phosphatidylinositol (4,5) bisphosphate 5-phosphatase; phosphatidylinositol polyphosphate 5-phosphatase type IV; CPD4; JBTS1; MORMS;
INPP5F
inositol polyphosphate-5-phosphatase F
INPP5F; inositol polyphosphate-5-phosphatase F; phosphatidylinositide phosphatase SAC2; hSac2; KIAA0966; SAC2; cI-27; Inositol polyphosphate 5 phosphatase F; MSTP007; MSTP047; Sac domain containing inositol phosphatase 2; Sac domain-containing phosphoinositide 5-phosphatase 2; Sac domain-containing inositol phosphatase 2; MSTPO47;
MAOA
monoamine oxidase A
MAOA; monoamine oxidase A; amine oxidase [flavin-containing] A; Amine oxidase [flavin containing] A; AOFA_HUMAN; EC 1.4.3.4; flavin containingA; HGNC:6833; MAO A; MAO-A; Monoamine oxidase type A; RP1 201D17_B.2;
ISPD
isoprenoid synthase domain containing
ISPD; isoprenoid synthase domain containing; 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein; 4 diphosphocytidyl 2C methyl D erythritol synthase homolog (Arabidopsis); hCG_1745121; Nip; notch1 induced protein; Isoprenoid synthase domain-containing protein; ISPD_HUMAN; notch1-induced protein; 4-diphosphocytidyl-2C-methyl-D-erythritol synthase homolog;
ITPR3
inositol 1,4,5-trisphosphate receptor, type 3
ITPR3; inositol 1,4,5-trisphosphate receptor, type 3; inositol 1,4,5 triphosphate receptor, type 3; inositol 1,4,5-trisphosphate receptor type 3; IP3R3; insP3R3; IP3 receptor; type 3 InsP3 receptor; inositol 1,4,5-triphosphate receptor, type 3; IP3R; FLJ3;
ITPRIP
inositol 1,4,5-trisphosphate receptor interacting protein
ITPRIP; inositol 1,4,5-trisphosphate receptor interacting protein; inositol 1,4,5 triphosphate receptor interacting protein , KIAA1754; inositol 1,4,5-trisphosphate receptor-interacting protein; bA127L20.2; DANGER; inositol 1,4,5-triphosphate receptor in;
NDUFAF4
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 4
NDUFAF4; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 4; C6orf66, chromosome 6 open reading frame 66; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4; bA22L21.1; HRPAP20; HSPC125; My013; C6orf66; Hormone-regulated proliferation-associated protein of 20 kDa; NDUF4_HUMAN; hormone-regulated proliferation-associated protein, 20 kDa;
KRTCAP2
keratinocyte associated protein 2
KRTCAP2; keratinocyte associated protein 2; keratinocyte-associated protein 2; KCP2; KCP-2; KTAP2_HUMAN; keratinocytes associated protein 2;
LILRA5
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
LILRA5; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5; LILRB7; leukocyte immunoglobulin-like receptor subfamily A member 5; CD85; CD85f; ILT11; LIR9; CD85 antigen-like family member F; ILT-11; Immunoglobulin like transcript 11 protein; Immunoglobulin-like transcript 11; Leukocyte Ig like receptor 9; Leukocyte immunoglobulin like receptor subfamily A (with TM domain) member 5; Leukocyte immunoglobulin-like receptor 9; Leukocyte immunoglobulin-like receptor subfamily B (with TM and ITIM domains) member 7; LIR-9; LIRA5_HUMAN; leukocyte Ig-like receptor 9; immunoglobulin-like transcript 11 protein; leukocyte immunoglobulin-like receptor subfamily A member 5 soluble; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7;
NOMO1
NODAL modulator 1
NOMO1; NODAL modulator 1; PM5; NOMO 1; Nomo; NOMO1_HUMAN; pM5 protein; pM5 protein telomeric copy; pM5 protein 3; nodal modulator 3; pM5 protein, telomeric copy; NOMO3;
MOGAT1
monoacylglycerol O-acyltransferase 1
MOGAT1; monoacylglycerol O-acyltransferase 1; DGAT2L1, diacylglycerol O acyltransferase 2 like 1; 2-acylglycerol O-acyltransferase 1; DGAT2L; MGAT1; 1110064N14Rik; Diacylglycerol O acyltransferase 2 like 1; MGC118035; 0610030A14Rik; Acyl CoA:monoacylglycerol acyltransferase 1; DGAT2L1; Diacylglycerol acyltransferase 2 like; Diacylglycerol O-acyltransferase candidate 2; hDC2; mDC2; Monoacylglycerol O acyltransferase 1; OTTMUSP00000025181; diacylglycerol O-acyltransferase 2 like 1; acyl-CoA:monoacylglycerol acyltransferase 1; diacylglycerol acyltransferase 2-like protein 1;
MAGEB4
melanoma antigen family B, 4
MAGEB4; melanoma antigen family B, 4; melanoma-associated antigen B4; cancer/testis antigen family 3; member 6; CT3.6; melanoma associated antigen B4; MGC33144; MAGE-B4 antigen; cancer/testis antigen family 3, member 6;
NSUN2
NOP2/Sun domain family, member 2
NSUN2; NOP2/Sun domain family, member 2; NOL1/NOP2/Sun domain family 2 , NOL1/NOP2/Sun domain family, member 2; tRNA (cytosine(34)-C(5))-methyltransferase; FLJ20303; Misu; Myc induced SUN domain containing protein; TRM4; tRNA methyltransferase 4 homolog;
NSUN4
NOP2/Sun domain family, member 4
NSUN4; NOP2/Sun domain family, member 4; NOL1/NOP2/Sun domain family 4 , NOL1/NOP2/Sun domain family, member 4; putative methyltransferase NSUN4; MGC22960; EC=2.1.1.-; NOL1/NOP2/Sun domain family member 4; NOL1/NOP2/Sun domain family, member 4; NSUN4_HUMAN; Shtap; Sperm head and tail associated protein; NOL1/NOP2/Sun domain family 4; RP4-603I14.2;
SLC16A1
solute carrier family 16 (monocarboxylate transporter), member 1
SLC16A1; solute carrier family 16 (monocarboxylate transporter), member 1; MCT; HHF7; MCT1; monocarboxylate transporter 1; MCT 1; solute carrier family 16 member 1; solute carrier family 16 (monocarboxylic acid transporters), member 1; solute carrier family 16, member 1 (monocarboxylic acid transporter 1);
SLCO1B7
solute carrier organic anion transporter family, member 1B7 (non-functional)
SLCO1B7; solute carrier organic anion transporter family, member 1B7 (non-functional); liver-specific organic anion transporter 3TM12; LST3; Liver specific organic anion transporter 3; Liver specific organic anion transporter 3TM12; Organic anion transporter LST 3b; organic anion transporter LST-3b; liver-specific organic anion transporter 3; LST-3TM12;
LMAN2L
lectin, mannose-binding 2-like
LMAN2L; lectin, mannose-binding 2-like; VIP36-like protein; DKFZp564L2423; VIPL; MGC11139; lectin, mannose binding 2 like; LMAN2 like protein; VIP36 like protein [Precursor]; LMAN2-like protein;
KIR2DS2
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
KIR2DL+KIR2DS1+KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; KIR2DS2; killer cell immunoglobulin-like receptor 2DS2; 183ActI; CD158J; cl 49; nkat5; NKAT-5; p58 KIR; 1060P11.9.2; NK receptor 183 ActI; p58 NK receptor CL-49; MHC class I;
KIR2DS5
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
KIR2DS5; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; killer cell immunoglobulin-like receptor 2DS5; CD158G; nkat9; CD158 antigen like family member G; Flags: Precursor; Killer cell immunoglobulin like receptor 2DS5; Killer cell immunoglobulin like receptor two domains short cytoplasmic tail 5; MHC class I NK cell receptor; Natural killer associated transcript 9; Natural killer cell inhibitory receptor; NKAT 9; NKAT-9; CD158 antigen-like family member G; natural killer-associated transcript 9;
KIR3DL2
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 3DL2; CD158K; cl 5; nkat4; nkat4a; nkat4b; CD158 antigen like family member K; CD158 antigen-like family member K; KI3L2_HUMAN; Killer cell immunoglobulin like receptor 3DL2; killer cell immunoglobulin like receptor KIR3DL2; Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2; KIR antigen 3DL2; Kirl2; MHC class I NK cell receptor; Natural killer associated transcript 4; natural killer cell inhibitory receptor; Natural killer-associated transcript 4; NK associated transcript 4; NK associated transcript 4A, included; NK associated transcript 4B, included; NKAT-4; p140; p70 natural killer cell receptor clone CL 5; p70 natural killer cell receptor clone CL-5; p70 NK receptor CL 5; p70 NK receptor CL-5; killer Ig receptor; p70 killer cell inhibitory receptor; killer cell immunoglobulin-like receptor KIR3DL2;
LOC727787
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
LOC727787; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 2 like; LOC727787|-|-;
KMO
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)
KMO; kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); kynurenine 3-monooxygenase; dJ317G22.1; Kynurenine 3 hydroxylase; Kynurenine 3 monooxygenase (kynurenine 3 hydroxylase); Kynurenine 3 monooxygenase; RP1-317G22.1; kynurenine 3-hydroxylase; AI046660;
MC3R
melanocortin 3 receptor
MC3R; melanocortin 3 receptor; MC3; OB20; OQTL; BMIQ9; MC3-R; melanocortin receptor 3; obesity quantitative trait locus;
MIER1
mesoderm induction early response 1 homolog (Xenopus laevis)
MIER1; mesoderm induction early response 1 homolog (Xenopus laevis); mesoderm induction early response protein 1; hMI ER1; KIAA1610; MI ER1; ER1; Mesoderm induction early response 1; MI-ER1; hMI-ER1; RP5-944N15.1;
NCAPG2
non-SMC condensin II complex, subunit G2
NCAPG2; non-SMC condensin II complex, subunit G2; leucine zipper protein 5 , LUZP5; condensin-2 complex subunit G2; CAP G2; FLJ20311; hCAP G2; MTB; Chromosome associated protein G2; Leucine zipper protein 5; LUZP5; Non SMC condensin II complex subunit G2; Condensin 2 complex subunit G2; NCAPG 2; Non SMC condensin II complex, subunit G2; more than blood homolog; chromosome-associated protein G2; CAP-G2; hCAP-G2;
MANBA
mannosidase, beta A, lysosomal
MANBA; mannosidase, beta A, lysosomal; beta-mannosidase; mannase; mannanase; lysosomal beta A mannosidase; MANB1;
MYH14
myosin, heavy chain 14, non-muscle
MYH14; myosin, heavy chain 14, non-muscle; DFNA4; MHC16; MYH17; PNMHH; DFNA4A; myosin; FP17425; NMHC II-C; NMHC-II-C; myosin-14; MYH14 variant protein; myosin, heavy polypeptide 14; non-muscle myosin heavy chain IIc; nonmuscle myosin heavy chain II-C; myosin heavy chain, non-muscle IIc;
ltp-BR1
nonspecific lipid transfer protein
ltp-BR1; nonspecific lipid transfer protein; LTP1; NLTP1; nonspecific lipid transfer protein 1; PAPI;
MAGEB3
melanoma antigen family B, 3
MAGEB3; melanoma antigen family B, 3; melanoma-associated antigen B3; cancer/testis antigen family 3; member 5; CT3.5; Cancer/testis antigen family 3 member 5; MAGB3_HUMAN; MAGE B3 antigen; MAGE-B3 antigen; Melanoma associated antigen B3; cancer/testis antigen family 3, member 5;
SLC16A5
solute carrier family 16, member 5 (monocarboxylic acid transporter 6)
SLC16A5; solute carrier family 16, member 5 (monocarboxylic acid transporter 6); solute carrier family 16 (monocarboxylic acid transporters), member 5; monocarboxylate transporter 6; MCT5; MCT6; MCT 5; MCT 6; monocarboxylate transporter 5; solute carrier;
SLC16A13
solute carrier family 16, member 13 (monocarboxylic acid transporter 13)
SLC16A13; solute carrier family 16, member 13 (monocarboxylic acid transporter 13); solute carrier family 16 (monocarboxylic acid transporters), member 13; monocarboxylate transporter 13; MCT13; MCT 13; Solute carrier family 16 (monocarboxylic acid transporters) member 13; Solute carrier family 16 member 13 (monocarboxylic acid transporter 13); Solute carrier family 16 member 13;
LNPEP
leucyl/cystinyl aminopeptidase
LNPEP; leucyl/cystinyl aminopeptidase; leucyl-cystinyl aminopeptidase; CAP; cystinyl aminopeptidase; P LAP; placental leucine aminopeptidase; PLAP; otase; oxytocinase; vasopressinase; AT (4) receptor; angiotensin IV receptor; insulin-regulated aminopeptid; Aeromonas Aminopeptidase; Aminopeptidase protein; Aminopeptidase; Bacterial leucyl aminopeptidase; EC 3.4.11.10; Aeromonas proteolytica aminopeptidase; EC 3.4.11.1; EC 3.4.11.5; LAP; LAPEP; PEPS; Leucine aminopeptidase; Leucyl aminopeptidase; Peptidase S; Proline aminopeptidase; Prolyl aminopeptidase; leucine aminopeptidase 3; leucyl peptidase; cytosol aminopeptidase; cathepsin III; L-leucine aminopeptidase; leucinaminopeptidase; leucinamide aminopeptidase; FTBL proteins; proteinates FTBL; aminopeptidase II; aminopeptidase III; aminopeptidase I;
MC5R
melanocortin 5 receptor
MC5R; melanocortin 5 receptor; melanocortin receptor 5; OTTHUMP00000162511; melanocortin-5 receptor; MC2;
CMBL
carboxymethylenebutenolidase homolog (Pseudomonas)
CMBL; carboxymethylenebutenolidase homolog (Pseudomonas); carboxymethylenebutenolidase like (Pseudomonas); carboxymethylenebutenolidase homolog; FLJ23617; CMBL_HUMAN; carboxymethylenebutenolidase-like (Pseudomonas);
LRIG1
leucine-rich repeats and immunoglobulin-like domains 1
LRIG1; leucine-rich repeats and immunoglobulin-like domains 1; leucine-rich repeats and immunoglobulin-like domains protein 1; DKFZP586O1624; leucine rich repeat protein LRIG1; LIG 1; LIG1; ortholog of mouse integral membrane glycoprotein LIG 1; Leucine rich repeat protein; leucine rich repeats and immunoglobulin like domains 1; LIG-1; LRIG1_HUMAN; OTTHUMP00000213345; OTTHUMP00000213346; leucine-rich repeat protein LRIG1; ortholog of mouse integral membrane glycoprotein LIG-1;
MINPP1
multiple inositol-polyphosphate phosphatase 1
MINPP1; multiple inositol-polyphosphate phosphatase 1; multiple inositol polyphosphate histidine phosphatase, 1; multiple inositol polyphosphate phosphatase 1; MIPP; ins(1,3,4,5)P(4) 3-phosphatase; multiple inositol polyphosphate phosphatase 2; inositol (;
NCCRP1
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)
NCCRP1; non-specific cytotoxic cell receptor protein 1 homolog (zebrafish); non-specific cytotoxic cell receptor protein 1 homolog; FBXO50; LOC342897; NCCRP 1; Gm163; NCRP1_HUMAN; Non specific cytotoxic cell receptor protein 1 homolog (zebrafish); Non specific cytotoxic cell receptor protein 1 homolog; Nonspecific cytotoxic cell receptor protein 1 homolog; RGD1305932; NCCRP-1;
PRCC
papillary renal cell carcinoma (translocation-associated)
PRCC; papillary renal cell carcinoma (translocation-associated); proline-rich protein PRCC; RCCP1; papillary renal cell carcinoma translocation-associated gene protein; TPRC; MGC4723; MGC17178;
MAGEA10
melanoma antigen family A, 10
MAGEA10; melanoma antigen family A, 10; MAGE10; melanoma-associated antigen 10; cancer/testis antigen family 1; member 10; CT1.10; MAGE 10 antigen; melanoma associated antigen 10; MGC10599; MAGE-10 antigen; cancer/testis antigen 1.10; cancer/testis antige;
MAGEA5
melanoma antigen family A, 5
MAGEA5; melanoma antigen family A, 5; MAGE5; melanoma-associated antigen 5; cancer/testis antigen family 1; member 5; CT1.5; MAGE 5a antigen; MAGE 5b antigen; MGC129526; Cancer/testis antigen 1.5; Cancer/testis antigen family 1 member 5; MAGE 5 antigen; MAGEA4; Melanoma antigen family A 5; Melanoma associated antigen 5; MAGE-5 antigen; MAGE-5a antigen; MAGE-5b antigen; cancer/testis antigen family 1, member 5;
MAGEB17
melanoma antigen family B, 17
MAGEB17; melanoma antigen family B, 17; melanoma antigen family B, 17 (pseudogene); MAGBH_HUMAN; Melanoma-associated antigen B17;
MAGEB2
melanoma antigen family B, 2
MAGEB2; melanoma antigen family B, 2; melanoma-associated antigen B2; cancer/testis antigen family 3; member 2; CT3.2; DAM6; DSS/AHC critical interval MAGE superfamily 6; MAGE XP 2; melanoma associated antigen B2; MGC26438; MAGE-B2 antigen; MAGE XP-2 anti;
MAGEC2
melanoma antigen family C, 2
MAGEC2; melanoma antigen family C, 2; MAGEE1, melanoma antigen, family E, 1, cancer/testis specific; melanoma-associated antigen C2; cancer/testis antigen 10; CT10; MAGE C2; Cancer testis antigen 10; HCA587; Hepatocellular carcinoma associated antigen 587; Hepatocellular carcinoma-associated antigen 587; MAGC2_HUMAN; MAGE C2 antigen; MAGE E1 antigen; MAGE-C2 antigen; MAGE-E1 antigen; Melanoma associated antigen C2; MGC13377; hepatocellular cancer antigen 587; melanoma antigen, family E, 1, cancer/testis specific; MAGEE1;
MAGEF1
melanoma antigen family F, 1
MAGEF1; melanoma antigen family F, 1; melanoma-associated antigen F1; MAGE-F1 antigen; MGC19617;
MAN1A2
mannosidase, alpha, class 1A, member 2
MAN1A2; mannosidase, alpha, class 1A, member 2; mannosyl-oligosaccharide 1,2-alpha-mannosidase IB; MAN1B; Alpha 1,2 mannosidase IB; Mannosidase alpha class 1A member 2; Mannosyl oligosaccharide 1,2 alpha mannosidase IB; Processing alpha 1,2 mannosidase IB; alpha1,2-mannosidase; alpha-1,2-mannosidase IB; processing alpha-1,2-mannosidase IB;
MAN1C1
mannosidase, alpha, class 1C, member 1
MAN1C1; mannosidase, alpha, class 1C, member 1; mannosyl-oligosaccharide 1,2-alpha-mannosidase IC; HMIC; 1 2 alpha mannosidase IC; Alpha 1 2 mannosidase IC; MAN1A3; MAN1C; Mannosidase alpha class 1C member 1; Mannosyl oligosaccharide 1 2 alpha mannosidase IC; pp6318; Processing alpha 1 2 mannosidase IC; 1,2-alpha-mannosidase IC; processing alpha-1,2-mannosidase IC;
MAN2A2
mannosidase, alpha, class 2A, member 2
MAN2A2; mannosidase, alpha, class 2A, member 2; alpha-mannosidase 2x; HsT19662; MANA2X; MAN IIx; alpha-mannosidase IIx; mannosidase, alpha type II-X; manosidase, alpha-, type II, isozyme X; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;
MAN2B1
mannosidase, alpha, class 2B, member 1
MAN2B1; mannosidase, alpha, class 2B, member 1; MANB; lysosomal alpha-mannosidase; LAMAN; EC 3.2.1.24; Lysosomal acid alpha mannosidase; Lysosomal alpha mannosidase; Mannosidase alpha class 2B member 1; Mannosidase, alpha B; Mannosidase, alpha B, lysosomal; mannosidase alpha-B; lysosomal acid alpha-mannosidase;
MAN2B2
mannosidase, alpha, class 2B, member 2
MAN2B2; mannosidase, alpha, class 2B, member 2; epididymis-specific alpha-mannosidase; core specific lysosomal alpha 1; 6 Mannosidase; KIAA0935; Epididymis specific alpha mannosidase; Core specific lysosomal alpha 1 6 Mannosidase; MAN2B 2; Mannosidase alpha class 2B member 2; core-specific lysosomal alpha-1,6-Mannosidase;
METAP1D
methionyl aminopeptidase type 1D (mitochondrial)
METAP1D; methionyl aminopeptidase type 1D (mitochondrial); methionine aminopeptidase 1D, mitochondrial; MAP1D; Metap1l; methionine aminopeptidase 1D; mitochondrial; AMP1D_HUMAN; CDS of metAP 3 within PCR fragment; CDS of metAP-3 within PCR fragment; methionyl aminopeptidase type 1D, mitochondrial;
MUM1L1
melanoma associated antigen (mutated) 1-like 1
MUM1L1; melanoma associated antigen (mutated) 1-like 1; PWWP domain-containing protein MUM1L1; FLJ33516; MUM1-like protein 1; mutated melanoma-associated antigen 1-like protein 1; MGC129994; MGC129995;
NDP
Norrie disease (pseudoglioma)
NDP; Norrie disease (pseudoglioma); EVR2, exudative vitreoretinopathy 2 (X linked); norrin; EVR2; Exudative vitreoretinopathy 2 (X linked); FEVR; ND; NDP_HUMAN; Norrie disease protein; Norrin precursor; X linked exudative vitreoretinopathy 2 protein; X-linked exudative vitreoretinopathy 2 protein;
mec-2
MEChanosensory abnormality
mec-2; MEChanosensory abnormality; MEChanosensory abnormality family member (mec-2); F14D12.4; Mechanosensory protein 2;
mec-4
MEChanosensory abnormality
mec-4; MEChanosensory abnormality; MEChanosensory abnormality family member (mec-4); Degenerin mec 4; mec 13; Mechanosensory abnormality protein 4; T01C8.7;
mec-5
MEChanosensory abnormality
mec-5; MEChanosensory abnormality; MEChanosensory abnormality family member (mec-5); E03G2.3;
MMD
monocyte to macrophage differentiation-associated
MMD; monocyte to macrophage differentiation-associated; monocyte to macrophage differentiation protein; MMA; PAQR11; 1810073C06Rik; AA690185; 1200017E07Rik; Maf; MGC94095; OTTMUSP00000001266; OTTMUSP00000001267; Progestin and adipoQ receptor family member 11; Progestin and adipoQ receptor family member XI; RP23-220F20.1; macrophage maturation-associated;
MMD2
monocyte to macrophage differentiation-associated 2
MMD2; monocyte to macrophage differentiation-associated 2; monocyte to macrophage differentiation factor 2; PAQR10; FLJ37205; MMD 2; Monocyte to macrophage differentiation associated 2; Progestin and adipoQ receptor family member X; progestin and adipoQ receptor family member 10; monocyte-to-macrophage differentiation factor 2;
STRA13
stimulated by retinoic acid 13 homolog (mouse)
STRA13; stimulated; stimulated by retinoic acid 13; centromere protein X; FAAP10; MGC14480; MHF2; FANCM-interacting histone fold protein 2; Fanconi anemia-associated polypeptide of 10 kDa; retinoic acid-inducible gene D9 protein homolog; stimulated by ret;
MIA3
melanoma inhibitory activity family, member 3
MIA3; melanoma inhibitory activity family, member 3; melanoma inhibitory activity protein 3; C219 reactive peptide; FLJ39207; KIAA0268; TANGO; UNQ6077; ARNT; C219-reactive peptide; D320; MIA3_HUMAN; RP11-378J18.4; TANGO1; Transport and Golgi organization protein 1;
NIPA2
non imprinted in Prader-Willi/Angelman syndrome 2
NIPA2; non imprinted in Prader-Willi/Angelman syndrome 2; magnesium transporter NIPA2; MGC5466; NIPA 2; Non imprinted in Prader Willi/Angelman syndrome 2; Non imprinted in Prader Willi/Angelman syndrome region protein 2; non-imprinted in Prader-Willi/Angelman syndrome region protein 2;
NSUN6
NOP2/Sun domain family, member 6
NSUN6; NOP2/Sun domain family, member 6; NOL1/NOP2/Sun domain family 6 , NOL1/NOP2/Sun domain family, member 6 , NOPD1; putative methyltransferase NSUN6; FLJ23743; NOL1/NOP2/Sun domain family 6; NOL1/NOP2/Sun domain family member 6; NOL1/NOP2/Sun domain;
MGAT4C
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)
MGAT4C; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative); alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C; HGNT IV H; gnT-IVc; glcNAc-T IVc; N-acetylglucosaminyltransferase IVc; N-a;
MICAL2
microtubule associated monoxygenase, calponin and LIM domain containing 2
MICAL2; microtubule associated monoxygenase, calponin and LIM domain containing 2; protein-methionine sulfoxide oxidase MICAL2; KIAA0750; protein MICAL-2; flavoprotein oxidoreductase MICAL2; molecule interacting with CasL protein 2; MICAL-2; MICAL2PV1; MI;
MOGAT2
monoacylglycerol O-acyltransferase 2
MOGAT2; monoacylglycerol O-acyltransferase 2; 2-acylglycerol O-acyltransferase 2; DGAT2L5; FLJ22644; MGAT2; hDC5; hMGAT2; acyl CoA:monoacylglycerol acyltransferase 2; acyl-CoA:monoacylglycerol acyltransferase 2; diacylglycerol O-acyltransferase candidate;
NDUFC2
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa
NDUFC2; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD, B14.5b); NADH dehydrogenase [ubiquinone] 1 subunit C2; B14.5b; complex I subunit B14.5b; HLC 1; human lung cancer oncogene 1; CI-B14.5b; Complex I B14.5b; Complex I-B14.5b; HLC-1; HLC1; Human lung cancer oncogene 1 protein; NADH dehydrogenase ubiquinone 1 subunit C2; NADH ubiquinone oxidoreductase subunit B14.5b; NADH-ubiquinone oxidoreductase subunit B14.5b; NDUC2_HUMAN; OTTHUMP00000233778; OTTHUMP00000233779; OTTHUMP00000233781; NADHDH2;
NDUFB1
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa
NDUFB1; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1 (7kD, MNLL); NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1; CI MNLL; complex I MNLL subunit; MNLL; CI-MNLL; Complex I-MNLL; NADH-ubiquinone oxidoreductase MNLL subunit; NDUB1_HUMAN; CI-SGDH;
SLC16A14
solute carrier family 16, member 14 (monocarboxylic acid transporter 14)
SLC16A14; solute carrier family 16, member 14 (monocarboxylic acid transporter 14); solute carrier family 16 (monocarboxylic acid transporters), member 14; monocarboxylate transporter 14; FLJ30794; MCT14; MCT 14; solute carrier family 16 member 14;
NDUFA11
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa
NDUFA11; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11; B14.7; complex I B14.7 subunit; FLJ76501; 2010012C24Rik; AV006275; CI-B14.7; Complex I-B14.7; NADH-ubiquinone oxidoreductase subunit B14.7; NDUAB_HUMAN;
NDUFA3
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa
NDUFA3; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 (9kD, B9); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3; B9; complex I B9 subunit; CIB9; Complex IB9; NADH ubiquinone oxidoreductase B9 subunit; complex I-B9; NADH-ubiquinone oxidoreductase B9 subunit; CI-B9;
NDUFA4L2
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2
NDUFA4L2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2; FLJ26118; NUOMS; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4 like 2; NADH ubiquinone oxidoreductase MLRQ subunit homolog; NADH-ubiquinone oxidoreductase MLRQ subunit homolog; NADH:ubiquinone oxidoreductase MLRQ subunit homolog;
NDUFA6
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa
NDUFA6; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (14kD, B14); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6; B14; CI B14; complex I B14 subunit; LYRM6; NADHB14; CI-B14; Complex I-B14; LYR motif-containing protein 6; NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 6; NADH-ubiquinone oxidoreductase B14 subunit; NDUA6_HUMAN;
PLCXD3
phosphatidylinositol-specific phospholipase C, X domain containing 3
PLCXD3; phosphatidylinositol-specific phospholipase C, X domain containing 3; PI-PLC X domain-containing protein 3; Phosphatidylinositol specific phospholipase C X domain containing protein 3; PI PLC X domain containing protein 3;
NSUN7
NOP2/Sun domain family, member 7
NSUN7; NOP2/Sun domain family, member 7; NOL1/NOP2/Sun domain family, member 7; putative methyltransferase NSUN7; FLJ14001; NOL1/NOP2/Sun domain family member 7;
NANOS1
nanos homolog 1
NANOS1; nanos homolog 1 (Drosophila); nanos homolog 1; NOS1; NOS-1; EC_Rep1a;
NDUFS1
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)
NDUFS1; NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 1 (75kD) (NADH coenzyme Q reductase); NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial; CI 75k; complex I 75kDa subunit; NADH ubiquinone oxidoreductase 75 kDa subunit; mitochondrial; Complex I 75Kd; Complex I, mitochondrial respiratory chain, 75 kD subunit; NADH coenzyme Q reductase; NADH dehydrogenase (ubiquinone) FeS protein 1 (75kD) (NADH coenzyme Q reductase); NADH ubiquinone oxidoreductase 75 kDa subunit mitochondrial; PRO1304; complex I, mitochondrial respiratory chain, 75-kD subunit; mitochondrial NADH-ubiquinone oxidoreductase 75 kDa subunit; CI-75k; CI-75Kd;
NDUFS5
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)
NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 5 (15kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 5; CI 15k; complex I 51kDa subunit; NADH dehydrogenase [ubiquinone] iron sulfur protein 5; CI-15 kDa; Complex I-15 kDa; NADH-ubiquinone oxidoreductase 15 kDa subunit; NADH:ubiquinone oxidoreductase 15 kDa IP subunit; CI15K; CI-15k;
NDUFS6
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)
NDUFS6; NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 6 (13kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial; CI 13kA; complex I 13kDa subunit A; NADH dehydrogenase [ubiquinone] iron sulfur protein 6; mitochondrial; CI 13kD A; CI-13kD-A; Complex I 13kD A; Complex I-13kD-A; NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron sulfur protein 6, mitochondrial; NADH ubiquinone oxidoreductase 13 kDa A subunit; NADH-ubiquinone oxidoreductase 13 kDa-A subunit; NDUS6_HUMAN; NADH:ubiquinone oxidoreductase NDUFS6 subunit; complex I, mitochondrial respiratory chain, 13-kD subunit; CI-13kA; CI13KDA;
NDUFV3
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa
NDUFV3; NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa; NADH dehydrogenase (ubiquinone) flavoprotein 3 (10kD); NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial; CI 10k; complex I 10kDa subunit; CI-10k; CI-9kD; complex I, mitochondrial respiratory chain, 10-kD subunit; Complex I-9kD; mitochondrial NADH oxidoreductase-like protein; NADH ubiquinone oxidoreductase 9 kD subunit; NADH-ubiquinone oxidoreductase 9 kDa subunit; NADH-ubiquinone oxidoreductase flavoprotein 3, 10kD; NDUV3_HUMAN; Renal carcinoma antigen NY-REN-4; NADH-ubiquinone oxidoreductase 9 kD subunit;
NOTCH1A
notch homolog 1a
NOTCH1A; notch homolog 1a; neurogenic locus notch homolog protein 1; Deadly seven; des; n1a; Notch 1a; wu:fc01e02; wu:fc37a05;
NOTCH1B
notch homolog 1b
NOTCH1B; notch homolog 1b; neurogenic locus notch homolog protein 1; etID309871.5; Notch 1b; Notch receptor protein 1b; wu:fc55e11;
NOTO
notochord homeobox
NOTO; notochord homeobox; notochord homolog (Xenopus laevis); homeobox protein notochord; notochord homolog;
NOTUM
notum pectinacetylesterase homolog
NOTUM; notum pectinacetylesterase homolog (Drosophila); protein notum homolog;
NPHP1
nephronophthisis 1 (juvenile) homolog (human)
NPHP1; nephronophthisis 1 (juvenile) homolog (human); nephrocystin-1; JBTS4; Juvenile nephronophthisis 1 protein; Nephrocystin 1; NPH1; SLSN1;
NOBOX
NOBOX oogenesis homeobox
NOBOX; NOBOX oogenesis homeobox; homeobox protein NOBOX; Og2x; OG2 homeobox; newborn ovary homeobox protein; oocyte-specific homeobox protein; homeodomain-containing protein OG-2; OG2;
NOP14
NOP14 nucleolar protein homolog (yeast)
NOP14; NOP14 nucleolar protein homolog (yeast); C4orf9, chromosome 4 open reading frame 9 , NOL14, nucleolar protein 14 , nucleolar protein 14 homolog (yeast); nucleolar protein 14; NOP14 homolog (S. cerevisiae); RES4 25; UTP2; C4orf9; chromosome 4 open reading frame 9; NOL14; NOP 14; Nucleolar complex protein 14; Nucleolar protein 14 homolog; RES425; NOP14 homolog; probable nucleolar complex protein 14; RES4-25;
PIP5KL1
phosphatidylinositol-4-phosphate 5-kinase-like 1
PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase-like 1; phosphatidylinositol-4-phosphate 5-kinase-like protein 1; bA203J24.5; MGC46424; EC 2.7.1.68; phosphatidylinositol 4 phosphate 5 kinase like 1; phosphatidylinositol phosphate kinase homolog; PI(4)P 5 kinase like protein 1; PIPKH; PtdIns(4)P 5 kinase like protein 1; PI(4)P 5-kinase-like protein 1; ptdIns(4)P-5-kinase-like protein 1; RP11-203J24.5;
NOP58
NOP58 ribonucleoprotein homolog (yeast)
NOP58; NOP58 ribonucleoprotein homolog (yeast); nucleolar protein 58; HSPC120; NOP5; NOL5; NOP5/NOP58; NOP58 ribonucleoprotein homolog; NOP58_HUMAN; Nucleolar protein 5; Nucleolar protein NOP5/NOP58;
GRIN3A
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
GRIN3A; glutamate receptor, ionotropic, N-methyl-D-aspartate 3A; glutamate [NMDA] receptor subunit 3A; GluN3A; NMDAR3A; N-methyl-D-aspartate receptor subtype 3A; NR3A; NMDAR-L; FLJ45414;
NRARP
NOTCH-regulated ankyrin repeat protein
NRARP; NOTCH-regulated ankyrin repeat protein; notch-regulated ankyrin repeat-containing protein; MGC61598;
GRIN3B
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
GRIN3B; glutamate receptor, ionotropic, N-methyl-D-aspartate 3B; NR3B; GluN3B; glutamate receptor ionotropic, NMDA 3B; NMDAR3B; NMDA receptor subunit 3B; glutamate [NMDA] receptor subunit 3B; N-methyl-D-aspartate receptor subtype 3B; NMDA type glutamate receptor subunit NR3B;
PAOX
polyamine oxidase (exo-N4-amino)
PAOX; polyamine oxidase (exo-N4-amino); polyamine oxidase; PAO; DKFZp434J245; MGC45464; Peroxisomal N(1) acetyl spermine/spermidine oxidase; Peroxisomal N1 acetyl spermine/spermidine oxidase; Polyamine oxidase (exo N4 amino); RP11 122K13.11; peroxisomal N1-acetyl-spermine/spermidine oxidase;
PEP4
phosphoenolpyruvate carboxylase4
PEP4; phosphoenolpyruvate carboxylase4; phosphoenolpyruvate carboxylase 2; PEPC 1; PEPCase 1; Phosphoenolpyruvate carboxylase 1; Ppc-; PepC2; PEPC 2; gpm372; gpm879; QCH5g04; QAN24f10; six61489; MR32-MseI; PEPCase 2; gnp_QCH5g04; siX61489_ov; gnp_QAN24f10; six61489(466); pep;
RAI1
retinoic acid induced 1
RAI1; retinoic acid induced 1; SMCR, Smith Magenis syndrome chromosome region; retinoic acid-induced protein 1; DKFZP434A139; KIAA1820; MGC12824; SMS; Smith-Magenis syndrome chromosome region; SMCR;
PEBP4
phosphatidylethanolamine-binding protein 4
PEBP4; phosphatidylethanolamine-binding protein 4; CORK1; cousin of RKIP 1 protein; hPEBP4; MGC22776; cousin-of-RKIP 1 protein; protein cousin-of-RKIP 1; CORK-1; PEBP-4; PRO4408; GWTM1933;
PCBD2
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2
PCBD2; pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2; 6 pyruvoyl tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2; pterin-4-alpha-carbinolamine dehydratase 2; DCOH2; DCOHM; 4 alpha hydroxy tetrahydropterin dehydratase 2; 4-alpha-hydroxy-tetrahydropterin dehydratase 2; DcoH like protein DCoHm; DcoH-like protein DCoHm; Dimerization cofactor of hepatocyte nuclear factor 1 (HNF1) from muscle; Dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1); Dimerization cofactor of hepatocyte nuclear factor 1 from muscle; EC 4.2.1.96; HNF-1-alpha dimerization cofactor; HNF1 alpha dimerization cofactor; OTTHUMP00000223129; OTTHUMP00000223130; PHS 2; PHS2; PHS2_HUMAN; Pterin 4 alpha carbinolamine dehydratase 2; Pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2; pterin-4 alpha-carbinolamine dehydratase 2; 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2;
SIGMAR1
sigma non-opioid intracellular receptor 1
SIGMAR1; sigma non-opioid intracellular receptor 1; opioid receptor, sigma 1 , OPRS1; SR BP1; SR-BP; SIG-1R; sigma1R; hSigmaR1; SR31747 binding protein 1; sigma 1-type opioid receptor; aging-associated gene 8 protein; SRBP; ALS16; OPRS1; SR-BP1; MGC3851;
PELI3
pellino homolog 3 (Drosophila)
PELI3; pellino homolog 3 (Drosophila); E3 ubiquitin-protein ligase pellino homolog 3; MGC35521; E3 ubiquitin protein ligase pellino homolog 3; PEL 13; PELI3_HUMAN; Pellino 3; Pellino 3 alpha; Pellino-3; Protein pellino homolog 3;
PELI2
pellino homolog 2 (Drosophila)
PELI2; pellino homolog 2 (Drosophila); pellino (Drosophila) homolog 2; E3 ubiquitin-protein ligase pellino homolog 2; Pellino homolog 2; pellino-2; protein pellino homolog 2;
PLEKHA1
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
PLEKHA1; pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1; pleckstrin homology domain-containing family A member 1; tandem PH domain containing protein 1; TAPP1; OTTHUMP00000020651; PH domain containing family A member 1; Pleckstrin homology domain containing family A member 1; Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member; TAPP 1; OTTHUMP00000020650; OTTHUMP00000206097; tandem PH domain-containing protein 1;
PLEKHA4
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4
PLEKHA4; pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4; pleckstrin homology domain-containing family A member 4; PEPP1; 2410005C22Rik; C88169; MGC72599; Phosphoinositol 3 phosphate binding protein 1; Pleckstrin homology domain containing family A member 4; PEPP-1; PH domain-containing family A member 4; phosphoinositol 3-phosphate binding protein-1; phosphoinositol 3-phosphate-binding protein 1; phosphoinositol 3-phosphate-binding PH domain protein 1;
PIGK
phosphatidylinositol glycan anchor biosynthesis, class K
PIGK; phosphatidylinositol glycan anchor biosynthesis, class K; phosphatidylinositol glycan, class K; GPI-anchor transamidase; GPI transamidase subunit; GPI8; hGPI8; PIG-K; GPI8 homolog; phosphatidylinositol-glycan biosynthesis class K protein; MGC22559;
PIGN
phosphatidylinositol glycan anchor biosynthesis, class N
PIGN; phosphatidylinositol glycan anchor biosynthesis, class N; phosphatidylinositol glycan, class N; GPI ethanolamine phosphate transferase 1; MDC4; PIG N; MCD4 homolog; phosphatidylinositol-glycan biosynthesis class N protein; MCD4; MCAHS; PIG-N; MCAHS1;
PVRIG
poliovirus receptor related immunoglobulin domain containing
PVRIG; poliovirus receptor related immunoglobulin domain containing; transmembrane protein PVRIG; C7orf15; MGC2463; Poliovirus receptor-related immunoglobulin domain-containing protein; PVRIG_HUMAN;
PITPNC1
phosphatidylinositol transfer protein, cytoplasmic 1
PITPNC1; phosphatidylinositol transfer protein, cytoplasmic 1; cytoplasmic phosphatidylinositol transfer protein 1; RDGB BETA; RDGBB; RDGBB1; M rdgB beta; M-rdgB beta; Mammalian rdgB homolog beta; MrdgBbeta; Phosphatidylinositol transfer protein cytoplasmic 1; PITC1_HUMAN; RdgBbeta; Retinal degeneration B beta 1; Retinal degeneration B homolog beta; RDGB-BETA;
PITPNM2
phosphatidylinositol transfer protein, membrane-associated 2
PITPNM2; phosphatidylinositol transfer protein, membrane-associated 2; membrane-associated phosphatidylinositol transfer protein 2; NIR3; RDGB2; RDGBA2; PITPnm 2; retinal degeneration B alpha 2; PYK2 N-terminal domain-interacting receptor 3; NIR-3; KIAA14;
PLCXD1
phosphatidylinositol-specific phospholipase C, X domain containing 1
PLCXD1; phosphatidylinositol-specific phospholipase C, X domain containing 1; PI-PLC X domain-containing protein 1; FLJ11323; Phosphatidylinositol specific phospholipase C X domain containing 1; Phosphatidylinositol specific phospholipase C X domain containing protein 1; PI PLC X domain containing protein 1; PLCX1_HUMAN; LL0XNC01-136G2.1;
PIGA
phosphatidylinositol glycan anchor biosynthesis, class A
PIGA; phosphatidylinositol glycan anchor biosynthesis, class A; GPI3; PIG-A; MCAHS2; phosphatidylinositol N-acetylglucosaminyltransferase subunit A; GPI anchor biosynthesis; GLCNAC-PI synthesis protein; class A GlcNAc-inositol phospholipid assembly protein; phosphatidylinositol-glycan biosynthesis, class A protein;
PRKAG3
protein kinase, AMP-activated, gamma 3 non-catalytic subunit
PRKAG3; protein kinase, AMP-activated, gamma 3 non-catalytic subunit; 5-AMP-activated protein kinase subunit gamma-3; AMPK gamma3; AMPK gamma-3 chain; AMPK subunit gamma-3; 5-AMP-activated protein kinase, gamma-3 subunit; AMPKG3;
RDH5
retinol dehydrogenase 5 (11-cis/9-cis)
RDH5; retinol dehydrogenase 5 (11-cis/9-cis); RDH1, retinol dehydrogenase 5 (11 cis and 9 cis); 11-cis retinol dehydrogenase; HSD17B9; SDR9C5; short chain dehydrogenase/reductase family 9C; member 5; 11 cis RDH; 11 cis retinol dehydrogenase; 9 cis retinol specific dehydrogenase; FLJ39337; FLJ97089; RDH 5; RDH1; Retinol dehydrogenase 1; Retinol dehydrogenase 5 (11 cis/9 cis); Retinol dehydrogenase 5; Short chain dehydrogenase/reductase family 9C member 5; 11-cis RDH; OTTHUMP00000242975; OTTHUMP00000242976; OTTHUMP00000242988; 9-cis-retinol specific dehydrogenase; retinol dehydrogenase 5 (11-cis and 9-cis); short chain dehydrogenase/reductase family 9C, member 5;
PPA2
pyrophosphatase (inorganic) 2
PPA2; pyrophosphatase (inorganic) 2; inorganic pyrophosphatase 2, mitochondrial; FLJ20459; HSPC124; PPase2; Pyrophosphatase SID6 306; PPase 2; OTTHUMP00000158985; OTTHUMP00000158986; OTTHUMP00000218513; OTTHUMP00000218514; pyrophosphatase SID6-306; pyrophosphate phospho-hydrolase 2; SID6-306;
PHYHD1
phytanoyl-CoA dioxygenase domain containing 1
PHYHD1; phytanoyl-CoA dioxygenase domain containing 1; phytanoyl-CoA dioxygenase domain-containing protein 1; MGC16638; OTTHUMP00000022302; OTTHUMP00000022303; OTTHUMP00000022304; OTTHUMP00000022305; OTTHUMP00000199642; PHYD 1; PHYD1_HUMAN; Phytanoyl CoA dioxygenase domain containing protein 1;
PHYHIPL
phytanoyl-CoA 2-hydroxylase interacting protein-like
PHYHIPL; phytanoyl-CoA 2-hydroxylase interacting protein-like; phytanoyl CoA hydroxylase interacting protein like; phytanoyl-CoA hydroxylase-interacting protein-like; Em:AC025038.1; KIAA1796;
PIGX
phosphatidylinositol glycan anchor biosynthesis, class X
PIGX; phosphatidylinositol glycan anchor biosynthesis, class X; phosphatidylinositol glycan, class X; phosphatidylinositol-glycan biosynthesis class X protein; FLJ20522; PIG-X; GPI-mannosyltransferase subunit;
PIGY
phosphatidylinositol glycan anchor biosynthesis, class Y
PIGY; phosphatidylinositol glycan anchor biosynthesis, class Y; phosphatidylinositol glycan, class Y; protein preY, mitochondrial; MGC14156; phosphatidylinositol-glycan biosynthesis class Y protein; phosphatidylinositol N-acetylglucosaminyltransferase sub;
PIK3IP1
phosphoinositide-3-kinase interacting protein 1
PIK3IP1; phosphoinositide-3-kinase interacting protein 1; phosphoinositide-3-kinase-interacting protein 1; HGFL; MGC17330; kringle domain-containing protein HGFL; hHGFL(S);
PILRB
paired immunoglobin-like type 2 receptor beta
PILRB; paired immunoglobin-like type 2 receptor beta; paired immunoglobulin-like type 2 receptor beta; FDFACT1; FDFACT2; activating receptor PILRbeta; cell surface receptor FDFACT; activating receptor PILR-beta; cell surface receptor FDFACT1; cell surface;
PIP5K1B
phosphatidylinositol-4-phosphate 5-kinase, type I, beta
PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase, type I, beta; phosphatidylinositol 4-phosphate 5-kinase type-1 beta; MSS4; STM7; PIP5KIbeta; PIP5K1-beta; protein STM-7; ptdIns(4)P-5-kinase 1 beta; phosphatidylinositol 4-phosphate 5-kinase type I beta;
PTPN20B
protein tyrosine phosphatase, non-receptor type 20B
PTPN20B; protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20; bA42B19.1; DKFZP566K0524; PTP Typ;
PTPN3
protein tyrosine phosphatase, non-receptor type 3
PTPN3; protein tyrosine phosphatase, non-receptor type 3; tyrosine-protein phosphatase non-receptor type 3; PTPH1; protein-tyrosine phosphatase H1; cytoskeletal-associated protein tyrosine phosphatase; PTP-H1; DKFZp686N0569;
RNASE11
ribonuclease, RNase A family, 11 (non-active)
RNASE11; ribonuclease, RNase A family, 11 (non-active); C14orf6, chromosome 14 open reading frame 6; probable ribonuclease 11; C14orf6; RNase 11; ribonuclease 11;
RNASE9
ribonuclease, RNase A family, 9 (non-active)
RNASE9; ribonuclease, RNase A family, 9 (non-active); inactive ribonuclease-like protein 9; h461; ribonuclease 9; ribonuclear enzyme; ribonuclease-like protein 9; HEL128;
PNO1
partner of NOB1 homolog (S. cerevisiae)
PNO1; partner of NOB1 homolog (S. cerevisiae); KH type RNA binding protein 1 , KH type RNA binding protein 1 , KHRBP1; RNA-binding protein PNO1; RNA binding protein; RRP20; KH type RNA binding protein 1; KHRBP 1; KHRBP1; Partner of NOB1; Partner of NOB1 homolog; PNO 1; PNO1_HUMAN; RNA binding protein PNO1; KH-type RNA-binding protein 1;
PF08_0023
conserved Plasmodium protein PF08_0023, unknown function
PF08_0023; conserved Plasmodium protein, unknown function; Hypothetical protein 14; Putative uncharacterized protein;
PRAME
preferentially expressed antigen in melanoma
PRAME; preferentially expressed antigen in melanoma; MAPE; melanoma antigen preferentially expressed in tumors; cancer/testis antigen 130; CT130; 4930534P07Rik; OIP 4; OIP-4; OIP4; OPA interacting protein 4; Opa interacting protein OIP4; OPA-interacting protein 4; PRAME_HUMAN; Preferentially expressed antigen of melanoma; RP23-250F8.3; Opa-interacting protein OIP4;
PREX1
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
PREX1; phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1; phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein; KIAA1415; P REX1; ptdIns(3,4,5)-dependent Rac exchanger 1; P-REX1;
SSX5
synovial sarcoma, X breakpoint 5
SSX5; synovial sarcoma, X breakpoint 5; protein SSX5; SSX5_HUMAN;
SPDYE3
speedy homolog E3 (Xenopus laevis)
SPDYE3; speedy homolog E3 (Xenopus laevis); speedy protein E3; MGC119294; MGC57359; Putative Speedy protein E3; Putative WBSCR19 like protein 7; SPDE3_HUMAN; Speedy homolog E3; Putative WBSCR19-like protein 7;
SPDYE4
speedy homolog E4 (Xenopus laevis)
SPDYE4; speedy homolog E4 (Xenopus laevis); speedy protein E4; Speedy homolog E4; putative Speedy protein E4;
SPDYE5
speedy homolog E5 (Xenopus laevis)
SPDYE5; speedy homolog E5 (Xenopus laevis); putative speedy protein E5; SPDE5_HUMAN;
RPN12a
26S proteasome non-ATPase regulatory subunit RPN12A
RPN12a; 26S proteasome non-ATPase regulatory subunit RPN12A; 26S proteasome non ATPase regulatory subunit RPN12A; AT1G64520; F1N19.9; F1N19_9; Regulatory Particle non ATPase 12a; regulatory particle non-ATPase 12A (RPN12a); FUNCTIONS IN: peptidase activity; INVOLVED IN: in 14 processes; LOCATED IN: proteasome complex, nucleus, proteasome regulatory particle, lid subcomplex, chloroplast envelope; EXPRESSED IN: 23 plant structures; EXPRESSED DURING: 15 growth stages; CONTAINS InterPro DOMAIN/s: 26S proteasome non-ATPase regulatory subunit Rpn12 (InterPro:IPR006746), SAC3/GANP/Nin1/mts3/eIF-3 p25 (InterPro:IPR005062); BEST Arabidopsis thaliana protein match is: regulatory particle non-ATPase 12B (TAIR:AT5G42040.1); Has 474 Blast hits to 474 proteins in 207 species: Archae - 0; Bacteria - 0; Metazoa - 195; Fungi - 129; Plants - 70; Viruses - 0; Other Eukaryotes - 80 (source: NCBI BLink).; regulatory particle non-ATPase 12A;
RSAD1
radical S-adenosyl methionine domain containing 1
RSAD1; radical S-adenosyl methionine domain containing 1; radical S-adenosyl methionine domain-containing protein 1, mitochondrial; FLJ11164; oxygen-independent coproporphyrinogen-III oxidase-like protein RSAD1; FLJ20975;
PNKD
paroxysmal nonkinesigenic dyskinesia
PNKD; paroxysmal nonkinesigenic dyskinesia; paroxysmal nonkinesiogenic dyskinesia; probable hydrolase PNKD; BRP17; DKFZp564N1362; DYT8; FKSG19; FPD1; KIAA1184; KIPP1184; MGC31943; MR 1; myofibrillogenesis regulator 1; PDC; PKND1; TAHCCP2; brain protein 17; trans-activated by hepatitis C virus core protein 2; MR1; MR-1;
rec-8
abnormal RECombination
rec-8; abnormal RECombination; abnormal RECombination family member (rec-8); rec 8;
SSX2IP
synovial sarcoma, X breakpoint 2 interacting protein
SSX2IP; synovial sarcoma, X breakpoint 2 interacting protein; afadin- and alpha-actinin-binding protein; SSX2-interacting protein; afadin DIL domain-interacting protein; ADIP; FLJ10848; KIAA0923; MGC75026;
AHCYL2
adenosylhomocysteinase-like 2
AHCYL2; adenosylhomocysteinase-like 2; S adenosylhomocysteine hydrolase like 2; putative adenosylhomocysteinase 3; KIAA0828; FLJ21719; Adenosylhomocysteinase 3; Adenosylhomocysteinase3; AdoHcyase 3; AdoHcyase; AdoHcyase3; AHC; Hypothetical protein FLJ27233; S adenosyl L homocysteine hydrolase 3; S adenosyl L homycysteine hydrolase; S-adenosyl-L-homocysteine hydrolase 3; S-adenosylhomocysteine hydrolase-like protein 2; SAH 3; SAHH3_HUMAN; S-adenosylhomocysteine hydrolase-like 2;
PSMD13
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13
PSMD13; proteasome (prosome, macropain) 26S subunit, non-ATPase, 13; 26S proteasome non-ATPase regulatory subunit 13; p40.5; Rpn9; 26S proteasome non ATPase regulatory subunit 13; 26S proteasome regulatory subunit S11; S11; 26S proteasome subunit p40.5; 26S proteasome regulatory subunit RPN9; 26S proteasome regulatory subunit p40.5; HSPC027;
PTPN21
protein tyrosine phosphatase, non-receptor type 21
PTPN21; protein tyrosine phosphatase, non-receptor type 21; PTPD1; PTPRL10; tyrosine-protein phosphatase non-receptor type 21; protein tyrosine phosphatase D1; protein-tyrosine phosphatase D1; dJ1175B15.2 (protein tyrosine phosphatase, non-receptor type 21);
RAB3GAP2
RAB3 GTPase activating protein subunit 2 (non-catalytic)
RAB3GAP2; RAB3 GTPase activating protein subunit 2 (non-catalytic); rab3 GTPase-activating protein non-catalytic subunit; DKFZP434D245; KIAA0839; RAB3 GAP150; RGAP-iso; rab3-GAP p150; rab3-GAP regulatory subunit; rab3 GTPase-activating protein 150 kDa sub;
ADARB2
adenosine deaminase, RNA-specific, B2
ADARB2; adenosine deaminase, RNA-specific, B2; adenosine deaminase, RNA specific, B2 (RED2 homolog rat); double-stranded RNA-specific editase B2; ADAR3; hRED2; RED2; RED2 homolog (rat); RED2 homolog; homolog of rat BLUE; RNA-editing enzyme 2; RNA-editing;
RNPEPL1
arginyl aminopeptidase (aminopeptidase B)-like 1
RNPEPL1; arginyl aminopeptidase (aminopeptidase B)-like 1; arginyl aminopeptidase-like 1; Argininyl aminopeptidase like 1; Arginyl aminopeptidase (aminopeptidase B) like 1; Arginyl aminopeptidase like 1; FLJ10806; FLJ26675; MGC99544; RNPEP like 1; RNPEP-like 1; RNPL1_HUMAN; argininyl aminopeptidase-like 1;
RDH16
retinol dehydrogenase 16 (all-trans)
RDH16; retinol dehydrogenase 16 (all-trans); retinol dehydrogenase 16 (all trans and 13 cis); retinol dehydrogenase 16; microsomal NAD+ dependent retinol dehydrogenase 4; RODH 4; SDR9C8; short chain dehydrogenase/reductase family 9C; member 8; sterol/reti;
RETSAT
retinol saturase (all-trans-retinol 13,14-reductase)
RETSAT; retinol saturase (all-trans-retinol 13,14-reductase); all-trans-retinol 13,14-reductase; FLJ20296; all trans 13,14 dihydroretinol saturase; All trans retinol 13,14 reductase; all-trans-13,14-dihydroretinol saturase; PPAR-alpha-regulated and starvation-induced gene protein;
SLC6A15
solute carrier family 6 (neutral amino acid transporter), member 15
SLC6A15; solute carrier family 6 (neutral amino acid transporter), member 15; solute carrier family 6 (neurotransmitter transporter), member 15; sodium-dependent neutral amino acid transporter B(0)AT2; FLJ10316; homolog of rat orphan transporter v7 3; hv7;
SLC7A13
solute carrier family 7 (anionic amino acid transporter), member 13
SLC7A13; solute carrier family 7 (anionic amino acid transporter), member 13; solute carrier family 7 member 13; AGT 1; XAT2; AGT-1; AGT1; S7A13_HUMAN; Sodium-independent aspartate/glutamate transporter 1; Solute carrier family 7, (cationic amino acid transporter, y+ system) member 13; X-amino acid transporter 2; amino acid transporter XAT2;
SLC7A2
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
SLC7A2; solute carrier family 7 (cationic amino acid transporter, y+ system), member 2; ATRC2; low affinity cationic amino acid transporter 2; CAT 2; HCAT2; CAT2;
SEMA3E
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
SEMA3E; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E; SEMAH; semaphorin-3E; coll 5; KIAA0331; M sema H; M SemaK; coll-5; M-SEMAH; M-SemaK;
SEMA3F
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
SEMA3F; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F; SEMA4; SEMAK; SEMA-IV; semaphorin-3F; sema IV; sema III/F; semaphorin IV; semaphorin III/F; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, 3F;
SLC16A11
solute carrier family 16, member 11 (monocarboxylic acid transporter 11)
SLC16A11; solute carrier family 16, member 11 (monocarboxylic acid transporter 11); solute carrier family 16 (monocarboxylic acid transporters), member 11; monocarboxylate transporter 11; FLJ90193; MCT11; MCT 11; MOT11_HUMAN; Solute carrier family 16 member 11 (monocarboxylic acid transporter 11); Solute carrier family 16 member 11; OTTHUMP00000128280;
SLC16A12
solute carrier family 16, member 12 (monocarboxylic acid transporter 12)
SLC16A12; solute carrier family 16, member 12 (monocarboxylic acid transporter 12); solute carrier family 16 (monocarboxylic acid transporters), member 12; monocarboxylate transporter 12; MCT12; CJMG; DKFZp686E188;
SLC16A9
solute carrier family 16, member 9 (monocarboxylic acid transporter 9)
SLC16A9; solute carrier family 16, member 9 (monocarboxylic acid transporter 9); C10orf36, chromosome 10 open reading frame 36 , solute carrier family 16 (monocarboxylic acid transporters), member 9; monocarboxylate transporter 9; FLJ43803; MCT9; C10orf36; MCT 9; Monocarboxylic acid transporter 9; MOT9_HUMAN; Solute carrier family 16 (monocarboxylic acid transporters) member 9; Solute carrier family 16 member 9; solute carrier family 16 (monocarboxylic acid transporters), member 9;
RYR3
ryanodine receptor 3
RYR3; ryanodine receptor 3; Brain ryanodine receptor calcium release channel; Brain ryanodine receptor-calcium release channel; Brain type ryanodine receptor; Brain-type ryanodine receptor; HBRR; RYR 3; RYR-3; RYR3_HUMAN;
SPTBN5
spectrin, beta, non-erythrocytic 5
SPTBN5; spectrin, beta, non-erythrocytic 5; spectrin beta chain, brain 4; beta V spectrin; BSPECV; HUBSPECV; HUSPECV; brain 4; non-erythroid beta chain 4; Beta-V spectrin; Spectrin; Spectrin beta chain; Spectrin, non-erythroid beta chain 4; SPTBN4; SPTN5_HUMAN;
SEPN1
selenoprotein N, 1
SEPN1; selenoprotein N, 1; MDRS1, rigid spine muscular dystrophy 1 , RSMD1; selenoprotein N; RSS; selN; SELN_HUMAN; MDRS1; RSMD1;
SQRDL
sulfide quinone reductase-like (yeast)
SQRDL; sulfide quinone reductase-like (yeast); sulfide:quinone oxidoreductase, mitochondrial; CGI 44; CGI44; mitochondrial; SQRD_HUMAN; Sulfide dehydrogenase like; Sulfide quinone reductase like; Sulfide:quinone oxidoreductase; CGI-44;
HM13
histocompatibility (minor) 13
HM13; histocompatibility (minor) 13; minor histocompatibility antigen H13; dJ324O17.1; H13; IMP1; IMPAS; intramembrane protease; presenilin like protein 3; PSENL3; PSL3; signal peptide peptidase beta; signal peptide peptidase like 1; SPP; SPPL1; IMP-1; hI;
SELS
selenoprotein S
SELS; selenoprotein S; VCP-interacting membrane protein; VIMP; ADO15; SBBI8; SEPS1; AD-015;
SEMA3G
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
SEMA3G; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G; semaphorin-3G; FLJ00014; sem2; MGC119473; Sema domain immunoglobulin domain (Ig) short basic domain secreted (semaphorin) 3G; Semaphorin 3G; Semaphorin sem2;
SEMA3B
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
SEMA3B; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B; SemA; SEMA5; SEMAA; semaV; LUCA-1; semaphorin-3B; sema A(V); semaphorin A; semaphorin-V;
SEMA3D
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
SEMA3D; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D; coll-2; Sema-Z2; semaphorin-3D; collapsin 2;
SART1
squamous cell carcinoma antigen recognized
SART1; squamous cell carcinoma antigen recognized; squamous cell carcinoma antigen recognised by T cells; U4/U6.U5 tri-snRNP-associated protein 1; Ara1; small nuclear ribonucleoprotein 110kDa (U4/U6.U5); SNRNP110; Snu66; Ara 1; HOMS 1; HOMS1; hSART 1; hSART1; hSnu 66; hSnu66; IgE autoantigen; SART 1; SART1 259; SART1(259) protein; SART1(800) protein; SART1259; Snu 66; Squamous cell carcinoma antigen recognized by T cells 1; U4/U6.U5 tri snRNP associated 110 kDa protein; U4/U6.U5 tri snRNP associated protein 1; SART-1; hSART-1; SNU66 homolog; U4/U6.U5 tri-snRNP-associated 110 kDa protein;
SART3
squamous cell carcinoma antigen recognized
SART3; squamous cell carcinoma antigen recognized; squamous cell carcinoma antigen recognised by T cells 3; squamous cell carcinoma antigen recognized by T-cells 3; KIAA0156; RP11 13G14; hSART 3; p110(nrb); RP11-13G14; Tat interacting protein of 110 kDa; TIP110; SART-3; hSART-3; tat-interacting protein of 110 kDa; P100; p110; DSAP1;
SCHIP1
schwannomin interacting protein 1
SCHIP1; schwannomin interacting protein 1; schwannomin-interacting protein 1; SCHIP 1; schwannomin interacting protein 1 variant 1; schwannomin interacting protein 1 variant 2; FLJ39160; SCHIP-1;
SCNN1B
sodium channel, non-voltage-gated 1, beta subunit
SCNN1B; sodium channel, non-voltage-gated 1, beta subunit; BESC1; ENaCb; SCNEB; ENaCbeta; amiloride-sensitive sodium channel subunit beta; beta-ENaC; beta-NaCH; epithelial Na(+) channel subunit beta; epithelial sodium channel beta-2 subunit; epithelial sodium channel beta-3 subunit; sodium channel, nonvoltage-gated 1, beta; nasal epithelial sodium channel beta subunit; nonvoltage-gated sodium channel 1 subunit beta; amiloride-sensitive sodium channel subunit beta 1;
SLC1A4
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4
SLC1A4; solute carrier family 1 (glutamate/neutral amino acid transporter), member 4; neutral amino acid transporter A; solute carrier family 1 member 4; alanine/serine/cysteine/threonine transporter 1; SATT; ASCT1; ASCT-1; AW045657;
SLC1A5
solute carrier family 1 (neutral amino acid transporter), member 5
SLC1A5; solute carrier family 1 (neutral amino acid transporter), member 5; R16; AAAT; ATBO; M7V1; RDRC; ASCT2; M7VS1; neutral amino acid transporter B(0); ATB(0); RD114 virus receptor; baboon M7 virus receptor; neutral amino acid transporter B; solute carrier family 1 member 5; RD114/simian type D retrovirus receptor; sodium-dependent neutral amino acid transporter type 2;
SEMG1
semenogelin I
SEMG1; semenogelin I; SEMG; semenogelin-1; cancer/testis antigen 103; CT103; semen coagulating protein; SGI; dJ172H20.2; FLJ78262; MGC14719;
SHISA2
shisa homolog 2 (Xenopus laevis)
SHISA2; shisa homolog 2 (Xenopus laevis); C13orf13, chromosome 13 open reading frame 13 , TMEM46, transmembrane protein 46; protein shisa-2 homolog; bA398O19.2; hShisa; PRO28631; WGAR9166; SHSA2_HUMAN; Transmembrane protein 46; OTTHUMP00000018153; TMEM46; C13orf13;
SHISA3
shisa homolog 3 (Xenopus laevis)
SHISA3; shisa homolog 3 (Xenopus laevis); protein shisa-3 homolog; hShisa3; shisa homolog 3; SHSA3_HUMAN;
SHISA6
shisa homolog 6 (Xenopus laevis)
SHISA6; shisa homolog 6 (Xenopus laevis); protein shisa-6 homolog; FLJ45455; SHSA6_HUMAN;
SHISA9
shisa homolog 9 (Xenopus laevis)
SHISA9; shisa homolog 9 (Xenopus laevis); protein shisa-9; 2700045P11Rik; CKAMP44; Cystine knot AMPAR modulating protein; DKFZp686D24206; DKFZp686E24206; FLJ10015; FLJ37653; FLJ58277; FLJ99079; FLJ99234; Shisa homolog 9; SHSA9_HUMAN; cystine-knot AMPAR modulating protein;
SLC36A1
solute carrier family 36 (proton/amino acid symporter), member 1
SLC36A1; solute carrier family 36 (proton/amino acid symporter), member 1; proton-coupled amino acid transporter 1; LYAAT 1; PAT1; TRAMD3; hPAT1; proton/amino acid transporter 1; solute carrier family 36 member 1; lysosomal amino acid transporter 1; Dct1;
SLC36A3
solute carrier family 36 (proton/amino acid symporter), member 3
SLC36A3; solute carrier family 36 (proton/amino acid symporter), member 3; proton-coupled amino acid transporter 3; PAT3; TRAMD2; tramdorin2; FLJ16658; MGC119638; MGC119639; MGC119641; PAT 3; Proton/amino acid transporter 3; Solute carrier family 36 (proton/amino acid symporter) member 3; Solute carrier family 36 member 3; TRAMD 2; Tramdorin 2; tramdorin-2; solute carrier family 36, member 3;
CNPY3
canopy 3 homolog (zebrafish)
CNPY3; canopy 3 homolog (zebrafish); TNRC5, trinucleotide repeat containing 5; protein canopy homolog 3; CAG4A; CAG repeat containing; CTG repeat protein 4a; protein associated with TLR4; expanded repeat domain, CAG/CTG 5; trinucleotide repeat containing;
SLC6A14
solute carrier family 6 (amino acid transporter), member 14
SLC6A14; solute carrier family 6 (amino acid transporter), member 14; solute carrier family 6 (neurotransmitter transporter), member 14; sodium- and chloride-dependent neutral and basic amino acid transporter B(0+); amino acid transporter B0+; amino acid;
SLC7A6
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6
SLC7A6; solute carrier family 7 (amino acid transporter light chain, y+L system), member 6; Y+L amino acid transporter 2; KIAA0245; LAT 2; LAT3; y+LAT 2; DKFZp686K15246; AI643885; Cationic amino acid transporter y+ system; Solute carrier family 7 (cationic amino acid transporter y+ system) member 6; Solute carrier family 7 member 6; y(+)L type amino acid transporter 2; Y+LAT2; amino acid permease; y(+)L-type amino acid transporter 2; cationic amino acid transporter, y+ system; solute carrier family 7 (cationic amino acid transporter, y+ system), member 6; LAT-2; y+LAT-2;
SSX4B
synovial sarcoma, X breakpoint 4B
SSX4B; synovial sarcoma, X breakpoint 4B; protein SSX4; OTTHUMT00000056510; Cancer/testis antigen 5.4; CT5.4; MGC119056; MGC12411; MGC169015; MGC169016; SSX4; SSX4A; Synovial sarcoma X breakpoint 4; Synovial sarcoma X breakpoint 4B;
SMG5
SMG5 nonsense mediated mRNA decay factor
SMG5; SMG5 nonsense mediated mRNA decay factor; EST1B; SMG-5; LPTSRP1; LPTS-RP1; protein SMG5; hSMG-5; RP11-54H19.7; EST1-like protein B; Est1p-like protein B; LPTS interacting protein; LPTS-interacting protein; ever shorter telomeres 1B; EST1 telomerase component homolog B; smg-5 homolog, nonsense mediated mRNA decay factor;
SMG7
SMG7 nonsense mediated mRNA decay factor
SMG7; SMG7 nonsense mediated mRNA decay factor; EST1C; SGA56M; C1orf16; protein SMG7; EST1-like protein C; ever shorter telomeres 1C; EST1 telomerase component homolog C; breast cancer-associated antigen SGA-56M; smg-7 homolog, nonsense mediated mRNA decay factor;
IGHMBP2
immunoglobulin mu binding protein 2
IGHMBP2; immunoglobulin mu binding protein 2; DNA-binding protein SMUBP-2; cardiac transcription factor 1; CATF1; HCSA; HMN6; SMARD1; SMUBP2; GF-1; glial factor 1; ATP-dependent helicase IGHMBP2; immunoglobulin mu-binding protein 2; FLJ34220; FLJ41171;
SS18L2
synovial sarcoma translocation gene on chromosome 18-like 2
SS18L2; synovial sarcoma translocation gene on chromosome 18-like 2; SS18-like protein 2; KIAA iso; SYT homolog 2; SS18 like protein 2; Synovial sarcoma translocation gene on chromosome 18 like 2; KIAA-iso;
TNMD
tenomodulin
TNMD; tenomodulin; BRICD4; ChM1L; myodulin; TEM; tendin; hTeM; hChM1L; chondromodulin-IB; BRICHOS domain containing 4; chondromodulin-1-like protein; chondromodulin-I-like protein;
ADAD1
adenosine deaminase domain containing 1 (testis-specific)
ADAD1; adenosine deaminase domain containing 1 (testis-specific); adenosine deaminase domain-containing protein 1; Tenr; DN 144H19.1; Adenosine deaminase domain containing 1 (testis specific); FLJ32741; MGC124895; MGC94331; Testis nuclear RNA binding protein; testis nuclear RNA-binding protein;
SS18L1
synovial sarcoma translocation gene on chromosome 18-like 1
SS18L1; synovial sarcoma translocation gene on chromosome 18-like 1; calcium-responsive transactivator; KIAA0693; SS18; SS18-like protein 1; SSXT; synovial sarcoma translocation; SYT homolog 1; CREST; LP2261;
ANO2
anoctamin 2
ANO2; anoctamin 2; C12orf3, chromosome 12 open reading frame 3 , TMEM16B, transmembrane protein 16B; anoctamin-2; transmembrane protein 16B (eight membrane spanning domains); transmembrane protein 16B (eight membrane-spanning domains); C12orf3; TMEM16B;
AGMO
alkylglycerol monooxygenase
AGMO; alkylglycerol monooxygenase; TMEM195, transmembrane protein 195; FLJ16237; Transmembrane protein 195; TMEM195;
UGT2B15
UDP glucuronosyltransferase 2 family, polypeptide B15
UGT2B15; UDP glucuronosyltransferase 2 family, polypeptide B15; UDP glycosyltransferase 2 family, polypeptide B15; UDP-glucuronosyltransferase 2B15; UGT2B8; EC 2.4.1.17; HLUG4; UDP glucuronosyltransferase 2 family polypeptide B15; UDP glucuronosyltransferase 2 family, member B15; UDP glucuronosyltransferase 2 family, member B8; UDP glucuronosyltransferase 2B15; UDP glucuronosyltransferase UGT2B15; UDP glucuronyltransferase family 2 beta 15; UDP glycosyltransferase 2 family, member B15; UDP glycosyltransferase 2B15; UDPGT 2B15; UDPGT2B15; UDPGTh 3; UDPGTH3; Uridine diphosphate glucuronosyltransferase 2 family, member B8; Uridine diphosphate glycosyltransferase 2 family, member B15; UDPGTh-3; UDP-glucuronosyltransferase 2B8; UDP-glucuronosyltransferase UGT2B15; UDP-glucuronyltransferase, family 2, beta-15; UDPGT 2B8;
UGT2B17
UDP glucuronosyltransferase 2 family, polypeptide B17
UGT2B17; UDP glucuronosyltransferase 2 family, polypeptide B17; UDP glycosyltransferase 2 family, polypeptide B17; UDP-glucuronosyltransferase 2B17; C19 steroid specific UDP glucuronosyltransferase; C19 steroid specific UDPGT; UDB17; UDP glucuronosyltransferase 2B17; UDPGT 2B17; C19-steroid-specific UDPGT; UDP glycosyltransferase 2 family, member B17; UDP-glucuronyltransferase, family 2, beta-17; C19-steroid-specific UDP-glucuronosyltransferase; UDPGT2B17;
UGT2B7
UDP glucuronosyltransferase 2 family, polypeptide B7
UGT2B7; UDP glucuronosyltransferase 2 family, polypeptide B7; UDP glycosyltransferase 2 family, polypeptide B7; UDP-glucuronosyltransferase 2B7; UGT2B9; 3 4 catechol estrogen specific; UDP glucuronosyltransferase 2 family polypeptide B7; UDP glucuronosyltransferase 2B7; UDP glucuronyltransferase family 2 beta 7; UDP glycosyltransferase 2 family polypeptide B7; UDPGT; UDPGTh 2; UDPGTh2; UGTB2B9; UDPGTh-2; UDPGT 2B7; 3,4-catechol estrogen specific; UDP-glucuronosyltransferase 2B9; 3,4-catechol estrogen-specific UDPGT; UDP-glucuronyltransferase, family 2, beta-7; UDPGT2B7; UDPGT 2B9;
UGT1A4
UDP glucuronosyltransferase 1 family, polypeptide A4
UGT1A4; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glycosyltransferase 1 family, polypeptide A4; UDP-glucuronosyltransferase 1-4; HUG BR2; UGT1D; Bilirubin UDP glucuronosyltransferase isozyme 2; Bilirubin-specific UDPGT isozyme 2; HUG-BR2; UD14_HUMAN; UDP glucuronosyltransferase 1 family polypeptide A4; UDP glycosyltransferase 1 family polypeptide A4; UDP-glucuronosyltransferase 1-D; UDP-glucuronosyltransferase 1A4; UDPGT 1-4; UDPGT; UGT-1D; UGT1*4; UGT1-04; UGT1.4; bilirubin UDP-glucuronosyltransferase isozyme 2;
UGT1A5
UDP glucuronosyltransferase 1 family, polypeptide A5
UGT1A5; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glycosyltransferase 1 family, polypeptide A5; UDP-glucuronosyltransferase 1-5; UGT1E; Ugt1; B5; UD15_HUMAN; UDP glucuronosyltransferase 1 family polypeptide A5s; UDP glycosyltransferase 1 family polypeptide A5; UDP-glucuronosyltransferase 1-E; UDP-glucuronosyltransferase 1A5; UDPGT 1-5; UDPGT; UGT-1E; UGT1*5; UGT1-05; UGT1.5; Ugt1a6; UDP-glucuronosyltransferase 1 family polypeptide A5s;
TRPS1
trichorhinophalangeal syndrome I
TRPS1; trichorhinophalangeal syndrome I; zinc finger transcription factor Trps1; LGCR; zinc finger protein GC79; tricho-rhino-phalangeal syndrome type I protein; GC79; MGC134928;
UQCRC1
ubiquinol-cytochrome c reductase core protein I
UQCRC1; ubiquinol-cytochrome c reductase core protein I; cytochrome b-c1 complex subunit 1, mitochondrial; D3S3191; QCR1; UQCR1; mitochondrial; Complex III subunit 1; Core protein I; Cytochrome b c1 complex subunit 1, mitochondrial; Cytochrome b-c1 complex subunit 1; OTTHUMP00000164820; QCR1_HUMAN; Ubiquinol cytochrome c reductase core protein I; Ubiquinol-cytochrome-c reductase complex core protein 1;
SLC18A3
Slc18a3 solute carrier family 18 (vesicular monoamine), member 3
SLC18A3; solute carrier family 18 (vesicular monoamine), member 3; vesicular acetylcholine transporter; solute carrier family 18 member 3; VAT; VAChT;
TRMU
tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase
TRMU; tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase; TRMT, tRNA (5 methylaminomethyl 2 thiouridylate) methyltransferase; mitochondrial tRNA-specific 2-thiouridylase 1; FLJ10140; MTO2; MGC99627; Mitochondrial tRNA specific 2 thiouridylase 1; MTO 2; MTO2 homolog; MTU 1; MTU1; TRMT 1; TRMT; tRNA (5 methylaminomethyl 2 thiouridylate) methyltransferase; tRNA 5 methylaminomethyl 2 thiouridylate methyltransferase; TRNT 1; TRNT1; mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase; TRMT1;
TRNAU1AP
tRNA selenocysteine 1 associated protein 1
TRNAU1AP; tRNA selenocysteine 1 associated protein 1; tRNA selenocysteine associated protein 1 , TRSPAP1; tRNA selenocysteine 1-associated protein 1; FLJ20503; SECP43; tRNA selenocysteine associated protein 1; tRNA selenocysteine-associated protein 1; tRN;
TSKU
tsukushi small leucine rich proteoglycan homolog (Xenopus laevis)
TSKU; tsukushi small leucine rich proteoglycan homolog (Xenopus laevis); leucine rich repeat containing 54 , LRRC54, tsukushin; tsukushin; E2IG4; TSK; E2 induced gene 4 protein; Leucine rich repeat containing protein 54; LRRC54; Tsukushi; tsukushi homolog; E2-induced gene 4 protein; leucine rich repeat containing 54; leucine-rich repeat-containing protein 54; tsukushi, small leucine rich proteoglycan;
OXER1
oxoeicosanoid (OXE) receptor 1
OXER1; oxoeicosanoid (OXE) receptor 1; oxoeicosanoid receptor 1; 5 oxo ETE acid G protein coupled receptor 1; GPCR; GPR170; TG1019; G-protein coupled receptor 170; G-protein coupled receptor R527; G-protein coupled receptor TG1019; 5-oxo-ETE G-protein cou;
XPNPEP3
X-prolyl aminopeptidase (aminopeptidase P) 3, putative
XPNPEP3; X-prolyl aminopeptidase (aminopeptidase P) 3, putative; probable Xaa-Pro aminopeptidase 3; APP3; NPHPL1; Aminopeptidase P3; OTTHUMP00000199806; Probable Xaa Pro aminopeptidase 3; X Pro aminopeptidase 3; X prolyl aminopeptidase (aminopeptidase P) 3; X-Pro aminopeptidase 3; XPP3_HUMAN;
NALCN
sodium leak channel, non-selective
NALCN; sodium leak channel, non-selective; VGCNL1, voltage gated channel like 1; sodium leak channel non-selective protein; bA430M15.1; CanIon; voltage gated channel like 1; voltage gated channel-like protein 1; four repeat voltage-gated ion channel; VGC;
UGT2A3
UDP glucuronosyltransferase 2 family, polypeptide A3
UGT2A3; UDP glucuronosyltransferase 2 family, polypeptide A3; UDP-glucuronosyltransferase 2A3; FLJ21934; UDP glucuronosyltransferase 2 family polypeptide A3; UDP glucuronosyltransferase 2A3; UDPGT 2A3;
UGT2B11
UDP glucuronosyltransferase 2 family, polypeptide B11
UGT2B11; UDP glucuronosyltransferase 2 family, polypeptide B11; UDP glycosyltransferase 2 family, polypeptide B11; UDP-glucuronosyltransferase 2B11; MGC129611; MGC129612; OTTHUMP00000159761; UDB11_HUMAN; UDP glycosyltransferase 2 family protein; UDPGT 2B11;
UQCRQ
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa
UQCRQ; ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa; cytochrome b-c1 complex subunit 8; complex III subunit 8; QCR8; QP C; ubiquinol cytochrome c reductase; complex III subunit VII; UQCR7; complex III subunit VIII; low molecular mass;
PSMD12
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12
PSMD12; proteasome (prosome, macropain) 26S subunit, non-ATPase, 12; 26S proteasome non-ATPase regulatory subunit 12; p55; Rpn5; 26S proteasome regulatory subunit p55; 26S proteasome regulatory subunit RPN5; MGC75406; proteasome (prosome, macropain) 26S subunit, non ATPase12; Proteasome 26S non ATPase subunit 12 isoform 2; PSD12_HUMAN;
HTR3A
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
HTR3A; 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic; HTR3; 5HT3R; 5-HT-3; 5-HT3A; 5-HT3R; 5-hydroxytryptamine receptor 3A; 5-HT3-A; serotonin receptor 3A; 5HT3 serotonin receptor; 5-hydroxytryptamine receptor 3; serotonin-gated ion channel receptor;
CEACAM16
carcinoembryonic antigen-related cell adhesion molecule 16
CEACAM16; carcinoembryonic antigen-related cell adhesion molecule 16; Carcinoembryonic antigen like 2; Carcinoembryonic antigen like 2 protein; Carcinoembryonic antigen related cell adhesion molecule 16; CEAL2; carcinoembryonic antigen-like 2; carcinoembryonic antigen like-2 protein;
EML3
echinoderm microtubule associated protein like 3
EML3; echinoderm microtubule associated protein like 3; echinoderm microtubule-associated protein-like 3; ELP95; FLJ35827; ELP 95; EMAP 3; EML 3; FLJ 35827; MGC 111422; EMAP-3;
GABRG3
gamma-aminobutyric acid (GABA) A receptor, gamma 3
GABRG3; gamma-aminobutyric acid (GABA) A receptor, gamma 3; gamma-aminobutyric acid receptor subunit gamma-3; GABA(A) receptor; GABA(A) receptor subunit gamma 3; GABR G3; GABRG 3; Gamma aminobutyric acid (GABA) A receptor gamma 3; Gamma aminobutyric acid A receptor gamma 3; Gamma aminobutyric acid receptor subunit gamma 3; GABA(A) receptor subunit gamma-3;
GABRG1
gamma-aminobutyric acid (GABA) A receptor, gamma 1
GABRG1; gamma-aminobutyric acid (GABA) A receptor, gamma 1; gamma-aminobutyric acid receptor subunit gamma-1; GABA(A) receptor; gamma; gamma-1 polypeptide; GABA(A) receptor, gamma; GABA(A) receptor subunit gamma-1; MGC33838; DKFZp686H2042;
ITPR2
inositol 1,4,5-trisphosphate receptor, type 2
ITPR2; inositol 1,4,5-trisphosphate receptor, type 2; inositol 1,4,5 triphosphate receptor, type 2; inositol 1,4,5-trisphosphate receptor type 2; IP3R2; 4; 5-trisphosphate receptor; Inositol 1 4 5 trisphosphate receptor type 2; Inositol 145 trisphosphate receptor type 2; InsP3 R2; InsP3R2; IP3 R2; IP3 receptor isoform 2; IP3R 2; ITPR 2; ITPR2_HUMAN; Type 2 inositol 1 4 5 trisphosphate receptor; Type 2 inositol 1; Type 2 inositol 145 trisphosphate receptor; Type 2 InsP3 receptor; IP3 receptor; inositol 1,4,5-triphosphate receptor, type 2; type 2 inositol 1,4,5-trisphosphate receptor;
ITPRIPL1
inositol 1,4,5-trisphosphate receptor interacting protein-like 1
ITPRIPL1; inositol 1,4,5-trisphosphate receptor interacting protein-like 1; inositol 1,4,5 triphosphate receptor interacting protein like 1 , KIAA1754 like , KIAA1754L; inositol 1,4,5-trisphosphate receptor-interacting protein-like 1; inositol 1,4,5-trip;
ITPKA
inositol-trisphosphate 3-kinase A
ITPKA; inositol-trisphosphate 3-kinase A; inositol 1,4,5 trisphosphate 3 kinase A; IP3 3KA; IP3KA; IP3K A; IP3 3-kinase A; insP 3-kinase A; inositol 1,4,5-trisphosphate 3-kinase A; IP3-3KA;
IGSF3
immunoglobulin superfamily, member 3
IGSF3; immunoglobulin superfamily, member 3; immunoglobulin superfamily member 3; EWI 3; MGC117164; V8; immunoglobin superfamily, member 3; glu-Trp-Ile EWI motif-containing protein 3; EWI-3;
IPMK
inositol polyphosphate multikinase
IPMK; inositol polyphosphate multikinase; Inositol 1,3,4,6 tetrakisphosphate 5 kinase; 3; 4; 6-tetrakisphosphate 5-kinase; Inositol 1; IPMK_HUMAN; inositol 1,3,4,6-tetrakisphosphate 5-kinase;
NAPEPLD
Napepld N-acyl phosphatidylethanolamine phospholipase D
NAPEPLD; N-acyl phosphatidylethanolamine phospholipase D; N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D; NAPE-hydrolyzing phospholipase D; Metallo-beta-lactamase domain containing 1; Mbldc1; NAPE-PLD; A530089G06;
NANOS3
nanos homolog 3 (Drosophila)
NANOS3; nanos homolog 3 (Drosophila); nanos homolog 3; NANOS1L; NOS3; NANO3_HUMAN; NOS-3;
GRIN2D
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
GRIN2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; EB11; NR2D; GluN2D; NMDAR2D; glutamate receptor ionotropic, NMDA 2D; estrogen receptor binding CpG island; N-methyl D-aspartate receptor subtype 2D; N-methyl-d-aspartate receptor subunit 2D; glutamate [NMDA] receptor subunit epsilon-4;
RDH10
retinol dehydrogenase 10 (all-trans)
RDH10; retinol dehydrogenase 10 (all-trans); SDR16C4; retinol dehydrogenase 10; short chain dehydrogenase/reductase family 16C, member 4;
SLC16A8
solute carrier family 16, member 8 (monocarboxylic acid transporter 3)
SLC16A8; solute carrier family 16, member 8 (monocarboxylic acid transporter 3); solute carrier 16 (monocarboxylic acid transporters), member 8; monocarboxylate transporter 3; MCT3; REMP; MCT 3; Monocarboxylic acid transporter 3; OTTHUMP00000028510; Solute carrier 16 (monocarboxylic acid transporters) member 8; Solute carrier family 16 member 8;
PIGW
phosphatidylinositol glycan anchor biosynthesis, class W
PIGW; phosphatidylinositol glycan anchor biosynthesis, class W; phosphatidylinositol glycan, class W; phosphatidylinositol-glycan biosynthesis class W protein; FLJ37433; Gwt1; PIG-W; PIGW_HUMAN;
RAI14
retinoic acid induced 14
RAI14; retinoic acid induced 14; ankycorbin; DKFZp564G013; KIAA1334; NORPEG; novel retinal pigment epithelial; RAI13; retinoic acid-induced protein 14; novel retinal pigment epithelial cell protein; ankyrin repeat and coiled-coil structure-containing prot;
SEMA4F
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
SEMA4F; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F; SEMAM; semaphorin-4F; m Sema M; SEMAW; M SEMA; PRO2353; Sema domain immunoglobulin domain (Ig) transmembrane; Sema M; Sema W; Semaphorin M; Semaphorin W; semaphorin-M; semaphorin-W; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4F; M-SEMA; m-Sema-M;
KIR2DL5A
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A; CD158F; KIR2DL5; KIR2DL5.1;
KIR3DS1
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
KIR3DS1;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1;killer cell immunoglobulin-like receptor 3DS1;nkat10;NKAT-10;killer Ig receptor;MHC class I NK cell receptor;natural killer-associated transcript 10;killer cell immunoglobulin-like receptor KIR3DS1;KIR-G1;NKAT10;CD158E2;KIR-123FM;MGC119726;MGC119728;MGC125316;
MDGA1
MAM domain containing glycosylphosphatidylinositol anchor 1
MDGA1; MAM domain containing glycosylphosphatidylinositol anchor 1; MAM domain-containing glycosylphosphatidylinositol anchor protein 1; GPIM; MAMDC3; GPI and MAM protein; MAM domain-containing protein 3; glycosylphosphatidylinositol-MAM; glycosyl-phospha;
IgG
Immunoglobulin G
IgG; Immunoglobulin G; Llama IgG; Llama; Ig gamma 1 chain C region; IGHG1; Immunoglobin heavy constant gamma 1; Immunoglobulin G;
HIV1
Human immunodeficiency virus 1
HIV 1; HTLV3; Human Immunodeficiency Virus 1; CA; Capsid protein p24; Human immunodeficiency virus type 1 p24; HIVEP1; human immunodeficiency virus type I enhancer binding protein 1; human immunodeficiency virus type I enhancer binding protein 1 , zinc finger protein 40 , ZNF40; zinc finger protein 40; CIRIP; CRYBP1; MBP 1; PRDII BF1; Schnurri 1; ZAS1; ZNF40A; HIVEP 1; Cirhin interaction protein; GAAP; Gate keeper of apoptosis-activating protein; HIV EP1; HIV-EP1; Human immunodeficiency virus type I enhancer-binding protein 1; Major histocompatibility complex binding protein 1; Major histocompatibility complex-binding protein 1; MBP-1; Positive regulatory domain II binding factor 1; Positive regulatory domain II-binding factor 1; PRDII-BF1; ZEP1_HUMAN; ZNF40; OTTHUMP00000016036; major histocompatibility complex bi; Schnurri-1;
UQCC
ubiquinol-cytochrome c reductase complex chaperone
UQCC; ubiquinol-cytochrome c reductase complex chaperone; BFZB; CBP3; C20orf44;
LILRB4
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
LILRB4;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4;6608;ENSG00000186818;HM18;ILT3;LIR5;CD85K;LIR-5;LILRB5;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 4;leukocyte immunoglobulin-like receptor subfamily B member 4;ILT-3;immunoglobulin-like transcript 3;CD85 antigen-like family member K;monocyte inhibitory receptor HM18;leukocyte immunoglobulin-like receptor 5;leukocyte immunoglobulin-like receptor, subfamily B, member 4;leukocyte immunoglobulin-like receptor subfamily B member 4 soluble isoform;
PTPN18
protein tyrosine phosphatase, non-receptor type 18 (brain-derived)
PTPN18;protein tyrosine phosphatase, non-receptor type 18 (brain-derived);9649;ENSG00000072135;BDP1;PTP-HSCF;2q21.1;tyrosine-protein phosphatase non-receptor type 18;tyrosine-protein phosphatase non-receptor type 18;brain-derived phosphatase;EC 3.1.3.48;
VSIG10
V-set and immunoglobulin domain containing 10
VSIG10;V-set and immunoglobulin domain containing 10;26078;ENSG00000176834;12q24.23;MGC1013, FLJ20674;V-set and immunoglobulin domain-containing protein 10;V-set and immunoglobulin domain-containing protein 10;
GABRR2
gamma-aminobutyric acid (GABA) A receptor, rho 2
GABRR2;gamma-aminobutyric acid (GABA) A receptor, rho 2;4091;ENSG00000111886;6q15;gamma-aminobutyric acid receptor subunit rho-2;gamma-aminobutyric acid receptor subunit rho-2;GABA(C) receptor;GABA(A) receptor, rho 2;GABA(A) receptor subunit rho-2;GABA-C receptor, rho-2 subunit;gamma-aminobutyric acid (GABA) receptor, rho 2;
GRID2IP
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein
GRID2IP;glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein;18464;ENSG00000215045;DELPHILIN;7p22.1;delphilin;delphilin;glutamate receptor, ionotropic, delta 2-interacting protein 1;glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1;
IGDCC3
immunoglobulin superfamily, DCC subclass, member 3
IGDCC3;immunoglobulin superfamily, DCC subclass, member 3;9700;ENSG00000174498;PUNC;HsT18880;15q22.3-q23;immunoglobulin superfamily DCC subclass member 3;immunoglobulin superfamily DCC subclass member 3;putative neuronal cell adhesion molecule;
IGSF9B
immunoglobulin superfamily, member 9B
IGSF9B;immunoglobulin superfamily, member 9B;32326;ENSG00000080854;11q25;KIAA1030;protein turtle homolog B;protein turtle homolog B;immunoglobulin superfamily member 9B;
IGSF9
immunoglobulin superfamily, member 9
IGSF9;immunoglobulin superfamily, member 9;18132;ENSG00000085552;Nrt1;IGSF9A;FP18798;1q22-q23;KIAA1355;protein turtle homolog A;protein turtle homolog A;immunoglobulin superfamily member 9A;
ILDR2
immunoglobulin-like domain containing receptor 2
ILDR2;immunoglobulin-like domain containing receptor 2;18131;ENSG00000143195;C1orf32;dJ782G3.1;RP4-782G3.2;1q24.1;immunoglobulin-like domain-containing receptor 2;immunoglobulin-like domain-containing receptor 2;
INO80B
INO80 complex subunit B
INO80B;INO80 complex subunit B;13324;ENSG00000115274;IES2;hIes2;PAPA-1;ZNHIT4;HMGA1L4;HMGIYL4;PAP-1BP;2p13.1;INO80 complex subunit B;INO80 complex subunit B;IES2 homolog;PAP-1 binding protein;zinc finger, HIT type 4;PAP-1-associated protein 1;high mobility group AT-hook 1-like 4;zinc finger HIT domain-containing protein 4;PAP (Pim-1 associated protein) associated protein 1;
INO80E
INO80 complex subunit E
INO80E;INO80 complex subunit E;26905;ENSG00000169592;CCDC95;16p11.2;FLJ00079, FLJ90652;INO80 complex subunit E;INO80 complex subunit E;coiled-coil domain containing 95;coiled-coil domain-containing protein 95;
NYAP2
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
NYAP2;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2;29291;ENSG00000144460;KIAA1486;2q36.3;KIAA1486;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2;
KNDC1
kinase non-catalytic C-lobe domain (KIND) containing 1
KNDC1;kinase non-catalytic C-lobe domain (KIND) containing 1;29374;ENSG00000171798;RASGEF2;C10orf23;bB439H18.3;RP13-439H18.3;10q26.3;FLJ16067;protein very KIND;protein very KIND;cerebral protein 9;RasGEF domain family, member 2;KIND domain-containing protein 1;ras-GEF domain-containing family member 2;kinase non-catalytic C-lobe domain-containing protein 1;
KNCN
kinocilin
KNCN;kinocilin;26488;ENSG00000162456;L5;Kino;RP11-49P4.2;1p33;FLJ32011, MGC120370, MGC120371, MGC120372;kinocilin;kinocilin;
KPRP
keratinocyte proline-rich protein
KPRP;keratinocyte proline-rich protein;31823;ENSG00000203786;C1orf45;1q21.3;keratinocyte proline-rich protein;keratinocyte proline-rich protein;hKPRP;keratinocyte expressed, proline-rich protein;
LILRB5
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 [ Homo sap
LILRB5;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5;6609;ENSG00000105609;LIR8;CD85C;LIR-8;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 5;leukocyte immunoglobulin-like receptor subfamily B member 5;CD85 antigen-like family member C;leukocyte immunoglobulin-like receptor 8;
LRIT1
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1
LRIT1;leucine-rich repeat, immunoglobulin-like and transmembrane domains 1;23404;ENSG00000148602;PAL;LRRC21;FIGLER9;10q23;DKFZp434K091;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1;retina-specific protein PAL;leucine rich repeat containing 21;leucine-rich repeat-containing protein 21;photoreceptor-associated LRR superfamily protein;fibronectin type III, immunoglobulin and leucine rich repeat domains 9;
LRIG2
leucine-rich repeats and immunoglobulin-like domains 2
LRIG2;leucine-rich repeats and immunoglobulin-like domains 2;20889;ENSG00000198799;LIG2;LIG-2;1p13.1;KIAA0806, DKFZp451C181;leucine-rich repeats and immunoglobulin-like domains protein 2;leucine-rich repeats and immunoglobulin-like domains protein 2;
LRIT2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
LRIT2;leucine-rich repeat, immunoglobulin-like and transmembrane domains 2;23443;ENSG00000204033;LRRC22;10q23.1;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;leucine rich repeat containing 22;leucine-rich repeat-containing protein 22;
MANEA
mannosidase, endo-alpha
MANEA;mannosidase, endo-alpha;21072;ENSG00000172469;ENDO;hEndo;6q16.1;FLJ12838, DKFZp686D20120;glycoprotein endo-alpha-1,2-mannosidase;glycoprotein endo-alpha-1,2-mannosidase;mandaselin;endomannosidase;endo-alpha mannosidase;alpha 1,2-endomannosidase;EC 3.2.1.130;
MNAT1
menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)
MNAT1;menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis);7181;ENSG00000020426;MAT1;TFB3;CAP35;RNF66;14q23;CDK-activating kinase assembly factor MAT1;CDK-activating kinase assembly factor MAT1;RING finger protein 66;RING finger protein MAT1;CDK7/cyclin-H assembly factor;cyclin G1 interacting protein;cyclin-G1-interacting protein;menage a trois 1 (CAK assembly factor);
NDUFC1
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa
NDUFC1;NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa;7705;ENSG00000109390;KFYI;4q31.1;MGC117464, MGC126847, MGC138266;NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial;NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial;CI-KFYI;complex I-KFYI;complex I KFYI subunit;NADH-ubiquinone oxidoreductase KFYI subunit;
NLE1
notchless homolog 1 (Drosophila)
NLE1;notchless homolog 1 (Drosophila);19889;ENSG00000073536;Nle;17q12;FLJ10458;notchless protein homolog 1;notchless protein homolog 1;Notchless gene homolog;
NSUN3
NOP2/Sun domain family, member 3
NSUN3;NOP2/Sun domain family, member 3;26208;ENSG00000178694;MST077;MSTP077;3q11.1;FLJ22109, FLJ22609;putative methyltransferase NSUN3;putative methyltransferase NSUN3;NOL1/NOP2/Sun domain family 3;NOL1/NOP2/Sun domain family member 3;NOL1/NOP2/Sun domain family, member 3;EC 2.1.1.-;
NSUN5
NOP2/Sun domain family, member 5
NSUN5;NOP2/Sun domain family, member 5;16385;ENSG00000130305;NOL1;p120;NOL1R;NSUN5A;WBSCR20;WBSCR20A;7q11.23;MGC986, FLJ10267;putative methyltransferase NSUN5;putative methyltransferase NSUN5;NOL1-related protein;NOP2/Sun domain family, member 5A;NOL1/NOP2/Sun domain family member 5;NOL1/NOP2/Sun domain family, member 5;Williams Beuren syndrome chromosome region 20A;williams-Beuren syndrome chromosomal region 20A protein;Williams-Beuren syndrome critical region protein 20 copy A;
OPALIN
oligodendrocytic myelin paranodal and inner loop protein
OPALIN;oligodendrocytic myelin paranodal and inner loop protein;20707;ENSG00000197430;TMP10;HTMP10;TMEM10;10q23-q24;opalin;opalin;transmembrane protein 10;transmembrane protein TMP10;
PIGG
phosphatidylinositol glycan anchor biosynthesis, class G
PIGG;phosphatidylinositol glycan anchor biosynthesis, class G;25985;ENSG00000174227;GPI7;LAS21;PRO4405;RLGS1930;4p16.3;FLJ20265, FLJ39925, MGC131903, DKFZp434A1810, DKFZp434C1712, DKFZp434M1131;GPI ethanolamine phosphate transferase 2;GPI ethanolamine phosphate transferase 2;PIG-G;hGPI7;GPI7 homolog;phosphatidylinositol glycan, class G;phosphatidylinositol-glycan biosynthesis class G protein;
PLEKHA2
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 [ Homo
PLEKHA2;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2;14336;ENSG00000169499;TAPP2;8p11.22;FLJ25921;pleckstrin homology domain-containing family A member 2;pleckstrin homology domain-containing family A member 2;TAPP-2;tandem PH Domain containing protein-2;tandem PH domain-containing protein 2;PH domain-containing family A member 2;pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2;
RNASE12
ribonuclease, RNase A family, 12 (non-active)
RNASE12;ribonuclease, RNase A family, 12 (non-active);24211;ENSG00000206171;14q11.1;ribonuclease-like protein 12;ribonuclease-like protein 12;
SBNO1
strawberry notch homolog 1 (Drosophila)
SBNO1;strawberry notch homolog 1 (Drosophila);22973;ENSG00000139697;Sno;MOP3;12q24.31;FLJ10701, FLJ10833, FLJ14066, FLJ16176, FLJ35199;protein strawberry notch homolog 1;protein strawberry notch homolog 1;monocyte protein 3;
SEMA3C
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C [ Homo sapie
SEMA3C;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C;10725;ENSG00000075223;SemE;SEMAE;7q21-q31;semaphorin-3C;semaphorin-3C;sema E;semaphorin E;semaphorin-E;
SEMA4C
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (s
SEMA4C;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C;10731;ENSG00000168758;SEMAF;SEMAI;SEMACL1;M-SEMA-F;2q11.2;FLJ20369, KIAA1739, MGC126382, MGC126383;semaphorin-4C;semaphorin-4C;M-Sema F;
SLC16A10
solute carrier family 16, member 10 (aromatic amino acid transporter)
SLC16A10;solute carrier family 16, member 10 (aromatic amino acid transporter);17027;ENSG00000112394;TAT1;PRO0813;6q21-q22;monocarboxylate transporter 10;monocarboxylate transporter 10;MCT 10;T-type amino acid transporter 1;aromatic amino acid transporter 1;solute carrier family 16 member 10;solute carrier family 16 (monocarboxylic acid transporters), member 10;
SLC16A3
solute carrier family 16, member 3 (monocarboxylic acid transporter 4)
SLC16A3;solute carrier family 16, member 3 (monocarboxylic acid transporter 4);10924;ENSG00000141526;MCT3;MCT4;MCT 3;MCT 4;MCT-3;MCT-4;17q25;MGC138472, MGC138474;monocarboxylate transporter 4;monocarboxylate transporter 4;monocarboxylate transporter 3;solute carrier family 16 (monocarboxylic acid transporters), member 3;
SLC25A26
solute carrier family 25 (S-adenosylmethionine carrier), member 26
SLC25A26;solute carrier family 25 (S-adenosylmethionine carrier), member 26;20661;ENSG00000144741;SAMC;3p14.1;FLJ77340, DKFZp434E079;S-adenosylmethionine mitochondrial carrier protein;S-adenosylmethionine mitochondrial carrier protein;solute carrier family 25, member 26;mitochondrial S-adenosylmethionine transporter;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 26;
SLC36A4
solute carrier family 36 (proton/amino acid symporter), member 4
SLC36A4;solute carrier family 36 (proton/amino acid symporter), member 4;19660;ENSG00000180773;PAT4;11q21;FLJ38932;proton-coupled amino acid transporter 4;proton-coupled amino acid transporter 4;proton/amino acid transporter 4;solute carrier family 36 member 4;
SLC7A10
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 [ Homo
SLC7A10;solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10;11058;ENSG00000130876;asc-1;HASC-1;19q13.1;FLJ20839;asc-type amino acid transporter 1;asc-type amino acid transporter 1;solute carrier family 7 member 10;solute carrier family 7, (neutral amino acid transporter, y+ system) member 10;solute carrier family 7, (cationic amino acid transporter, y+ system) member 10;
SPDYC
speedy homolog C (Xenopus laevis)
SPDYC;speedy homolog C (Xenopus laevis);32681;ENSG00000204710;RINGOC;Ringo2;11q13.1;speedy protein C;speedy protein C;RINGO C;speedy C;hSpy/Ringo C;rapid inducer of G2/M progression in oocytes C;
ST18
suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein)
ST18;suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein);18695;ENSG00000147488;ZNF387;8q11.23;KIAA0535;suppression of tumorigenicity 18 protein;suppression of tumorigenicity 18 protein;zinc finger protein 387;
THADA
thyroid adenoma associated
THADA;thyroid adenoma associated;19217;ENSG00000115970;GITA;2p21;FLJ21877, FLJ44016, FLJ44876, FLJ77530, KIAA1767;thyroid adenoma-associated protein;thyroid adenoma-associated protein;death receptor-interacting protein;gene inducing thyroid adenomas protein;
TMIGD2
transmembrane and immunoglobulin domain containing 2
TMIGD2;transmembrane and immunoglobulin domain containing 2;28324;ENSG00000167664;IGPR1;IGPR-1;19p13.3;MGC23244;transmembrane and immunoglobulin domain-containing protein 2;transmembrane and immunoglobulin domain-containing protein 2;immunoglobulin-containing and proline-rich receptor 1;transmembrane and immunoglobulin domain-containing protein 2 variant 2;transmembrane and immunoglobulin domain-containing protein 2 variant 3;
UFSP1
UFM1-specific peptidase 1 (non-functional)
UFSP1;UFM1-specific peptidase 1 (non-functional);33821;ENSG00000176125;UFSP;7q22.1;inactive Ufm1-specific protease 1;inactive Ufm1-specific protease 1;
ADRA1D
adrenoceptor alpha 1D
ADRA1D;adrenoceptor alpha 1D;280;ENSG00000171873;DAR;ADRA1;ADRA1A;ADRA1R;ALPHA1;dJ779E11.2;20p13;alpha-1D adrenergic receptor;alpha-1D adrenergic receptor;alpha-1D adrenoceptor;alpha-1D adrenoreceptor;alpha-1A adrenergic receptor;alpha-1D-adrenergic receptor;alpha-adrenergic receptor 1a;adrenergic, alpha-1A-, receptor;adrenergic, alpha-1D-, receptor;adrenergic, alpha -1D-, receptor;
ADM2
adrenomedullin 2
ADM2;adrenomedullin 2;28898;ENSG00000128165;AM2;dJ579N16.4;22q13.33;FLJ21135;ADM2;ADM2;intermedin;
ATP8A1
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1
ATP8A1;ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1;13531;ENSG00000124406;ATPIA;ATPP2;ATPASEII;4p13;MGC26327, MGC130042, MGC130043;probable phospholipid-transporting ATPase IA;probable phospholipid-transporting ATPase IA;ATPase II;chromaffin granule ATPase II;aminophospholipid translocase;ATPase class I type 8A member 1;EC 3.6.3.1;
CNPY4
canopy 4 homolog (zebrafish)
CNPY4;canopy 4 homolog (zebrafish);28631;ENSG00000166997;PRAT4B;7q22.1;MGC40499;protein canopy homolog 4;protein canopy homolog 4;PRotein Associated with Tlr4;
ANO4
anoctamin 4
ANO4;anoctamin 4;23837;ENSG00000151572;TMEM16D;12q23.1;FLJ34221, FLJ34272, FLJ35277, MGC130026;anoctamin-4;anoctamin-4;transmembrane protein 16D;
ANO8
anoctamin 8
ANO8;anoctamin 8;29329;ENSG00000074855;TMEM16H;KIAA1623;19p13.11;anoctamin-8;anoctamin-8;transmembrane protein 16H;
ANO9
anoctamin 9
ANO9;anoctamin 9;20679;ENSG00000185101;PIG5;TP53I5;TMEM16J;11p15.5;anoctamin-9;anoctamin-9;transmembrane protein 16J;p53-induced gene 5 protein;tumor protein p53 inducible protein 5;tumor protein p53-inducible protein 5;
PITPNM1
phosphatidylinositol transfer protein, membrane-associated 1
PITPNM1;phosphatidylinositol transfer protein, membrane-associated 1;9003;ENSG00000110697;Rd9;NIR2;RDGB;DRES9;RDGB1;RDGBA;PITPNM;RDGBA1;11q13;FLJ44997;membrane-associated phosphatidylinositol transfer protein 1;membrane-associated phosphatidylinositol transfer protein 1;NIR-2;PITPnm 1;retinal degeneration B alpha 1;drosophila retinal degeneration B homolog;PYK2 N-terminal domain-interacting receptor 2;
IGSF22
immunoglobulin superfamily, member 22
IGSF22;immunoglobulin superfamily, member 22;26750;ENSG00000179057;11p15.1;FLJ37794;immunoglobulin superfamily member 22;immunoglobulin superfamily member 22;
Slc7a9
solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system),
SLC7A9;solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9;ENSRNOG00000012344;1q21;MGC114282;B(0,+)-type amino acid transporter 1;B(0,+)-type amino acid transporter 1;b(0,+)AT;solute carrier family 7 member 9;glycoprotein-associated amino acid transporter b0,+AT1;solute carrier family 7 (cationic amino acid transporter, y+ system), member 9;
ANO3
anoctamin 3
ANO3;anoctamin 3;14004;ENSG00000134343;TMEM16C;C11orf25;GENX-3947;11p14.2;anoctamin-3;anoctamin-3;transmembrane protein 16C (eight membrane-spanning domains);
RMI2
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)
RMI2;RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae);28349;ENSG00000175643;BLAP18;C16orf75;16p13.13;MGC24665;recQ-mediated genome instability protein 2;recQ-mediated genome instability protein 2;hRMI2;BLM-associated protein of 18 kDa;RecQ-mediated genome instability 2, S. cerevisiae, homolog of;
NCMAP
noncompact myelin associated protein
NCMAP;noncompact myelin associated protein;29332;ENSG00000184454;MP11;C1orf130;1p36.11;FLJ42528;uncharacterized protein C1orf130;uncharacterized protein C1orf130;myelin protein of 11 kDa;
NYAP1
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1
NYAP1;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1;22009;ENSG00000166924;C7orf51;KIAA1486L;7q22.1;FLJ37538;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1;
PLGRKT
plasminogen receptor, C-terminal lysine transmembrane protein
PLGRKT;plasminogen receptor, C-terminal lysine transmembrane protein;23633;ENSG00000107020;AD025;MDS030;C9orf46;PLG-RKT;Plg-R(KT);9p24.1;FLJ14688, FLJ39176;plasminogen receptor (KT);plasminogen receptor (KT);5033414D02Rik;transmembrane protein C9orf46;plasminogen receptor with a C-terminal lysine;
CLPX
ClpX caseinolytic peptidase X homolog (E. coli)
CLPX;ClpX caseinolytic peptidase X homolog (E. coli);2088;ENSG00000166855;15q22.31;ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial;ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial;ClpX caseinolytic protease X homolog;energy-dependent regulator of proteolysis;
CNPY1
canopy1
CNPY1;canopy1;ENSDARG00000003757;chromosome: 2;protein canopy-1;protein canopy-1;D121 protein;EC 3.6.5.4;
ECHDC3
enoyl CoA hydratase domain containing 3
ECHDC3;enoyl CoA hydratase domain containing 3;23489;ENSG00000134463;10p14;FLJ20909;enoyl-CoA hydratase domain-containing protein 3, mitochondrial;enoyl-CoA hydratase domain-containing protein 3, mitochondrial;enoyl Coenzyme A hydratase domain containing 3;
EDEM3
ER degradation enhancer, mannosidase alpha-like 3
EDEM3;ER degradation enhancer, mannosidase alpha-like 3;16787;ENSG00000116406;C1orf22;1q25;ER degradation-enhancing alpha-mannosidase-like 3;ER degradation-enhancing alpha-mannosidase-like 3;ER degradation-enhancing -mannosidase-like protein 3;
PIEZO2
piezo-type mechanosensitive ion channel component 2
PIEZO2;piezo-type mechanosensitive ion channel component 2;26270;ENSG00000154864;FAM38B;HsT748;HsT771;FAM38B2;C18orf30;C18orf58;18p11.22;FLJ23144, FLJ23403, FLJ25916, FLJ34907, FLJ37734, FLJ45725;piezo-type mechanosensitive ion channel component 2;piezo-type mechanosensitive ion channel component 2;protein PIEZO2;family with sequence similarity 38, member B;family with sequence similarity 38, member B2;
PEMT
phosphatidylethanolamine N-methyltransferase
PEMT;phosphatidylethanolamine N-methyltransferase;8830;ENSG00000133027;PNMT;PEAMT;PEMPT;PEMT2;17p11.2;MGC2483;phosphatidylethanolamine N-methyltransferase;phosphatidylethanolamine N-methyltransferase;EC 2.1.1.17;
ELAVL3
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)
ELAVL3;ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);3314;ENSG00000196361;HUC;HUCL;PLE21;19p13.2;MGC20653, DKFZp547J036;ELAV-like protein 3;ELAV-like protein 3;Hu antigen C;hu-antigen C;paraneoplastic limbic encephalitis antigen 21;paraneoplastic cerebellar degeneration-associated antigen;
Slc6a2
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
SLC6A2;solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2;ENSMUSG00000055368;NET;NE-T;Slc6a5;8 C5;8 45.0 cM;sodium-dependent noradrenaline transporter;sodium-dependent noradrenaline transporter;NE transporter;norepinephrine transporter;solute carrier family 6 member 2;EC 2.3.1.5;
PELI1
pellino E3 ubiquitin protein ligase 1
PELI1;pellino E3 ubiquitin protein ligase 1;8827;ENSG00000197329;2p13.3;MGC50990, DKFZp686C18116;E3 ubiquitin-protein ligase pellino homolog 1;E3 ubiquitin-protein ligase pellino homolog 1;pellino-1;pellino homolog 1;protein pellino homolog 1;pellino-related intracellular-signaling molecule;
ISLR
immunoglobulin superfamily containing leucine-rich repeat
ISLR;immunoglobulin superfamily containing leucine-rich repeat;6133;ENSG00000129009;HsT17563;15q23-q24;MGC102816;immunoglobulin superfamily containing leucine-rich repeat protein;immunoglobulin superfamily containing leucine-rich repeat protein;
AGXT2L2
alanine-glyoxylate aminotransferase 2-like 2
AGXT2L2;alanine-glyoxylate aminotransferase 2-like 2;28249;ENSG00000175309;5q35.3;MGC15875, MGC45484, MGC117348;alanine--glyoxylate aminotransferase 2-like 2;alanine--glyoxylate aminotransferase 2-like 2;
0610007C21Rik
all-trans retinoic acid induced differentiation factor
p18; Apr3; HSPC013; AI316792; 0610007C21Rik;
ASPM
asp (abnormal spindle)-like, microcephaly associated (Drosophila)
ASPM; abnormal spindle-like microcephaly-associated protein homolog; asp (abnormal spindle)-like, microcephaly associated;
ALG11
ALG11 asparagine-linked glycosylation 11, alpha-1,2-mannosyltransferase homolog (yeast) [ Homo sapiens ]
AI849156; alg11; ALG11_HUMAN; Asparagine-linked glycosylation 11; Asparagine-linked glycosylation 11, alpha-1,2-mannosyltransferase homolog (yeast); Asparagine-linked glycosylation protein 11 homolog; AW492253; B230397C21; GT8; KIAA0266; OTTMUSP00000022781; RGD1564725;
ALG3
asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)
D16Ertd36e;
Ceacam12
carcinoembryonic antigen-related cell adhesion molecule 12
Ceacam12C1; Ceacam12C3; Ceacam12-C1; Ceacam12-C3; 1600031J20Rik;
Ceacam14
carcinoembryonic antigen-related cell adhesion molecule 14
AV033953; 1600021E03Rik; 1600025E09Rik;
CNOT1
CNOT1 CCR4-NOT transcription complex, subunit 1 [ Homo sapiens ]
CCR4-NOT transcription complex, subunit 1; CCR4-associated factor 1; NOT1; AD-005; CDC39; adrenal gland protein AD-005; NOT1H; CCR4-NOT transcription complex subunit 1; KIAA1007; NOT1 (negative regulator of transcription 1, yeast) homolog; Negative regulator of transcription subunit 1 homolog; hNOT1; CNOT1;
Diap3
diaphanous homolog 3 (Drosophila)
Dia2; Drf3; mDia2; Diaph3; mKIAA4117; p134MDia2; 4930417P13Rik;
EML6
echinoderm microtubule associated protein like 6
EMAP-6; RP23-176O5.5; 2900083P10Rik; C230094A16Rik;
ENOX2
ENOX2 ecto-NOX disulfide-thiol exchanger 2 [ Homo sapiens ]
ecto-NOX disulfide-thiol exchanger 2; 2259; Ensembl:ENSG00000165675; APK1 antigen; cytosolic ovarian carcinoma antigen 1; tumor-associated hydroquinone oxidase; APK1; tNOX; COVA1;
Ear11
eosinophil-associated, ribonuclease A family, member 11
R1; R7; EAR; ECP; Rnase3; eosinophil cationic protein; EAR-11; RNase 3; ribonuclease 1; ribonuclease 3; ribonuclease 7;
KIR3DL3
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
KIR44; KIRC1; CD158Z; KIR3DL7;
LILRA6
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
ILT5; ILT8; CD85b; LILRB3; LILRB6;
Lilrb3l
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3-like
Pirb; Lilrb3; Pir-A1; Pir-A2;
MGAT5B
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B
GnT-IX; mGnTVB; C330018B01; RP23-41E14.1;
NDUFB2
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2
8kDa; AGGG; CI-AGGG; AI325567; 1810011O01Rik;
PHYHIP
phytanoyl-CoA hydroxylase interacting protein
Lnap1ip; AW049870; PAHX-AP1; PAHX-AP#1; C630010D02Rik;
A630055G03Rik
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)
Gm537; Gm929; A630055G03Rik;
RYR1
ryanodine receptor 1 (skeletal)
RYR1; ryanodine receptor 1 (skeletal); ryanodine receptor 1; skeletal muscle calcium release channel; skeletal muscle ryanodine receptor; skeletal muscle-type ryanodine receptor; type 1 ryanodine receptor; RYR-1;
1200011M11Rik
smg-8 homolog, nonsense mediated mRNA decay factor (C. elegans)
RP23-352L3.2; 1200011M11Rik;
UQCR10
ubiquinol-cytochrome c reductase, complex III subunit X
QCR9; UCRC; HSPC051; HSPC119; HSPC151; UCCR7.2; cytochrome b-c1 complex subunit 9; OTTHUMP00000199673; OTTHUMP00000199674; complex III subunit 9; complex III subunit X; cytochrome C1, nonheme 7kDa protein; cytochrome c1 non-heme 7 kDa protein; ubiquinol-cytochrome c reductase complex (7.2 kD); ubiquinol-cytochrome c reductase complex 7.2 kDa protein; ubiquinol-cytochrome c reductase, complex III subunit X, 7.2kDa; UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X;
Ugt1a6a
UDP glucuronosyltransferase 1 family, polypeptide A6A
UDPGT; UGT1.6; Ugt1a6; Ugt1a7; UGT1-06; UDPGT 1-6;
Ugt2b5
UDP glucuronosyltransferase 2 family, polypeptide B5
M-1; Udpgt-3; Ugt2b17; AI118071; Udpgt2b5;
VSIG8
V-set and immunoglobulin domain containing 8
VSIG8; V-set and immunoglobulin domain containing 8;
Acnat1
acyl-coenzyme A amino acid N-acyltransferase 1
Acnat1; acyl-coenzyme A amino acid N-acyltransferase 1;
ATP8B2
ATPase, aminophospholipid transporter, class I, type 8B, member 2
ATP8B2; ATPID; ATPase, aminophospholipid transporter, class I, type 8B, member 2;
Fibcd1
FIBCD1 fibrinogen C domain containing 1 [ Homo sapiens ]
fibrinogen C domain containing 1; 25922; Ensembl:ENSG00000130720; FLJ14810; fibrinogen C domain-containing protein 1;
Ino80
INO80
4632409L19Rik; DNA helicase INO80; hINO80; homolog of yeast INO80; INO80; INO80 complex subunit A; INO80 homolog; INO80A; INOC1; KIAA1259; Putative DNA helicase INO80 complex homolog 1;
Mgat2
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; GNT-II; glcNAc-T II; mannoside acetylglucosaminyltransferase 2; beta-1,2-N-acetylglucosaminyltransferase II; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II;
Rbpjl
recombination signal binding protein for immunoglobulin kappa J region-like
RBPJL; SUHL; RBPSUHL; recombination signal binding protein for immunoglobulin kappa J region-like; recombining binding protein suppressor of hairless-like protein; transcription factor RBP-L;
SERPINE3
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 3
LOC361914
similar to solute carrier family 7 (cationic amino acid transporter, y+ system), member 12
CD66a
carcinoembryonic antigen-related cell adhesion molecule 1
Bgp; Cc1; Hv2; Bgp1; Cea1; Cea7; Hv-2; MHVR; bb-1; C-CAM; CD66a; Cea-1; Cea-7; MHVR1; Mhv-1; mCEA1; mmCGM1; mmCGM2; mmCGM1a;
CD66c
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
NCA; CEAL; CD66c;
vnc
vnc variable nurse cells [ Drosophila melanogaster (fruit fly) ]
ard1; CG11989; dArd1; DmAAF50178; Dmel\CG11989; Dromel_CG11989_FBtr0076348_ard1_mORF; l(3)67BDk; vnc Ard1; CG11989-PA; CG11989-PB; CG11989-PC; CG11989-PD; CG11989-PE; arrest defective 1; arrest defective1; lethal (3) 67BDk; variable nurse cell; variable nurse cells; vnc-PA; vnc-PB; vnc-PC; vnc-PD; vnc-PE;
LINC00341
LINC00341 long intergenic non-protein coding RNA 341 [ Homo sapiens (human) ]
long intergenic non-protein coding RNA 341; C14orf139; NCRNA00341; chromosome 14 open reading frame 139; non-protein coding RNA 341;
LINC00597
LINC00597 long intergenic non-protein coding RNA 597 [ Homo sapiens (human) ]
long intergenic non-protein coding RNA 597; C15orf5; chromosome 15 open reading frame 5; LINC00597;
LINC00478
LINC00478 long intergenic non-protein coding RNA 478 [ Homo sapiens (human) ]
C21orf34; C21orf35; FLJ38295; LINC00478; long intergenic non-protein coding RNA 478;
LINC00313
LINC00313 long intergenic non-protein coding RNA 313 [ Homo sapiens (human) ]
C21orf84; NCRNA00313; long intergenic non-protein coding RNA 313; chromosome 21 open reading frame 84; non-protein coding RNA 313;
DSCR9
DSCR9 Down syndrome critical region gene 9 (non-protein coding) [ Homo sapiens (human) ]
NCRNA00038; Down syndrome critical region gene 9 (non-protein coding); DSCR9;
HCG9
HCG9 HLA complex group 9 (non-protein coding) [ Homo sapiens (human) ]
HLA complex group 9 (non-protein coding); PERB11; HCGIX; HCG IX; HCGIX4; HLA complex group 9; HcgIX protein; HCGIX-4;
IGKV1-5
IGKV1-5?immunoglobulin kappa variable 1-5 [?Homo sapiens?(human) ]
V1; L12; IGKV; L12a; IGKV15; IGKV1-5; immunoglobulin kappa variable 1-5;
IGLV6-57
IGLV6-57 immunoglobulin lambda variable 6-57 [ Homo sapiens (human) ]
immunoglobulin lambda variable 6-57; IGLV657; V1-22;
Pseudomonas aeruginosa serotype?IATS O11
Pseudomonas aeruginosa serotype IATS O11
Pseudomonas aeruginosa; P Aeruginosa; P. Aeruginosa; IATS O11;
GP
nonstructural, soluble, secreted glycoprotein
GP; nonstructural, soluble, secreted glycoprotein; structural glycoprotein; YP_138523.1; processed by furin to yield GP1-GP2 heterodimer that forms membrane-anchored trimers (peplomers); YP_138524.1; forms di;
Radioimmunoassay
Creative BioMart provides Radioimmunoassay (RIA) that uses antibodies to detect and quantitate the amount of antigen (analyte) in a sample. This assay is typically very sensitive and specific. It is possible to detect as low as a few picograms of analyte in the experimental tube when using antibodie...
Phosphatidylinositol Accumulation Assay
G protein-coupled receptors (GPCRs) are a large protein family of receptors that sense molecules outside the cell and activate inside signal transduction pathways and cellular responses. There are two principal pathways: cAMP and phosphatidylinositol. Phosphatidylinositol Accumulation Assay Phosphat...
High Concentration Formulation (HCF) Technology
Development of formulations for protein drugs requiring high dosing may become challenging for solubility limited proteins and for 1.5 mL allowable administration volume that requires 100 mg/mL protein concentrations. The optimization of formulation conditions for highly concentrated biologics neces...
Ligand-Protein Interactions Screening Based on Gold Nanoparticles
Gold nanoparticles (AuNPs) are widely used as colorimetric probes for biosensing, relying on their unique particle size-dependent and/or interparticle distance dependent extinction spectrum and solution color. They have been extensively used as colorimetric probes for chemical and biological analysi...
Non-Animal Skin Sensitization Testing Services
Allergic Contact Dermatitis (ACD) is a complex disease, and it is estimated that 15-20% of the general population suffers from contact allergy, with increasing prevalence. Assessment of skin sensitization potential is therefore an important component of the safety evaluation process for cosmetics an...
Co-Immunoprecipitation (Co-IP) Service
Many protein-protein associations that exist within the cell remain intact when a cell is lysed under non-denaturing conditions. Co-immunoprecipitation, advanced technique developed from immunoprecipitation, is the most straightforward way to determine whether two proteins of interest are physiologi...
KeratinoSens™ Assay
The KeratinoSensTM assay is a cell-based reporter gene assay. It identifies skin sensitizers by assaying the induction of luciferase under the control of the antioxidant response element (ARE) present in the promoter of the human AKR1C2 gene that is known to be up-regulated by sensitizers. The lucif...
De Novo Protein Design
De novo protein design, also known as "the inverse protein folding problem", is a computational approach to protein design from scratch, rather than using a known protein structure. Identification of a primary sequence that can fold properly in to the desired structural topology forms the basis for ...
Membrane Protein Platform: Nanodisc
Membrane proteins play an essential role in exchanging material, information, and energy between cells and the external environment and are one of the current research hotspots. However, since membrane proteins have hydrophobic moieties and are easily polymerized in vitro, it is necessary to find a ...
Virus-Like Particles (VLPs) Technology Platform
Virus-like particles (VLPs) are large particles assembled from one or several structural proteins of multiple viruses. VLPs are missing viral nucleic acids and cannot replicate autonomously. Depending on their origin and structural characteristics, VLPs can be classified into several types, includin...
Nanodisc Technology Platform
Nanodiscs are discoidal lipid bilayers 8-16 nm in diameter stabilized and solubilized in aqueous solution by two encircling amphipathic helical protein ribbons (called membrane scaffolding proteins). The size of the Nanodisc is determined by the length of the membrane scaffolding proteins and the ra...
Liposome Technology Platform
The traditional method of extracting membrane proteins is to use a detergent to separate the target membrane protein from all other components. Various reagents can disrupt the membrane, but the membrane that these reagents disrupt also removes the membrane surrounding the protein, which may affect ...
New Monoclonal Antibody Shows Robust Efficacy onMany Advanced Solid Tumors
A Research in Its First Phase I Clinical Trial in Humans Have Demonstrated Its Encouraging Effect on Many Advanced Tumor Patients Recently a new research results were reported at the24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland on Nov. 7. It was about...
Inhibition of Enzyme NOX4 Prevents Liver Fibrosis than TGF-beta
Liver fibrosis is an illness caused by the overproduction of extracellular matrix proteins in the liver tissue. NOX4, a family member of NADPH oxidase enzyme,plays an important role in liver fibrosis by inhibiting it. TGF-beta, a complex cytokine, the transforming growth factor-beta, involves in the...
Diagnose Parkinson's disease in Two Minutes
Every year in the United States, there are 50,000 newly diagnosed Parkinson's disease. It is a neurological disorder. When nerve cells in brain stop generating dopamine, the Parkinson's disease will occur as the dopamine helps control muscle movement. Without dopamine, the nerve cells cannot properl...
Two proteins, ATG12 and ATG5 Might Help People Developing Innovative Cancer Therapies
Scientists at The Scripps Research Institute (TSRI) have found two key subunits within a cell that helps maintaining cell health. They identified how the two proteins help create organelles. Their discoveries make people think about interfering with the formation of these organelles and lead to new ...
Turning the Fiction Biotechnology into Reality: Advances in Bio-industry Field
We would find lot of amazing concepts or ideas in many well composed fictions or movies. Such as being invisible, fly only with a backpack device, transfer to another place in virtue of molecules shifting etc. and each people are standing on different perspectives to think the corresponding gains. I...
A New Nanotechnology Brings Hope for MS and Other Immune-related Diseases
Multiple sclerosis (MS), a nervous system disease, affects brain and spinal cord. It damages the myelin sheath. This damage slows down or blocks messages between brain and body, leading to the symptoms of MS. Patients suffering from MS deal with everything from numb limbs to blindness or paralysis...
Use a More Cheap with Equal Effect Paper-based Diagnostic Method to Test Whether You Are Pregnant, Have Diabetes, Malaria etc.?
You could find the new finding on the American Chemical Society journalLangmuir. The new advance in diagnostics research was conducted by University of Washington bioengineer Daniel Ratner and his team. Now we already can do home based tests for some conditions, such as for pregnancy, diabetes, mal...
Part of Proprietary Technology Platforms of Creative BioMart
With innovative thoughts and fast growing technologies,Creative BioMart experts have developed many efficient and advanced proprietarytechnical platforms that have gained numerous praises. As a biotech manufacture, its goal is to mutually benefit research communities, institutions and others. Here...
Nature: No Haploid Phase in Candida Albicans
Candida albicansis adiploidfungusthat grows both as yeastandfilamentouscells. It is also a causal agent ofopportunisticoralandgenitalinfections in humans. It has high mortality with 45 percent and is one of the four main microbial pathogens in hospital acquired infections. However, the treatment...
The Combination of Genome-wide and Proteome-wide Screening
In clinical application or research purpose, plasma screening has been widely used due to its easy accessibility, so as mass spectrometry. Nowadays, gene variants are easy to identify, however theses phenotypes that link to those variants are not easy. Using mass spectrometry, researchers analyze...
Cell: Researchers Found a Novel Rule of Membrane Proteins
Like the teeth of a zipper, the charged amino acids (as the red and blue color show) form connections between protein segments and thus form pores in the cell membrane. Membrane proteins, attached to or associated with themembraneof acellor anorganelle, perform a variety of functions vita...
Cell: Scientists Found another Role of Enzyme Superoxide Dismutase
Since 1960s, the initial discovery of Superoxide dismutase (SOD1), an enzyme that was believed having solo role in protecting living cells against damage from free radicals by scientists. The enzyme is present in all living cells, from the most ancient bacteria to every cell in the human body. ...
Nature Immunology: Target on Specific Point of Protein Bcl6
Recently in Nature Immunology, researchers declaimed that we might have chance to shut down Bcl6 in DLBCL, while not affecting its vital function in T cells and macrophages that are needed to support a healthy immune system. Diffuse large B-cell lymphoma (DLBCL), the seventhly commonly diagnosed ca...
2nd Monoclonal Antibodies Summit & Trade Exhibition
When Mar. 19 Mar. 20, 2013 Where Novotel London West Hotel, Shortlands, London Introduction Creative BioMart is very pleased to introduce the conference to mutually promote advances in diagnostic therapeutic antibody development. As the name shows, monoclonal antibodies are ...
Scientific Report: Testing DNA Methylation with Novel Assay
According to the Scientific Report, researchers have developed a new, single molecule test for detecting methylated DNA. DNA Methylationis abiochemicalprocess that involves the addition of amethyl groupto thecytosineoradenineDNAnucleotides. Through this way, it regulates gene expressionincell...
The Company Acquire of Life Technologies Corp
The auction of Life Technologies Corp, which is a genetic testing company, has been attracting more visitors with exception for previous KKR Co LP, Hellman Friedman LLC, Thermo Fisher Scientific Inc,Danaher Corpand a buyout consortium of Blackstone Group LP, private equity firms and so on. Thi...
Scientists Found Novel Monoclonal Antibody for CLL
Chronic lymphocytic leukemia (CLL) is one kind of blood cancer. It is the second most common type of leukemia in adults. It is also the most common type of blood cancer in America. According to authentic statistics, it is estimated that 16,060 men and women will be diagnosed with and 4,580 men a...
Scientists Innovatively Modified an Approach to Dissect Kinases
The top is a structural model of uniRapR domain which binds small molecule rapamycin. The bottom left depicts inactive state of the protein of interest modified with uniRapR domain. Binding of rapamycin and uniRapR reactivates the protein (bottom right). The approach mentioned here i...
PNAS: Scientists Unveiled a Novel Feature of DEAD-box Proteins
As reported on the Early Edition of the Proceeding of the National Academy of Science on Apr. 29, 2013, scientists have uncovered how DEAD-box proteins and its cofactors can specifically work on other proteins with nonspecific biochemical activity. DEAD-box proteins are a large class of RNA-depen...
Scientists Found the Key Protein of P. Aeruginosa Infecting Humans
Pseudomonas aeruginosa, an environmental pathogen, usually exists in soil, water and other environment outside of the body. However, it causes common hospital acquired infection. According to yesterdays mBio report, scientists have discovered the previously unknown virulence factor inP. a...
Introduction to an Innovative Antibody Selection Method
It is reported in the Cell that researchers have developed a powerful innovative technique to find antibodies, especially therapeutic antibodies. A few years ago, the researchers developed a basic method to select antibodies thatnot only bind to a given target, but also have a desired biolog...
Methionine Adenosyltransferase II alpha Related Researches and Products
Methionine adenosyltransferase II alpha (MAT2A) is an essential enzyme that is in charge of S-adenosylmethionine (SAMe) biosynthesis. It is extensively distributed within body. In liver, increased MAT2A expression correlates with growth, while SAMe inhibits MAT2A expression and growth. Thus ...
Virus-specific Antibody—New Clue to against Norovirus Infection
The picture shows its X-ray crystallographic structure It could be said that norovirus was identified in 1972 and got its current namenorovirus in 2002 approved by ICTV . ...
Lipid-based Protein Immobilization—A Novel Membrane Protein Research Tool
Lipid-based Protein Immobilization, or LPI, allows for immobilization and work-up of intact, native membrane proteins. Lipid-based Protein Immobilization allows immobilization of cell vesicles with intact, conformationally correct membrane pr...
Novel Method for Detection of Ovarian Cancer Might Launch Soon
Ovarian cancer is considered to be the most difficult to detect in kinds of cancers. It is difficult to note or detect at early cancer stage, if pain occurs, people might treat it as other symptoms as often been mistaken for other diseases. This makes cancer prevention and control very difficult. D...
Effective Monoclonal Antibodies: Solve the Problems in Preparation
As a key driving force for biotechnology industry, therapeutic antibodies are safe and effective to against cancer, autoimmune diseases and infectious diseases in terms of targeted therapy. In 2011, the worldwide sale of therapeutic antibodies reached $64.57 billion, accounting for 51.8% of biopha...
DNA Methylation—the Hot “Candidate” of 2013 Nobel Prize
The annual Nobel Prize feast is approaching and the whole science field is eager to celebrate laurels and DNA Methylation is one of the expected laurels. DNA methylation is a form of chemical modification of DNA. In the condition of non-DNA code change, it changes indiv...
Things You May Would Like to Know about Recombinant Antibodies
What is a Recombinant Antibody? A recombinant antibody is an antibody that combines genetic material from two or more sources, produced with the help of specific technology, such as recombinant DNA technology. During the process, a fragment of D...
Hybridoma Offers a Powerful Solution for Monoclonal Antibodies
Since the first description of the hybridoma technology in 1970s, it has been bound to enormous promise for clinical uses and the discoverer also shared a Nobel Prize in Physiology and Medicine in 1984 because of this. With the ...
A Novel Biomarker for Metabolic Dysfunction and New Hope for Obesity—Protein PAR2
In studies, scientists confirmed that the amount of inflammatory protein PAR2 in overweight/obese humans and mices abdominal adipose tissue show abnormality and they found the common fatty acids in the diet will increase the expression of PA...
Creative BioMart Enhances Technologies and Products for Use in Biomedical Research
Creative BioMart, one of the world's leading manufacturers of recombinant proteins and biosimilar cell lines, has used over 10 years of experience in the specialty biosimilar sector to enhance its technologies and products, including the featured gene screening and amplification system, for use in t...
Blueprinting Proteins, Once Difficult Now Easier
Recently, a new study has brought hope to the blueprinting of a certain proteins, which is a big step forward in the field of drug discovery and development. Named in meso in situ serial crystallography (IMISX), this new method makes the job of blueprinting certain proteins relatively faster, cheape...
Creative BioMart Introduced Its Novel Computer-aided Enzyme Design Services
Scientists aiming at discovering new protein and enzyme now have access to Creative BioMart’s quality computer-aided enzyme design (CAED) services. This enzymatic design service was issued under the rigorous requirements of Creative BioMart to provide world-leading biotech services. The past decades...
Antibodies Were Turned into Highly Tuned Nanobodies by New Technology
Antibodies, one of the most useful tools in biology and medicine, play an important role in recognizing and homing in on molecular targets. Nanobodies, the tiny cousins of antibodies, can do the same work. And because of their simplicity, Nanobodies are comparatively easier to produce. Unluckily, bo...
New Findings about Plexin D1 You May Want to Know
Generally speaking, men tend to store fat in the belly while women are prone to store more fat on the hips and thighs. These actually produce the classic apple and pear shapes. According to previous studies, people who carry more weight around the bellies are more likely to develop diabetes and hear...
The 4th International Conference on Biotechnology and Environment Management 2014
When September 15 to 16, 2014 Where Paris, France Introduction The 4th International conference on Biotechnology and Environment Management 2014 (ICBEM 2014) is a f...
Creative BioMart Launched a Novel Service for Transcription Factor Assay
When: October 13, 2014 Where: 45-16 Ramsey Road Shirley What: Launch of new service Introduction: Creative BioMart announced today for the official release of its new service--transcription factor assay service which is backed by various of tools that can meet various of needs and facili...
Creative BioMart “Morning Talk”: Give Answers to Diagnostic Enzymes
Generally speaking, enzymes used for clinical purpose or intended metabolic investigation are diagnostic enzymes. Examples of diagnostic enzymes include Adenosine Aminohydrolase (ADA), Neuron Specific Enolase (NSE), Catalase (CAT), Glucose Oxidase (GOD), Glycerol Kinase (...
Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers
In face of patent expiration or other threats, big pharmaceutics are facing challenges too. In priority, innovative technology or novel developments are necessary. On 2010, Celgene declared the acquisition of ABII for $2.9 billion for cancer treatment. ...
What Quality Collaboration Brings for Technology Transfer?
Collaborations and transferring technology between academic research groups and companies are commonly practiced in the biology-related field. In fact, many innovative therapies or medical/industrial/clinical techniques grow from research laboratories. But first Id like to express my opinion ...
Prediction on 2013 Nobel Prize in Physiology or Medicine
On Monday 7 October, 11:30 a.m. at the earliest - The Nobel Prize in Physiology or Medicine will be announced by Gran K. Hansson, Secretary of the Nobel Committee for Physiology or Medicine. Before this date, kinds of predictions will follow. Here, lets take an inventory of such predictions. ...
Discussion on the Prospect of Biosimilar Monoclonal Antibodies Drugs
In the past few years, monoclonal antibody drugs have dominated the world's largest bio-pharmaceutical drug sales, and in the coming years, monoclonal antibody drugs will continue to be the main force. The rapid development of monoclonal antibody drugs as well as the approaching of patent expirat...
An Interesting Phenomenon for the Input and Output of Pharmaceutical Industry
Unlike pharmaceutical industry, many industries will have smooth progress during developing process. However, pharmaceutical industry may suffer from huge frustration even failure in their RD process. It is estimated that the overall failure rate of developing of a new drug could reach 95%, and the...
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKlinefor multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugsImmune mobilising mTCR Against Cancer (ImmTACs) in earlier times. ...
What Biopharmaceutical Innovations and New Drug Discovery Bring?
There is no exact definition for innovation. While there at least should be a substantial improvement and not a small change over what is currently available, for example, the growth and maturation of high throughput screening and microarray technique. The Biopharmaceutical and drug discovery...
The 2013 World Biotechnology Congress
When June 3-6, 2013 Where 900 Boylston Street, Hynes Convention Center, Boston, MA, United States Introduction The World Biotechnology Co...
The Building of Merck Serono was Bought by A Consortium
On May 22, 2013, it was reported that the former building of drug company Merck Serono in Geneva was bought by the two richest men in Switzerland: Hansjrg Wyss and Ernesto Bertarelli, actually to a consortiumCampus Biotech. Dramatically it is Bertarelli who sold the Serono to Merck in 2007. About...
The Exclusive Right Buyout of Sanofi’s Ophthalmology Antibodies by Regeneron
Sanofi and Regeneron are old partners that have worked together for many times and gained achievements, for example the colon-cancer drug Zaltrap and REGN727. On May 3, 2013, Regeneron Pharmaceuticals announced two preclinical programs for its grow...
Soligenix Collaborates with Intrexon on Promoting Monoclonal Antibody Therapy for Melioidosis
On May 1, 2013, Soligenix, Inc., a biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures announced its collaboration between Intrexon to develop a treatment for Melioidosis. Intrexon is a synthetic biology company that utilizes its...
Another Forward Step of Laboratory Standardization in Diagnostic Procedure
In medical transplant cases, finding allogeneic stem cells are one challenge, according to the statistics, there are about 50,000 people a year urgently require a stem cell transplant; while another challenge is the precision and speed of detecting the difference between donors and recipient whi...
2013 Sample Prep and Target Enrichment in Molecular Diagnostics Conference
When 10 Apr, 2013 to 11 Apr, 2013 Where Boston, MA, United States Introduction Sample preparation is important for research. Pre-detection processing is a pivotal part of molecular diagnostics. Its modernization should closely follow or even precede the emergence of new diagnostic...
The 5th Immunotherapeutics & Immunomonitoring Conference
When 31 Jan 2013 to 01 Feb 2013 Where The Westin Gaslamp Quarter, San Diego, United States Introduction Immunology is a broad branch of biomedica...
The Cooperation between BaroFold and Lonza for PreEMT Protein Refolding Technology
On Jan. 16, 2013, Lonza, a biological development company, and BaroFold, Inc., an innovative protein technology developer, announced a non-exclusive technology and license agreement. The technology will offer them a comprehensive toolbox for microbial recombinant pr...
2013, the 2nd Biotechnology World Congress
Agenda Pharmaceutical Biotechnology: biopharmaceuticals discovery (CNS, cancer, cardiovascular , endocrine, immune); vaccines; antibodies ; protein engineering. Plant and Environm...
A New Patent of Monoclonal Antibodies for the Treatment of Serious Diseases Research and Development Registered
On Dec. 21, 2012, one of our peer companies, Immunomedics, Inc. (Nasdaq:IMMU) announced that it has received notice its patent application for Anti-CD19 antibodies which would be issued as US patent No. 8,337,840 on Dec. 25, 2012. IMMU primarily attaches importance to the development o...
A New Effective and Accurate New Technology to Edit genome was Found by MIT and Published on Science Online
On the online edition of Science, you will find a report said that researchers from MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes. This will benefit any research that correlates with g...
Begin to Prepare for the Molecular Diagnostics
The 2013 Molecular Diagnostics World Congress Introduction: The research scope of molecular diagnostics captures the genome expression and proteins expression patterns and uses them to differentiate between what is normal and abnormal. Scientist and practitioners have created and developed man...
World Pharma/Clinical Trial Regulatory (From Nov. 29 to Nov. 30)
On Nov. 30, 2012, Exelixis, Inc. (EXEL) announced that the U.S. Food and Drug Administration (FDA) have approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC). COMETRIQ is an inhibitor of multiple receptor tyrosine kinases involved in both normal...
FDA Nod for the First Drug-eluting Stent to Treat Peripheral Arterial Disease
On Nov. 15, 2012, The U.S. Food and Drug Administration (FDA) approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent) to treat peripheral artery disease (PAD) symptoms. This is the first drug-eluting stent to treat PAD. PAD is a progressive process that fatty material (plaque) bu...
pSivida's Fluocinolone Insert Iluvien Get Negative Response in U.K. and U.S.
Iluvien, a fluocinolone insert for the treatment of vision loss in diabetes, developed using pSivida's Durasert technology and later its licensee was gained by Alimera Sciences, is an injectable microinsert which delivers the drug into the back of the eye for up to three years to treat chronic diabe...
Worldwide Biotech/Biopharma Alliance (during Nov. 14 and Nov. 12)
On Nov. 14, 2012, Fujifilm Diosynth Biotechnologies added another licensed product to its list of commercial biopharmaceutical products, following the announcement that ThromboGenics' has received FDA approval for the launch of JETREA? (ocriplasmin) in the USA for the treatment of Symptomatic Vitreo...
The 2nd Novel Immunotherapeutics Summit of GTC
Why Experts from academia and industry to discuss cutting edge research, immuno-strategies and novel findings and therapeutics against various diseases. Representatives from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson Johnso...
The New Diabetes Drug of Novo Nordisk A/S (NVO) Get Approval by FDA
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. On Nov. 8, 2012, the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) completed the New Drug Application (NDA) for insulin degludec...
Worldwide Biotech/Biopharma Executives (From Nov. 7 to Nov. 2, 2012)
On Nov. 7, 2012, Array BioPharma Inc. announced John A. Orwin, chief executive officer of Affymax, Inc., joined the Company's board of directors. On Nov. 6, 2012, Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (APRI) announced that Bassam Damaj, Ph.D., has resigned as a Director, Presid...
Worldwide Biotech/Biopharma Alliance (From Nov. 12 to Otc. 30, 2012)
On Nov. 12, 2012, Caris Life Sciences Enhances Molecular Profiling Service With Addition of ROS1 and MGMT-Methylation Biomarkers. These markers are believed to serve as clinically-important aids in the development of treatment plans for patients with non-small cell lung cancer (NSCLC) and glioblasto...
Monoclonal antibodies
Monoclonal Antibodies are obtained from cells derived by cell division from a single ancestral cell. Thereby, monoclonal antibodies have the same sequence, structure and bioactivity. Nowadays, monoclonal antibodies are a class of antibodies expressed by hybridoma derived from a single clone and can ...
Principle and Protocol of Co-Immunoprecipitation
Co-Immunoprecipitation (Co-IP) was developed from the immunoprecipitation technique with which Co-IP shares the fundamental principle of the specific antigen-antibody reaction. Immunoprecipitation(IP) technique is used for isolate individual protein. Using an antibody that is specific for a particul...
RNA Binding Protein Immunoprecipitation (RIP)
Background The discovery of non-coding RNA makes RNA become the focus of life science research once again. Because RNA is an unstable biological macromolecule, most RNAs need to be bound to a specific RNA-binding protein to form an RNA / prot...
Crosslinking and ImmunoPrecipitation (CLIP)
Principle Ultraviolet (UV) crosslinking is a classical in vitro tool used by RNA biochemists to study RNAprotein complexes in living tissues. Scientists have successfully used CLIP (crosslinking and immunoprecipitation of RNAprotein complexes) to identify a number of target RNAs of the Nova famil...
Fast Chromatin Immunoprecipitation Assay
1. Introduction The chromatin immunoprecipitation assay (ChIP assay) has greatly facilitated the expansion of our knowledge of the proteinDNA interactions involved in regulating gene expression, DNA repair, and cell division. The function of the assay is that it gives a researcher the ability to ...
Principle and Protocol of Pull-down Technology
Fusion protein pull-down technology is a method to study the interaction between two or more proteins in vitro. According to the different bait protein labels, pull-down is usually divided into GST pull-down analysis, MBP pull-down analysis and His pull-down analysis. Pulldown is usually used to ver...
Chromatin Immunoprecipitation (ChIP)
Chromatin Immunoprecipitation (ChIP) principle and introduction Chromatin immunoprecipitation (ChIP) has become an important and popular method for the study of DNA-protein interactions. During the ChIP experiment, protein complexes that interact with DNA are cross-linked to their binding sites...
Immunocytochemistry protocol
Immunocytochemistry (ICC) is a widely used technique to study the expression situation of specific protein or antigen in cells. The target molecule is recognized and combined by specific primary antibody. The primary antibody is bound by a secondary antibody labeled with fluorophore so that it allow...
Immunofluorescence
Immunofluorescence principle Immunofluorescence utilizes the specificity of antibodies with fluorescent dyes to recognize their antigen, and therefore allows visualization of the distribution of the target molecule through fluorescent dyes with a fluorescence microscope. Immunofluorescence is wid...
Immunohistochemistry protocol
Fig. The schematic diagram of immunohistochemistry. Here we provide a protocol for usual immunohistochemistry. Fix Tissue samples are dissected from animals follow an appropriate protocol. Samples are immediately fixed in Carnoys solution and left overnight. Embed The foll...
Immunoprecipitation
Principle Crosslink immunoprecipitation refers to the process of antigen purification utilising a specific antibody. The principle involves crosslinking to covalently attach a specific antibody to a protein A agarose resin (recombinant protein combining antibody-binding domains from protein A), w...
Notch Signal Pathway
In 1917, Morgan and colleagues found a gene in Drosophila, which is named Notch because of a loss of function that leads to a gap in the edge of wings. Subsequent studies found that Notch is expressed in many species from invertebrates to vertebrates. The structure of Notch families is highly co...
